activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	750656	CHEMBL770568	Inhibition of RET kinase activity	B	O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1		CHEMBL115220	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	750656	CHEMBL770568	Inhibition of RET kinase activity	B	O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1		CHEMBL115220	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	1701846	CHEMBL861018	Inhibition of RET	B	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23		CHEMBL6246	>	IC50	nM	40000.0	CHEMBL2041	Homo sapiens	IC50	uM	40.0
	1781988	CHEMBL911838	Inhibition of RET	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	31.0	CHEMBL2041	Homo sapiens	IC50	uM	0.031
	1815199	CHEMBL908511	Inhibition of RET	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	8300.0	CHEMBL2041	Homo sapiens	IC50	nM	8300.0
	1826436	CHEMBL919913	Inhibition of RET	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	1900.0	CHEMBL2041	Homo sapiens	IC50	nM	1900.0
	1891431	CHEMBL905855	Inhibition of Ret	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	Ki	nM	407.0	CHEMBL2041	Homo sapiens	Ki	nM	407.0
	1989307	CHEMBL899076	Inhibition of RET kinase expressed in Sf9 cells at 5000 nm	B	CS(=O)(=O)c1ccc2nccc(Nc3cc(O)c(F)cc3Cl)c2c1		CHEMBL394453	=	Activity	cpm	460.0	CHEMBL2041	Homo sapiens	Activity	cpm	460.0
	1989308	CHEMBL899076	Inhibition of RET kinase expressed in Sf9 cells at 5000 nm	B	COc1cc2ncnc(Nc3ccc(Cl)c(O)c3)c2cc1OC		CHEMBL235851	=	Activity	cpm	298.0	CHEMBL2041	Homo sapiens	Activity	cpm	298.0
	1989309	CHEMBL899076	Inhibition of RET kinase expressed in Sf9 cells at 5000 nm	B	NS(=O)(=O)c1ccc(-c2cnc3c(c2)/C(=C/c2cc(Br)c(O)c(Br)c2)C(=O)N3)cc1		CHEMBL235850	=	Activity	cpm	355.0	CHEMBL2041	Homo sapiens	Activity	cpm	355.0
	1989310	CHEMBL899076	Inhibition of RET kinase expressed in Sf9 cells at 5000 nm	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc2c(c1)CS(=O)(=O)C2		CHEMBL391229	=	Activity	cpm	428.0	CHEMBL2041	Homo sapiens	Activity	cpm	428.0
	1989311	CHEMBL899076	Inhibition of RET kinase expressed in Sf9 cells at 5000 nm	B	CS(=O)(=O)Cc1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL235849	=	Activity	cpm	1312.0	CHEMBL2041	Homo sapiens	Activity	cpm	1312.0
	1989312	CHEMBL899076	Inhibition of RET kinase expressed in Sf9 cells at 5000 nm	B	CN(C)S(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL235642	=	Activity	cpm	1208.0	CHEMBL2041	Homo sapiens	Activity	cpm	1208.0
	1989313	CHEMBL899076	Inhibition of RET kinase expressed in Sf9 cells at 5000 nm	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Activity	cpm	950.0	CHEMBL2041	Homo sapiens	Activity	cpm	950.0
	1989314	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Oc1cc(Nc2ccnc3cc(-c4ccc(CN5CCOCC5)o4)c(Cl)cc23)c(Cl)cc1F		CHEMBL236928	>	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	1989315	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(CN4CCOCC4)n3)c(S(C)(=O)=O)cc12		CHEMBL399208	=	IC50	nM	34.0	CHEMBL2041	Homo sapiens	IC50	nM	34.0
	1989316	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Oc1cc(Nc2ccnc3cc(-c4cc5ccccc5o4)ccc23)ccc1Br		CHEMBL237557	=	IC50	nM	85.0	CHEMBL2041	Homo sapiens	IC50	nM	85.0
	1989317	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	IC50	nM	3.0	CHEMBL2041	Homo sapiens	IC50	nM	3.0
	1989318	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(=O)(=O)NCC3CC3)cc12		CHEMBL395359	=	IC50	nM	90.0	CHEMBL2041	Homo sapiens	IC50	nM	90.0
	1989319	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Cc1ccc(O)cc1Nc1ccnc2ccc(C(=O)NC(C)C)cc12		CHEMBL237346	=	IC50	nM	95.0	CHEMBL2041	Homo sapiens	IC50	nM	95.0
	1989320	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Cc1ccc(O)cc1Nc1ccnc2ccc(-c3cccnc3)cc12		CHEMBL237345	=	IC50	nM	80.0	CHEMBL2041	Homo sapiens	IC50	nM	80.0
	1989321	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Oc1cccc(Nc2ccnc3cc(-c4ccccn4)ccc23)c1		CHEMBL237344	=	IC50	nM	6.0	CHEMBL2041	Homo sapiens	IC50	nM	6.0
	1989322	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12		CHEMBL395358	=	IC50	nM	75.0	CHEMBL2041	Homo sapiens	IC50	nM	75.0
	1989323	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	OCc1nc(-c2ccc3c(Nc4cc(O)c(F)cc4Cl)ccnc3c2)cs1		CHEMBL237128	=	IC50	nM	25.0	CHEMBL2041	Homo sapiens	IC50	nM	25.0
	1989324	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(C=O)n3)ccc12		CHEMBL237127	=	IC50	nM	25.0	CHEMBL2041	Homo sapiens	IC50	nM	25.0
	1989325	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Oc1cc(Nc2ccnc3cc(-c4cccc(CNCCN5CCOCC5)c4)ccc23)c(F)cc1Cl		CHEMBL237126	=	IC50	nM	75.0	CHEMBL2041	Homo sapiens	IC50	nM	75.0
	1989326	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Cc1ccc(O)cc1Nc1cc(C(F)(F)F)nc2cc(-c3ccncc3)ccc12		CHEMBL393115	>	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	1989327	CHEMBL899077	Inhibition of RET kinase in Sf9 cells	B	Oc1cccc(Nc2c(Cl)cnc3cc(-c4cncs4)ccc23)c1		CHEMBL392856	=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	1996172	CHEMBL898754	Inhibition of Ret at 10 uM	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL400211	=	Inhibition	%	42.0	CHEMBL2041	Homo sapiens	Inhibition	%	42.0
	2031972	CHEMBL887807	Inhibition of RET in mouse NIH3T3MEN2A cells	B	COc1cc2c(cc1OC)/C(=C\c1ccc(O)cc1)C(=O)N2		CHEMBL391567	=	IC50	nM	170.0	CHEMBL2041	Homo sapiens	IC50	uM	0.17
	2031973	CHEMBL887807	Inhibition of RET in mouse NIH3T3MEN2A cells	B	COc1cc2c(cc1OC)/C(=C\c1ccc(NC(=O)N3CCN(C)CC3)cc1)C(=O)N2		CHEMBL247713	>	IC50	nM	3000.0	CHEMBL2041	Homo sapiens	IC50	uM	3.0
	2031974	CHEMBL887807	Inhibition of RET in mouse NIH3T3MEN2A cells	B	COc1cc2c(cc1OC)/C(=C\c1ccc(NC(=O)Nc3ccc(O)cc3)cc1)C(=O)N2		CHEMBL396098	=	IC50	nM	50.0	CHEMBL2041	Homo sapiens	IC50	uM	0.05
	2031975	CHEMBL887807	Inhibition of RET in mouse NIH3T3MEN2A cells	B	COc1cc2c(cc1OC)/C(=C\c1ccc(NC(=O)Nc3ccccc3)cc1)C(=O)N2		CHEMBL246685	=	IC50	nM	200.0	CHEMBL2041	Homo sapiens	IC50	uM	0.2
Not Active	2031976	CHEMBL887808	Inhibition of RET in mouse NIH3T3MEN2A cells up to 3 uM	B	COc1cc2c(cc1OC)N(C)C(=O)/C2=C/c1ccc(NC(=O)Nc2ccccc2)cc1		CHEMBL395859		Activity			CHEMBL2041	Homo sapiens	Activity		
	2031977	CHEMBL887807	Inhibition of RET in mouse NIH3T3MEN2A cells	B	COc1ccc(NC(=O)Nc2ccc(/C=C3/C(=O)Nc4cc(OC)c(OC)cc43)cc2)cc1		CHEMBL246064	=	IC50	nM	580.0	CHEMBL2041	Homo sapiens	IC50	uM	0.58
Not Determined	2034012	CHEMBL888279	Inhibition of RET	B	c1ccc2c(-c3cnc4[nH]nc(-c5nc6ccccc6[nH]5)c4c3)cncc2c1		CHEMBL391437		IC50			CHEMBL2041	Homo sapiens	IC50		
	2034107	CHEMBL888279	Inhibition of RET	B	CNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(OC(F)(F)F)ccc5[nH]4)c3c2)c1		CHEMBL400906	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	2034108	CHEMBL888279	Inhibition of RET	B	CCCNCc1cncc(-c2cnc3[nH]nc(-c4nc5c(COC)cccc5[nH]4)c3c2)c1		CHEMBL400568	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	2034109	CHEMBL888279	Inhibition of RET	B	COCc1cccc2[nH]c(-c3nn(C)c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL251740	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	2034110	CHEMBL888279	Inhibition of RET	B	O=C(O)c1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL249501	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	2034111	CHEMBL888279	Inhibition of RET	B	COC(=O)c1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL399042	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	2034112	CHEMBL888279	Inhibition of RET	B	CC(C)NCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL401064	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	2034113	CHEMBL888279	Inhibition of RET	B	COCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncnc5)cc34)nc12		CHEMBL249302	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	2034114	CHEMBL888279	Inhibition of RET	B	COCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5ccncc5)cc34)nc12		CHEMBL249096	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	2034115	CHEMBL888279	Inhibition of RET	B	COCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cnc6ccccc6c5)cc34)nc12		CHEMBL249095	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	2034116	CHEMBL888279	Inhibition of RET	B	CC(C)OCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL249094	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	2034117	CHEMBL888279	Inhibition of RET	B	COCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL248891	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	2034118	CHEMBL888279	Inhibition of RET	B	OCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL248890	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	2034207	CHEMBL888279	Inhibition of RET	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5c(COC)cccc5[nH]4)c3c2)c1C		CHEMBL249519	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	2034208	CHEMBL888279	Inhibition of RET	B	COCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc(CN(C)C)c5)cc34)nc12		CHEMBL249518	=	IC50	nM	3230.0	CHEMBL2041	Homo sapiens	IC50	uM	3.23
	2034209	CHEMBL888279	Inhibition of RET	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(OC)ccc5[nH]4)c3c2)c1		CHEMBL429478	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	uM	1.0
	2034210	CHEMBL888279	Inhibition of RET	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(F)ccc5[nH]4)c3c2)c1		CHEMBL248713	=	IC50	nM	110.0	CHEMBL2041	Homo sapiens	IC50	uM	0.11
	2034211	CHEMBL888279	Inhibition of RET	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(F)c(F)cc5[nH]4)c3c2)c1		CHEMBL248712	=	IC50	nM	390.0	CHEMBL2041	Homo sapiens	IC50	uM	0.39
	2034212	CHEMBL888279	Inhibition of RET	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(N6CCN(C)CC6)ccc5[nH]4)c3c2)c1		CHEMBL400569	=	IC50	nM	140.0	CHEMBL2041	Homo sapiens	IC50	uM	0.14
	2034213	CHEMBL888279	Inhibition of RET	B	CNCc1cncc(-c2cnc3[nH]nc(-c4nc5c(COC)cccc5[nH]4)c3c2)c1		CHEMBL400749	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	uM	1.0
	2034214	CHEMBL888279	Inhibition of RET	B	CCN(CC)C(=O)c1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL251739	=	IC50	nM	1230.0	CHEMBL2041	Homo sapiens	IC50	uM	1.23
	2034215	CHEMBL888279	Inhibition of RET	B	CC(C)NC(=O)c1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL249502	=	IC50	nM	410.0	CHEMBL2041	Homo sapiens	IC50	uM	0.41
	2034216	CHEMBL888279	Inhibition of RET	B	c1ccc2c(-c3cnc4[nH]nc(-c5nc6cc(N7CCOCC7)ccc6[nH]5)c4c3)cncc2c1		CHEMBL249500	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	uM	1.0
	2034217	CHEMBL888279	Inhibition of RET	B	CN1CCN(c2ccc3[nH]c(-c4n[nH]c5ncc(-c6cncc7ccccc67)cc45)nc3c2)CC1		CHEMBL249304	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	uM	1.0
	2034218	CHEMBL888279	Inhibition of RET	B	CCN(CC)Cc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL249303	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	uM	1.0
	2034219	CHEMBL888279	Inhibition of RET	B	COCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cccnc5)cc34)nc12		CHEMBL400859	=	IC50	nM	1100.0	CHEMBL2041	Homo sapiens	IC50	uM	1.1
Not Determined	2034221	CHEMBL888279	Inhibition of RET	B	Cc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL400858		IC50			CHEMBL2041	Homo sapiens	IC50		
	2147372	CHEMBL922157	Activity of human Ret kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	80.0	CHEMBL2041	Homo sapiens	Activity	%	80.0
	2182831	CHEMBL941457	Inhibition of RET at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	-4.0	CHEMBL2041	Homo sapiens	INH	%	-4.0
	2198005	CHEMBL1005547	Inhibition of Tel-fused RET kinase-mediated mouse BaF3 cell proliferation	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	1385.0	CHEMBL2041	Homo sapiens	IC50	uM	1.385
	2206951	CHEMBL974009	Inhibition of Ret by cellular assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	EC50	nM	1000.0	CHEMBL2041	Homo sapiens	EC50	uM	1.0
	2206998	CHEMBL990560	Inhibition of Ret	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	2207956	CHEMBL974009	Inhibition of Ret by cellular assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	EC50	nM	77.0	CHEMBL2041	Homo sapiens	EC50	nM	77.0
	2250948	CHEMBL1011042	Inhibition of RET	B	Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1		CHEMBL524266	>	IC50	nM	4000.0	CHEMBL2041	Homo sapiens	IC50	uM	4.0
	2251193	CHEMBL1009902	Inhibition of Ret	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	1.0	CHEMBL2041	Homo sapiens	IC50	nM	1.0
	2396084	CHEMBL1006323	Inhibition of RET at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	Inhibition	%	76.0	CHEMBL2041	Homo sapiens	INH	%	76.0
	2470333	CHEMBL995012	Inhibition of RET at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	INH	%	10.0
	2470334	CHEMBL995013	Inhibition of RET M918T mutant at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	INH	%	10.0
	2470335	CHEMBL995014	Inhibition of RET V804L mutant at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	INH	%	10.0
	2470336	CHEMBL995015	Inhibition of RET V804M mutant at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	INH	%	10.0
	2476624	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	4.8	CHEMBL2041	Homo sapiens	Activity	%	4.8
Not Evaluated	2476827	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL2041	Homo sapiens	Activity		
Not Evaluated	2478666	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL2041	Homo sapiens	Activity		
	2478869	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	7.5	CHEMBL2041	Homo sapiens	Activity	%	7.5
Not Evaluated	2479724	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL2041	Homo sapiens	Activity		
Active	2480723	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL2041	Homo sapiens	Activity		
	2506975	CHEMBL942627	Inhibition of Ret at 10 uM	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	2506976	CHEMBL942627	Inhibition of Ret at 10 uM	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	2511605	CHEMBL973459	Inhibition of RET	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.46	CHEMBL2041	Homo sapiens	IC50	uM	0.00046
	2511940	CHEMBL969690	Inhibition of human Ret at 1 uM assessed as residual enzyme activity	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	Activity	%	7.0	CHEMBL2041	Homo sapiens	Activity	%	7.0
	2526377	CHEMBL981412	Binding affinity to Ret	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	28.0	CHEMBL2041	Homo sapiens	Kd	nM	28.0
	2526378	CHEMBL981412	Binding affinity to Ret	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Kd	nM	80.0	CHEMBL2041	Homo sapiens	Kd	nM	80.0
	2567277	CHEMBL975464	Inhibition of human Ret kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	1.0	CHEMBL2041	Homo sapiens	Activity	%	1.0
Not Evaluated	2577345	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL2041	Homo sapiens	Activity		
Not Evaluated	2577548	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL2041	Homo sapiens	Activity		
Active	2593550	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL2041	Homo sapiens	Activity		
Active	2593753	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL2041	Homo sapiens	Activity		
	2594019	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	1.0	CHEMBL2041	Homo sapiens	Activity	%	1.0
Dose-dependent effect	2594537	CHEMBL958180	Inhibition of RET tyrosine phosphorylation expressed in mouse NIH3T3 cells transfected with RET C634R mutant associated with MEN2A syndrome after 24 hrs by Western blot analysis	B	COc1cc2c3c(-c4ccc(O)cc4)c[nH]c(=O)c3n(C)c2cc1OC		CHEMBL461340		Activity			CHEMBL2041	Homo sapiens	Activity		
	2594571	CHEMBL958179	Inhibition of recombinant RET active protein by immunoblotting	B	COc1cc2[nH]c3c(=O)[nH]cc(-c4ccc(O)cc4)c3c2cc1OC		CHEMBL461162	=	IC50	nM	110.0	CHEMBL2041	Homo sapiens	IC50	uM	0.11
	2594572	CHEMBL958179	Inhibition of recombinant RET active protein by immunoblotting	B	COc1cc2c3c(-c4ccc(O)cc4)c[nH]c(=O)c3n(C)c2cc1OC		CHEMBL461340	=	IC50	nM	60.0	CHEMBL2041	Homo sapiens	IC50	uM	0.06
	2594573	CHEMBL958179	Inhibition of recombinant RET active protein by immunoblotting	B	Cn1c2ccccc2c2c(-c3ccc(O)cc3)c[nH]c(=O)c21		CHEMBL512392	=	IC50	nM	480.0	CHEMBL2041	Homo sapiens	IC50	uM	0.48
	2594574	CHEMBL958179	Inhibition of recombinant RET active protein by immunoblotting	B	COc1ccc2c(c1)c1c(-c3ccc(O)cc3)c[nH]c(=O)c1n2C		CHEMBL461341	=	IC50	nM	600.0	CHEMBL2041	Homo sapiens	IC50	uM	0.6
	2594575	CHEMBL958179	Inhibition of recombinant RET active protein by immunoblotting	B	COc1cc2c3ccn(Cc4ccccc4)c(=O)c3n(C)c2cc1OC		CHEMBL512393	>	IC50	nM	600.0	CHEMBL2041	Homo sapiens	IC50	uM	0.6
	2594576	CHEMBL958179	Inhibition of recombinant RET active protein by immunoblotting	B	COc1cc2c3c(C)c[nH]c(=O)c3n(C)c2cc1OC		CHEMBL501371	>	IC50	nM	600.0	CHEMBL2041	Homo sapiens	IC50	uM	0.6
	2594577	CHEMBL958179	Inhibition of recombinant RET active protein by immunoblotting	B	COc1cc2c3c(-c4ccccc4)c[nH]c(=O)c3n(C)c2cc1OC		CHEMBL515871	=	IC50	nM	250.0	CHEMBL2041	Homo sapiens	IC50	uM	0.25
	2594578	CHEMBL958179	Inhibition of recombinant RET active protein by immunoblotting	B	COc1cc2c3c(-c4cccc(O)c4)c[nH]c(=O)c3n(C)c2cc1OC		CHEMBL473101	=	IC50	nM	90.0	CHEMBL2041	Homo sapiens	IC50	uM	0.09
Not Evaluated	2594962	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL2041	Homo sapiens	Activity		
Not Evaluated	2595165	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL2041	Homo sapiens	Activity		
	2595231	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	1.4	CHEMBL2041	Homo sapiens	Activity	%	1.4
	2596362	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	2.2	CHEMBL2041	Homo sapiens	Activity	%	2.2
Not Evaluated	2597631	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL2041	Homo sapiens	Activity		
Not Evaluated	2597834	CHEMBL1035888	Binding affinity to human RET at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL2041	Homo sapiens	Activity		
	2603064	CHEMBL1023859	Inhibition of RET	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	=	Kd	nM	95.0	CHEMBL2041	Homo sapiens	Kd	nM	95.0
	2618038	CHEMBL1016027	Inhibition of Ret	B	Cl.N[C@@H](CCCCN/C=C1\C(=O)Nc2ccccc21)C(=O)O		CHEMBL458440	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	2618054	CHEMBL1016027	Inhibition of Ret	B	Cl.N[C@@H](CCCCN/C=C1\C(=O)Nc2ccc(Br)cc21)C(=O)O		CHEMBL458441	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	2618055	CHEMBL1016027	Inhibition of Ret	B	Cl.N[C@@H](CCCN/C=C1\C(=O)Nc2ccc(Br)cc21)C(=O)O		CHEMBL503236	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	2618056	CHEMBL1016027	Inhibition of Ret	B	Cl.N[C@@H](CCCN/C=C1\C(=O)Nc2ccccc21)C(=O)O		CHEMBL458352	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	2661404	CHEMBL1058610	Inhibition of RET	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	IC50	nM	1933.0	CHEMBL2041	Homo sapiens	IC50	uM	1.933
	2705002	CHEMBL1055624	Inhibition of RET at 10 uM by HotSpot assay relative to control	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	Inhibition	%	6.65	CHEMBL2041	Homo sapiens	INH	%	6.65
	2721707	CHEMBL1055109	Inhibition of Ret at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	2906623	CHEMBL1061179	Binding constant for RET kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	100.0	CHEMBL2041	Homo sapiens	Kd	nM	100.0
	2906624	CHEMBL1061179	Binding constant for RET kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	14.0	CHEMBL2041	Homo sapiens	Kd	nM	14.0
	2906625	CHEMBL1061179	Binding constant for RET kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	17.0	CHEMBL2041	Homo sapiens	Kd	nM	17.0
	2906626	CHEMBL1061179	Binding constant for RET kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	80.0	CHEMBL2041	Homo sapiens	Kd	nM	80.0
	2906627	CHEMBL1061179	Binding constant for RET kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	500.0	CHEMBL2041	Homo sapiens	Kd	nM	500.0
	2906628	CHEMBL1061179	Binding constant for RET kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906629	CHEMBL1061179	Binding constant for RET kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	71.0	CHEMBL2041	Homo sapiens	Kd	nM	71.0
	2906630	CHEMBL1061179	Binding constant for RET kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	150.0	CHEMBL2041	Homo sapiens	Kd	nM	150.0
	2906631	CHEMBL1061179	Binding constant for RET kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	4200.0	CHEMBL2041	Homo sapiens	Kd	nM	4200.0
	2906632	CHEMBL1061179	Binding constant for RET kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906633	CHEMBL1061179	Binding constant for RET kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906634	CHEMBL1061179	Binding constant for RET kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	730.0	CHEMBL2041	Homo sapiens	Kd	nM	730.0
	2906635	CHEMBL1061179	Binding constant for RET kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906636	CHEMBL1061179	Binding constant for RET kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1300.0	CHEMBL2041	Homo sapiens	Kd	nM	1300.0
	2906637	CHEMBL1061179	Binding constant for RET kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906638	CHEMBL1061179	Binding constant for RET kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906639	CHEMBL1061179	Binding constant for RET kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906640	CHEMBL1061179	Binding constant for RET kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	310.0	CHEMBL2041	Homo sapiens	Kd	nM	310.0
	2906641	CHEMBL1061179	Binding constant for RET kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906642	CHEMBL1061179	Binding constant for RET kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	1000.0	CHEMBL2041	Homo sapiens	Kd	nM	1000.0
	2906643	CHEMBL1061179	Binding constant for RET kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906644	CHEMBL1061179	Binding constant for RET kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906645	CHEMBL1061179	Binding constant for RET kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906646	CHEMBL1061179	Binding constant for RET kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906647	CHEMBL1061179	Binding constant for RET kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906648	CHEMBL1061179	Binding constant for RET kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	350.0	CHEMBL2041	Homo sapiens	Kd	nM	350.0
	2906649	CHEMBL1061179	Binding constant for RET kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906650	CHEMBL1061179	Binding constant for RET kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906651	CHEMBL1061179	Binding constant for RET kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906652	CHEMBL1061179	Binding constant for RET kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906653	CHEMBL1061179	Binding constant for RET kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906654	CHEMBL1061179	Binding constant for RET kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	13.0	CHEMBL2041	Homo sapiens	Kd	nM	13.0
	2906655	CHEMBL1061179	Binding constant for RET kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	15.0	CHEMBL2041	Homo sapiens	Kd	nM	15.0
	2906656	CHEMBL1061179	Binding constant for RET kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	37.0	CHEMBL2041	Homo sapiens	Kd	nM	37.0
	2906657	CHEMBL1061179	Binding constant for RET kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	12.0	CHEMBL2041	Homo sapiens	Kd	nM	12.0
	2906658	CHEMBL1061179	Binding constant for RET kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	28.0	CHEMBL2041	Homo sapiens	Kd	nM	28.0
	2906659	CHEMBL1061179	Binding constant for RET kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906660	CHEMBL1061179	Binding constant for RET kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	34.0	CHEMBL2041	Homo sapiens	Kd	nM	34.0
	2906661	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	120.0	CHEMBL2041	Homo sapiens	Kd	nM	120.0
	2906662	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	20.0	CHEMBL2041	Homo sapiens	Kd	nM	20.0
	2906663	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	4.5	CHEMBL2041	Homo sapiens	Kd	nM	4.5
	2906664	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	120.0	CHEMBL2041	Homo sapiens	Kd	nM	120.0
	2906665	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	240.0	CHEMBL2041	Homo sapiens	Kd	nM	240.0
	2906666	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906667	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	47.0	CHEMBL2041	Homo sapiens	Kd	nM	47.0
	2906668	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	72.0	CHEMBL2041	Homo sapiens	Kd	nM	72.0
	2906669	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	840.0	CHEMBL2041	Homo sapiens	Kd	nM	840.0
	2906670	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906671	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906672	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	390.0	CHEMBL2041	Homo sapiens	Kd	nM	390.0
	2906673	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906674	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	330.0	CHEMBL2041	Homo sapiens	Kd	nM	330.0
	2906675	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906676	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906677	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906678	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	270.0	CHEMBL2041	Homo sapiens	Kd	nM	270.0
	2906679	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906680	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	4200.0	CHEMBL2041	Homo sapiens	Kd	nM	4200.0
	2906681	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906682	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906683	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906684	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906685	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906686	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	130.0	CHEMBL2041	Homo sapiens	Kd	nM	130.0
	2906687	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	7600.0	CHEMBL2041	Homo sapiens	Kd	nM	7600.0
	2906688	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906689	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906690	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906691	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906692	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	7.4	CHEMBL2041	Homo sapiens	Kd	nM	7.4
	2906693	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	28.0	CHEMBL2041	Homo sapiens	Kd	nM	28.0
	2906694	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	24.0	CHEMBL2041	Homo sapiens	Kd	nM	24.0
	2906695	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	19.0	CHEMBL2041	Homo sapiens	Kd	nM	19.0
	2906696	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	26.0	CHEMBL2041	Homo sapiens	Kd	nM	26.0
	2906697	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	2906698	CHEMBL1051257	Binding constant for RET(M918T) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	14.0	CHEMBL2041	Homo sapiens	Kd	nM	14.0
	2921972	CHEMBL1052940	Inhibition of RET assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	65.0	CHEMBL2041	Homo sapiens	Activity	%	65.0
	2921973	CHEMBL1052941	Inhibition of RET M918T mutant assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	2921974	CHEMBL1052942	Inhibition of RET V804L mutant assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	2921975	CHEMBL1052943	Inhibition of RET V804M mutant assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	96.0	CHEMBL2041	Homo sapiens	Activity	%	96.0
	2928493	CHEMBL1043885	Binding affinity to RET assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	79.0	CHEMBL2041	Homo sapiens	Activity	%	79.0
	2930031	CHEMBL1057695	Binding affinity to RET	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	9.9	CHEMBL2041	Homo sapiens	Kd	nM	9.9
	2938447	CHEMBL1041418	Inhibition of RET at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	3.0	CHEMBL2041	Homo sapiens	INH	%	3.0
	2943672	CHEMBL1044071	Inhibition of Ret	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC		CHEMBL571040	=	IC50	nM	700.0	CHEMBL2041	Homo sapiens	IC50	microM	0.7
	2943686	CHEMBL1044071	Inhibition of Ret	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC		CHEMBL569880	<	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	microM	0.1
	2948619	CHEMBL1047366	Inhibition of Ret at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	96.0	CHEMBL2041	Homo sapiens	INH	%	96.0
Active	2983874	CHEMBL1050687	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of RET by enzyme fragment complementation assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387		Activity			CHEMBL2041	Homo sapiens	Activity		
	2992239	CHEMBL1044542	Inhibition of human RET at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	21.0	CHEMBL2041	Homo sapiens	INH	%	21.0
	2993577	CHEMBL1040952	Inhibition of human recombinant Ret	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	3052465	CHEMBL1072503	Residual activity of RET at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	101.0	CHEMBL2041	Homo sapiens	Residual activity	%	101.0
	3052717	CHEMBL1043796	Residual activity of RET at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	58.0	CHEMBL2041	Homo sapiens	Residual activity	%	58.0
	3054026	CHEMBL1071356	Residual activity of RET at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	5.0	CHEMBL2041	Homo sapiens	Residual activity	%	5.0
	3055313	CHEMBL1072503	Residual activity of RET at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	92.0	CHEMBL2041	Homo sapiens	Residual activity	%	92.0
	3055565	CHEMBL1043796	Residual activity of RET at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	68.0	CHEMBL2041	Homo sapiens	Residual activity	%	68.0
	3056870	CHEMBL1071356	Residual activity of RET at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	13.0	CHEMBL2041	Homo sapiens	Residual activity	%	13.0
	3057122	CHEMBL1072503	Residual activity of RET at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	97.0	CHEMBL2041	Homo sapiens	Residual activity	%	97.0
	3058442	CHEMBL1043796	Residual activity of RET at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	81.0	CHEMBL2041	Homo sapiens	Residual activity	%	81.0
	3059726	CHEMBL1071356	Residual activity of RET at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	21.0	CHEMBL2041	Homo sapiens	Residual activity	%	21.0
	3063556	CHEMBL1050471	Binding affinity to human RET at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	40.0	CHEMBL2041	Homo sapiens	Activity	%	40.0
	3063646	CHEMBL1043375	Binding affinity to human RET at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	5.6	CHEMBL2041	Homo sapiens	Activity	%	5.6
	3063736	CHEMBL1045142	Binding affinity to human RET at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	94.0	CHEMBL2041	Homo sapiens	Activity	%	94.0
	3066891	CHEMBL1066097	Inhibition of RET at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	3066981	CHEMBL1066097	Inhibition of RET at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	3098439	CHEMBL1067036	Inhibition of human Ret at 0.1 uM	B	COc1ccccc1NC(=O)CC(Nc1ccc(Oc2ccnc3cc(-c4cn(C)cn4)sc23)c(F)c1)C(F)(F)F		CHEMBL591924	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3101513	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	IC50	nM	760.0	CHEMBL2041	Homo sapiens	IC50	uM	0.76
	3101514	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	O=C1Nc2cccc(Br)c2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL592651	=	IC50	nM	1700.0	CHEMBL2041	Homo sapiens	IC50	uM	1.7
	3101515	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)c2ccccc12		CHEMBL597366	=	IC50	nM	45000.0	CHEMBL2041	Homo sapiens	IC50	uM	45.0
	3101516	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	1300.0	CHEMBL2041	Homo sapiens	IC50	uM	1.3
	3101517	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	IC50	nM	1600.0	CHEMBL2041	Homo sapiens	IC50	uM	1.6
	3101518	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(Cl)cc32)[nH]1		CHEMBL2062155	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	uM	1.0
	3101519	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	IC50	nM	770.0	CHEMBL2041	Homo sapiens	IC50	uM	0.77
	3101520	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	O=CN1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL315546	=	IC50	nM	1100.0	CHEMBL2041	Homo sapiens	IC50	uM	1.1
	3101521	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	170.0	CHEMBL2041	Homo sapiens	IC50	uM	0.17
	3101522	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	IC50	nM	460.0	CHEMBL2041	Homo sapiens	IC50	uM	0.46
	3101523	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	O=C1Nc2ccccc2/C1=C\c1ccc(O)cc1		CHEMBL103307	=	IC50	nM	2300.0	CHEMBL2041	Homo sapiens	IC50	uM	2.3
	3101524	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	3101525	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1cccc2c1/C(=C/c1ccc(N3CCN(C=O)CC3)cc1)C(=O)N2		CHEMBL89040	=	IC50	nM	3700.0	CHEMBL2041	Homo sapiens	IC50	uM	3.7
	3101526	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1cccc2c1/C(=C/c1ccc(N(C)C)c3ccccc13)C(=O)N2		CHEMBL597960	=	IC50	nM	210.0	CHEMBL2041	Homo sapiens	IC50	uM	0.21
	3101527	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1cccc2c1/C(=C/c1ccc(-c3ccccc3)cc1)C(=O)N2		CHEMBL599192	=	IC50	nM	23000.0	CHEMBL2041	Homo sapiens	IC50	uM	23.0
	3101528	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1cccc2c1/C(=C/c1ccc(N3CCOCC3)cc1)C(=O)N2		CHEMBL90277	=	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	3101529	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)cc32)[nH]1		CHEMBL598991	=	IC50	nM	5900.0	CHEMBL2041	Homo sapiens	IC50	uM	5.9
	3101530	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Nc1ccc2c(c1)/C(=C\c1ccc(-c3ccoc3)o1)C(=O)N2		CHEMBL597177	=	IC50	nM	34000.0	CHEMBL2041	Homo sapiens	IC50	uM	34.0
	3101531	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Nc1ccc2c(c1)/C(=C\c1ccc(Br)o1)C(=O)N2		CHEMBL597176	=	IC50	nM	66000.0	CHEMBL2041	Homo sapiens	IC50	uM	66.0
	3101532	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	CCN(CC)c1ccc(/C=C2/C(=O)Nc3ccc(N)cc32)cc1		CHEMBL596974	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	uM	1.0
	3101533	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	COc1ccc(/C=C2/C(=O)Nc3ccc(N)cc32)cc1		CHEMBL608424	=	IC50	nM	63000.0	CHEMBL2041	Homo sapiens	IC50	uM	63.0
	3101534	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	COc1ccc(/C=C2\C(=O)Nc3ccc(N)cc32)cc1		CHEMBL591696	=	IC50	nM	5300.0	CHEMBL2041	Homo sapiens	IC50	uM	5.3
	3101535	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(N)cc32)[nH]1		CHEMBL597181	=	IC50	nM	300.0	CHEMBL2041	Homo sapiens	IC50	uM	0.3
	3101536	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL232144	=	IC50	nM	460.0	CHEMBL2041	Homo sapiens	IC50	uM	0.46
	3101537	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C\c1ccc(-c2ccsc2)o1		CHEMBL603491	=	IC50	nM	78000.0	CHEMBL2041	Homo sapiens	IC50	uM	78.0
	3101538	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C\c1ccc(-c2ccoc2)o1		CHEMBL601232	=	IC50	nM	12000.0	CHEMBL2041	Homo sapiens	IC50	uM	12.0
	3101539	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(-c4cccnc4)cc32)[nH]1		CHEMBL602074	=	IC50	nM	580.0	CHEMBL2041	Homo sapiens	IC50	uM	0.58
	3101540	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(-c4occc4C)cc32)[nH]1		CHEMBL602073	=	IC50	nM	1100.0	CHEMBL2041	Homo sapiens	IC50	uM	1.1
	3101541	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cn1nccc1-c1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL601871	=	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	3101542	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	O=C1Nc2ccc(-c3ccco3)cc2/C1=C/c1ccc[nH]1		CHEMBL599809	=	IC50	nM	40000.0	CHEMBL2041	Homo sapiens	IC50	uM	40.0
	3101543	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C\c1ccc(Br)o1		CHEMBL607581	=	IC50	nM	22000.0	CHEMBL2041	Homo sapiens	IC50	uM	22.0
	3101544	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C/c1c[nH]c2ccccc12		CHEMBL599808	=	IC50	nM	7500.0	CHEMBL2041	Homo sapiens	IC50	uM	7.5
	3101545	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(Br)cc32)[nH]1		CHEMBL599807	=	IC50	nM	1400.0	CHEMBL2041	Homo sapiens	IC50	uM	1.4
	3101546	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1ccc2c(c1)/C(=C/c1[nH]c(C)cc1C)C(=O)N2		CHEMBL89483	=	IC50	nM	8000.0	CHEMBL2041	Homo sapiens	IC50	uM	8.0
	3101547	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL233373	=	IC50	nM	66000.0	CHEMBL2041	Homo sapiens	IC50	uM	66.0
	3101548	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	COc1cccc2c1NC(=O)/C2=C\c1[nH]c(C)cc1C		CHEMBL606334	=	IC50	nM	5500.0	CHEMBL2041	Homo sapiens	IC50	uM	5.5
	3101549	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	COc1ccc2c(c1)/C(=C/c1[nH]c(C)cc1C)C(=O)N2		CHEMBL597345	=	IC50	nM	4100.0	CHEMBL2041	Homo sapiens	IC50	uM	4.1
	3101550	CHEMBL1071417	Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(OC(F)(F)F)cc32)[nH]1		CHEMBL605000	=	IC50	nM	2000.0	CHEMBL2041	Homo sapiens	IC50	uM	2.0
	3117950	CHEMBL1072226	Inhibition of RET	B	CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599224	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	3118003	CHEMBL1072226	Inhibition of RET	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2		CHEMBL599428	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	3118056	CHEMBL1072226	Inhibition of RET	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	3121100	CHEMBL1065600	Inhibition of Ret	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	=	IC50	nM	3200.0	CHEMBL2041	Homo sapiens	IC50	nM	3200.0
	3124005	CHEMBL1067554	Inhibition of RET	B	CC(C)(C)c1cc(NC(=O)c2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1		CHEMBL598626	=	IC50	nM	202.0	CHEMBL2041	Homo sapiens	IC50	uM	0.202
	3124006	CHEMBL1067554	Inhibition of RET	B	O=C(Nc1cc(Oc2cccc3[nH]c(=O)[nH]c23)c(F)c(F)c1F)c1cccc(OC(F)(F)F)c1		CHEMBL602123	=	IC50	nM	237.0	CHEMBL2041	Homo sapiens	IC50	uM	0.237
	3124007	CHEMBL1067554	Inhibition of RET	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1		CHEMBL597592	=	IC50	nM	698.0	CHEMBL2041	Homo sapiens	IC50	uM	0.698
	3127410	CHEMBL1064452	Inhibition of RET by scintillation proximity assay	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	3127444	CHEMBL1064452	Inhibition of RET by scintillation proximity assay	B	CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C		CHEMBL604712	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	3213852	CHEMBL1111268	Inhibition of RET at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	61.0	CHEMBL2041	Homo sapiens	INH	%	61.0
	3213853	CHEMBL1111269	Inhibition of RET M918T mutant at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	44.0	CHEMBL2041	Homo sapiens	INH	%	44.0
	3224946	CHEMBL1101499	Inhibition of RET at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3224947	CHEMBL1101500	Inhibition of RET V804L (mutant) at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3224948	CHEMBL1101752	Inhibition of RET Y791F (mutant) at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3226155	CHEMBL1112289	Binding affinity to RET	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3ncccc3O)cc2)no1		CHEMBL1079545	=	Kd	nM	4.7	CHEMBL2041	Homo sapiens	Kd	nM	4.7
	3226156	CHEMBL1112289	Binding affinity to RET	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cc4ccccc4cn3)cc2)no1		CHEMBL1081509	=	Kd	nM	7.3	CHEMBL2041	Homo sapiens	Kd	nM	7.3
	3226157	CHEMBL1112289	Binding affinity to RET	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cn4c(n3)sc3ccccc34)cc2)no1		CHEMBL575925	=	Kd	nM	3.0	CHEMBL2041	Homo sapiens	Kd	nM	3.0
	3226325	CHEMBL1101499	Inhibition of RET at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3226326	CHEMBL1101500	Inhibition of RET V804L (mutant) at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3226327	CHEMBL1101752	Inhibition of RET Y791F (mutant) at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3291469	CHEMBL1111968	Inhibition of RET assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	3294627	CHEMBL1103939	Inhibition of Ret	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)c5cnn(-c6ccccc6)c5C(F)(F)F)cc4F)c3s2)c1		CHEMBL1094718	<	Inhibition	%	40.0	CHEMBL2041	Homo sapiens	INH	%	40.0
	3315906	CHEMBL1120252	Inhibition of Ret	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4ccc(N5CCN(C)CC5)cc4)cnn3c2N)cc1		CHEMBL1085511	=	IC50	nM	4700.0	CHEMBL2041	Homo sapiens	IC50	uM	4.7
	3316806	CHEMBL1120365	Inhibition of RET at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	57.0	CHEMBL2041	Homo sapiens	INH	%	57.0
	3326150	CHEMBL1168777	Inhibition of RET at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3332125	CHEMBL1166836	Inhibition of RET at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3332126	CHEMBL1166837	Inhibition of RET M918T mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3332127	CHEMBL1166838	Inhibition of RET V804L mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3332128	CHEMBL1166839	Inhibition of RET V804M mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3333540	CHEMBL1166836	Inhibition of RET at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3333541	CHEMBL1166837	Inhibition of RET M918T mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3333542	CHEMBL1166838	Inhibition of RET V804L mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3333543	CHEMBL1166839	Inhibition of RET V804M mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3334945	CHEMBL1166836	Inhibition of RET at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3334946	CHEMBL1166837	Inhibition of RET M918T mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3334947	CHEMBL1166838	Inhibition of RET V804L mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3334948	CHEMBL1166839	Inhibition of RET V804M mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3336365	CHEMBL1166836	Inhibition of RET at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3336366	CHEMBL1166837	Inhibition of RET M918T mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3336367	CHEMBL1166838	Inhibition of RET V804L mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3336368	CHEMBL1166839	Inhibition of RET V804M mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3337636	CHEMBL1166836	Inhibition of RET at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3338967	CHEMBL1166836	Inhibition of RET at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3339221	CHEMBL1166836	Inhibition of RET at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3340524	CHEMBL1166836	Inhibition of RET at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3341907	CHEMBL1166836	Inhibition of RET at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	77.0	CHEMBL2041	Homo sapiens	INH	%	77.0
	3341908	CHEMBL1166837	Inhibition of RET M918T mutant at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	67.0	CHEMBL2041	Homo sapiens	INH	%	67.0
	3341909	CHEMBL1166838	Inhibition of RET V804L mutant at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	89.0	CHEMBL2041	Homo sapiens	INH	%	89.0
	3341910	CHEMBL1166839	Inhibition of RET V804M mutant at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	76.0	CHEMBL2041	Homo sapiens	INH	%	76.0
	3343354	CHEMBL1166836	Inhibition of RET at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3343355	CHEMBL1166837	Inhibition of RET M918T mutant at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3343356	CHEMBL1166838	Inhibition of RET V804L mutant at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3343357	CHEMBL1166839	Inhibition of RET V804M mutant at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	3344705	CHEMBL1167139	Inhibition of RET assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	58.0	CHEMBL2041	Homo sapiens	Activity	%	58.0
	3344706	CHEMBL1167140	Inhibition of RET assessed as residual activity at 1 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	78.0	CHEMBL2041	Homo sapiens	Activity	%	78.0
	3345928	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(SCc2ccccc2)nc2c(c1-c1ccsc1)CCCC2		CHEMBL1170353	=	IC50	nM	8000.0	CHEMBL2041	Homo sapiens	IC50	uM	8.0
	3345929	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(SCc2ccc(Cl)cc2)nc2c(c1-c1ccsc1)CCCC2		CHEMBL1170354	=	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	3345930	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(SCC(=O)c2ccccc2)nc2c(c1-c1ccsc1)CCCC2		CHEMBL1170563	=	IC50	nM	2300.0	CHEMBL2041	Homo sapiens	IC50	uM	2.3
	3345931	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(SCC(=O)c2ccc(Cl)cc2)nc2c(c1-c1ccsc1)CCCC2		CHEMBL1170564	=	IC50	nM	8600.0	CHEMBL2041	Homo sapiens	IC50	uM	8.6
	3345932	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(SCC(=O)Nc2ccc(Cl)cc2)nc2c(c1-c1ccsc1)CCCC2		CHEMBL1172300	=	IC50	nM	14000.0	CHEMBL2041	Homo sapiens	IC50	uM	14.0
	3345933	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	CN1CCc2nc(SCC(=O)c3ccc(Cl)cc3)c(C#N)c(-c3ccsc3)c2C1		CHEMBL1170550	=	IC50	nM	27000.0	CHEMBL2041	Homo sapiens	IC50	uM	27.0
	3345934	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(N)nc(SCc2ccccc2)c(C#N)c1-c1ccsc1		CHEMBL1170551	=	IC50	nM	19000.0	CHEMBL2041	Homo sapiens	IC50	uM	19.0
	3345935	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(N)nc(SCc2ccc(Cl)cc2)c(C#N)c1-c1ccsc1		CHEMBL1170552	=	IC50	nM	8300.0	CHEMBL2041	Homo sapiens	IC50	uM	8.3
	3345936	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	COc1ccc(CSc2nc(N)c(C#N)c(-c3ccsc3)c2C#N)cc1		CHEMBL1170760	=	IC50	nM	13000.0	CHEMBL2041	Homo sapiens	IC50	uM	13.0
	3345937	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	Cc1ccc(CSc2nc(N)c(C#N)c(-c3ccsc3)c2C#N)cc1		CHEMBL1171520	=	IC50	nM	11000.0	CHEMBL2041	Homo sapiens	IC50	uM	11.0
	3345938	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(N)nc(SCc2ccc(Cl)c(Cl)c2)c(C#N)c1-c1ccsc1		CHEMBL1169812	=	IC50	nM	9200.0	CHEMBL2041	Homo sapiens	IC50	uM	9.2
	3345939	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(N)nc(SCC(=O)c2ccccc2)c(C#N)c1-c1ccsc1		CHEMBL1171960	=	IC50	nM	3400.0	CHEMBL2041	Homo sapiens	IC50	uM	3.4
	3345940	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(N)nc(SCC(=O)c2ccc(Cl)cc2)c(C#N)c1-c1ccsc1		CHEMBL1172147	=	IC50	nM	690.0	CHEMBL2041	Homo sapiens	IC50	uM	0.69
	3345941	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	COc1ccc(C(=O)CSc2nc(N)c(C#N)c(-c3ccsc3)c2C#N)cc1		CHEMBL1172148	=	IC50	nM	3600.0	CHEMBL2041	Homo sapiens	IC50	uM	3.6
	3345942	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	Cc1ccc(C(=O)CSc2nc(N)c(C#N)c(-c3ccsc3)c2C#N)cc1		CHEMBL1170217	=	IC50	nM	5000.0	CHEMBL2041	Homo sapiens	IC50	uM	5.0
	3345943	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1ccc(C(=O)CSc2nc(N)c(C#N)c(-c3ccsc3)c2C#N)cc1		CHEMBL1170218	=	IC50	nM	39000.0	CHEMBL2041	Homo sapiens	IC50	uM	39.0
	3345944	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(N)nc(SCC(=O)c2ccc(C(F)(F)F)cc2)c(C#N)c1-c1ccsc1		CHEMBL1172696	=	IC50	nM	3600.0	CHEMBL2041	Homo sapiens	IC50	uM	3.6
	3345945	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(N)nc(SCC(=O)c2cccc(Cl)c2)c(C#N)c1-c1ccsc1		CHEMBL1171688	=	IC50	nM	26000.0	CHEMBL2041	Homo sapiens	IC50	uM	26.0
	3345946	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(SCc2ccc(F)cc2)nc2c(c1-c1cccs1)CCCC2		CHEMBL1172697	=	IC50	nM	4800.0	CHEMBL2041	Homo sapiens	IC50	uM	4.8
	3345947	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	N#Cc1c(SCc2ccccc2)nc2c(c1-c1cccs1)CCCC2		CHEMBL1171912	=	IC50	nM	1600.0	CHEMBL2041	Homo sapiens	IC50	uM	1.6
	3345948	CHEMBL1173924	Inhibition of human recombinant histidine-tagged RET (700-1020) expressed in Sf9 cells by ELISA	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	97.0	CHEMBL2041	Homo sapiens	IC50	uM	0.097
	3358780	CHEMBL1175246	Inhibition of RET at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	3358781	CHEMBL1175247	Inhibition of RET M918T mutant at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	3358782	CHEMBL1175248	Inhibition of RET V804L mutant at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	3358783	CHEMBL1175249	Inhibition of RET V804M mutant at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	3359222	CHEMBL1175246	Inhibition of RET at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	3359223	CHEMBL1175247	Inhibition of RET M918T mutant at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	3359224	CHEMBL1175248	Inhibition of RET V804L mutant at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	3359225	CHEMBL1175249	Inhibition of RET V804M mutant at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	3407768	CHEMBL1219798	Inhibition of RET at 1 uM by radiometric method	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218	<	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	INH	%	10.0
	3407769	CHEMBL1219798	Inhibition of RET at 1 uM by radiometric method	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346	<	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	INH	%	10.0
	3420249	CHEMBL1226945	Inhibition of Ret	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	3441779	CHEMBL1243929	Inhibition of Ret	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	<	IC50	nM	1.0	CHEMBL2041	Homo sapiens	IC50	nM	1.0
Active	3441780	CHEMBL1243930	Inhibition of Ret autophosphorylation in human TT cells at 0.04 to 10 uM after 2 hrs by Western blot analysis	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	3441781	CHEMBL1243930	Inhibition of Ret autophosphorylation in human TT cells at 0.04 to 10 uM after 2 hrs by Western blot analysis	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	3441782	CHEMBL1243930	Inhibition of Ret autophosphorylation in human TT cells at 0.04 to 10 uM after 2 hrs by Western blot analysis	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	3443509	CHEMBL1244275	Inhibition of RET at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	101.0	CHEMBL2041	Homo sapiens	INH	%	101.0
	3443510	CHEMBL1244276	Inhibition of RET V804L mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	31.0	CHEMBL2041	Homo sapiens	INH	%	31.0
	3443511	CHEMBL1244277	Inhibition of RET Y791F mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	99.0	CHEMBL2041	Homo sapiens	INH	%	99.0
	3443726	CHEMBL1244275	Inhibition of RET at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	3443727	CHEMBL1244276	Inhibition of RET V804L mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	11.0	CHEMBL2041	Homo sapiens	INH	%	11.0
	3443728	CHEMBL1244277	Inhibition of RET Y791F mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	99.0	CHEMBL2041	Homo sapiens	INH	%	99.0
	3444881	CHEMBL1244275	Inhibition of RET at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	93.0	CHEMBL2041	Homo sapiens	INH	%	93.0
	3444882	CHEMBL1244276	Inhibition of RET V804L mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	INH	%	4.0
	3444883	CHEMBL1244277	Inhibition of RET Y791F mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	93.0	CHEMBL2041	Homo sapiens	INH	%	93.0
	3445004	CHEMBL1244951	Binding affinity to RET	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	9.9	CHEMBL2041	Homo sapiens	Kd	nM	9.9
	3445005	CHEMBL1244952	Binding affinity to RET M918T mutant	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	3.0	CHEMBL2041	Homo sapiens	Kd	nM	3.0
	3445006	CHEMBL1244953	Binding affinity to RET(V804L)	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	13.0	CHEMBL2041	Homo sapiens	Kd	nM	13.0
	3445007	CHEMBL1244954	Binding affinity to RET V804M mutant	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	9.1	CHEMBL2041	Homo sapiens	Kd	nM	9.1
	3445278	CHEMBL1244951	Binding affinity to RET	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	20.0	CHEMBL2041	Homo sapiens	Kd	nM	20.0
	3445279	CHEMBL1244952	Binding affinity to RET M918T mutant	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	14.0	CHEMBL2041	Homo sapiens	Kd	nM	14.0
	3445280	CHEMBL1244953	Binding affinity to RET(V804L)	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	6.7	CHEMBL2041	Homo sapiens	Kd	nM	6.7
	3445281	CHEMBL1244954	Binding affinity to RET V804M mutant	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	4.7	CHEMBL2041	Homo sapiens	Kd	nM	4.7
	3445505	CHEMBL1244275	Inhibition of RET at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	61.0	CHEMBL2041	Homo sapiens	INH	%	61.0
	3445506	CHEMBL1244276	Inhibition of RET V804L mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	5.0	CHEMBL2041	Homo sapiens	INH	%	5.0
	3445507	CHEMBL1244277	Inhibition of RET Y791F mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	61.0	CHEMBL2041	Homo sapiens	INH	%	61.0
	3445722	CHEMBL1244275	Inhibition of RET at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	90.0	CHEMBL2041	Homo sapiens	INH	%	90.0
	3445723	CHEMBL1244276	Inhibition of RET V804L mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	39.0	CHEMBL2041	Homo sapiens	INH	%	39.0
	3445724	CHEMBL1244277	Inhibition of RET Y791F mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	92.0	CHEMBL2041	Homo sapiens	INH	%	92.0
	3445917	CHEMBL1244275	Inhibition of RET at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	101.0	CHEMBL2041	Homo sapiens	INH	%	101.0
	3446107	CHEMBL1244275	Inhibition of RET at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	81.0	CHEMBL2041	Homo sapiens	INH	%	81.0
	3446139	CHEMBL1244315	Inhibition of recombinant Ret by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	IC50	nM	1700.0	CHEMBL2041	Homo sapiens	IC50	uM	1.7
	3446143	CHEMBL1244315	Inhibition of recombinant Ret by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	2100.0	CHEMBL2041	Homo sapiens	IC50	uM	2.1
	3446147	CHEMBL1244315	Inhibition of recombinant Ret by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	<	IC50	nM	1.0	CHEMBL2041	Homo sapiens	IC50	uM	0.001
	3446178	CHEMBL1244315	Inhibition of recombinant Ret by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	9.0	CHEMBL2041	Homo sapiens	IC50	uM	0.009
	3448598	CHEMBL1244951	Binding affinity to RET	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	3448599	CHEMBL1244952	Binding affinity to RET M918T mutant	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	3448600	CHEMBL1244953	Binding affinity to RET(V804L)	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	3448601	CHEMBL1244954	Binding affinity to RET V804M mutant	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	uM	10.0
	3449031	CHEMBL1244951	Binding affinity to RET	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	350.0	CHEMBL2041	Homo sapiens	Kd	nM	350.0
	3449032	CHEMBL1244952	Binding affinity to RET M918T mutant	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	130.0	CHEMBL2041	Homo sapiens	Kd	nM	130.0
	3449033	CHEMBL1244953	Binding affinity to RET(V804L)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	27.0	CHEMBL2041	Homo sapiens	Kd	nM	27.0
	3449034	CHEMBL1244954	Binding affinity to RET V804M mutant	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	20.0	CHEMBL2041	Homo sapiens	Kd	nM	20.0
	3449318	CHEMBL1244951	Binding affinity to RET	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	12.0	CHEMBL2041	Homo sapiens	Kd	nM	12.0
	3449319	CHEMBL1244951	Binding affinity to RET	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	13.0	CHEMBL2041	Homo sapiens	Kd	nM	13.0
	3449320	CHEMBL1244952	Binding affinity to RET M918T mutant	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	7.4	CHEMBL2041	Homo sapiens	Kd	nM	7.4
	3449321	CHEMBL1244952	Binding affinity to RET M918T mutant	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	19.0	CHEMBL2041	Homo sapiens	Kd	nM	19.0
	3449322	CHEMBL1244953	Binding affinity to RET(V804L)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	8.7	CHEMBL2041	Homo sapiens	Kd	nM	8.7
	3449323	CHEMBL1244953	Binding affinity to RET(V804L)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	39.0	CHEMBL2041	Homo sapiens	Kd	nM	39.0
	3449324	CHEMBL1244953	Binding affinity to RET(V804L)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	230.0	CHEMBL2041	Homo sapiens	Kd	nM	230.0
	3449325	CHEMBL1244954	Binding affinity to RET V804M mutant	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	5.8	CHEMBL2041	Homo sapiens	Kd	nM	5.8
	3449326	CHEMBL1244954	Binding affinity to RET V804M mutant	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	22.0	CHEMBL2041	Homo sapiens	Kd	nM	22.0
	3449327	CHEMBL1244954	Binding affinity to RET V804M mutant	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	260.0	CHEMBL2041	Homo sapiens	Kd	nM	260.0
	3449495	CHEMBL1244951	Binding affinity to RET	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	1900.0	CHEMBL2041	Homo sapiens	Kd	nM	1900.0
	3449496	CHEMBL1244952	Binding affinity to RET M918T mutant	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	1300.0	CHEMBL2041	Homo sapiens	Kd	nM	1300.0
	3463342	CHEMBL1251602	Inhibition of RET at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	30.0	CHEMBL2041	Homo sapiens	INH	%	30.0
	3463343	CHEMBL1251603	Inhibition of RET V804L mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	48.0	CHEMBL2041	Homo sapiens	INH	%	48.0
	3463344	CHEMBL1251604	Inhibition of RET Y791F mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	29.0	CHEMBL2041	Homo sapiens	INH	%	29.0
	3463886	CHEMBL1251602	Inhibition of RET at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	41.0	CHEMBL2041	Homo sapiens	INH	%	41.0
	3463887	CHEMBL1251603	Inhibition of RET V804L mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	66.0	CHEMBL2041	Homo sapiens	INH	%	66.0
	3463888	CHEMBL1251604	Inhibition of RET Y791F mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	48.0	CHEMBL2041	Homo sapiens	INH	%	48.0
	3464105	CHEMBL1251602	Inhibition of RET at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	87.0	CHEMBL2041	Homo sapiens	INH	%	87.0
	3464106	CHEMBL1251603	Inhibition of RET V804L mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	93.0	CHEMBL2041	Homo sapiens	INH	%	93.0
	3464107	CHEMBL1251604	Inhibition of RET Y791F mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	91.0	CHEMBL2041	Homo sapiens	INH	%	91.0
	3504220	CHEMBL1260165	Inhibition of RET	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	=	IC50	nM	113.0	CHEMBL2041	Homo sapiens	IC50	uM	0.113
	3526134	CHEMBL1274460	Binding affinity to RET	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	1.6	CHEMBL2041	Homo sapiens	Kd	nM	1.6
	3526963	CHEMBL1274181	Inhibition of RET	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	3556137	CHEMBL1285879	Inhibition of RET	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	IC50	nM	160.0	CHEMBL2041	Homo sapiens	IC50	nM	160.0
	3556142	CHEMBL1285618	Inhibition of RET at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	84.0	CHEMBL2041	Homo sapiens	INH	%	84.0
	3603125	CHEMBL1291222	Inhibition of RET at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scnc1-c1cscn1		CHEMBL1288160	=	Inihibition	%	21.0	CHEMBL2041	Homo sapiens	Inihibition	%	21.0
	5089656	CHEMBL1633376	Inhibition of RET V804L mutant at 10 uM	B	C(#Cc1n[nH]c2ccccc12)c1ccncc1		CHEMBL1631892	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	5089657	CHEMBL1633377	Inhibition of RET Y791F mutant at 10 uM	B	C(#Cc1n[nH]c2ccccc12)c1ccncc1		CHEMBL1631892	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	5120089	CHEMBL1648819	Inhibition of RET at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccncc2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644642	=	Inhibition	%	3.0	CHEMBL2041	Homo sapiens	INH	%	3.0
	5120103	CHEMBL1648819	Inhibition of RET at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644618	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	INH	%	4.0
	5120158	CHEMBL1648819	Inhibition of RET at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(C2CCOCC2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644639	=	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	INH	%	10.0
	5120169	CHEMBL1648819	Inhibition of RET at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644620	=	Inhibition	%	11.0	CHEMBL2041	Homo sapiens	INH	%	11.0
	5120223	CHEMBL1648819	Inhibition of RET at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCOC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644619	=	Inhibition	%	37.0	CHEMBL2041	Homo sapiens	INH	%	37.0
	5120409	CHEMBL1648698	Inhibition of human Ret at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	108.0	CHEMBL2041	Homo sapiens	INH	%	108.0
	5120422	CHEMBL1648699	Inhibition of human Ret V804L mutant at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	109.0	CHEMBL2041	Homo sapiens	INH	%	109.0
	5121154	CHEMBL1648700	Inhibition of human Ret V804M mutant at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	116.0	CHEMBL2041	Homo sapiens	INH	%	116.0
	5123942	CHEMBL1647703	Inhibition of RET at 10 uM	B	Nc1nccc2cc(O[C@H]3CCCNC3)ccc12		CHEMBL1643368	>	Inhibition	%	80.0	CHEMBL2041	Homo sapiens	INH	%	80.0
	5139764	CHEMBL1648819	Inhibition of RET at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccccn2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644615	=	Inhibition	%	-1.0	CHEMBL2041	Homo sapiens	INH	%	-1.0
	5152428	CHEMBL1656380	Inhibition of RET by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	5152440	CHEMBL1656380	Inhibition of RET by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	=	IC50	nM	7200.0	CHEMBL2041	Homo sapiens	IC50	nM	7200.0
	5152452	CHEMBL1656380	Inhibition of RET by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1651522	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	5152464	CHEMBL1656380	Inhibition of RET by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651523	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	5243761	CHEMBL1685865	Inhibition of Ret at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	5243869	CHEMBL1686081	Inhibition of Ret at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	-2.0	CHEMBL2041	Homo sapiens	INH	%	-2.0
	5243982	CHEMBL1685865	Inhibition of Ret at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	8.0	CHEMBL2041	Homo sapiens	INH	%	8.0
	5244090	CHEMBL1686081	Inhibition of Ret at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	3.0	CHEMBL2041	Homo sapiens	INH	%	3.0
	5244963	CHEMBL1685865	Inhibition of Ret at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	12.0	CHEMBL2041	Homo sapiens	INH	%	12.0
	5245071	CHEMBL1686081	Inhibition of Ret at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	-3.0	CHEMBL2041	Homo sapiens	INH	%	-3.0
	5245222	CHEMBL1685865	Inhibition of Ret at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	14.0	CHEMBL2041	Homo sapiens	INH	%	14.0
	5246052	CHEMBL1686081	Inhibition of Ret at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	INH	%	4.0
	5249163	CHEMBL1686640	Inhibition of RET	B	CCNC(=O)Nc1ccc(Oc2ncnc(N)c2/C=N/OC)cc1Cl		CHEMBL1681932	=	IC50	nM	183.0	CHEMBL2041	Homo sapiens	IC50	nM	183.0
	5249449	CHEMBL1686800	Inhibition of RET at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scc(Cl)c1-c1ncn[nH]1		CHEMBL1682017	=	Inhibition	%	16.0	CHEMBL2041	Homo sapiens	INH	%	16.0
	5310439	CHEMBL1693597	Inhibition of RET	B	CN(C)Cc1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1		CHEMBL1688860	=	IC50	nM	1.6	CHEMBL2041	Homo sapiens	IC50	nM	1.6
	5310440	CHEMBL1693597	Inhibition of RET	B	CC(C)(N)c1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1		CHEMBL1688861	=	IC50	nM	0.8	CHEMBL2041	Homo sapiens	IC50	nM	0.8
	6167672	CHEMBL1769213	Inhibition of RET	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	Ki	uM	1.0
	6169208	CHEMBL1768986	Inhibition of human RET assessed as residual activity at 10 uM	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	Activity	%	46.0	CHEMBL2041	Homo sapiens	Activity	%	46.0
	6171342	CHEMBL1768691	Inhibition of RET	B	CC(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1		CHEMBL1766529	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	6193892	CHEMBL1777651	Inhibition of RET at 10 uM by ELISA based method	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177	=	Inhibition	%	0.6	CHEMBL2041	Homo sapiens	INH	%	0.6
	6193903	CHEMBL1777651	Inhibition of RET at 10 uM by ELISA based method	B	Oc1ccc(NCn2nnc3ccccc32)cc1		CHEMBL1775067	=	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	INH	%	10.0
	6193914	CHEMBL1777651	Inhibition of RET at 10 uM by ELISA based method	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	71.8	CHEMBL2041	Homo sapiens	INH	%	71.8
	6196675	CHEMBL1776845	Inhibition of human RET	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(C#N)cc2F)n[nH]1		CHEMBL1774056	=	IC50	nM	19.0	CHEMBL2041	Homo sapiens	IC50	uM	0.019
	6198146	CHEMBL1776308	Inhibition of RET assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
Active	6204079	CHEMBL1781722	Inhibition of Ret	B	CNC(=O)c1cc(Oc2ccc3sc(Nc4cccc(C(C)(C)C)c4)nc3c2)ccn1		CHEMBL1778403		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	6204080	CHEMBL1781722	Inhibition of Ret	B	CNC(=O)c1cc(Oc2ccc3oc(Nc4cccc(C(C)C)c4)nc3c2)ccn1		CHEMBL1778392		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	6204515	CHEMBL1781444	Inhibition of RET M918T mutant at 1 uM by Ambit competition binding assay	B	O=C(c1ccc(-c2ccccn2)s1)N1N=C(c2cccnc2)CC1c1ccccc1O		CHEMBL1778666	=	Inhibition	%	70.0	CHEMBL2041	Homo sapiens	INH	%	70.0
	6212367	CHEMBL1786066	Inhibition of RET expressed in Bac-to-Bac Baculovirus expression system using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	6219908	CHEMBL1785336	Inhibition of human RET using KKKSPGEYVNIEFG by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	0.2	CHEMBL2041	Homo sapiens	IC50	nM	0.2
	6221272	CHEMBL1787834	Inhibition of RET at 10 uM	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	6265576	CHEMBL1798285	Inhibition of RET at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL2041	Homo sapiens	INH	%	65.0
	6265680	CHEMBL1798285	Inhibition of RET at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL2041	Homo sapiens	INH	%	65.0
	6281550	CHEMBL1804349	Inhibition of human Ret	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	=	IC50	nM	640.0	CHEMBL2041	Homo sapiens	IC50	nM	640.0
	6286550	CHEMBL1810169	Inhibition of RET at 0.1 uM	B	Cc1nc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL1807483	=	Inhibition	%	71.0	CHEMBL2041	Homo sapiens	INH	%	71.0
	6293005	CHEMBL1811085	Inhibition of RET kinase	B	CCCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(OC)ccc5[nH]4)c3c2)c1		CHEMBL1807197	=	IC50	nM	36.0	CHEMBL2041	Homo sapiens	IC50	nM	36.0
	6293006	CHEMBL1811085	Inhibition of RET kinase	B	CNC(=O)c1cc(Oc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)ccn1		CHEMBL1807196	=	IC50	nM	6.0	CHEMBL2041	Homo sapiens	IC50	nM	6.0
	6293007	CHEMBL1811085	Inhibition of RET kinase	B	COc1cc2c(cc1OC)/C(=C\c1ccc(NC(=O)Nc3ccc(O)cc3)cc1)C(=O)N2		CHEMBL396098	=	IC50	nM	50.0	CHEMBL2041	Homo sapiens	IC50	nM	50.0
	6293008	CHEMBL1811085	Inhibition of RET kinase	B	COCCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(N6CCN(C)CC6)ccc5[nH]4)c3c2)c1		CHEMBL1807198	=	IC50	nM	190.0	CHEMBL2041	Homo sapiens	IC50	nM	190.0
	6293009	CHEMBL1811085	Inhibition of RET kinase	B	CC(C)NCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(N6CCN(C)CC6)ccc5[nH]4)c3c2)c1		CHEMBL1807506	=	IC50	nM	410.0	CHEMBL2041	Homo sapiens	IC50	nM	410.0
	6293010	CHEMBL1811085	Inhibition of RET kinase	B	CCN(CC)CCc1ccc(Nc2nccc(-c3c[nH]c4ncccc34)n2)cc1		CHEMBL1807507	=	IC50	nM	500.0	CHEMBL2041	Homo sapiens	IC50	nM	500.0
	6293011	CHEMBL1811085	Inhibition of RET kinase	B	c1ccc2c(-c3cnc4[nH]nc(-c5nc6cc(N7CCOCC7)ccc6[nH]5)c4c3)cncc2c1		CHEMBL249500	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	6293012	CHEMBL1811085	Inhibition of RET kinase	B	O=C(N[C@H]1CC[C@H](O)CC1)c1ccc2nc(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)[nH]c2c1		CHEMBL1807508	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	6293013	CHEMBL1811085	Inhibition of RET kinase	B	Oc1ccccc1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL213204	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	6293014	CHEMBL1811085	Inhibition of RET kinase	B	Cc1cc(N)ccc1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1807509	=	IC50	nM	1600.0	CHEMBL2041	Homo sapiens	IC50	nM	1600.0
	6293015	CHEMBL1811085	Inhibition of RET kinase	B	COc1cc2c(cc1OC)/C(=C\c1ccc(OC(=O)c3cnccn3)cc1)C(=O)N2		CHEMBL1807510	=	IC50	nM	1800.0	CHEMBL2041	Homo sapiens	IC50	nM	1800.0
	6293016	CHEMBL1811085	Inhibition of RET kinase	B	Cc1cc2c(F)c(Oc3ncnc(N)c3/C=N/OCCCN3CCNCC3)ccc2[nH]1		CHEMBL1807511	=	IC50	nM	1800.0	CHEMBL2041	Homo sapiens	IC50	nM	1800.0
	6293017	CHEMBL1811085	Inhibition of RET kinase	B	Cc1cc(CCN2CCN(C)CC2)ccc1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1807512	=	IC50	nM	2700.0	CHEMBL2041	Homo sapiens	IC50	nM	2700.0
	6293018	CHEMBL1811085	Inhibition of RET kinase	B	CCCCCCCCCC(=O)Oc1ccc(/C=C2/C(=O)Nc3cc(OC)c(OC)cc32)cc1		CHEMBL1807513	=	IC50	nM	4500.0	CHEMBL2041	Homo sapiens	IC50	nM	4500.0
	6293019	CHEMBL1811085	Inhibition of RET kinase	B	Cc1ccccc1NC(=O)c1ccc2nc(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)[nH]c2c1		CHEMBL1807514	=	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	6293020	CHEMBL1811085	Inhibition of RET kinase	B	NC1CCN(c2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1806508	=	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	6293021	CHEMBL1811085	Inhibition of RET kinase	B	N[C@H]1CC[C@@H](Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1807515	=	IC50	nM	3721.0	CHEMBL2041	Homo sapiens	IC50	nM	3721.0
	6293022	CHEMBL1811085	Inhibition of RET kinase	B	Cc1ccccc1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL212491	=	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	6293023	CHEMBL1811085	Inhibition of RET kinase	B	O[C@H]1CC[C@@H](Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1807516	=	IC50	nM	11000.0	CHEMBL2041	Homo sapiens	IC50	nM	11000.0
	6293024	CHEMBL1811085	Inhibition of RET kinase	B	c1cnc2[nH]cc(-c3ccnc(N[C@@H]4C[C@@H]5CC[C@@H]4C5)n3)c2c1		CHEMBL1807517	=	IC50	nM	55000.0	CHEMBL2041	Homo sapiens	IC50	nM	55000.0
	6293025	CHEMBL1811085	Inhibition of RET kinase	B	CN(C)CCN(C)C(=O)c1ccc2nc(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)[nH]c2c1		CHEMBL1807518	=	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	nM	100000.0
	6293026	CHEMBL1811085	Inhibition of RET kinase	B	CO[C@H]1CC[C@@H](Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1807519	=	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	nM	100000.0
	6293027	CHEMBL1811085	Inhibition of RET kinase	B	c1cnc2[nH]cc(-c3ccnc(NCC4CCCCC4)n3)c2c1		CHEMBL213207	=	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	nM	100000.0
	6293028	CHEMBL1811085	Inhibition of RET kinase	B	Fc1ccccc1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL377048	=	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	nM	100000.0
	6293029	CHEMBL1811085	Inhibition of RET kinase	B	Clc1ccc(Nc2nccc(-c3c[nH]c4ncccc34)n2)c(Cl)c1		CHEMBL1807520	=	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	nM	100000.0
	6293030	CHEMBL1811085	Inhibition of RET kinase	B	CCCCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(OC)ccc5[nH]4)c3c2)c1		CHEMBL1807521	=	IC50	nM	38.0	CHEMBL2041	Homo sapiens	IC50	nM	38.0
	6293031	CHEMBL1811085	Inhibition of RET kinase	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(F)c(F)cc5[nH]4)c3c2)c1		CHEMBL248712	=	IC50	nM	39.0	CHEMBL2041	Homo sapiens	IC50	nM	39.0
	6293032	CHEMBL1811085	Inhibition of RET kinase	B	COc1cc2[nH]c3c(c2cc1OC)C(c1cccc(O)c1)CNC3=O		CHEMBL1806510	=	IC50	nM	90.0	CHEMBL2041	Homo sapiens	IC50	nM	90.0
	6293033	CHEMBL1811085	Inhibition of RET kinase	B	CN(C)Cc1cncc(-c2ccc3[nH]c(-c4n[nH]c5ncc(N6CCN(C)CC6)cc45)nc3c2)c1		CHEMBL1807713	=	IC50	nM	104.0	CHEMBL2041	Homo sapiens	IC50	nM	104.0
	6293034	CHEMBL1811085	Inhibition of RET kinase	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(F)ccc5[nH]4)c3c2)c1		CHEMBL248713	=	IC50	nM	106.0	CHEMBL2041	Homo sapiens	IC50	nM	106.0
	6293035	CHEMBL1811085	Inhibition of RET kinase	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(F)ccc5[nH]4)c3c2)c1		CHEMBL248713	=	IC50	nM	110.0	CHEMBL2041	Homo sapiens	IC50	nM	110.0
	6293036	CHEMBL1811085	Inhibition of RET kinase	B	COc1cc2[nH]c3c(c2cc1OC)C(c1ccc(O)cc1)CNC3=O		CHEMBL1807714	=	IC50	nM	110.0	CHEMBL2041	Homo sapiens	IC50	nM	110.0
	6293037	CHEMBL1811085	Inhibition of RET kinase	B	CNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(N6CCN(C)CC6)ccc5[nH]4)c3c2)c1		CHEMBL1807715	=	IC50	nM	111.0	CHEMBL2041	Homo sapiens	IC50	nM	111.0
	6293038	CHEMBL1811085	Inhibition of RET kinase	B	COc1cc(Nc2nccc(-c3c[nH]c4ncccc34)n2)cc(OC)c1OC		CHEMBL1807716	=	IC50	nM	128.0	CHEMBL2041	Homo sapiens	IC50	nM	128.0
	6293039	CHEMBL1811085	Inhibition of RET kinase	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(N6CCN(C)CC6)ccc5[nH]4)c3c2)c1		CHEMBL400569	=	IC50	nM	140.0	CHEMBL2041	Homo sapiens	IC50	nM	140.0
	6293040	CHEMBL1811085	Inhibition of RET kinase	B	COCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5c[nH]c6ncccc56)cc34)nc12		CHEMBL1807717	=	IC50	nM	150.0	CHEMBL2041	Homo sapiens	IC50	nM	150.0
	6293041	CHEMBL1811085	Inhibition of RET kinase	B	CNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(OC)ccc5[nH]4)c3c2)c1		CHEMBL1807718	=	IC50	nM	201.0	CHEMBL2041	Homo sapiens	IC50	nM	201.0
	6293042	CHEMBL1811085	Inhibition of RET kinase	B	CCC(=O)Cc1ccc(Oc2ncnc(N)c2/C=N/OC)cc1Cl		CHEMBL1807719	=	IC50	nM	212.0	CHEMBL2041	Homo sapiens	IC50	nM	212.0
	6293043	CHEMBL1811085	Inhibition of RET kinase	B	CNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc6c(cc5[nH]4)OC(F)(F)O6)c3c2)c1		CHEMBL1807720	=	IC50	nM	218.0	CHEMBL2041	Homo sapiens	IC50	nM	218.0
	6293044	CHEMBL1811085	Inhibition of RET kinase	B	Cc1cc(CCO)ccc1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL426509	=	IC50	nM	337.0	CHEMBL2041	Homo sapiens	IC50	nM	337.0
	6293045	CHEMBL1811085	Inhibition of RET kinase	B	CCCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(N6CCN(C)CC6)ccc5[nH]4)c3c2)c1		CHEMBL1807721	=	IC50	nM	375.0	CHEMBL2041	Homo sapiens	IC50	nM	375.0
	6293046	CHEMBL1811085	Inhibition of RET kinase	B	CC(C)NC(=O)c1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL249502	=	IC50	nM	410.0	CHEMBL2041	Homo sapiens	IC50	nM	410.0
	6293047	CHEMBL1811085	Inhibition of RET kinase	B	CN1CCN(c2ccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCC7)c6)cc45)nc3c2)CC1		CHEMBL1807722	=	IC50	nM	475.0	CHEMBL2041	Homo sapiens	IC50	nM	475.0
	6293048	CHEMBL1811085	Inhibition of RET kinase	B	CCNCCc1ccc(Nc2nccc(-c3c[nH]c4ncccc34)n2)cc1		CHEMBL1807723	=	IC50	nM	484.0	CHEMBL2041	Homo sapiens	IC50	nM	484.0
	6293049	CHEMBL1811085	Inhibition of RET kinase	B	CN(C)CCc1ccc(Nc2nccc(-c3c[nH]c4ncccc34)n2)cc1		CHEMBL1807724	=	IC50	nM	537.0	CHEMBL2041	Homo sapiens	IC50	nM	537.0
	6293050	CHEMBL1811085	Inhibition of RET kinase	B	c1cnc2[nH]cc(-c3ccnc(Nc4ccc(CCN5CCCC5)cc4)n3)c2c1		CHEMBL1807725	=	IC50	nM	692.0	CHEMBL2041	Homo sapiens	IC50	nM	692.0
	6293051	CHEMBL1811085	Inhibition of RET kinase	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	=	IC50	nM	740.0	CHEMBL2041	Homo sapiens	IC50	nM	740.0
	6293052	CHEMBL1811085	Inhibition of RET kinase	B	CN1CCN(CCc2ccc(Nc3nccc(-c4c[nH]c5ncccc45)n3)cc2)CC1		CHEMBL1807773	=	IC50	nM	753.0	CHEMBL2041	Homo sapiens	IC50	nM	753.0
	6293053	CHEMBL1811085	Inhibition of RET kinase	B	Cc1cccc(Nc2nccc(-c3c[nH]c4ncccc34)n2)c1		CHEMBL214819	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	6293054	CHEMBL1811085	Inhibition of RET kinase	B	CCN(CC)Cc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL249303	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	6293055	CHEMBL1811085	Inhibition of RET kinase	B	CN1CCN(c2ccc3[nH]c(-c4n[nH]c5ncc(-c6cncc7ccccc67)cc45)nc3c2)CC1		CHEMBL249304	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	6293056	CHEMBL1811085	Inhibition of RET kinase	B	O=C(NC1CC1)c1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL1807774	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	6293057	CHEMBL1811085	Inhibition of RET kinase	B	COCCCO/N=C/c1c(N)ncnc1Oc1ccc2[nH]c(C)cc2c1F		CHEMBL220951	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	6293058	CHEMBL1811085	Inhibition of RET kinase	B	CN1CCN(c2ccc3[nH]c(-c4n[nH]c5ncc(Br)cc45)nc3c2)CC1		CHEMBL1807775	=	IC50	nM	1073.0	CHEMBL2041	Homo sapiens	IC50	nM	1073.0
	6293059	CHEMBL1811085	Inhibition of RET kinase	B	COCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cccnc5)cc34)nc12		CHEMBL400859	=	IC50	nM	1100.0	CHEMBL2041	Homo sapiens	IC50	nM	1100.0
	6293060	CHEMBL1811085	Inhibition of RET kinase	B	Cc1cc(CCN(C)C)ccc1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1807776	=	IC50	nM	1117.0	CHEMBL2041	Homo sapiens	IC50	nM	1117.0
	6293061	CHEMBL1811085	Inhibition of RET kinase	B	CC(C)(C)NC(=O)c1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL1807777	=	IC50	nM	1227.0	CHEMBL2041	Homo sapiens	IC50	nM	1227.0
	6293062	CHEMBL1811085	Inhibition of RET kinase	B	CCN(CC)C(=O)c1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12		CHEMBL251739	=	IC50	nM	1230.0	CHEMBL2041	Homo sapiens	IC50	nM	1230.0
	6293063	CHEMBL1811085	Inhibition of RET kinase	B	CN1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1807778	=	IC50	nM	1232.0	CHEMBL2041	Homo sapiens	IC50	nM	1232.0
	6293064	CHEMBL1811085	Inhibition of RET kinase	B	CNCCc1ccc(Nc2nccc(-c3c[nH]c4ncccc34)n2)cc1		CHEMBL1807779	=	IC50	nM	1262.0	CHEMBL2041	Homo sapiens	IC50	nM	1262.0
	6293065	CHEMBL1811085	Inhibition of RET kinase	B	COCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cc[nH]c5)cc34)nc12		CHEMBL1807780	=	IC50	nM	1268.0	CHEMBL2041	Homo sapiens	IC50	nM	1268.0
	6293066	CHEMBL1811085	Inhibition of RET kinase	B	COCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc(CN6CCOCC6)c5)cc34)nc12		CHEMBL1807781	=	IC50	nM	2990.0	CHEMBL2041	Homo sapiens	IC50	nM	2990.0
	6293067	CHEMBL1811085	Inhibition of RET kinase	B	COCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc(CN(C)C)c5)cc34)nc12		CHEMBL249518	=	IC50	nM	3230.0	CHEMBL2041	Homo sapiens	IC50	nM	3230.0
	6293068	CHEMBL1811085	Inhibition of RET kinase	B	Cc1cc2c(F)c(Oc3ncnc(N)c3/C=N/OCCCN3CCCCC3)ccc2[nH]1		CHEMBL1807782	=	IC50	nM	4246.0	CHEMBL2041	Homo sapiens	IC50	nM	4246.0
	6293069	CHEMBL1811085	Inhibition of RET kinase	B	CO/N=C/c1c(N)ncnc1Oc1ccc(O)cc1		CHEMBL1807783	=	IC50	nM	9204.0	CHEMBL2041	Homo sapiens	IC50	nM	9204.0
	6293070	CHEMBL1811085	Inhibition of RET kinase	B	c1cnc2[nH]cc(-c3ccnc(NC4CCOCC4)n3)c2c1		CHEMBL1807784	=	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	6293071	CHEMBL1811085	Inhibition of RET kinase	B	FC(F)(F)c1ccccc1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL385827	=	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	6293072	CHEMBL1811085	Inhibition of RET kinase	B	c1cnc2[nH]cc(-c3ccnc(NC4CCCC4)n3)c2c1		CHEMBL1808237	=	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	6293073	CHEMBL1811085	Inhibition of RET kinase	B	CCc1ccccc1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL213277	=	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	6293074	CHEMBL1811085	Inhibition of RET kinase	B	COCc1cccc2[nH]c(-c3n[nH]c4ncc(Br)cc34)nc12		CHEMBL1808238	=	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	6293075	CHEMBL1811085	Inhibition of RET kinase	B	C=CCO/N=C/c1c(N)ncnc1Oc1ccc2[nH]c(C)cc2c1F		CHEMBL221224	=	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	6293076	CHEMBL1811085	Inhibition of RET kinase	B	Fc1ccc2nc(-c3n[nH]c4ncc(-c5cccnc5)cc34)[nH]c2c1		CHEMBL1808239	=	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	nM	100000.0
	6293077	CHEMBL1811085	Inhibition of RET kinase	B	Cc1cc2c(F)c(Oc3ncnc(N)c3/C=N/OCCCN(C)C)ccc2[nH]1		CHEMBL220444	=	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	nM	100000.0
	6293078	CHEMBL1811085	Inhibition of RET kinase	B	CO/N=C/c1c(N)ncnc1Oc1ccc2[nH]c(C)cc2c1		CHEMBL223486	=	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	nM	100000.0
	6304886	CHEMBL1816203	Inhibition of RET	B	O=C(Nc1ccc(Oc2ncnc3scc(-c4ccccc4)c23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL1813632	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	6340928	CHEMBL1826952	Activity of RET V804L kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	91.0	CHEMBL2041	Homo sapiens	Activity	%	91.0
	6340968	CHEMBL1827292	Activity of RET M918T mutant kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	95.0	CHEMBL2041	Homo sapiens	Activity	%	95.0
	6341004	CHEMBL1827629	Activity of RET V804M mutant kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	99.0	CHEMBL2041	Homo sapiens	Activity	%	99.0
	6341123	CHEMBL1826695	Activity of RET kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	6353478	CHEMBL1825790	Inhibition of RET at 10 uM	B	O=C(Cn1c(=O)ccc2cc(C(F)(F)F)ccc21)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1822146	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	INH	%	4.0
	6375427	CHEMBL1840253	Inhibition of RET at 1 uM by radiometric assay	B	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)NCCNC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)CC[C@]3(C)CC[C@]21C		CHEMBL1836927	=	Inhibition	%	48.0	CHEMBL2041	Homo sapiens	INH	%	48.0
	6387472	CHEMBL1839922	Inhibition of recombinant RET	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	6387485	CHEMBL1839935	Inhibition of RET juxtamembrane domain-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	3352.0	CHEMBL2041	Homo sapiens	IC50	nM	3352.0
	7567539	CHEMBL1908818	Binding constant for RET kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7567540	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7567541	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7567542	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7568010	CHEMBL1908818	Binding constant for RET kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7568011	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7568012	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7568013	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7568478	CHEMBL1908818	Binding constant for RET kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	71.0	CHEMBL2041	Homo sapiens	Kd	nM	71.0
	7568479	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	53.0	CHEMBL2041	Homo sapiens	Kd	nM	53.0
	7568480	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7568481	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	6000.0	CHEMBL2041	Homo sapiens	Kd	nM	6000.0
	7568910	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	37.0	CHEMBL2041	Homo sapiens	Kd	nM	37.0
	7568911	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	24.0	CHEMBL2041	Homo sapiens	Kd	nM	24.0
	7568912	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	18.0	CHEMBL2041	Homo sapiens	Kd	nM	18.0
	7568913	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	14.0	CHEMBL2041	Homo sapiens	Kd	nM	14.0
	7569053	CHEMBL1908818	Binding constant for RET kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	6.1	CHEMBL2041	Homo sapiens	Kd	nM	6.1
	7569054	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	7.5	CHEMBL2041	Homo sapiens	Kd	nM	7.5
	7569055	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7569056	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	3800.0	CHEMBL2041	Homo sapiens	Kd	nM	3800.0
	7569513	CHEMBL1908818	Binding constant for RET kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7569514	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	3300.0	CHEMBL2041	Homo sapiens	Kd	nM	3300.0
	7569515	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7569516	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7569985	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7569986	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7569987	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7569988	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7570448	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	690.0	CHEMBL2041	Homo sapiens	Kd	nM	690.0
	7570449	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	580.0	CHEMBL2041	Homo sapiens	Kd	nM	580.0
	7570450	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	460.0	CHEMBL2041	Homo sapiens	Kd	nM	460.0
	7570451	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	510.0	CHEMBL2041	Homo sapiens	Kd	nM	510.0
	7570875	CHEMBL1908818	Binding constant for RET kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	13.0	CHEMBL2041	Homo sapiens	Kd	nM	13.0
	7570876	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	19.0	CHEMBL2041	Homo sapiens	Kd	nM	19.0
	7570877	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	8.7	CHEMBL2041	Homo sapiens	Kd	nM	8.7
	7570878	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	5.8	CHEMBL2041	Homo sapiens	Kd	nM	5.8
	7571029	CHEMBL1908818	Binding constant for RET kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7571030	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7571031	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7571032	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7571486	CHEMBL1908818	Binding constant for RET kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7571487	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	1300.0	CHEMBL2041	Homo sapiens	Kd	nM	1300.0
	7571488	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	2100.0	CHEMBL2041	Homo sapiens	Kd	nM	2100.0
	7571489	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7571962	CHEMBL1908818	Binding constant for RET kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	720.0	CHEMBL2041	Homo sapiens	Kd	nM	720.0
	7571963	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	630.0	CHEMBL2041	Homo sapiens	Kd	nM	630.0
	7571964	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	280.0	CHEMBL2041	Homo sapiens	Kd	nM	280.0
	7571965	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	190.0	CHEMBL2041	Homo sapiens	Kd	nM	190.0
	7572425	CHEMBL1908818	Binding constant for RET kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7572426	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7572427	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7572428	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7572841	CHEMBL1908818	Binding constant for RET kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	150.0	CHEMBL2041	Homo sapiens	Kd	nM	150.0
	7572842	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	140.0	CHEMBL2041	Homo sapiens	Kd	nM	140.0
	7573010	CHEMBL1908818	Binding constant for RET kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7573011	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7573012	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7573013	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7573467	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	730.0	CHEMBL2041	Homo sapiens	Kd	nM	730.0
	7573468	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	390.0	CHEMBL2041	Homo sapiens	Kd	nM	390.0
	7573469	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	3200.0	CHEMBL2041	Homo sapiens	Kd	nM	3200.0
	7573470	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7573943	CHEMBL1908818	Binding constant for RET kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	9.2	CHEMBL2041	Homo sapiens	Kd	nM	9.2
	7573944	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	6.4	CHEMBL2041	Homo sapiens	Kd	nM	6.4
	7573945	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	1.2	CHEMBL2041	Homo sapiens	Kd	nM	1.2
	7573946	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	0.83	CHEMBL2041	Homo sapiens	Kd	nM	0.83
	7574380	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	120.0	CHEMBL2041	Homo sapiens	Kd	nM	120.0
	7574381	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	140.0	CHEMBL2041	Homo sapiens	Kd	nM	140.0
	7574988	CHEMBL1908818	Binding constant for RET kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	31.0	CHEMBL2041	Homo sapiens	Kd	nM	31.0
	7574989	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	30.0	CHEMBL2041	Homo sapiens	Kd	nM	30.0
	7574990	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	9.8	CHEMBL2041	Homo sapiens	Kd	nM	9.8
	7574991	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	9.6	CHEMBL2041	Homo sapiens	Kd	nM	9.6
	7575449	CHEMBL1908818	Binding constant for RET kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1300.0	CHEMBL2041	Homo sapiens	Kd	nM	1300.0
	7575450	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	330.0	CHEMBL2041	Homo sapiens	Kd	nM	330.0
	7575451	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7575452	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7575943	CHEMBL1908818	Binding constant for RET kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	350.0	CHEMBL2041	Homo sapiens	Kd	nM	350.0
	7575944	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	130.0	CHEMBL2041	Homo sapiens	Kd	nM	130.0
	7575945	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	27.0	CHEMBL2041	Homo sapiens	Kd	nM	27.0
	7575946	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	20.0	CHEMBL2041	Homo sapiens	Kd	nM	20.0
	7576351	CHEMBL1908818	Binding constant for RET kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7576352	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7576353	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7576354	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7576962	CHEMBL1908818	Binding constant for RET kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7576963	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7576964	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7576965	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7577421	CHEMBL1908818	Binding constant for RET kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	0.74	CHEMBL2041	Homo sapiens	Kd	nM	0.74
	7577422	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	0.67	CHEMBL2041	Homo sapiens	Kd	nM	0.67
	7577423	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	1.6	CHEMBL2041	Homo sapiens	Kd	nM	1.6
	7577424	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	2.8	CHEMBL2041	Homo sapiens	Kd	nM	2.8
	7577457	CHEMBL1908818	Binding constant for RET kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	2500.0	CHEMBL2041	Homo sapiens	Kd	nM	2500.0
	7577458	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	920.0	CHEMBL2041	Homo sapiens	Kd	nM	920.0
	7577459	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7577460	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7577927	CHEMBL1908818	Binding constant for RET kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7577928	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7577929	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7577930	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7578332	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	130.0	CHEMBL2041	Homo sapiens	Kd	nM	130.0
	7578333	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	150.0	CHEMBL2041	Homo sapiens	Kd	nM	150.0
	7578334	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	71.0	CHEMBL2041	Homo sapiens	Kd	nM	71.0
	7578335	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	81.0	CHEMBL2041	Homo sapiens	Kd	nM	81.0
	7578970	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7578971	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7578972	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	1900.0	CHEMBL2041	Homo sapiens	Kd	nM	1900.0
	7578973	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	180.0	CHEMBL2041	Homo sapiens	Kd	nM	180.0
	7579344	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	500.0	CHEMBL2041	Homo sapiens	Kd	nM	500.0
	7579345	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	240.0	CHEMBL2041	Homo sapiens	Kd	nM	240.0
	7579346	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7579347	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7579826	CHEMBL1908818	Binding constant for RET kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	150.0	CHEMBL2041	Homo sapiens	Kd	nM	150.0
	7579827	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	47.0	CHEMBL2041	Homo sapiens	Kd	nM	47.0
	7579828	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	35.0	CHEMBL2041	Homo sapiens	Kd	nM	35.0
	7579829	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	35.0	CHEMBL2041	Homo sapiens	Kd	nM	35.0
	7580295	CHEMBL1908818	Binding constant for RET kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	4.8	CHEMBL2041	Homo sapiens	Kd	nM	4.8
	7580296	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	4.0	CHEMBL2041	Homo sapiens	Kd	nM	4.0
	7580297	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	350.0	CHEMBL2041	Homo sapiens	Kd	nM	350.0
	7580298	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	340.0	CHEMBL2041	Homo sapiens	Kd	nM	340.0
	7580698	CHEMBL1908818	Binding constant for RET kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	34.0	CHEMBL2041	Homo sapiens	Kd	nM	34.0
	7580699	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	14.0	CHEMBL2041	Homo sapiens	Kd	nM	14.0
	7580700	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7580701	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7581716	CHEMBL1908818	Binding constant for RET kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7581717	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7581718	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7581719	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7582187	CHEMBL1908818	Binding constant for RET kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7582188	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7582189	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7582190	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7582651	CHEMBL1908818	Binding constant for RET kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7582652	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	7600.0	CHEMBL2041	Homo sapiens	Kd	nM	7600.0
	7582653	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7582654	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7583051	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	28.0	CHEMBL2041	Homo sapiens	Kd	nM	28.0
	7583052	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	26.0	CHEMBL2041	Homo sapiens	Kd	nM	26.0
	7583053	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	8.6	CHEMBL2041	Homo sapiens	Kd	nM	8.6
	7583054	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	13.0	CHEMBL2041	Homo sapiens	Kd	nM	13.0
	7583232	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7583233	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7583234	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7583235	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7583629	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7583630	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7583631	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7583632	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7584074	CHEMBL1908818	Binding constant for RET kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7584075	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7584076	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7584077	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7584545	CHEMBL1908818	Binding constant for RET kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7584546	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7584547	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7584548	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7585007	CHEMBL1908818	Binding constant for RET kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	4.1	CHEMBL2041	Homo sapiens	Kd	nM	4.1
	7585008	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	4.1	CHEMBL2041	Homo sapiens	Kd	nM	4.1
	7585009	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	2.2	CHEMBL2041	Homo sapiens	Kd	nM	2.2
	7585010	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	3.1	CHEMBL2041	Homo sapiens	Kd	nM	3.1
	7585411	CHEMBL1908818	Binding constant for RET kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7585412	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7585413	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7585414	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7585562	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	100.0	CHEMBL2041	Homo sapiens	Kd	nM	100.0
	7585563	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	120.0	CHEMBL2041	Homo sapiens	Kd	nM	120.0
	7585564	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	970.0	CHEMBL2041	Homo sapiens	Kd	nM	970.0
	7585565	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	54.0	CHEMBL2041	Homo sapiens	Kd	nM	54.0
	7585970	CHEMBL1908818	Binding constant for RET kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7585971	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7585972	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7585973	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7586416	CHEMBL1908818	Binding constant for RET kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7586417	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7586418	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7586419	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7586887	CHEMBL1908818	Binding constant for RET kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7586888	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7586889	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7586890	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7587341	CHEMBL1908818	Binding constant for RET kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7587342	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7587343	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7587344	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7587523	CHEMBL1908818	Binding constant for RET kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	8.0	CHEMBL2041	Homo sapiens	Kd	nM	8.0
	7587524	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	3.0	CHEMBL2041	Homo sapiens	Kd	nM	3.0
	7587525	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	13.0	CHEMBL2041	Homo sapiens	Kd	nM	13.0
	7587526	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	9.1	CHEMBL2041	Homo sapiens	Kd	nM	9.1
	7587942	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	390.0	CHEMBL2041	Homo sapiens	Kd	nM	390.0
	7587943	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	360.0	CHEMBL2041	Homo sapiens	Kd	nM	360.0
	7587944	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7587945	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7588395	CHEMBL1908818	Binding constant for RET kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7588396	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7588397	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7588398	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7588866	CHEMBL1908818	Binding constant for RET kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7588867	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7588868	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7588869	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7589488	CHEMBL1908818	Binding constant for RET kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	120.0	CHEMBL2041	Homo sapiens	Kd	nM	120.0
	7589489	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	100.0	CHEMBL2041	Homo sapiens	Kd	nM	100.0
	7589490	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	1300.0	CHEMBL2041	Homo sapiens	Kd	nM	1300.0
	7589491	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	1600.0	CHEMBL2041	Homo sapiens	Kd	nM	1600.0
	7589912	CHEMBL1908818	Binding constant for RET kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	20.0	CHEMBL2041	Homo sapiens	Kd	nM	20.0
	7589913	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	14.0	CHEMBL2041	Homo sapiens	Kd	nM	14.0
	7589914	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	6.7	CHEMBL2041	Homo sapiens	Kd	nM	6.7
	7589915	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	4.7	CHEMBL2041	Homo sapiens	Kd	nM	4.7
	7590379	CHEMBL1908818	Binding constant for RET kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7590380	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7590381	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7590382	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7590853	CHEMBL1908818	Binding constant for RET kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7590854	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7590855	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7590856	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7590862	CHEMBL1908818	Binding constant for RET kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7590863	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7590864	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7590865	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7591461	CHEMBL1908818	Binding constant for RET kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	14.0	CHEMBL2041	Homo sapiens	Kd	nM	14.0
	7591462	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	20.0	CHEMBL2041	Homo sapiens	Kd	nM	20.0
	7591463	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7591464	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7591883	CHEMBL1908818	Binding constant for RET kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	71.0	CHEMBL2041	Homo sapiens	Kd	nM	71.0
	7591884	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	47.0	CHEMBL2041	Homo sapiens	Kd	nM	47.0
	7591885	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	27.0	CHEMBL2041	Homo sapiens	Kd	nM	27.0
	7591886	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	26.0	CHEMBL2041	Homo sapiens	Kd	nM	26.0
	7592355	CHEMBL1908818	Binding constant for RET kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7592356	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7592357	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7592358	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7592839	CHEMBL1908818	Binding constant for RET kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7592840	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7592841	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7592842	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7593428	CHEMBL1908818	Binding constant for RET kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	17.0	CHEMBL2041	Homo sapiens	Kd	nM	17.0
	7593429	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	4.5	CHEMBL2041	Homo sapiens	Kd	nM	4.5
	7593430	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	4.3	CHEMBL2041	Homo sapiens	Kd	nM	4.3
	7593431	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	3.2	CHEMBL2041	Homo sapiens	Kd	nM	3.2
	7593863	CHEMBL1908818	Binding constant for RET kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	150.0	CHEMBL2041	Homo sapiens	Kd	nM	150.0
	7593864	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	72.0	CHEMBL2041	Homo sapiens	Kd	nM	72.0
	7593865	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	320.0	CHEMBL2041	Homo sapiens	Kd	nM	320.0
	7593866	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	89.0	CHEMBL2041	Homo sapiens	Kd	nM	89.0
	7594366	CHEMBL1908818	Binding constant for RET kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7594367	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7594368	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7594369	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7594818	CHEMBL1908818	Binding constant for RET kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	4800.0	CHEMBL2041	Homo sapiens	Kd	nM	4800.0
	7594819	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	3800.0	CHEMBL2041	Homo sapiens	Kd	nM	3800.0
	7594820	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7594821	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	4200.0	CHEMBL2041	Homo sapiens	Kd	nM	4200.0
	7595396	CHEMBL1908818	Binding constant for RET kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7595397	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7595398	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7595399	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7595840	CHEMBL1908818	Binding constant for RET kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	4200.0	CHEMBL2041	Homo sapiens	Kd	nM	4200.0
	7595841	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	840.0	CHEMBL2041	Homo sapiens	Kd	nM	840.0
	7595842	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7595843	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7595872	CHEMBL1908818	Binding constant for RET kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7595873	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	1300.0	CHEMBL2041	Homo sapiens	Kd	nM	1300.0
	7595874	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7595875	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7596343	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	870.0	CHEMBL2041	Homo sapiens	Kd	nM	870.0
	7596344	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	1100.0	CHEMBL2041	Homo sapiens	Kd	nM	1100.0
	7596345	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7596346	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7596790	CHEMBL1908818	Binding constant for RET kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	13.0	CHEMBL2041	Homo sapiens	Kd	nM	13.0
	7596791	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	7.4	CHEMBL2041	Homo sapiens	Kd	nM	7.4
	7596792	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	39.0	CHEMBL2041	Homo sapiens	Kd	nM	39.0
	7596793	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	22.0	CHEMBL2041	Homo sapiens	Kd	nM	22.0
	7597368	CHEMBL1908818	Binding constant for RET kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	80.0	CHEMBL2041	Homo sapiens	Kd	nM	80.0
	7597369	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	120.0	CHEMBL2041	Homo sapiens	Kd	nM	120.0
	7597370	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	140.0	CHEMBL2041	Homo sapiens	Kd	nM	140.0
	7597371	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	240.0	CHEMBL2041	Homo sapiens	Kd	nM	240.0
	7597852	CHEMBL1908818	Binding constant for RET kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7597853	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7597854	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7597855	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
	7598322	CHEMBL1908818	Binding constant for RET kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	310.0	CHEMBL2041	Homo sapiens	Kd	nM	310.0
	7598323	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	270.0	CHEMBL2041	Homo sapiens	Kd	nM	270.0
	7598324	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	5900.0	CHEMBL2041	Homo sapiens	Kd	nM	5900.0
	7598325	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	2300.0	CHEMBL2041	Homo sapiens	Kd	nM	2300.0
	7598764	CHEMBL1908818	Binding constant for RET kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	15.0	CHEMBL2041	Homo sapiens	Kd	nM	15.0
	7598765	CHEMBL1908819	Binding constant for RET(M918T) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	28.0	CHEMBL2041	Homo sapiens	Kd	nM	28.0
	7598766	CHEMBL1908820	Binding constant for RET(V804L) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	15.0	CHEMBL2041	Homo sapiens	Kd	nM	15.0
	7598767	CHEMBL1908821	Binding constant for RET(V804M) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	12.0	CHEMBL2041	Homo sapiens	Kd	nM	12.0
	7922678	CHEMBL1918823	Inhibition of human recombinant RET at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	57.0	CHEMBL2041	Homo sapiens	INH	%	57.0
	7931131	CHEMBL1919468	Inhibition of RET relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	6.0	CHEMBL2041	Homo sapiens	INH	%	6.0
	7948002	CHEMBL1924391	Inhibition of RET at 10 uM	B	CNc1nc2[nH]c(-c3cccc(CNC(=O)COC)n3)cc2c2c1ncn2C		CHEMBL1923983	>	Inhibition	%	75.0	CHEMBL2041	Homo sapiens	INH	%	75.0
	7948009	CHEMBL1924440	Inhibition of RET	B	CNc1nc2[nH]c(-c3cccc(CNC(=O)COC)n3)cc2c2c1ncn2C		CHEMBL1923983	=	IC50	nM	614.0	CHEMBL2041	Homo sapiens	IC50	uM	0.614
	7961143	CHEMBL1931553	Inhibition of RET	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	3700.0	CHEMBL2041	Homo sapiens	IC50	uM	3.7
	7961144	CHEMBL1931553	Inhibition of RET	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	30.0	CHEMBL2041	Homo sapiens	IC50	uM	0.03
	7984707	CHEMBL1936628	Inhibition of RET	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1		CHEMBL1933576	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	7984708	CHEMBL1936628	Inhibition of RET	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1		CHEMBL1933582	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	7989291	CHEMBL1936691	Inhibition of human RET at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)C(C)(C)CNC4=O)nc1C(=O)NC1CCCC1		CHEMBL1933142	>=	Inhibition	%	80.0	CHEMBL2041	Homo sapiens	INH	%	80.0
	7989292	CHEMBL1936691	Inhibition of human RET at 3 uM	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	>=	Inhibition	%	80.0	CHEMBL2041	Homo sapiens	INH	%	80.0
	7989293	CHEMBL1936691	Inhibition of human RET at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	>=	Inhibition	%	80.0	CHEMBL2041	Homo sapiens	INH	%	80.0
	7989294	CHEMBL1936691	Inhibition of human RET at 3 uM	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	>=	Inhibition	%	80.0	CHEMBL2041	Homo sapiens	INH	%	80.0
	7989385	CHEMBL1937079	Inhibition of human RET	B	C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21		CHEMBL1933288	=	IC50	nM	161.0	CHEMBL2041	Homo sapiens	IC50	nM	161.0
	7991872	CHEMBL1937678	Inhibition of RET at 10 uM	B	Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934300	=	Inhibition	%	37.8	CHEMBL2041	Homo sapiens	INH	%	37.8
	7991873	CHEMBL1937678	Inhibition of RET at 10 uM	B	CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934301	=	Inhibition	%	19.0	CHEMBL2041	Homo sapiens	INH	%	19.0
	7991874	CHEMBL1937678	Inhibition of RET at 10 uM	B	CCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934302	=	Inhibition	%	43.0	CHEMBL2041	Homo sapiens	INH	%	43.0
	7991875	CHEMBL1937678	Inhibition of RET at 10 uM	B	CCCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934303	=	Inhibition	%	25.8	CHEMBL2041	Homo sapiens	INH	%	25.8
	7991876	CHEMBL1937678	Inhibition of RET at 10 uM	B	CCCC(CCC)C(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934304	=	Inhibition	%	14.4	CHEMBL2041	Homo sapiens	INH	%	14.4
	7991877	CHEMBL1937678	Inhibition of RET at 10 uM	B	C=CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934305	=	Inhibition	%	31.9	CHEMBL2041	Homo sapiens	INH	%	31.9
	7991878	CHEMBL1937678	Inhibition of RET at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccco1		CHEMBL1934306	=	Inhibition	%	22.8	CHEMBL2041	Homo sapiens	INH	%	22.8
	7991879	CHEMBL1937678	Inhibition of RET at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccncc1		CHEMBL1934307	=	Inhibition	%	28.9	CHEMBL2041	Homo sapiens	INH	%	28.9
	7991880	CHEMBL1937678	Inhibition of RET at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	84.8	CHEMBL2041	Homo sapiens	INH	%	84.8
Not Determined	7991881	CHEMBL1937678	Inhibition of RET at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Determined	7991882	CHEMBL1937678	Inhibition of RET at 10 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Determined	7991883	CHEMBL1937678	Inhibition of RET at 10 uM	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Determined	7991884	CHEMBL1937678	Inhibition of RET at 10 uM	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(O)c(O)c1		CHEMBL56393		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Determined	7991885	CHEMBL1937678	Inhibition of RET at 10 uM	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	7992216	CHEMBL1936088	Inhibition of RET at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	104.0	CHEMBL2041	Homo sapiens	INH	%	104.0
	7996716	CHEMBL1944368	Inhibition of RET at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	7996717	CHEMBL1944369	Inhibition of RET M918T mutant at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	7996718	CHEMBL1944370	Inhibition of RET V804L mutant at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	7996719	CHEMBL1944371	Inhibition of RET V804M mutant at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	7996758	CHEMBL1944368	Inhibition of RET at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	96.0	CHEMBL2041	Homo sapiens	INH	%	96.0
	7996759	CHEMBL1944369	Inhibition of RET M918T mutant at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	98.0	CHEMBL2041	Homo sapiens	INH	%	98.0
	7996760	CHEMBL1944370	Inhibition of RET V804L mutant at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	98.0	CHEMBL2041	Homo sapiens	INH	%	98.0
	7996761	CHEMBL1944371	Inhibition of RET V804M mutant at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	97.0	CHEMBL2041	Homo sapiens	INH	%	97.0
	8013077	CHEMBL1947864	Inhibition of RET using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	IC50	nM	7700.0	CHEMBL2041	Homo sapiens	IC50	uM	7.7
	8018894	CHEMBL1949060	Inhibition of Ret assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	84.0	CHEMBL2041	Homo sapiens	Activity	%	84.0
	8018895	CHEMBL1949060	Inhibition of Ret assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	77.0	CHEMBL2041	Homo sapiens	Activity	%	77.0
	8018896	CHEMBL1949060	Inhibition of Ret assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	80.0	CHEMBL2041	Homo sapiens	Activity	%	80.0
	8020341	CHEMBL1948785	Binding affinity to human RET V804M mutant at 10 uM relative to control	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(F)cccc3Cl)n21		CHEMBL1945723	=	Activity	%	14.0	CHEMBL2041	Homo sapiens	Activity	%	14.0
	8061593	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	46.33	CHEMBL2041	Homo sapiens	Inhibition	%	46.33
	8061594	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	11.07	CHEMBL2041	Homo sapiens	Inhibition	%	11.07
	8061595	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	28.44	CHEMBL2041	Homo sapiens	Inhibition	%	28.44
	8061700	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	6.59	CHEMBL2041	Homo sapiens	Inhibition	%	6.59
	8061701	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.17	CHEMBL2041	Homo sapiens	Inhibition	%	4.17
	8061702	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	7.03	CHEMBL2041	Homo sapiens	Inhibition	%	7.03
	8061924	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	18.33	CHEMBL2041	Homo sapiens	Inhibition	%	18.33
	8061925	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	7.13	CHEMBL2041	Homo sapiens	Inhibition	%	7.13
	8062115	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	20.18	CHEMBL2041	Homo sapiens	Inhibition	%	20.18
	8062116	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	46.16	CHEMBL2041	Homo sapiens	Inhibition	%	46.16
	8062117	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	27.14	CHEMBL2041	Homo sapiens	Inhibition	%	27.14
	8062231	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	13.63	CHEMBL2041	Homo sapiens	Inhibition	%	13.63
	8062232	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.35	CHEMBL2041	Homo sapiens	Inhibition	%	0.35
	8062233	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	34.35	CHEMBL2041	Homo sapiens	Inhibition	%	34.35
	8062455	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.99	CHEMBL2041	Homo sapiens	Inhibition	%	2.99
	8062456	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.88	CHEMBL2041	Homo sapiens	Inhibition	%	2.88
	8062457	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.98	CHEMBL2041	Homo sapiens	Inhibition	%	3.98
	8062617	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	9.97	CHEMBL2041	Homo sapiens	Inhibition	%	9.97
	8062618	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	30.28	CHEMBL2041	Homo sapiens	Inhibition	%	30.28
	8062619	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	20.77	CHEMBL2041	Homo sapiens	Inhibition	%	20.77
	8062939	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	5.58	CHEMBL2041	Homo sapiens	Inhibition	%	5.58
	8062940	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-1.85	CHEMBL2041	Homo sapiens	Inhibition	%	-1.85
	8062941	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.54	CHEMBL2041	Homo sapiens	Inhibition	%	1.54
	8063071	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	47.61	CHEMBL2041	Homo sapiens	Inhibition	%	47.61
	8063072	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.17	CHEMBL2041	Homo sapiens	Inhibition	%	1.17
	8063073	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	39.48	CHEMBL2041	Homo sapiens	Inhibition	%	39.48
	8063462	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.17	CHEMBL2041	Homo sapiens	Inhibition	%	2.17
	8063463	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.33	CHEMBL2041	Homo sapiens	Inhibition	%	2.33
	8063464	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.51	CHEMBL2041	Homo sapiens	Inhibition	%	2.51
	8063572	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	36.17	CHEMBL2041	Homo sapiens	Inhibition	%	36.17
	8063794	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	6.29	CHEMBL2041	Homo sapiens	Inhibition	%	6.29
	8063795	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	4.67	CHEMBL2041	Homo sapiens	Inhibition	%	4.67
	8063796	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	6.95	CHEMBL2041	Homo sapiens	Inhibition	%	6.95
	8063976	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	66.63	CHEMBL2041	Homo sapiens	Inhibition	%	66.63
	8063977	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	85.83	CHEMBL2041	Homo sapiens	Inhibition	%	85.83
	8063978	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	74.09	CHEMBL2041	Homo sapiens	Inhibition	%	74.09
	8064315	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.58	CHEMBL2041	Homo sapiens	Inhibition	%	4.58
	8064316	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.31	CHEMBL2041	Homo sapiens	Inhibition	%	1.31
	8064317	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	7.82	CHEMBL2041	Homo sapiens	Inhibition	%	7.82
	8064525	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	3.72	CHEMBL2041	Homo sapiens	Inhibition	%	3.72
	8064526	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.31	CHEMBL2041	Homo sapiens	Inhibition	%	0.31
	8064527	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	3.85	CHEMBL2041	Homo sapiens	Inhibition	%	3.85
	8064663	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	76.56	CHEMBL2041	Homo sapiens	Inhibition	%	76.56
	8064664	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	7.47	CHEMBL2041	Homo sapiens	Inhibition	%	7.47
	8064665	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	76.26	CHEMBL2041	Homo sapiens	Inhibition	%	76.26
	8064887	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	6.8	CHEMBL2041	Homo sapiens	Inhibition	%	6.8
	8064888	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	4.53	CHEMBL2041	Homo sapiens	Inhibition	%	4.53
	8064889	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	6.85	CHEMBL2041	Homo sapiens	Inhibition	%	6.85
	8065053	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.91	CHEMBL2041	Homo sapiens	Inhibition	%	-0.91
	8065054	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	6.71	CHEMBL2041	Homo sapiens	Inhibition	%	6.71
	8065055	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	13.28	CHEMBL2041	Homo sapiens	Inhibition	%	13.28
	8065393	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	8.97	CHEMBL2041	Homo sapiens	Inhibition	%	8.97
	8065394	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	5.88	CHEMBL2041	Homo sapiens	Inhibition	%	5.88
	8065395	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	13.74	CHEMBL2041	Homo sapiens	Inhibition	%	13.74
	8065568	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	7.52	CHEMBL2041	Homo sapiens	Inhibition	%	7.52
	8065569	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.11	CHEMBL2041	Homo sapiens	Inhibition	%	4.11
	8065570	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	7.75	CHEMBL2041	Homo sapiens	Inhibition	%	7.75
	8065907	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.06	CHEMBL2041	Homo sapiens	Inhibition	%	3.06
	8065908	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.42	CHEMBL2041	Homo sapiens	Inhibition	%	3.42
	8065909	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.78	CHEMBL2041	Homo sapiens	Inhibition	%	3.78
	8066117	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	4.94	CHEMBL2041	Homo sapiens	Inhibition	%	4.94
	8066118	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.74	CHEMBL2041	Homo sapiens	Inhibition	%	-0.74
	8066119	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.86	CHEMBL2041	Homo sapiens	Inhibition	%	0.86
	8066477	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	23.1	CHEMBL2041	Homo sapiens	Inhibition	%	23.1
	8066478	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	17.06	CHEMBL2041	Homo sapiens	Inhibition	%	17.06
	8066479	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	27.24	CHEMBL2041	Homo sapiens	Inhibition	%	27.24
	8066643	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.65	CHEMBL2041	Homo sapiens	Inhibition	%	0.65
	8066644	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	6.95	CHEMBL2041	Homo sapiens	Inhibition	%	6.95
	8066645	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.39	CHEMBL2041	Homo sapiens	Inhibition	%	0.39
	8066991	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	69.69	CHEMBL2041	Homo sapiens	Inhibition	%	69.69
	8066992	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	37.54	CHEMBL2041	Homo sapiens	Inhibition	%	37.54
	8066993	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	66.39	CHEMBL2041	Homo sapiens	Inhibition	%	66.39
	8067166	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	31.75	CHEMBL2041	Homo sapiens	Inhibition	%	31.75
	8067167	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.86	CHEMBL2041	Homo sapiens	Inhibition	%	2.86
	8067168	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	22.13	CHEMBL2041	Homo sapiens	Inhibition	%	22.13
	8067390	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	5.15	CHEMBL2041	Homo sapiens	Inhibition	%	5.15
	8067391	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	5.11	CHEMBL2041	Homo sapiens	Inhibition	%	5.11
	8067392	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	5.5	CHEMBL2041	Homo sapiens	Inhibition	%	5.5
	8067511	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.26	CHEMBL2041	Homo sapiens	Inhibition	%	4.26
	8067512	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	6.51	CHEMBL2041	Homo sapiens	Inhibition	%	6.51
	8067513	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.39	CHEMBL2041	Homo sapiens	Inhibition	%	1.39
	8067721	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.76	CHEMBL2041	Homo sapiens	Inhibition	%	0.76
	8067722	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	4.16	CHEMBL2041	Homo sapiens	Inhibition	%	4.16
	8067723	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.64	CHEMBL2041	Homo sapiens	Inhibition	%	3.64
	8067945	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	9.96	CHEMBL2041	Homo sapiens	Inhibition	%	9.96
	8067946	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.71	CHEMBL2041	Homo sapiens	Inhibition	%	1.71
	8067947	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	13.05	CHEMBL2041	Homo sapiens	Inhibition	%	13.05
	8068080	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	9.58	CHEMBL2041	Homo sapiens	Inhibition	%	9.58
	8068081	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	6.17	CHEMBL2041	Homo sapiens	Inhibition	%	6.17
	8068082	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	4.62	CHEMBL2041	Homo sapiens	Inhibition	%	4.62
	8068244	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.93	CHEMBL2041	Homo sapiens	Inhibition	%	1.93
	8068245	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	9.13	CHEMBL2041	Homo sapiens	Inhibition	%	9.13
	8068246	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	9.16	CHEMBL2041	Homo sapiens	Inhibition	%	9.16
	8068468	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.14	CHEMBL2041	Homo sapiens	Inhibition	%	2.14
	8068469	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.71	CHEMBL2041	Homo sapiens	Inhibition	%	0.71
	8068470	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.39	CHEMBL2041	Homo sapiens	Inhibition	%	0.39
	8068593	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	80.58	CHEMBL2041	Homo sapiens	Inhibition	%	80.58
	8068594	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	66.5	CHEMBL2041	Homo sapiens	Inhibition	%	66.5
	8068595	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	84.41	CHEMBL2041	Homo sapiens	Inhibition	%	84.41
	8068991	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	5.22	CHEMBL2041	Homo sapiens	Inhibition	%	5.22
	8068992	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.64	CHEMBL2041	Homo sapiens	Inhibition	%	2.64
	8068993	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.06	CHEMBL2041	Homo sapiens	Inhibition	%	0.06
	8069116	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.59	CHEMBL2041	Homo sapiens	Inhibition	%	1.59
	8069117	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.36	CHEMBL2041	Homo sapiens	Inhibition	%	0.36
	8069118	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	4.32	CHEMBL2041	Homo sapiens	Inhibition	%	4.32
	8069340	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.12	CHEMBL2041	Homo sapiens	Inhibition	%	5.12
	8069341	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.74	CHEMBL2041	Homo sapiens	Inhibition	%	1.74
	8069411	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	25.37	CHEMBL2041	Homo sapiens	Inhibition	%	25.37
	8069412	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	33.5	CHEMBL2041	Homo sapiens	Inhibition	%	33.5
	8069413	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	33.58	CHEMBL2041	Homo sapiens	Inhibition	%	33.58
	8069796	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	3.79	CHEMBL2041	Homo sapiens	Inhibition	%	3.79
	8069797	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	14.41	CHEMBL2041	Homo sapiens	Inhibition	%	14.41
	8069798	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	10.76	CHEMBL2041	Homo sapiens	Inhibition	%	10.76
	8069922	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.59	CHEMBL2041	Homo sapiens	Inhibition	%	0.59
	8069923	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.83	CHEMBL2041	Homo sapiens	Inhibition	%	1.83
	8069924	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.07	CHEMBL2041	Homo sapiens	Inhibition	%	1.07
	8070146	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.03	CHEMBL2041	Homo sapiens	Inhibition	%	-0.03
	8070147	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.29	CHEMBL2041	Homo sapiens	Inhibition	%	2.29
	8070148	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	7.62	CHEMBL2041	Homo sapiens	Inhibition	%	7.62
	8070318	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.55	CHEMBL2041	Homo sapiens	Inhibition	%	4.55
	8070319	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.54	CHEMBL2041	Homo sapiens	Inhibition	%	3.54
	8070320	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	5.77	CHEMBL2041	Homo sapiens	Inhibition	%	5.77
	8070445	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	7.11	CHEMBL2041	Homo sapiens	Inhibition	%	7.11
	8070667	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.14	CHEMBL2041	Homo sapiens	Inhibition	%	2.14
	8070668	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.27	CHEMBL2041	Homo sapiens	Inhibition	%	3.27
	8070669	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	5.08	CHEMBL2041	Homo sapiens	Inhibition	%	5.08
	8070741	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	11.37	CHEMBL2041	Homo sapiens	Inhibition	%	11.37
	8070742	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	10.59	CHEMBL2041	Homo sapiens	Inhibition	%	10.59
	8070743	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	9.68	CHEMBL2041	Homo sapiens	Inhibition	%	9.68
	8070965	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	35.72	CHEMBL2041	Homo sapiens	Inhibition	%	35.72
	8070966	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	50.87	CHEMBL2041	Homo sapiens	Inhibition	%	50.87
	8070967	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	47.45	CHEMBL2041	Homo sapiens	Inhibition	%	47.45
	8071122	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.45	CHEMBL2041	Homo sapiens	Inhibition	%	2.45
	8071123	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.83	CHEMBL2041	Homo sapiens	Inhibition	%	3.83
	8071124	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.41	CHEMBL2041	Homo sapiens	Inhibition	%	-0.41
	8071472	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.65	CHEMBL2041	Homo sapiens	Inhibition	%	1.65
	8071473	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-1.82	CHEMBL2041	Homo sapiens	Inhibition	%	-1.82
	8071474	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.64	CHEMBL2041	Homo sapiens	Inhibition	%	3.64
	8071645	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	8.7	CHEMBL2041	Homo sapiens	Inhibition	%	8.7
	8071646	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-0.15	CHEMBL2041	Homo sapiens	Inhibition	%	-0.15
	8071647	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-4.94	CHEMBL2041	Homo sapiens	Inhibition	%	-4.94
	8071994	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	5.62	CHEMBL2041	Homo sapiens	Inhibition	%	5.62
	8071995	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.58	CHEMBL2041	Homo sapiens	Inhibition	%	2.58
	8071996	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	4.31	CHEMBL2041	Homo sapiens	Inhibition	%	4.31
	8072308	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	17.01	CHEMBL2041	Homo sapiens	Inhibition	%	17.01
	8072309	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	4.35	CHEMBL2041	Homo sapiens	Inhibition	%	4.35
	8072310	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	9.63	CHEMBL2041	Homo sapiens	Inhibition	%	9.63
	8072465	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.28	CHEMBL2041	Homo sapiens	Inhibition	%	-0.28
	8072466	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	7.51	CHEMBL2041	Homo sapiens	Inhibition	%	7.51
	8072467	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	11.02	CHEMBL2041	Homo sapiens	Inhibition	%	11.02
	8072814	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	15.14	CHEMBL2041	Homo sapiens	Inhibition	%	15.14
	8072815	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.72	CHEMBL2041	Homo sapiens	Inhibition	%	2.72
	8072816	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	18.74	CHEMBL2041	Homo sapiens	Inhibition	%	18.74
	8072981	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	6.36	CHEMBL2041	Homo sapiens	Inhibition	%	6.36
	8072982	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.14	CHEMBL2041	Homo sapiens	Inhibition	%	4.14
	8072983	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.67	CHEMBL2041	Homo sapiens	Inhibition	%	4.67
	8073205	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.7	CHEMBL2041	Homo sapiens	Inhibition	%	4.7
	8073206	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.95	CHEMBL2041	Homo sapiens	Inhibition	%	0.95
	8073207	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-2.51	CHEMBL2041	Homo sapiens	Inhibition	%	-2.51
	8073330	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	86.71	CHEMBL2041	Homo sapiens	Inhibition	%	86.71
	8073331	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	67.27	CHEMBL2041	Homo sapiens	Inhibition	%	67.27
	8073332	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	78.86	CHEMBL2041	Homo sapiens	Inhibition	%	78.86
	8073673	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	3.85	CHEMBL2041	Homo sapiens	Inhibition	%	3.85
	8073674	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	7.64	CHEMBL2041	Homo sapiens	Inhibition	%	7.64
	8073675	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	8.06	CHEMBL2041	Homo sapiens	Inhibition	%	8.06
	8073906	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	61.12	CHEMBL2041	Homo sapiens	Inhibition	%	61.12
	8073907	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	8.1	CHEMBL2041	Homo sapiens	Inhibition	%	8.1
	8073908	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	38.89	CHEMBL2041	Homo sapiens	Inhibition	%	38.89
	8074058	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	11.12	CHEMBL2041	Homo sapiens	Inhibition	%	11.12
	8074059	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	8.3	CHEMBL2041	Homo sapiens	Inhibition	%	8.3
	8074060	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	15.29	CHEMBL2041	Homo sapiens	Inhibition	%	15.29
	8074282	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	26.65	CHEMBL2041	Homo sapiens	Inhibition	%	26.65
	8074283	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	13.8	CHEMBL2041	Homo sapiens	Inhibition	%	13.8
	8074284	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	25.83	CHEMBL2041	Homo sapiens	Inhibition	%	25.83
	8074412	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	3.06	CHEMBL2041	Homo sapiens	Inhibition	%	3.06
	8074413	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.43	CHEMBL2041	Homo sapiens	Inhibition	%	0.43
	8074414	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.87	CHEMBL2041	Homo sapiens	Inhibition	%	1.87
	8074793	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	5.79	CHEMBL2041	Homo sapiens	Inhibition	%	5.79
	8074794	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.51	CHEMBL2041	Homo sapiens	Inhibition	%	2.51
	8074795	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.81	CHEMBL2041	Homo sapiens	Inhibition	%	3.81
	8074920	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	88.42	CHEMBL2041	Homo sapiens	Inhibition	%	88.42
	8074921	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	84.6	CHEMBL2041	Homo sapiens	Inhibition	%	84.6
	8074922	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	83.18	CHEMBL2041	Homo sapiens	Inhibition	%	83.18
	8075255	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	18.75	CHEMBL2041	Homo sapiens	Inhibition	%	18.75
	8075256	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	35.42	CHEMBL2041	Homo sapiens	Inhibition	%	35.42
	8075257	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	18.2	CHEMBL2041	Homo sapiens	Inhibition	%	18.2
	8075492	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.08	CHEMBL2041	Homo sapiens	Inhibition	%	-0.08
	8075493	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.92	CHEMBL2041	Homo sapiens	Inhibition	%	0.92
	8075494	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	5.91	CHEMBL2041	Homo sapiens	Inhibition	%	5.91
	8075857	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	7.27	CHEMBL2041	Homo sapiens	Inhibition	%	7.27
	8075858	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	5.17	CHEMBL2041	Homo sapiens	Inhibition	%	5.17
	8075859	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.26	CHEMBL2041	Homo sapiens	Inhibition	%	3.26
	8075999	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	22.09	CHEMBL2041	Homo sapiens	Inhibition	%	22.09
	8076000	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	7.17	CHEMBL2041	Homo sapiens	Inhibition	%	7.17
	8076001	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	23.39	CHEMBL2041	Homo sapiens	Inhibition	%	23.39
	8076371	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.25	CHEMBL2041	Homo sapiens	Inhibition	%	3.25
	8076372	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.95	CHEMBL2041	Homo sapiens	Inhibition	%	0.95
	8076373	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.66	CHEMBL2041	Homo sapiens	Inhibition	%	4.66
	8076505	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.55	CHEMBL2041	Homo sapiens	Inhibition	%	4.55
	8076506	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	7.14	CHEMBL2041	Homo sapiens	Inhibition	%	7.14
	8076507	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	8.29	CHEMBL2041	Homo sapiens	Inhibition	%	8.29
	8076729	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	3.04	CHEMBL2041	Homo sapiens	Inhibition	%	3.04
	8076730	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	13.96	CHEMBL2041	Homo sapiens	Inhibition	%	13.96
	8076731	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	14.21	CHEMBL2041	Homo sapiens	Inhibition	%	14.21
	8076831	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.8	CHEMBL2041	Homo sapiens	Inhibition	%	0.8
	8076832	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.64	CHEMBL2041	Homo sapiens	Inhibition	%	-0.64
	8076833	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.85	CHEMBL2041	Homo sapiens	Inhibition	%	2.85
	8077078	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	9.99	CHEMBL2041	Homo sapiens	Inhibition	%	9.99
	8077079	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	4.79	CHEMBL2041	Homo sapiens	Inhibition	%	4.79
	8077080	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	14.53	CHEMBL2041	Homo sapiens	Inhibition	%	14.53
	8077430	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.52	CHEMBL2041	Homo sapiens	Inhibition	%	3.52
	8077431	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	7.71	CHEMBL2041	Homo sapiens	Inhibition	%	7.71
	8077432	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	13.84	CHEMBL2041	Homo sapiens	Inhibition	%	13.84
	8077581	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.52	CHEMBL2041	Homo sapiens	Inhibition	%	1.52
	8077582	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	3.57	CHEMBL2041	Homo sapiens	Inhibition	%	3.57
	8077583	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	2.46	CHEMBL2041	Homo sapiens	Inhibition	%	2.46
	8077805	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	4.27	CHEMBL2041	Homo sapiens	Inhibition	%	4.27
	8077806	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	3.91	CHEMBL2041	Homo sapiens	Inhibition	%	3.91
	8077807	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	4.51	CHEMBL2041	Homo sapiens	Inhibition	%	4.51
	8077948	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.22	CHEMBL2041	Homo sapiens	Inhibition	%	3.22
	8077949	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.58	CHEMBL2041	Homo sapiens	Inhibition	%	0.58
	8077950	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	6.66	CHEMBL2041	Homo sapiens	Inhibition	%	6.66
	8078311	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	11.3	CHEMBL2041	Homo sapiens	Inhibition	%	11.3
	8078312	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	10.6	CHEMBL2041	Homo sapiens	Inhibition	%	10.6
	8078313	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	14.05	CHEMBL2041	Homo sapiens	Inhibition	%	14.05
	8078413	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.72	CHEMBL2041	Homo sapiens	Inhibition	%	2.72
	8078414	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.11	CHEMBL2041	Homo sapiens	Inhibition	%	0.11
	8078415	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	7.08	CHEMBL2041	Homo sapiens	Inhibition	%	7.08
	8078637	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.22	CHEMBL2041	Homo sapiens	Inhibition	%	1.22
	8078638	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	6.18	CHEMBL2041	Homo sapiens	Inhibition	%	6.18
	8078639	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.94	CHEMBL2041	Homo sapiens	Inhibition	%	1.94
	8078663	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	41.74	CHEMBL2041	Homo sapiens	Inhibition	%	41.74
	8078664	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	9.12	CHEMBL2041	Homo sapiens	Inhibition	%	9.12
	8078665	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	41.84	CHEMBL2041	Homo sapiens	Inhibition	%	41.84
	8078887	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	90.03	CHEMBL2041	Homo sapiens	Inhibition	%	90.03
	8078888	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	47.73	CHEMBL2041	Homo sapiens	Inhibition	%	47.73
	8078889	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	80.33	CHEMBL2041	Homo sapiens	Inhibition	%	80.33
	8079003	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	7.9	CHEMBL2041	Homo sapiens	Inhibition	%	7.9
	8079004	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.42	CHEMBL2041	Homo sapiens	Inhibition	%	4.42
	8079005	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.58	CHEMBL2041	Homo sapiens	Inhibition	%	4.58
	8079385	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.87	CHEMBL2041	Homo sapiens	Inhibition	%	0.87
	8079386	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	2.02	CHEMBL2041	Homo sapiens	Inhibition	%	2.02
	8079387	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.83	CHEMBL2041	Homo sapiens	Inhibition	%	-0.83
	8079527	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	23.21	CHEMBL2041	Homo sapiens	Inhibition	%	23.21
	8079528	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	9.89	CHEMBL2041	Homo sapiens	Inhibition	%	9.89
	8079529	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	21.33	CHEMBL2041	Homo sapiens	Inhibition	%	21.33
	8079890	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	54.96	CHEMBL2041	Homo sapiens	Inhibition	%	54.96
	8079891	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	47.58	CHEMBL2041	Homo sapiens	Inhibition	%	47.58
	8079892	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	55.46	CHEMBL2041	Homo sapiens	Inhibition	%	55.46
	8080219	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	7.25	CHEMBL2041	Homo sapiens	Inhibition	%	7.25
	8080220	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-3.85	CHEMBL2041	Homo sapiens	Inhibition	%	-3.85
	8080221	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	8.46	CHEMBL2041	Homo sapiens	Inhibition	%	8.46
	8080471	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	34.05	CHEMBL2041	Homo sapiens	Inhibition	%	34.05
	8080472	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	54.48	CHEMBL2041	Homo sapiens	Inhibition	%	54.48
	8080473	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	25.18	CHEMBL2041	Homo sapiens	Inhibition	%	25.18
	8080586	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	12.86	CHEMBL2041	Homo sapiens	Inhibition	%	12.86
	8080587	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	8.03	CHEMBL2041	Homo sapiens	Inhibition	%	8.03
	8080588	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	15.71	CHEMBL2041	Homo sapiens	Inhibition	%	15.71
	8080810	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.22	CHEMBL2041	Homo sapiens	Inhibition	%	3.22
	8080811	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.54	CHEMBL2041	Homo sapiens	Inhibition	%	0.54
	8080812	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	4.16	CHEMBL2041	Homo sapiens	Inhibition	%	4.16
	8080974	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	7.49	CHEMBL2041	Homo sapiens	Inhibition	%	7.49
	8080975	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	5.35	CHEMBL2041	Homo sapiens	Inhibition	%	5.35
	8080976	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	10.85	CHEMBL2041	Homo sapiens	Inhibition	%	10.85
	8081109	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	6.29	CHEMBL2041	Homo sapiens	Inhibition	%	6.29
	8081110	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	8.58	CHEMBL2041	Homo sapiens	Inhibition	%	8.58
	8081111	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.94	CHEMBL2041	Homo sapiens	Inhibition	%	1.94
	8081333	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	9.08	CHEMBL2041	Homo sapiens	Inhibition	%	9.08
	8081334	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	5.31	CHEMBL2041	Homo sapiens	Inhibition	%	5.31
	8081335	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	5.92	CHEMBL2041	Homo sapiens	Inhibition	%	5.92
	8081477	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	9.07	CHEMBL2041	Homo sapiens	Inhibition	%	9.07
	8081478	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	9.84	CHEMBL2041	Homo sapiens	Inhibition	%	9.84
	8081479	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	10.01	CHEMBL2041	Homo sapiens	Inhibition	%	10.01
	8081804	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.31	CHEMBL2041	Homo sapiens	Inhibition	%	3.31
	8081805	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-0.49	CHEMBL2041	Homo sapiens	Inhibition	%	-0.49
	8081806	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.27	CHEMBL2041	Homo sapiens	Inhibition	%	2.27
	8082056	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	77.99	CHEMBL2041	Homo sapiens	Inhibition	%	77.99
	8082057	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	82.38	CHEMBL2041	Homo sapiens	Inhibition	%	82.38
	8082058	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	69.94	CHEMBL2041	Homo sapiens	Inhibition	%	69.94
	8082393	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	5.23	CHEMBL2041	Homo sapiens	Inhibition	%	5.23
	8082394	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	7.26	CHEMBL2041	Homo sapiens	Inhibition	%	7.26
	8082395	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	11.54	CHEMBL2041	Homo sapiens	Inhibition	%	11.54
	8082566	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.37	CHEMBL2041	Homo sapiens	Inhibition	%	-0.37
	8082567	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.39	CHEMBL2041	Homo sapiens	Inhibition	%	0.39
	8082568	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.26	CHEMBL2041	Homo sapiens	Inhibition	%	0.26
	8082913	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	7.54	CHEMBL2041	Homo sapiens	Inhibition	%	7.54
	8082914	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	4.17	CHEMBL2041	Homo sapiens	Inhibition	%	4.17
	8082915	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.44	CHEMBL2041	Homo sapiens	Inhibition	%	2.44
	8083069	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	28.12	CHEMBL2041	Homo sapiens	Inhibition	%	28.12
	8083070	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	51.37	CHEMBL2041	Homo sapiens	Inhibition	%	51.37
	8083071	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	35.8	CHEMBL2041	Homo sapiens	Inhibition	%	35.8
	8083392	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	7.66	CHEMBL2041	Homo sapiens	Inhibition	%	7.66
	8083393	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.64	CHEMBL2041	Homo sapiens	Inhibition	%	0.64
	8083394	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.96	CHEMBL2041	Homo sapiens	Inhibition	%	2.96
	8083646	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	3.59	CHEMBL2041	Homo sapiens	Inhibition	%	3.59
	8083647	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	5.85	CHEMBL2041	Homo sapiens	Inhibition	%	5.85
	8083648	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	2.08	CHEMBL2041	Homo sapiens	Inhibition	%	2.08
	8083980	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	5.6	CHEMBL2041	Homo sapiens	Inhibition	%	5.6
	8083981	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.63	CHEMBL2041	Homo sapiens	Inhibition	%	1.63
	8083982	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.75	CHEMBL2041	Homo sapiens	Inhibition	%	4.75
	8084165	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	14.12	CHEMBL2041	Homo sapiens	Inhibition	%	14.12
	8084166	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	9.24	CHEMBL2041	Homo sapiens	Inhibition	%	9.24
	8084167	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	18.12	CHEMBL2041	Homo sapiens	Inhibition	%	18.12
	8084507	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	8.34	CHEMBL2041	Homo sapiens	Inhibition	%	8.34
	8084508	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-0.01	CHEMBL2041	Homo sapiens	Inhibition	%	-0.01
	8084509	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.67	CHEMBL2041	Homo sapiens	Inhibition	%	2.67
	8084668	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	12.51	CHEMBL2041	Homo sapiens	Inhibition	%	12.51
	8084669	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	38.72	CHEMBL2041	Homo sapiens	Inhibition	%	38.72
	8084670	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	14.24	CHEMBL2041	Homo sapiens	Inhibition	%	14.24
	8084892	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	51.86	CHEMBL2041	Homo sapiens	Inhibition	%	51.86
	8084893	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	76.19	CHEMBL2041	Homo sapiens	Inhibition	%	76.19
	8084894	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	59.78	CHEMBL2041	Homo sapiens	Inhibition	%	59.78
	8084990	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.07	CHEMBL2041	Homo sapiens	Inhibition	%	-0.07
	8084991	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-3.08	CHEMBL2041	Homo sapiens	Inhibition	%	-3.08
	8084992	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.94	CHEMBL2041	Homo sapiens	Inhibition	%	1.94
	8085246	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	9.55	CHEMBL2041	Homo sapiens	Inhibition	%	9.55
	8085247	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	19.49	CHEMBL2041	Homo sapiens	Inhibition	%	19.49
	8085248	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	13.22	CHEMBL2041	Homo sapiens	Inhibition	%	13.22
	8085470	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	7.87	CHEMBL2041	Homo sapiens	Inhibition	%	7.87
	8085471	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.82	CHEMBL2041	Homo sapiens	Inhibition	%	1.82
	8085472	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	7.69	CHEMBL2041	Homo sapiens	Inhibition	%	7.69
	8085578	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	18.7	CHEMBL2041	Homo sapiens	Inhibition	%	18.7
	8085579	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	13.33	CHEMBL2041	Homo sapiens	Inhibition	%	13.33
	8085580	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	27.52	CHEMBL2041	Homo sapiens	Inhibition	%	27.52
	8085767	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	37.34	CHEMBL2041	Homo sapiens	Inhibition	%	37.34
	8085768	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	57.74	CHEMBL2041	Homo sapiens	Inhibition	%	57.74
	8085769	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	45.26	CHEMBL2041	Homo sapiens	Inhibition	%	45.26
	8085991	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	78.87	CHEMBL2041	Homo sapiens	Inhibition	%	78.87
	8085992	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	82.69	CHEMBL2041	Homo sapiens	Inhibition	%	82.69
	8085993	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	77.71	CHEMBL2041	Homo sapiens	Inhibition	%	77.71
	8086106	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.87	CHEMBL2041	Homo sapiens	Inhibition	%	1.87
	8086107	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.56	CHEMBL2041	Homo sapiens	Inhibition	%	3.56
	8086108	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	5.78	CHEMBL2041	Homo sapiens	Inhibition	%	5.78
	8086492	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	7.08	CHEMBL2041	Homo sapiens	Inhibition	%	7.08
	8086493	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.68	CHEMBL2041	Homo sapiens	Inhibition	%	4.68
	8086494	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.94	CHEMBL2041	Homo sapiens	Inhibition	%	4.94
	8086591	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	15.42	CHEMBL2041	Homo sapiens	Inhibition	%	15.42
	8086592	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-1.31	CHEMBL2041	Homo sapiens	Inhibition	%	-1.31
	8086593	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.36	CHEMBL2041	Homo sapiens	Inhibition	%	-0.36
	8086815	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.99	CHEMBL2041	Homo sapiens	Inhibition	%	2.99
	8086816	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	4.69	CHEMBL2041	Homo sapiens	Inhibition	%	4.69
	8086817	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.52	CHEMBL2041	Homo sapiens	Inhibition	%	1.52
	8087026	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.32	CHEMBL2041	Homo sapiens	Inhibition	%	3.32
	8087027	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.35	CHEMBL2041	Homo sapiens	Inhibition	%	3.35
	8087028	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	14.72	CHEMBL2041	Homo sapiens	Inhibition	%	14.72
	8087184	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	9.61	CHEMBL2041	Homo sapiens	Inhibition	%	9.61
	8087185	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	6.39	CHEMBL2041	Homo sapiens	Inhibition	%	6.39
	8087186	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	11.46	CHEMBL2041	Homo sapiens	Inhibition	%	11.46
	8087522	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	83.54	CHEMBL2041	Homo sapiens	Inhibition	%	83.54
	8087523	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	8.57	CHEMBL2041	Homo sapiens	Inhibition	%	8.57
	8087524	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	80.21	CHEMBL2041	Homo sapiens	Inhibition	%	80.21
	8087884	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	13.36	CHEMBL2041	Homo sapiens	Inhibition	%	13.36
	8087885	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.81	CHEMBL2041	Homo sapiens	Inhibition	%	5.81
	8087886	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	11.38	CHEMBL2041	Homo sapiens	Inhibition	%	11.38
	8088026	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.73	CHEMBL2041	Homo sapiens	Inhibition	%	4.73
	8088027	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.5	CHEMBL2041	Homo sapiens	Inhibition	%	3.5
	8088028	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.85	CHEMBL2041	Homo sapiens	Inhibition	%	5.85
	8088398	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.09	CHEMBL2041	Homo sapiens	Inhibition	%	-0.09
	8088399	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.01	CHEMBL2041	Homo sapiens	Inhibition	%	2.01
	8088400	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	Inhibition	%	4.0
	8088526	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	7.16	CHEMBL2041	Homo sapiens	Inhibition	%	7.16
	8088527	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	17.13	CHEMBL2041	Homo sapiens	Inhibition	%	17.13
	8088528	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	12.16	CHEMBL2041	Homo sapiens	Inhibition	%	12.16
	8088750	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	33.56	CHEMBL2041	Homo sapiens	Inhibition	%	33.56
	8088751	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	8.18	CHEMBL2041	Homo sapiens	Inhibition	%	8.18
	8088752	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	32.49	CHEMBL2041	Homo sapiens	Inhibition	%	32.49
	8088843	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.65	CHEMBL2041	Homo sapiens	Inhibition	%	1.65
	8088844	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.56	CHEMBL2041	Homo sapiens	Inhibition	%	2.56
	8088845	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.13	CHEMBL2041	Homo sapiens	Inhibition	%	4.13
	8089195	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	7.67	CHEMBL2041	Homo sapiens	Inhibition	%	7.67
	8089196	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.55	CHEMBL2041	Homo sapiens	Inhibition	%	3.55
	8089197	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	4.36	CHEMBL2041	Homo sapiens	Inhibition	%	4.36
	8089343	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	11.61	CHEMBL2041	Homo sapiens	Inhibition	%	11.61
	8089344	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	12.56	CHEMBL2041	Homo sapiens	Inhibition	%	12.56
	8089345	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	20.74	CHEMBL2041	Homo sapiens	Inhibition	%	20.74
	8089567	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	14.84	CHEMBL2041	Homo sapiens	Inhibition	%	14.84
	8089568	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	16.43	CHEMBL2041	Homo sapiens	Inhibition	%	16.43
	8089569	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	6.44	CHEMBL2041	Homo sapiens	Inhibition	%	6.44
	8089687	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	7.24	CHEMBL2041	Homo sapiens	Inhibition	%	7.24
	8089688	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	10.52	CHEMBL2041	Homo sapiens	Inhibition	%	10.52
	8089689	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	6.5	CHEMBL2041	Homo sapiens	Inhibition	%	6.5
	8089867	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.76	CHEMBL2041	Homo sapiens	Inhibition	%	2.76
	8089868	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.95	CHEMBL2041	Homo sapiens	Inhibition	%	0.95
	8089869	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.45	CHEMBL2041	Homo sapiens	Inhibition	%	-0.45
	8090091	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.03	CHEMBL2041	Homo sapiens	Inhibition	%	-0.03
	8090092	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.97	CHEMBL2041	Homo sapiens	Inhibition	%	0.97
	8090093	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	3.56	CHEMBL2041	Homo sapiens	Inhibition	%	3.56
	8090256	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.04	CHEMBL2041	Homo sapiens	Inhibition	%	1.04
	8090257	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.85	CHEMBL2041	Homo sapiens	Inhibition	%	1.85
	8090258	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.11	CHEMBL2041	Homo sapiens	Inhibition	%	1.11
	8090423	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.46	CHEMBL2041	Homo sapiens	Inhibition	%	2.46
	8090424	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.94	CHEMBL2041	Homo sapiens	Inhibition	%	2.94
	8090425	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	6.92	CHEMBL2041	Homo sapiens	Inhibition	%	6.92
	8090647	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.76	CHEMBL2041	Homo sapiens	Inhibition	%	0.76
	8090648	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.64	CHEMBL2041	Homo sapiens	Inhibition	%	2.64
	8090649	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.35	CHEMBL2041	Homo sapiens	Inhibition	%	4.35
	8090786	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	5.18	CHEMBL2041	Homo sapiens	Inhibition	%	5.18
	8090787	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	6.22	CHEMBL2041	Homo sapiens	Inhibition	%	6.22
	8090788	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	12.36	CHEMBL2041	Homo sapiens	Inhibition	%	12.36
	8090991	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%		CHEMBL2041	Homo sapiens	Inhibition	%	
	8090992	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.74	CHEMBL2041	Homo sapiens	Inhibition	%	3.74
	8090993	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	6.6	CHEMBL2041	Homo sapiens	Inhibition	%	6.6
	8091215	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.99	CHEMBL2041	Homo sapiens	Inhibition	%	2.99
	8091216	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.01	CHEMBL2041	Homo sapiens	Inhibition	%	3.01
	8091217	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.34	CHEMBL2041	Homo sapiens	Inhibition	%	3.34
	8091352	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	12.27	CHEMBL2041	Homo sapiens	Inhibition	%	12.27
	8091353	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	10.24	CHEMBL2041	Homo sapiens	Inhibition	%	10.24
	8091354	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	14.87	CHEMBL2041	Homo sapiens	Inhibition	%	14.87
	8091507	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	7.45	CHEMBL2041	Homo sapiens	Inhibition	%	7.45
	8091508	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.64	CHEMBL2041	Homo sapiens	Inhibition	%	1.64
	8091509	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.76	CHEMBL2041	Homo sapiens	Inhibition	%	4.76
	8091731	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	6.85	CHEMBL2041	Homo sapiens	Inhibition	%	6.85
	8091732	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.22	CHEMBL2041	Homo sapiens	Inhibition	%	2.22
	8091733	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	6.48	CHEMBL2041	Homo sapiens	Inhibition	%	6.48
	8091847	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.4	CHEMBL2041	Homo sapiens	Inhibition	%	5.4
	8091848	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.68	CHEMBL2041	Homo sapiens	Inhibition	%	3.68
	8091849	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	9.37	CHEMBL2041	Homo sapiens	Inhibition	%	9.37
	8092208	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	3.19	CHEMBL2041	Homo sapiens	Inhibition	%	3.19
	8092209	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.33	CHEMBL2041	Homo sapiens	Inhibition	%	1.33
	8092210	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.85	CHEMBL2041	Homo sapiens	Inhibition	%	1.85
	8092359	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.87	CHEMBL2041	Homo sapiens	Inhibition	%	6.87
	8092360	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.04	CHEMBL2041	Homo sapiens	Inhibition	%	6.04
	8092361	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.78	CHEMBL2041	Homo sapiens	Inhibition	%	5.78
	8092583	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.3	CHEMBL2041	Homo sapiens	Inhibition	%	7.3
	8092584	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.33	CHEMBL2041	Homo sapiens	Inhibition	%	4.33
	8092585	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	8.47	CHEMBL2041	Homo sapiens	Inhibition	%	8.47
	8092731	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.84	CHEMBL2041	Homo sapiens	Inhibition	%	2.84
	8092732	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.99	CHEMBL2041	Homo sapiens	Inhibition	%	2.99
	8092733	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.96	CHEMBL2041	Homo sapiens	Inhibition	%	3.96
	8093084	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	72.1	CHEMBL2041	Homo sapiens	Inhibition	%	72.1
	8093085	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	38.26	CHEMBL2041	Homo sapiens	Inhibition	%	38.26
	8093086	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	72.03	CHEMBL2041	Homo sapiens	Inhibition	%	72.03
	8093172	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.15	CHEMBL2041	Homo sapiens	Inhibition	%	3.15
	8093173	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.52	CHEMBL2041	Homo sapiens	Inhibition	%	0.52
	8093174	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.18	CHEMBL2041	Homo sapiens	Inhibition	%	3.18
	8093396	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	4.24	CHEMBL2041	Homo sapiens	Inhibition	%	4.24
	8093397	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.59	CHEMBL2041	Homo sapiens	Inhibition	%	1.59
	8093398	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	6.39	CHEMBL2041	Homo sapiens	Inhibition	%	6.39
	8093536	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	12.85	CHEMBL2041	Homo sapiens	Inhibition	%	12.85
	8093537	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	15.51	CHEMBL2041	Homo sapiens	Inhibition	%	15.51
	8093538	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	16.87	CHEMBL2041	Homo sapiens	Inhibition	%	16.87
	8093899	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	60.71	CHEMBL2041	Homo sapiens	Inhibition	%	60.71
	8093900	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	67.37	CHEMBL2041	Homo sapiens	Inhibition	%	67.37
	8093901	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	50.32	CHEMBL2041	Homo sapiens	Inhibition	%	50.32
	8094019	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	Inhibition	%	4.0
	8094020	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	3.06	CHEMBL2041	Homo sapiens	Inhibition	%	3.06
	8094021	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	2.23	CHEMBL2041	Homo sapiens	Inhibition	%	2.23
	8094243	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	8.62	CHEMBL2041	Homo sapiens	Inhibition	%	8.62
	8094244	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	21.16	CHEMBL2041	Homo sapiens	Inhibition	%	21.16
	8094423	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.88	CHEMBL2041	Homo sapiens	Inhibition	%	1.88
	8094424	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	8.81	CHEMBL2041	Homo sapiens	Inhibition	%	8.81
	8094425	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.21	CHEMBL2041	Homo sapiens	Inhibition	%	2.21
	8094598	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.75	CHEMBL2041	Homo sapiens	Inhibition	%	5.75
	8094599	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	7.87	CHEMBL2041	Homo sapiens	Inhibition	%	7.87
	8094600	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	6.08	CHEMBL2041	Homo sapiens	Inhibition	%	6.08
	8094978	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	6.88	CHEMBL2041	Homo sapiens	Inhibition	%	6.88
	8094979	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	7.97	CHEMBL2041	Homo sapiens	Inhibition	%	7.97
	8094980	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.86	CHEMBL2041	Homo sapiens	Inhibition	%	4.86
	8095118	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	79.75	CHEMBL2041	Homo sapiens	Inhibition	%	79.75
	8095119	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	53.75	CHEMBL2041	Homo sapiens	Inhibition	%	53.75
	8095120	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	67.37	CHEMBL2041	Homo sapiens	Inhibition	%	67.37
	8095545	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	9.8	CHEMBL2041	Homo sapiens	Inhibition	%	9.8
	8095546	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	11.9	CHEMBL2041	Homo sapiens	Inhibition	%	11.9
	8095547	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	9.58	CHEMBL2041	Homo sapiens	Inhibition	%	9.58
	8095686	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	5.97	CHEMBL2041	Homo sapiens	Inhibition	%	5.97
	8095687	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	18.56	CHEMBL2041	Homo sapiens	Inhibition	%	18.56
	8095688	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	9.36	CHEMBL2041	Homo sapiens	Inhibition	%	9.36
	8096058	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	8.77	CHEMBL2041	Homo sapiens	Inhibition	%	8.77
	8096059	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.73	CHEMBL2041	Homo sapiens	Inhibition	%	3.73
	8096060	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	9.71	CHEMBL2041	Homo sapiens	Inhibition	%	9.71
	8096175	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	6.88	CHEMBL2041	Homo sapiens	Inhibition	%	6.88
	8096176	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.75	CHEMBL2041	Homo sapiens	Inhibition	%	5.75
	8096177	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%		CHEMBL2041	Homo sapiens	Inhibition	%	
	8096399	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	6.25	CHEMBL2041	Homo sapiens	Inhibition	%	6.25
	8096400	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.83	CHEMBL2041	Homo sapiens	Inhibition	%	4.83
	8096401	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	9.0	CHEMBL2041	Homo sapiens	Inhibition	%	9.0
	8096538	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	7.03	CHEMBL2041	Homo sapiens	Inhibition	%	7.03
	8096539	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	5.85	CHEMBL2041	Homo sapiens	Inhibition	%	5.85
	8096540	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	4.13	CHEMBL2041	Homo sapiens	Inhibition	%	4.13
	8096918	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.36	CHEMBL2041	Homo sapiens	Inhibition	%	7.36
	8096919	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.85	CHEMBL2041	Homo sapiens	Inhibition	%	7.85
	8096920	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	9.4	CHEMBL2041	Homo sapiens	Inhibition	%	9.4
	8097065	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.97	CHEMBL2041	Homo sapiens	Inhibition	%	3.97
	8097066	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.76	CHEMBL2041	Homo sapiens	Inhibition	%	0.76
	8097067	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.05	CHEMBL2041	Homo sapiens	Inhibition	%	1.05
	8097376	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	9.64	CHEMBL2041	Homo sapiens	Inhibition	%	9.64
	8097377	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	7.27	CHEMBL2041	Homo sapiens	Inhibition	%	7.27
	8097378	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	8.71	CHEMBL2041	Homo sapiens	Inhibition	%	8.71
	8097596	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	11.4	CHEMBL2041	Homo sapiens	Inhibition	%	11.4
	8097597	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.05	CHEMBL2041	Homo sapiens	Inhibition	%	3.05
	8097598	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	6.1	CHEMBL2041	Homo sapiens	Inhibition	%	6.1
	8097746	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	7.49	CHEMBL2041	Homo sapiens	Inhibition	%	7.49
	8097747	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	2.03	CHEMBL2041	Homo sapiens	Inhibition	%	2.03
	8097748	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	10.66	CHEMBL2041	Homo sapiens	Inhibition	%	10.66
	8098103	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	7.47	CHEMBL2041	Homo sapiens	Inhibition	%	7.47
	8098104	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	2.8	CHEMBL2041	Homo sapiens	Inhibition	%	2.8
	8098105	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.53	CHEMBL2041	Homo sapiens	Inhibition	%	1.53
	8098225	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	9.6	CHEMBL2041	Homo sapiens	Inhibition	%	9.6
	8098447	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.11	CHEMBL2041	Homo sapiens	Inhibition	%	0.11
	8098448	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.81	CHEMBL2041	Homo sapiens	Inhibition	%	0.81
	8098449	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.47	CHEMBL2041	Homo sapiens	Inhibition	%	0.47
	8098627	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.21	CHEMBL2041	Homo sapiens	Inhibition	%	3.21
	8098628	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.72	CHEMBL2041	Homo sapiens	Inhibition	%	1.72
	8098629	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.75	CHEMBL2041	Homo sapiens	Inhibition	%	2.75
	8098812	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	-3.34	CHEMBL2041	Homo sapiens	Inhibition	%	-3.34
	8098813	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	8.15	CHEMBL2041	Homo sapiens	Inhibition	%	8.15
	8098814	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	4.48	CHEMBL2041	Homo sapiens	Inhibition	%	4.48
	8099036	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	9.44	CHEMBL2041	Homo sapiens	Inhibition	%	9.44
	8099037	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	43.83	CHEMBL2041	Homo sapiens	Inhibition	%	43.83
	8099038	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	16.63	CHEMBL2041	Homo sapiens	Inhibition	%	16.63
	8099180	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.04	CHEMBL2041	Homo sapiens	Inhibition	%	3.04
	8099181	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.88	CHEMBL2041	Homo sapiens	Inhibition	%	3.88
	8099182	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	6.2	CHEMBL2041	Homo sapiens	Inhibition	%	6.2
	8099322	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	71.96	CHEMBL2041	Homo sapiens	Inhibition	%	71.96
	8099323	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	86.38	CHEMBL2041	Homo sapiens	Inhibition	%	86.38
	8099324	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	92.12	CHEMBL2041	Homo sapiens	Inhibition	%	92.12
	8099546	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	4.62	CHEMBL2041	Homo sapiens	Inhibition	%	4.62
	8099547	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	5.33	CHEMBL2041	Homo sapiens	Inhibition	%	5.33
	8099548	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	7.72	CHEMBL2041	Homo sapiens	Inhibition	%	7.72
	8099740	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	5.41	CHEMBL2041	Homo sapiens	Inhibition	%	5.41
	8099741	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	3.66	CHEMBL2041	Homo sapiens	Inhibition	%	3.66
	8099742	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	4.65	CHEMBL2041	Homo sapiens	Inhibition	%	4.65
	8099887	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	24.26	CHEMBL2041	Homo sapiens	Inhibition	%	24.26
	8099888	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	58.3	CHEMBL2041	Homo sapiens	Inhibition	%	58.3
	8099889	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	25.82	CHEMBL2041	Homo sapiens	Inhibition	%	25.82
	8100111	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.0	CHEMBL2041	Homo sapiens	Inhibition	%	3.0
	8100112	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.72	CHEMBL2041	Homo sapiens	Inhibition	%	3.72
	8100113	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.38	CHEMBL2041	Homo sapiens	Inhibition	%	4.38
	8100257	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	28.65	CHEMBL2041	Homo sapiens	Inhibition	%	28.65
	8100258	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	9.3	CHEMBL2041	Homo sapiens	Inhibition	%	9.3
	8100259	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	39.99	CHEMBL2041	Homo sapiens	Inhibition	%	39.99
	8100597	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	6.72	CHEMBL2041	Homo sapiens	Inhibition	%	6.72
	8100598	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.87	CHEMBL2041	Homo sapiens	Inhibition	%	4.87
	8100599	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	13.11	CHEMBL2041	Homo sapiens	Inhibition	%	13.11
	8100737	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.12	CHEMBL2041	Homo sapiens	Inhibition	%	3.12
	8100738	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.69	CHEMBL2041	Homo sapiens	Inhibition	%	2.69
	8100739	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	4.06	CHEMBL2041	Homo sapiens	Inhibition	%	4.06
	8100961	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.49	CHEMBL2041	Homo sapiens	Inhibition	%	3.49
	8100962	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.13	CHEMBL2041	Homo sapiens	Inhibition	%	3.13
	8100963	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	5.41	CHEMBL2041	Homo sapiens	Inhibition	%	5.41
	8101121	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.52	CHEMBL2041	Homo sapiens	Inhibition	%	3.52
	8101122	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.72	CHEMBL2041	Homo sapiens	Inhibition	%	2.72
	8101123	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.39	CHEMBL2041	Homo sapiens	Inhibition	%	4.39
	8101263	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.68	CHEMBL2041	Homo sapiens	Inhibition	%	0.68
	8101264	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.26	CHEMBL2041	Homo sapiens	Inhibition	%	2.26
	8101265	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.09	CHEMBL2041	Homo sapiens	Inhibition	%	2.09
	8101487	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	2.33	CHEMBL2041	Homo sapiens	Inhibition	%	2.33
	8101488	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	1.0	CHEMBL2041	Homo sapiens	Inhibition	%	1.0
	8101489	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.66	CHEMBL2041	Homo sapiens	Inhibition	%	0.66
	8101672	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%		CHEMBL2041	Homo sapiens	Inhibition	%	
	8101673	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.37	CHEMBL2041	Homo sapiens	Inhibition	%	2.37
	8101674	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	5.2	CHEMBL2041	Homo sapiens	Inhibition	%	5.2
	8101925	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	10.72	CHEMBL2041	Homo sapiens	Inhibition	%	10.72
	8101926	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	7.65	CHEMBL2041	Homo sapiens	Inhibition	%	7.65
	8101927	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	10.2	CHEMBL2041	Homo sapiens	Inhibition	%	10.2
	8102080	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	41.1	CHEMBL2041	Homo sapiens	Inhibition	%	41.1
	8102081	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	14.39	CHEMBL2041	Homo sapiens	Inhibition	%	14.39
	8102082	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	47.36	CHEMBL2041	Homo sapiens	Inhibition	%	47.36
	8102304	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	37.84	CHEMBL2041	Homo sapiens	Inhibition	%	37.84
	8102305	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	5.88	CHEMBL2041	Homo sapiens	Inhibition	%	5.88
	8102306	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	46.05	CHEMBL2041	Homo sapiens	Inhibition	%	46.05
	8102435	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	14.13	CHEMBL2041	Homo sapiens	Inhibition	%	14.13
	8102436	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	14.99	CHEMBL2041	Homo sapiens	Inhibition	%	14.99
	8102437	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	26.28	CHEMBL2041	Homo sapiens	Inhibition	%	26.28
	8102779	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	7.33	CHEMBL2041	Homo sapiens	Inhibition	%	7.33
	8102780	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.07	CHEMBL2041	Homo sapiens	Inhibition	%	0.07
	8102781	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	11.56	CHEMBL2041	Homo sapiens	Inhibition	%	11.56
	8102957	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.71	CHEMBL2041	Homo sapiens	Inhibition	%	1.71
	8102958	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.93	CHEMBL2041	Homo sapiens	Inhibition	%	1.93
	8102959	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.88	CHEMBL2041	Homo sapiens	Inhibition	%	1.88
	8103377	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	6.89	CHEMBL2041	Homo sapiens	Inhibition	%	6.89
	8103378	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.38	CHEMBL2041	Homo sapiens	Inhibition	%	1.38
	8103379	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	18.58	CHEMBL2041	Homo sapiens	Inhibition	%	18.58
	8103515	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	8.54	CHEMBL2041	Homo sapiens	Inhibition	%	8.54
	8103516	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	5.06	CHEMBL2041	Homo sapiens	Inhibition	%	5.06
	8103517	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	8.25	CHEMBL2041	Homo sapiens	Inhibition	%	8.25
	8103889	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	5.58	CHEMBL2041	Homo sapiens	Inhibition	%	5.58
	8103890	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	9.72	CHEMBL2041	Homo sapiens	Inhibition	%	9.72
	8103891	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	12.81	CHEMBL2041	Homo sapiens	Inhibition	%	12.81
	8104074	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	8.1	CHEMBL2041	Homo sapiens	Inhibition	%	8.1
	8104075	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.65	CHEMBL2041	Homo sapiens	Inhibition	%	2.65
	8104076	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	10.85	CHEMBL2041	Homo sapiens	Inhibition	%	10.85
	8104446	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	11.48	CHEMBL2041	Homo sapiens	Inhibition	%	11.48
	8104447	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	10.18	CHEMBL2041	Homo sapiens	Inhibition	%	10.18
	8104448	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	13.91	CHEMBL2041	Homo sapiens	Inhibition	%	13.91
	8104592	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	7.98	CHEMBL2041	Homo sapiens	Inhibition	%	7.98
	8104593	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	15.04	CHEMBL2041	Homo sapiens	Inhibition	%	15.04
	8104594	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	8.71	CHEMBL2041	Homo sapiens	Inhibition	%	8.71
	8104930	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	6.33	CHEMBL2041	Homo sapiens	Inhibition	%	6.33
	8104931	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.48	CHEMBL2041	Homo sapiens	Inhibition	%	3.48
	8104932	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	6.66	CHEMBL2041	Homo sapiens	Inhibition	%	6.66
	8105294	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.56	CHEMBL2041	Homo sapiens	Inhibition	%	-0.56
	8105295	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.11	CHEMBL2041	Homo sapiens	Inhibition	%	2.11
	8105296	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.66	CHEMBL2041	Homo sapiens	Inhibition	%	1.66
	8105460	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	6.29	CHEMBL2041	Homo sapiens	Inhibition	%	6.29
	8105461	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	9.41	CHEMBL2041	Homo sapiens	Inhibition	%	9.41
	8105462	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	6.78	CHEMBL2041	Homo sapiens	Inhibition	%	6.78
	8105822	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	15.51	CHEMBL2041	Homo sapiens	Inhibition	%	15.51
	8105823	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	16.17	CHEMBL2041	Homo sapiens	Inhibition	%	16.17
	8105824	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	16.23	CHEMBL2041	Homo sapiens	Inhibition	%	16.23
	8106102	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	6.84	CHEMBL2041	Homo sapiens	Inhibition	%	6.84
	8106103	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	5.7	CHEMBL2041	Homo sapiens	Inhibition	%	5.7
	8106104	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	13.27	CHEMBL2041	Homo sapiens	Inhibition	%	13.27
	8106267	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	37.93	CHEMBL2041	Homo sapiens	Inhibition	%	37.93
	8106268	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	30.74	CHEMBL2041	Homo sapiens	Inhibition	%	30.74
	8106269	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	39.7	CHEMBL2041	Homo sapiens	Inhibition	%	39.7
	8106647	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	82.07	CHEMBL2041	Homo sapiens	Inhibition	%	82.07
	8106648	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	39.4	CHEMBL2041	Homo sapiens	Inhibition	%	39.4
	8106649	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	79.71	CHEMBL2041	Homo sapiens	Inhibition	%	79.71
	8106776	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	9.2	CHEMBL2041	Homo sapiens	Inhibition	%	9.2
	8106777	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	3.84	CHEMBL2041	Homo sapiens	Inhibition	%	3.84
	8106778	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	5.14	CHEMBL2041	Homo sapiens	Inhibition	%	5.14
	8107000	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	36.2	CHEMBL2041	Homo sapiens	Inhibition	%	36.2
	8107121	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.08	CHEMBL2041	Homo sapiens	Inhibition	%	0.08
	8107122	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.99	CHEMBL2041	Homo sapiens	Inhibition	%	0.99
	8107123	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.29	CHEMBL2041	Homo sapiens	Inhibition	%	2.29
	8107293	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.96	CHEMBL2041	Homo sapiens	Inhibition	%	2.96
	8107294	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.59	CHEMBL2041	Homo sapiens	Inhibition	%	2.59
	8107295	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.21	CHEMBL2041	Homo sapiens	Inhibition	%	1.21
	8107517	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	5.91	CHEMBL2041	Homo sapiens	Inhibition	%	5.91
	8107518	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.83	CHEMBL2041	Homo sapiens	Inhibition	%	1.83
	8107519	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.29	CHEMBL2041	Homo sapiens	Inhibition	%	2.29
	8107718	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	37.99	CHEMBL2041	Homo sapiens	Inhibition	%	37.99
	8107719	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	6.67	CHEMBL2041	Homo sapiens	Inhibition	%	6.67
	8107720	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	41.28	CHEMBL2041	Homo sapiens	Inhibition	%	41.28
	8107853	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-0.62	CHEMBL2041	Homo sapiens	Inhibition	%	-0.62
	8107854	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.12	CHEMBL2041	Homo sapiens	Inhibition	%	1.12
	8107855	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	3.72	CHEMBL2041	Homo sapiens	Inhibition	%	3.72
	8108077	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	26.75	CHEMBL2041	Homo sapiens	Inhibition	%	26.75
	8108078	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	13.84	CHEMBL2041	Homo sapiens	Inhibition	%	13.84
	8108079	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	37.86	CHEMBL2041	Homo sapiens	Inhibition	%	37.86
	8108235	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.78	CHEMBL2041	Homo sapiens	Inhibition	%	1.78
	8108236	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	6.14	CHEMBL2041	Homo sapiens	Inhibition	%	6.14
	8108237	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	8.02	CHEMBL2041	Homo sapiens	Inhibition	%	8.02
	8108410	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	52.14	CHEMBL2041	Homo sapiens	Inhibition	%	52.14
	8108411	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	23.78	CHEMBL2041	Homo sapiens	Inhibition	%	23.78
	8108412	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	45.52	CHEMBL2041	Homo sapiens	Inhibition	%	45.52
	8108634	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	74.4	CHEMBL2041	Homo sapiens	Inhibition	%	74.4
	8108635	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	54.78	CHEMBL2041	Homo sapiens	Inhibition	%	54.78
	8108781	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	6.25	CHEMBL2041	Homo sapiens	Inhibition	%	6.25
	8108782	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.76	CHEMBL2041	Homo sapiens	Inhibition	%	5.76
	8108783	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	8.22	CHEMBL2041	Homo sapiens	Inhibition	%	8.22
	8108923	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	28.98	CHEMBL2041	Homo sapiens	Inhibition	%	28.98
	8108924	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	54.05	CHEMBL2041	Homo sapiens	Inhibition	%	54.05
	8108925	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	31.93	CHEMBL2041	Homo sapiens	Inhibition	%	31.93
	8109147	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	5.25	CHEMBL2041	Homo sapiens	Inhibition	%	5.25
	8109148	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	6.3	CHEMBL2041	Homo sapiens	Inhibition	%	6.3
	8109149	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	7.95	CHEMBL2041	Homo sapiens	Inhibition	%	7.95
	8109261	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.32	CHEMBL2041	Homo sapiens	Inhibition	%	4.32
	8109262	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.02	CHEMBL2041	Homo sapiens	Inhibition	%	4.02
	8109263	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	9.04	CHEMBL2041	Homo sapiens	Inhibition	%	9.04
	8109615	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.73	CHEMBL2041	Homo sapiens	Inhibition	%	0.73
	8109616	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.61	CHEMBL2041	Homo sapiens	Inhibition	%	1.61
	8109617	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.31	CHEMBL2041	Homo sapiens	Inhibition	%	2.31
	8109786	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.19	CHEMBL2041	Homo sapiens	Inhibition	%	3.19
	8109787	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.32	CHEMBL2041	Homo sapiens	Inhibition	%	2.32
	8109788	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	6.79	CHEMBL2041	Homo sapiens	Inhibition	%	6.79
	8110142	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	7.16	CHEMBL2041	Homo sapiens	Inhibition	%	7.16
	8110143	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.73	CHEMBL2041	Homo sapiens	Inhibition	%	4.73
	8110144	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	8.14	CHEMBL2041	Homo sapiens	Inhibition	%	8.14
	8110421	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	11.02	CHEMBL2041	Homo sapiens	Inhibition	%	11.02
	8110422	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	9.51	CHEMBL2041	Homo sapiens	Inhibition	%	9.51
	8110423	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	13.28	CHEMBL2041	Homo sapiens	Inhibition	%	13.28
	8110587	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	7.28	CHEMBL2041	Homo sapiens	Inhibition	%	7.28
	8110588	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	8.31	CHEMBL2041	Homo sapiens	Inhibition	%	8.31
	8110589	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	10.95	CHEMBL2041	Homo sapiens	Inhibition	%	10.95
	8110811	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	10.83	CHEMBL2041	Homo sapiens	Inhibition	%	10.83
	8110812	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	21.71	CHEMBL2041	Homo sapiens	Inhibition	%	21.71
	8110813	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	13.21	CHEMBL2041	Homo sapiens	Inhibition	%	13.21
	8110969	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	3.26	CHEMBL2041	Homo sapiens	Inhibition	%	3.26
	8110970	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	6.12	CHEMBL2041	Homo sapiens	Inhibition	%	6.12
	8110971	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	1.83	CHEMBL2041	Homo sapiens	Inhibition	%	1.83
	8111093	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	21.3	CHEMBL2041	Homo sapiens	Inhibition	%	21.3
	8111094	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	35.73	CHEMBL2041	Homo sapiens	Inhibition	%	35.73
	8111316	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	72.85	CHEMBL2041	Homo sapiens	Inhibition	%	72.85
	8111317	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	35.6	CHEMBL2041	Homo sapiens	Inhibition	%	35.6
	8111318	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	53.49	CHEMBL2041	Homo sapiens	Inhibition	%	53.49
	8111443	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.88	CHEMBL2041	Homo sapiens	Inhibition	%	0.88
	8111444	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.01	CHEMBL2041	Homo sapiens	Inhibition	%	0.01
	8111445	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	11.9	CHEMBL2041	Homo sapiens	Inhibition	%	11.9
	8111833	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.23	CHEMBL2041	Homo sapiens	Inhibition	%	2.23
	8111834	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	11.62	CHEMBL2041	Homo sapiens	Inhibition	%	11.62
	8111835	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	7.07	CHEMBL2041	Homo sapiens	Inhibition	%	7.07
	8112038	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.88	CHEMBL2041	Homo sapiens	Inhibition	%	1.88
	8112039	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.92	CHEMBL2041	Homo sapiens	Inhibition	%	0.92
	8112040	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.77	CHEMBL2041	Homo sapiens	Inhibition	%	2.77
	8112399	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.76	CHEMBL2041	Homo sapiens	Inhibition	%	-0.76
	8112400	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.04	CHEMBL2041	Homo sapiens	Inhibition	%	1.04
	8112401	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.73	CHEMBL2041	Homo sapiens	Inhibition	%	2.73
	8112567	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	9.67	CHEMBL2041	Homo sapiens	Inhibition	%	9.67
	8112568	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	11.4	CHEMBL2041	Homo sapiens	Inhibition	%	11.4
	8112569	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	14.24	CHEMBL2041	Homo sapiens	Inhibition	%	14.24
	8112741	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	79.66	CHEMBL2041	Homo sapiens	Inhibition	%	79.66
	8112963	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	3.73	CHEMBL2041	Homo sapiens	Inhibition	%	3.73
	8112964	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	8.41	CHEMBL2041	Homo sapiens	Inhibition	%	8.41
	8112965	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	4.19	CHEMBL2041	Homo sapiens	Inhibition	%	4.19
	8113115	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	18.22	CHEMBL2041	Homo sapiens	Inhibition	%	18.22
	8113116	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	16.68	CHEMBL2041	Homo sapiens	Inhibition	%	16.68
	8113117	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	20.14	CHEMBL2041	Homo sapiens	Inhibition	%	20.14
	8113475	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	5.38	CHEMBL2041	Homo sapiens	Inhibition	%	5.38
	8113476	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	10.07	CHEMBL2041	Homo sapiens	Inhibition	%	10.07
	8113477	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	7.27	CHEMBL2041	Homo sapiens	Inhibition	%	7.27
	8113599	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.65	CHEMBL2041	Homo sapiens	Inhibition	%	3.65
	8113600	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.71	CHEMBL2041	Homo sapiens	Inhibition	%	3.71
	8113601	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.73	CHEMBL2041	Homo sapiens	Inhibition	%	5.73
	8113823	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	7.22	CHEMBL2041	Homo sapiens	Inhibition	%	7.22
	8113824	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	8.02	CHEMBL2041	Homo sapiens	Inhibition	%	8.02
	8113825	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	8.15	CHEMBL2041	Homo sapiens	Inhibition	%	8.15
	8113939	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	2.33	CHEMBL2041	Homo sapiens	Inhibition	%	2.33
	8113940	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.66	CHEMBL2041	Homo sapiens	Inhibition	%	1.66
	8113941	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.01	CHEMBL2041	Homo sapiens	Inhibition	%	-0.01
	8114115	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	16.54	CHEMBL2041	Homo sapiens	Inhibition	%	16.54
	8114116	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	15.84	CHEMBL2041	Homo sapiens	Inhibition	%	15.84
	8114117	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	21.98	CHEMBL2041	Homo sapiens	Inhibition	%	21.98
	8114339	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.22	CHEMBL2041	Homo sapiens	Inhibition	%	3.22
	8114340	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.51	CHEMBL2041	Homo sapiens	Inhibition	%	3.51
	8114341	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.55	CHEMBL2041	Homo sapiens	Inhibition	%	5.55
	8114471	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	8.97	CHEMBL2041	Homo sapiens	Inhibition	%	8.97
	8114472	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	11.94	CHEMBL2041	Homo sapiens	Inhibition	%	11.94
	8114473	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	13.23	CHEMBL2041	Homo sapiens	Inhibition	%	13.23
	8114747	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	5.5	CHEMBL2041	Homo sapiens	Inhibition	%	5.5
	8114748	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	5.44	CHEMBL2041	Homo sapiens	Inhibition	%	5.44
	8114749	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	10.76	CHEMBL2041	Homo sapiens	Inhibition	%	10.76
	8115137	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	85.3	CHEMBL2041	Homo sapiens	Inhibition	%	85.3
	8115138	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	68.31	CHEMBL2041	Homo sapiens	Inhibition	%	68.31
	8115139	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	79.16	CHEMBL2041	Homo sapiens	Inhibition	%	79.16
	8115302	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	4.11	CHEMBL2041	Homo sapiens	Inhibition	%	4.11
	8115303	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	9.27	CHEMBL2041	Homo sapiens	Inhibition	%	9.27
	8115304	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	15.79	CHEMBL2041	Homo sapiens	Inhibition	%	15.79
	8115646	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	79.88	CHEMBL2041	Homo sapiens	Inhibition	%	79.88
	8115647	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	63.15	CHEMBL2041	Homo sapiens	Inhibition	%	63.15
	8115648	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	74.57	CHEMBL2041	Homo sapiens	Inhibition	%	74.57
	8115779	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	3.87	CHEMBL2041	Homo sapiens	Inhibition	%	3.87
	8115780	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.45	CHEMBL2041	Homo sapiens	Inhibition	%	0.45
	8115781	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	3.0	CHEMBL2041	Homo sapiens	Inhibition	%	3.0
	8116003	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	25.17	CHEMBL2041	Homo sapiens	Inhibition	%	25.17
	8116004	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.53	CHEMBL2041	Homo sapiens	Inhibition	%	2.53
	8116005	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	28.51	CHEMBL2041	Homo sapiens	Inhibition	%	28.51
	8116162	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	9.94	CHEMBL2041	Homo sapiens	Inhibition	%	9.94
	8116163	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	33.46	CHEMBL2041	Homo sapiens	Inhibition	%	33.46
	8116164	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	13.79	CHEMBL2041	Homo sapiens	Inhibition	%	13.79
	8116365	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	7.33	CHEMBL2041	Homo sapiens	Inhibition	%	7.33
	8116366	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.53	CHEMBL2041	Homo sapiens	Inhibition	%	4.53
	8116367	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	6.11	CHEMBL2041	Homo sapiens	Inhibition	%	6.11
	8116723	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.88	CHEMBL2041	Homo sapiens	Inhibition	%	0.88
	8116724	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.23	CHEMBL2041	Homo sapiens	Inhibition	%	1.23
	8116725	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	5.78	CHEMBL2041	Homo sapiens	Inhibition	%	5.78
	8116895	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	11.81	CHEMBL2041	Homo sapiens	Inhibition	%	11.81
	8116896	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	5.58	CHEMBL2041	Homo sapiens	Inhibition	%	5.58
	8116897	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	12.43	CHEMBL2041	Homo sapiens	Inhibition	%	12.43
	8117119	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	48.99	CHEMBL2041	Homo sapiens	Inhibition	%	48.99
	8117290	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.18	CHEMBL2041	Homo sapiens	Inhibition	%	0.18
	8117291	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	9.53	CHEMBL2041	Homo sapiens	Inhibition	%	9.53
	8117292	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	9.63	CHEMBL2041	Homo sapiens	Inhibition	%	9.63
	8117448	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	8.91	CHEMBL2041	Homo sapiens	Inhibition	%	8.91
	8117449	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.4	CHEMBL2041	Homo sapiens	Inhibition	%	2.4
	8117450	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	7.43	CHEMBL2041	Homo sapiens	Inhibition	%	7.43
	8117802	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	4.78	CHEMBL2041	Homo sapiens	Inhibition	%	4.78
	8117803	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	9.04	CHEMBL2041	Homo sapiens	Inhibition	%	9.04
	8117804	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	10.17	CHEMBL2041	Homo sapiens	Inhibition	%	10.17
	8118164	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.19	CHEMBL2041	Homo sapiens	Inhibition	%	3.19
	8118165	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	4.74	CHEMBL2041	Homo sapiens	Inhibition	%	4.74
	8118166	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	7.7	CHEMBL2041	Homo sapiens	Inhibition	%	7.7
	8118280	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	3.04	CHEMBL2041	Homo sapiens	Inhibition	%	3.04
	8118281	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.56	CHEMBL2041	Homo sapiens	Inhibition	%	-0.56
	8118282	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.45	CHEMBL2041	Homo sapiens	Inhibition	%	-0.45
	8118676	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.84	CHEMBL2041	Homo sapiens	Inhibition	%	2.84
	8118677	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	7.73	CHEMBL2041	Homo sapiens	Inhibition	%	7.73
	8118678	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.5	CHEMBL2041	Homo sapiens	Inhibition	%	6.5
	8118812	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.58	CHEMBL2041	Homo sapiens	Inhibition	%	3.58
	8118813	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.96	CHEMBL2041	Homo sapiens	Inhibition	%	5.96
	8118814	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	8.01	CHEMBL2041	Homo sapiens	Inhibition	%	8.01
	8119036	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.02	CHEMBL2041	Homo sapiens	Inhibition	%	5.02
	8119037	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	11.12	CHEMBL2041	Homo sapiens	Inhibition	%	11.12
	8119083	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	7.84	CHEMBL2041	Homo sapiens	Inhibition	%	7.84
	8119084	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.79	CHEMBL2041	Homo sapiens	Inhibition	%	4.79
	8119085	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	22.99	CHEMBL2041	Homo sapiens	Inhibition	%	22.99
	8119466	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	90.68	CHEMBL2041	Homo sapiens	Inhibition	%	90.68
	8119467	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	84.7	CHEMBL2041	Homo sapiens	Inhibition	%	84.7
	8119468	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	85.54	CHEMBL2041	Homo sapiens	Inhibition	%	85.54
	8119633	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.11	CHEMBL2041	Homo sapiens	Inhibition	%	-1.11
	8119634	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.14	CHEMBL2041	Homo sapiens	Inhibition	%	0.14
	8119635	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.37	CHEMBL2041	Homo sapiens	Inhibition	%	0.37
	8119976	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	4.76	CHEMBL2041	Homo sapiens	Inhibition	%	4.76
	8119977	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	5.1	CHEMBL2041	Homo sapiens	Inhibition	%	5.1
	8119978	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	7.75	CHEMBL2041	Homo sapiens	Inhibition	%	7.75
	8120339	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-1.02	CHEMBL2041	Homo sapiens	Inhibition	%	-1.02
	8120340	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.74	CHEMBL2041	Homo sapiens	Inhibition	%	0.74
	8120341	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.62	CHEMBL2041	Homo sapiens	Inhibition	%	1.62
	8120499	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	49.14	CHEMBL2041	Homo sapiens	Inhibition	%	49.14
	8120500	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	72.51	CHEMBL2041	Homo sapiens	Inhibition	%	72.51
	8120501	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	56.28	CHEMBL2041	Homo sapiens	Inhibition	%	56.28
	8120700	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.43	CHEMBL2041	Homo sapiens	Inhibition	%	4.43
	8120701	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.1	CHEMBL2041	Homo sapiens	Inhibition	%	1.1
	8120702	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.51	CHEMBL2041	Homo sapiens	Inhibition	%	1.51
	8120924	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	10.34	CHEMBL2041	Homo sapiens	Inhibition	%	10.34
	8120925	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.05	CHEMBL2041	Homo sapiens	Inhibition	%	4.05
	8120926	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	17.13	CHEMBL2041	Homo sapiens	Inhibition	%	17.13
	8121052	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	8.25	CHEMBL2041	Homo sapiens	Inhibition	%	8.25
	8121053	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.58	CHEMBL2041	Homo sapiens	Inhibition	%	1.58
	8121054	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	4.75	CHEMBL2041	Homo sapiens	Inhibition	%	4.75
	8121225	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	7.48	CHEMBL2041	Homo sapiens	Inhibition	%	7.48
	8121226	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	50.23	CHEMBL2041	Homo sapiens	Inhibition	%	50.23
	8121448	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.39	CHEMBL2041	Homo sapiens	Inhibition	%	3.39
	8121449	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.75	CHEMBL2041	Homo sapiens	Inhibition	%	1.75
	8121450	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.94	CHEMBL2041	Homo sapiens	Inhibition	%	1.94
	8121615	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	21.62	CHEMBL2041	Homo sapiens	Inhibition	%	21.62
	8121616	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	38.51	CHEMBL2041	Homo sapiens	Inhibition	%	38.51
	8121617	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	18.75	CHEMBL2041	Homo sapiens	Inhibition	%	18.75
	8121778	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	23.55	CHEMBL2041	Homo sapiens	Inhibition	%	23.55
	8121779	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.07	CHEMBL2041	Homo sapiens	Inhibition	%	4.07
	8121780	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	28.85	CHEMBL2041	Homo sapiens	Inhibition	%	28.85
	8122002	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	9.37	CHEMBL2041	Homo sapiens	Inhibition	%	9.37
	8122003	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.43	CHEMBL2041	Homo sapiens	Inhibition	%	3.43
	8122004	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.9	CHEMBL2041	Homo sapiens	Inhibition	%	5.9
	8122123	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	9.58	CHEMBL2041	Homo sapiens	Inhibition	%	9.58
	8122124	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	12.36	CHEMBL2041	Homo sapiens	Inhibition	%	12.36
	8122125	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	12.12	CHEMBL2041	Homo sapiens	Inhibition	%	12.12
	8122485	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	7.38	CHEMBL2041	Homo sapiens	Inhibition	%	7.38
	8122486	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	11.2	CHEMBL2041	Homo sapiens	Inhibition	%	11.2
	8122487	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	9.54	CHEMBL2041	Homo sapiens	Inhibition	%	9.54
	8122605	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.82	CHEMBL2041	Homo sapiens	Inhibition	%	2.82
	8122606	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	6.61	CHEMBL2041	Homo sapiens	Inhibition	%	6.61
	8122607	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	6.18	CHEMBL2041	Homo sapiens	Inhibition	%	6.18
	8122829	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.87	CHEMBL2041	Homo sapiens	Inhibition	%	4.87
	8122830	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	9.45	CHEMBL2041	Homo sapiens	Inhibition	%	9.45
	8122831	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	7.43	CHEMBL2041	Homo sapiens	Inhibition	%	7.43
	8122996	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.18	CHEMBL2041	Homo sapiens	Inhibition	%	3.18
	8122997	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.93	CHEMBL2041	Homo sapiens	Inhibition	%	2.93
	8122998	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.79	CHEMBL2041	Homo sapiens	Inhibition	%	5.79
	8123140	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.83	CHEMBL2041	Homo sapiens	Inhibition	%	6.83
	8123362	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	14.54	CHEMBL2041	Homo sapiens	Inhibition	%	14.54
	8123363	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	10.44	CHEMBL2041	Homo sapiens	Inhibition	%	10.44
	8123364	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	17.91	CHEMBL2041	Homo sapiens	Inhibition	%	17.91
	8123416	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.91	CHEMBL2041	Homo sapiens	Inhibition	%	1.91
	8123417	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	4.41	CHEMBL2041	Homo sapiens	Inhibition	%	4.41
	8123418	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	5.09	CHEMBL2041	Homo sapiens	Inhibition	%	5.09
	8123640	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	5.56	CHEMBL2041	Homo sapiens	Inhibition	%	5.56
	8123641	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	20.72	CHEMBL2041	Homo sapiens	Inhibition	%	20.72
	8123642	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.8	CHEMBL2041	Homo sapiens	Inhibition	%	2.8
	8123790	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	43.52	CHEMBL2041	Homo sapiens	Inhibition	%	43.52
	8123791	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	13.61	CHEMBL2041	Homo sapiens	Inhibition	%	13.61
	8123792	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	36.33	CHEMBL2041	Homo sapiens	Inhibition	%	36.33
	8123957	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.59	CHEMBL2041	Homo sapiens	Inhibition	%	2.59
	8123958	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	10.23	CHEMBL2041	Homo sapiens	Inhibition	%	10.23
	8123959	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	13.89	CHEMBL2041	Homo sapiens	Inhibition	%	13.89
	8124181	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.89	CHEMBL2041	Homo sapiens	Inhibition	%	3.89
	8124182	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.06	CHEMBL2041	Homo sapiens	Inhibition	%	-0.06
	8124183	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	2.51	CHEMBL2041	Homo sapiens	Inhibition	%	2.51
	8124300	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	13.06	CHEMBL2041	Homo sapiens	Inhibition	%	13.06
	8124301	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	10.96	CHEMBL2041	Homo sapiens	Inhibition	%	10.96
	8124302	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	30.97	CHEMBL2041	Homo sapiens	Inhibition	%	30.97
	8124663	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	3.09	CHEMBL2041	Homo sapiens	Inhibition	%	3.09
	8124664	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.64	CHEMBL2041	Homo sapiens	Inhibition	%	1.64
	8124665	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	5.72	CHEMBL2041	Homo sapiens	Inhibition	%	5.72
	8124828	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.44	CHEMBL2041	Homo sapiens	Inhibition	%	2.44
	8124829	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.83	CHEMBL2041	Homo sapiens	Inhibition	%	2.83
	8124830	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.45	CHEMBL2041	Homo sapiens	Inhibition	%	2.45
	8125052	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	4.66	CHEMBL2041	Homo sapiens	Inhibition	%	4.66
	8125053	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	4.7	CHEMBL2041	Homo sapiens	Inhibition	%	4.7
	8125054	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	8.34	CHEMBL2041	Homo sapiens	Inhibition	%	8.34
	8125253	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.04	CHEMBL2041	Homo sapiens	Inhibition	%	3.04
	8125254	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.58	CHEMBL2041	Homo sapiens	Inhibition	%	3.58
	8125255	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	Inhibition	%	4.0
	8125383	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	33.96	CHEMBL2041	Homo sapiens	Inhibition	%	33.96
	8125384	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	6.41	CHEMBL2041	Homo sapiens	Inhibition	%	6.41
	8125385	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	30.73	CHEMBL2041	Homo sapiens	Inhibition	%	30.73
	8125775	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	5.06	CHEMBL2041	Homo sapiens	Inhibition	%	5.06
	8125776	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.21	CHEMBL2041	Homo sapiens	Inhibition	%	2.21
	8125777	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.61	CHEMBL2041	Homo sapiens	Inhibition	%	4.61
	8125939	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	43.4	CHEMBL2041	Homo sapiens	Inhibition	%	43.4
	8125940	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	43.61	CHEMBL2041	Homo sapiens	Inhibition	%	43.61
	8125941	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	29.06	CHEMBL2041	Homo sapiens	Inhibition	%	29.06
	8126327	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	12.66	CHEMBL2041	Homo sapiens	Inhibition	%	12.66
	8126328	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.79	CHEMBL2041	Homo sapiens	Inhibition	%	5.79
	8126329	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	15.31	CHEMBL2041	Homo sapiens	Inhibition	%	15.31
	8126442	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	84.5	CHEMBL2041	Homo sapiens	Inhibition	%	84.5
	8126443	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	62.19	CHEMBL2041	Homo sapiens	Inhibition	%	62.19
	8126444	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	72.64	CHEMBL2041	Homo sapiens	Inhibition	%	72.64
	8126666	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	88.53	CHEMBL2041	Homo sapiens	Inhibition	%	88.53
	8126667	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	81.08	CHEMBL2041	Homo sapiens	Inhibition	%	81.08
	8126668	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	86.06	CHEMBL2041	Homo sapiens	Inhibition	%	86.06
	8126802	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	30.36	CHEMBL2041	Homo sapiens	Inhibition	%	30.36
	8126803	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	47.29	CHEMBL2041	Homo sapiens	Inhibition	%	47.29
	8126804	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	30.51	CHEMBL2041	Homo sapiens	Inhibition	%	30.51
	8127148	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.36	CHEMBL2041	Homo sapiens	Inhibition	%	2.36
	8127149	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.16	CHEMBL2041	Homo sapiens	Inhibition	%	3.16
	8127150	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	15.56	CHEMBL2041	Homo sapiens	Inhibition	%	15.56
	8127315	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	7.72	CHEMBL2041	Homo sapiens	Inhibition	%	7.72
	8127316	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	7.74	CHEMBL2041	Homo sapiens	Inhibition	%	7.74
	8127317	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	10.01	CHEMBL2041	Homo sapiens	Inhibition	%	10.01
	8127681	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	41.65	CHEMBL2041	Homo sapiens	Inhibition	%	41.65
	8127682	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	34.27	CHEMBL2041	Homo sapiens	Inhibition	%	34.27
	8127683	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	50.62	CHEMBL2041	Homo sapiens	Inhibition	%	50.62
	8127969	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.22	CHEMBL2041	Homo sapiens	Inhibition	%	4.22
	8127970	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	8.26	CHEMBL2041	Homo sapiens	Inhibition	%	8.26
	8127971	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.87	CHEMBL2041	Homo sapiens	Inhibition	%	3.87
	8128121	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	80.64	CHEMBL2041	Homo sapiens	Inhibition	%	80.64
	8128122	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	46.28	CHEMBL2041	Homo sapiens	Inhibition	%	46.28
	8128123	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	75.12	CHEMBL2041	Homo sapiens	Inhibition	%	75.12
	8128512	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	13.94	CHEMBL2041	Homo sapiens	Inhibition	%	13.94
	8128513	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	12.54	CHEMBL2041	Homo sapiens	Inhibition	%	12.54
	8128514	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	32.84	CHEMBL2041	Homo sapiens	Inhibition	%	32.84
	8128631	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	1.21	CHEMBL2041	Homo sapiens	Inhibition	%	1.21
	8128632	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	3.16	CHEMBL2041	Homo sapiens	Inhibition	%	3.16
	8128633	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	2.74	CHEMBL2041	Homo sapiens	Inhibition	%	2.74
	8128855	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	17.15	CHEMBL2041	Homo sapiens	Inhibition	%	17.15
	8128856	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	22.56	CHEMBL2041	Homo sapiens	Inhibition	%	22.56
	8128857	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	24.03	CHEMBL2041	Homo sapiens	Inhibition	%	24.03
	8128992	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.54	CHEMBL2041	Homo sapiens	Inhibition	%	3.54
	8128993	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.26	CHEMBL2041	Homo sapiens	Inhibition	%	1.26
	8128994	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.45	CHEMBL2041	Homo sapiens	Inhibition	%	2.45
	8129387	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	3.54	CHEMBL2041	Homo sapiens	Inhibition	%	3.54
	8129388	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.61	CHEMBL2041	Homo sapiens	Inhibition	%	0.61
	8129389	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.98	CHEMBL2041	Homo sapiens	Inhibition	%	-1.98
	8129576	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	7.38	CHEMBL2041	Homo sapiens	Inhibition	%	7.38
	8129577	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.57	CHEMBL2041	Homo sapiens	Inhibition	%	4.57
	8129578	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	8.79	CHEMBL2041	Homo sapiens	Inhibition	%	8.79
	8129715	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.02	CHEMBL2041	Homo sapiens	Inhibition	%	-1.02
	8129716	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.89	CHEMBL2041	Homo sapiens	Inhibition	%	0.89
	8129717	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.5	CHEMBL2041	Homo sapiens	Inhibition	%	1.5
	8129939	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.55	CHEMBL2041	Homo sapiens	Inhibition	%	1.55
	8129940	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.74	CHEMBL2041	Homo sapiens	Inhibition	%	1.74
	8129941	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	3.64	CHEMBL2041	Homo sapiens	Inhibition	%	3.64
	8130100	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.97	CHEMBL2041	Homo sapiens	Inhibition	%	3.97
	8130101	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.22	CHEMBL2041	Homo sapiens	Inhibition	%	1.22
	8130102	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.04	CHEMBL2041	Homo sapiens	Inhibition	%	1.04
	8130272	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.54	CHEMBL2041	Homo sapiens	Inhibition	%	2.54
	8130273	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	4.84	CHEMBL2041	Homo sapiens	Inhibition	%	4.84
	8130274	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	3.29	CHEMBL2041	Homo sapiens	Inhibition	%	3.29
	8130496	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.84	CHEMBL2041	Homo sapiens	Inhibition	%	-1.84
	8130497	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	8.91	CHEMBL2041	Homo sapiens	Inhibition	%	8.91
	8130498	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	3.53	CHEMBL2041	Homo sapiens	Inhibition	%	3.53
	8130656	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.61	CHEMBL2041	Homo sapiens	Inhibition	%	4.61
	8130657	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.46	CHEMBL2041	Homo sapiens	Inhibition	%	2.46
	8130658	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	5.39	CHEMBL2041	Homo sapiens	Inhibition	%	5.39
	8130996	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.17	CHEMBL2041	Homo sapiens	Inhibition	%	4.17
	8130997	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.11	CHEMBL2041	Homo sapiens	Inhibition	%	3.11
	8130998	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	7.04	CHEMBL2041	Homo sapiens	Inhibition	%	7.04
	8131135	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	71.26	CHEMBL2041	Homo sapiens	Inhibition	%	71.26
	8131136	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	73.94	CHEMBL2041	Homo sapiens	Inhibition	%	73.94
	8131137	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	68.99	CHEMBL2041	Homo sapiens	Inhibition	%	68.99
	8131479	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.4	CHEMBL2041	Homo sapiens	Inhibition	%	5.4
	8131480	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	7.16	CHEMBL2041	Homo sapiens	Inhibition	%	7.16
	8131481	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.3	CHEMBL2041	Homo sapiens	Inhibition	%	4.3
	8131646	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	13.47	CHEMBL2041	Homo sapiens	Inhibition	%	13.47
	8131647	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	7.78	CHEMBL2041	Homo sapiens	Inhibition	%	7.78
	8131648	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	15.88	CHEMBL2041	Homo sapiens	Inhibition	%	15.88
	8131870	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	56.57	CHEMBL2041	Homo sapiens	Inhibition	%	56.57
	8131871	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	33.79	CHEMBL2041	Homo sapiens	Inhibition	%	33.79
	8131872	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	56.64	CHEMBL2041	Homo sapiens	Inhibition	%	56.64
	8132011	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	84.89	CHEMBL2041	Homo sapiens	Inhibition	%	84.89
	8132012	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	64.77	CHEMBL2041	Homo sapiens	Inhibition	%	64.77
	8132013	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	73.88	CHEMBL2041	Homo sapiens	Inhibition	%	73.88
	8132297	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	29.06	CHEMBL2041	Homo sapiens	Inhibition	%	29.06
	8132298	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	43.04	CHEMBL2041	Homo sapiens	Inhibition	%	43.04
	8132299	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	12.95	CHEMBL2041	Homo sapiens	Inhibition	%	12.95
	8132444	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	8.48	CHEMBL2041	Homo sapiens	Inhibition	%	8.48
	8132445	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	6.64	CHEMBL2041	Homo sapiens	Inhibition	%	6.64
	8132446	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	8.23	CHEMBL2041	Homo sapiens	Inhibition	%	8.23
	8132668	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	11.84	CHEMBL2041	Homo sapiens	Inhibition	%	11.84
	8132669	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	9.06	CHEMBL2041	Homo sapiens	Inhibition	%	9.06
	8132670	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	11.94	CHEMBL2041	Homo sapiens	Inhibition	%	11.94
	8132836	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	4.56	CHEMBL2041	Homo sapiens	Inhibition	%	4.56
	8132837	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.9	CHEMBL2041	Homo sapiens	Inhibition	%	0.9
	8132838	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.47	CHEMBL2041	Homo sapiens	Inhibition	%	0.47
	8133181	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.88	CHEMBL2041	Homo sapiens	Inhibition	%	0.88
	8133182	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.76	CHEMBL2041	Homo sapiens	Inhibition	%	-0.76
	8133183	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.42	CHEMBL2041	Homo sapiens	Inhibition	%	-0.42
	8133319	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.36	CHEMBL2041	Homo sapiens	Inhibition	%	3.36
	8133320	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.64	CHEMBL2041	Homo sapiens	Inhibition	%	2.64
	8133321	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.45	CHEMBL2041	Homo sapiens	Inhibition	%	2.45
	8133715	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.85	CHEMBL2041	Homo sapiens	Inhibition	%	1.85
	8133716	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.37	CHEMBL2041	Homo sapiens	Inhibition	%	1.37
	8133717	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	9.08	CHEMBL2041	Homo sapiens	Inhibition	%	9.08
	8133895	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	38.79	CHEMBL2041	Homo sapiens	Inhibition	%	38.79
	8133896	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	27.23	CHEMBL2041	Homo sapiens	Inhibition	%	27.23
	8133897	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	60.74	CHEMBL2041	Homo sapiens	Inhibition	%	60.74
	8134267	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.19	CHEMBL2041	Homo sapiens	Inhibition	%	-1.19
	8134268	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.48	CHEMBL2041	Homo sapiens	Inhibition	%	0.48
	8134269	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.13	CHEMBL2041	Homo sapiens	Inhibition	%	2.13
	8134427	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.84	CHEMBL2041	Homo sapiens	Inhibition	%	2.84
	8134428	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.68	CHEMBL2041	Homo sapiens	Inhibition	%	3.68
	8134429	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.92	CHEMBL2041	Homo sapiens	Inhibition	%	2.92
	8134835	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	10.44	CHEMBL2041	Homo sapiens	Inhibition	%	10.44
	8134836	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	17.91	CHEMBL2041	Homo sapiens	Inhibition	%	17.91
	8134837	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	8.53	CHEMBL2041	Homo sapiens	Inhibition	%	8.53
	8134995	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	12.78	CHEMBL2041	Homo sapiens	Inhibition	%	12.78
	8134996	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	16.31	CHEMBL2041	Homo sapiens	Inhibition	%	16.31
	8134997	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	18.16	CHEMBL2041	Homo sapiens	Inhibition	%	18.16
	8135334	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.55	CHEMBL2041	Homo sapiens	Inhibition	%	2.55
	8135335	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.92	CHEMBL2041	Homo sapiens	Inhibition	%	1.92
	8135336	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	6.69	CHEMBL2041	Homo sapiens	Inhibition	%	6.69
	8135475	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.97	CHEMBL2041	Homo sapiens	Inhibition	%	3.97
	8135476	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.51	CHEMBL2041	Homo sapiens	Inhibition	%	3.51
	8135477	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.45	CHEMBL2041	Homo sapiens	Inhibition	%	6.45
	8135699	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	8.75	CHEMBL2041	Homo sapiens	Inhibition	%	8.75
	8135700	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	11.07	CHEMBL2041	Homo sapiens	Inhibition	%	11.07
	8135701	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	9.77	CHEMBL2041	Homo sapiens	Inhibition	%	9.77
	8135820	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.21	CHEMBL2041	Homo sapiens	Inhibition	%	0.21
	8135821	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.64	CHEMBL2041	Homo sapiens	Inhibition	%	1.64
	8135822	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.78	CHEMBL2041	Homo sapiens	Inhibition	%	2.78
	8136212	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.27	CHEMBL2041	Homo sapiens	Inhibition	%	0.27
	8136213	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.36	CHEMBL2041	Homo sapiens	Inhibition	%	0.36
	8136214	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.95	CHEMBL2041	Homo sapiens	Inhibition	%	3.95
	8136356	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	87.16	CHEMBL2041	Homo sapiens	Inhibition	%	87.16
	8136357	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	79.86	CHEMBL2041	Homo sapiens	Inhibition	%	79.86
	8136358	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	86.3	CHEMBL2041	Homo sapiens	Inhibition	%	86.3
	8136646	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	6.8	CHEMBL2041	Homo sapiens	Inhibition	%	6.8
	8136647	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	8.2	CHEMBL2041	Homo sapiens	Inhibition	%	8.2
	8136648	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.57	CHEMBL2041	Homo sapiens	Inhibition	%	3.57
	8137005	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	5.65	CHEMBL2041	Homo sapiens	Inhibition	%	5.65
	8137006	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.81	CHEMBL2041	Homo sapiens	Inhibition	%	3.81
	8137007	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	8.05	CHEMBL2041	Homo sapiens	Inhibition	%	8.05
	8137168	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	7.64	CHEMBL2041	Homo sapiens	Inhibition	%	7.64
	8137169	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	10.01	CHEMBL2041	Homo sapiens	Inhibition	%	10.01
	8137170	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	22.78	CHEMBL2041	Homo sapiens	Inhibition	%	22.78
	8137512	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	5.75	CHEMBL2041	Homo sapiens	Inhibition	%	5.75
	8137513	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	5.56	CHEMBL2041	Homo sapiens	Inhibition	%	5.56
	8137514	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	20.36	CHEMBL2041	Homo sapiens	Inhibition	%	20.36
	8137660	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.04	CHEMBL2041	Homo sapiens	Inhibition	%	3.04
	8137661	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.31	CHEMBL2041	Homo sapiens	Inhibition	%	3.31
	8137662	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	4.22	CHEMBL2041	Homo sapiens	Inhibition	%	4.22
	8137884	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.36	CHEMBL2041	Homo sapiens	Inhibition	%	1.36
	8137885	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.73	CHEMBL2041	Homo sapiens	Inhibition	%	3.73
	8137886	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	6.9	CHEMBL2041	Homo sapiens	Inhibition	%	6.9
	8138050	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.0	CHEMBL2041	Homo sapiens	Inhibition	%	-2.0
	8138051	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.24	CHEMBL2041	Homo sapiens	Inhibition	%	0.24
	8138052	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.3	CHEMBL2041	Homo sapiens	Inhibition	%	-0.3
	8138229	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	76.84	CHEMBL2041	Homo sapiens	Inhibition	%	76.84
	8138230	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	67.07	CHEMBL2041	Homo sapiens	Inhibition	%	67.07
	8138231	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	82.84	CHEMBL2041	Homo sapiens	Inhibition	%	82.84
	8138453	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.26	CHEMBL2041	Homo sapiens	Inhibition	%	5.26
	8138454	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.89	CHEMBL2041	Homo sapiens	Inhibition	%	2.89
	8138455	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	7.97	CHEMBL2041	Homo sapiens	Inhibition	%	7.97
	8138601	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.94	CHEMBL2041	Homo sapiens	Inhibition	%	0.94
	8138602	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.98	CHEMBL2041	Homo sapiens	Inhibition	%	2.98
	8138603	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	4.56	CHEMBL2041	Homo sapiens	Inhibition	%	4.56
	8138759	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	5.24	CHEMBL2041	Homo sapiens	Inhibition	%	5.24
	8138760	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.71	CHEMBL2041	Homo sapiens	Inhibition	%	1.71
	8138761	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.45	CHEMBL2041	Homo sapiens	Inhibition	%	1.45
	8138983	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.04	CHEMBL2041	Homo sapiens	Inhibition	%	0.04
	8138984	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.38	CHEMBL2041	Homo sapiens	Inhibition	%	2.38
	8138985	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	4.03	CHEMBL2041	Homo sapiens	Inhibition	%	4.03
	8139168	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	49.43	CHEMBL2041	Homo sapiens	Inhibition	%	49.43
	8139169	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	66.25	CHEMBL2041	Homo sapiens	Inhibition	%	66.25
	8139170	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	49.95	CHEMBL2041	Homo sapiens	Inhibition	%	49.95
	8139327	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.88	CHEMBL2041	Homo sapiens	Inhibition	%	5.88
	8139328	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.85	CHEMBL2041	Homo sapiens	Inhibition	%	3.85
	8139329	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.19	CHEMBL2041	Homo sapiens	Inhibition	%	5.19
	8139551	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.38	CHEMBL2041	Homo sapiens	Inhibition	%	5.38
	8139552	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.09	CHEMBL2041	Homo sapiens	Inhibition	%	5.09
	8139553	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	9.36	CHEMBL2041	Homo sapiens	Inhibition	%	9.36
	8139665	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.03	CHEMBL2041	Homo sapiens	Inhibition	%	5.03
	8139666	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.65	CHEMBL2041	Homo sapiens	Inhibition	%	3.65
	8139667	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	6.07	CHEMBL2041	Homo sapiens	Inhibition	%	6.07
	8140030	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.9	CHEMBL2041	Homo sapiens	Inhibition	%	3.9
	8140031	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.71	CHEMBL2041	Homo sapiens	Inhibition	%	7.71
	8140032	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.06	CHEMBL2041	Homo sapiens	Inhibition	%	6.06
	8140153	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.25	CHEMBL2041	Homo sapiens	Inhibition	%	3.25
	8140154	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	5.36	CHEMBL2041	Homo sapiens	Inhibition	%	5.36
	8140155	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.97	CHEMBL2041	Homo sapiens	Inhibition	%	3.97
	8140377	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.22	CHEMBL2041	Homo sapiens	Inhibition	%	3.22
	8140378	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.24	CHEMBL2041	Homo sapiens	Inhibition	%	3.24
	8140379	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.65	CHEMBL2041	Homo sapiens	Inhibition	%	4.65
	8140536	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	6.95	CHEMBL2041	Homo sapiens	Inhibition	%	6.95
	8140537	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.63	CHEMBL2041	Homo sapiens	Inhibition	%	1.63
	8140538	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	6.96	CHEMBL2041	Homo sapiens	Inhibition	%	6.96
	8140679	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.97	CHEMBL2041	Homo sapiens	Inhibition	%	3.97
	8140680	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	9.21	CHEMBL2041	Homo sapiens	Inhibition	%	9.21
	8140681	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	14.46	CHEMBL2041	Homo sapiens	Inhibition	%	14.46
	8140903	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	6.88	CHEMBL2041	Homo sapiens	Inhibition	%	6.88
	8140904	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	12.44	CHEMBL2041	Homo sapiens	Inhibition	%	12.44
	8140905	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	12.81	CHEMBL2041	Homo sapiens	Inhibition	%	12.81
	8140981	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.71	CHEMBL2041	Homo sapiens	Inhibition	%	3.71
	8140982	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	4.18	CHEMBL2041	Homo sapiens	Inhibition	%	4.18
	8140983	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.99	CHEMBL2041	Homo sapiens	Inhibition	%	0.99
	8141205	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.49	CHEMBL2041	Homo sapiens	Inhibition	%	3.49
	8141335	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	22.81	CHEMBL2041	Homo sapiens	Inhibition	%	22.81
	8141336	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	16.52	CHEMBL2041	Homo sapiens	Inhibition	%	16.52
	8141337	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	25.39	CHEMBL2041	Homo sapiens	Inhibition	%	25.39
	8141495	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	15.01	CHEMBL2041	Homo sapiens	Inhibition	%	15.01
	8141496	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	7.89	CHEMBL2041	Homo sapiens	Inhibition	%	7.89
	8141497	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	16.42	CHEMBL2041	Homo sapiens	Inhibition	%	16.42
	8141719	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	54.73	CHEMBL2041	Homo sapiens	Inhibition	%	54.73
	8141720	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	40.74	CHEMBL2041	Homo sapiens	Inhibition	%	40.74
	8141721	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	65.18	CHEMBL2041	Homo sapiens	Inhibition	%	65.18
	8141838	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	4.57	CHEMBL2041	Homo sapiens	Inhibition	%	4.57
	8141839	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.1	CHEMBL2041	Homo sapiens	Inhibition	%	-0.1
	8141840	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.16	CHEMBL2041	Homo sapiens	Inhibition	%	1.16
	8142223	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	8.94	CHEMBL2041	Homo sapiens	Inhibition	%	8.94
	8142224	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	3.01	CHEMBL2041	Homo sapiens	Inhibition	%	3.01
	8142225	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	11.74	CHEMBL2041	Homo sapiens	Inhibition	%	11.74
	8142391	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	3.21	CHEMBL2041	Homo sapiens	Inhibition	%	3.21
	8142392	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	2.29	CHEMBL2041	Homo sapiens	Inhibition	%	2.29
	8142393	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.78	CHEMBL2041	Homo sapiens	Inhibition	%	1.78
	8142791	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.11	CHEMBL2041	Homo sapiens	Inhibition	%	4.11
	8142792	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.13	CHEMBL2041	Homo sapiens	Inhibition	%	5.13
	8142793	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.88	CHEMBL2041	Homo sapiens	Inhibition	%	5.88
	8142940	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	2.09	CHEMBL2041	Homo sapiens	Inhibition	%	2.09
	8142941	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.26	CHEMBL2041	Homo sapiens	Inhibition	%	-0.26
	8142942	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.71	CHEMBL2041	Homo sapiens	Inhibition	%	-0.71
	8143319	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	6.12	CHEMBL2041	Homo sapiens	Inhibition	%	6.12
	8143320	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	9.98	CHEMBL2041	Homo sapiens	Inhibition	%	9.98
	8143321	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.75	CHEMBL2041	Homo sapiens	Inhibition	%	2.75
	8143506	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.98	CHEMBL2041	Homo sapiens	Inhibition	%	5.98
	8143507	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.81	CHEMBL2041	Homo sapiens	Inhibition	%	1.81
	8143508	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	6.36	CHEMBL2041	Homo sapiens	Inhibition	%	6.36
	8143889	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	15.41	CHEMBL2041	Homo sapiens	Inhibition	%	15.41
	8143890	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.52	CHEMBL2041	Homo sapiens	Inhibition	%	2.52
	8143891	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	6.2	CHEMBL2041	Homo sapiens	Inhibition	%	6.2
	8144003	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.3	CHEMBL2041	Homo sapiens	Inhibition	%	2.3
	8144004	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.42	CHEMBL2041	Homo sapiens	Inhibition	%	4.42
	8144005	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	6.81	CHEMBL2041	Homo sapiens	Inhibition	%	6.81
	8144227	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	7.14	CHEMBL2041	Homo sapiens	Inhibition	%	7.14
	8144228	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.03	CHEMBL2041	Homo sapiens	Inhibition	%	2.03
	8144229	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	9.28	CHEMBL2041	Homo sapiens	Inhibition	%	9.28
	8144366	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	8.36	CHEMBL2041	Homo sapiens	Inhibition	%	8.36
	8144367	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	16.5	CHEMBL2041	Homo sapiens	Inhibition	%	16.5
	8144368	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	9.63	CHEMBL2041	Homo sapiens	Inhibition	%	9.63
	8144720	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.07	CHEMBL2041	Homo sapiens	Inhibition	%	2.07
	8144721	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	5.54	CHEMBL2041	Homo sapiens	Inhibition	%	5.54
	8144722	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.57	CHEMBL2041	Homo sapiens	Inhibition	%	3.57
	8144873	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.88	CHEMBL2041	Homo sapiens	Inhibition	%	2.88
	8144874	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.49	CHEMBL2041	Homo sapiens	Inhibition	%	2.49
	8144875	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.21	CHEMBL2041	Homo sapiens	Inhibition	%	3.21
	8145234	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.34	CHEMBL2041	Homo sapiens	Inhibition	%	6.34
	8145235	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.31	CHEMBL2041	Homo sapiens	Inhibition	%	7.31
	8145236	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	10.84	CHEMBL2041	Homo sapiens	Inhibition	%	10.84
	8145324	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.54	CHEMBL2041	Homo sapiens	Inhibition	%	0.54
	8145325	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.4	CHEMBL2041	Homo sapiens	Inhibition	%	1.4
	8145547	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	9.16	CHEMBL2041	Homo sapiens	Inhibition	%	9.16
	8145548	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	4.92	CHEMBL2041	Homo sapiens	Inhibition	%	4.92
	8145549	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	8.94	CHEMBL2041	Homo sapiens	Inhibition	%	8.94
	8145671	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	8.2	CHEMBL2041	Homo sapiens	Inhibition	%	8.2
	8145672	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.51	CHEMBL2041	Homo sapiens	Inhibition	%	4.51
	8145673	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.94	CHEMBL2041	Homo sapiens	Inhibition	%	4.94
	8146056	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	23.83	CHEMBL2041	Homo sapiens	Inhibition	%	23.83
	8146057	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	13.18	CHEMBL2041	Homo sapiens	Inhibition	%	13.18
	8146058	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	24.42	CHEMBL2041	Homo sapiens	Inhibition	%	24.42
	8146176	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	7.32	CHEMBL2041	Homo sapiens	Inhibition	%	7.32
	8146177	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	6.46	CHEMBL2041	Homo sapiens	Inhibition	%	6.46
	8146178	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	17.63	CHEMBL2041	Homo sapiens	Inhibition	%	17.63
	8146400	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	24.74	CHEMBL2041	Homo sapiens	Inhibition	%	24.74
	8146401	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	9.72	CHEMBL2041	Homo sapiens	Inhibition	%	9.72
	8146402	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	22.97	CHEMBL2041	Homo sapiens	Inhibition	%	22.97
	8146560	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	47.32	CHEMBL2041	Homo sapiens	Inhibition	%	47.32
	8146561	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	3.4	CHEMBL2041	Homo sapiens	Inhibition	%	3.4
	8146562	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	56.19	CHEMBL2041	Homo sapiens	Inhibition	%	56.19
	8146727	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	2.63	CHEMBL2041	Homo sapiens	Inhibition	%	2.63
	8146728	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	2.09	CHEMBL2041	Homo sapiens	Inhibition	%	2.09
	8146729	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	1.2	CHEMBL2041	Homo sapiens	Inhibition	%	1.2
	8146951	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	11.62	CHEMBL2041	Homo sapiens	Inhibition	%	11.62
	8146952	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	18.52	CHEMBL2041	Homo sapiens	Inhibition	%	18.52
	8146953	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	18.45	CHEMBL2041	Homo sapiens	Inhibition	%	18.45
	8147120	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.43	CHEMBL2041	Homo sapiens	Inhibition	%	5.43
	8147121	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.68	CHEMBL2041	Homo sapiens	Inhibition	%	1.68
	8147122	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.6	CHEMBL2041	Homo sapiens	Inhibition	%	4.6
	8147262	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.64	CHEMBL2041	Homo sapiens	Inhibition	%	0.64
	8147263	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.17	CHEMBL2041	Homo sapiens	Inhibition	%	-0.17
	8147264	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.37	CHEMBL2041	Homo sapiens	Inhibition	%	-0.37
	8147486	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.18	CHEMBL2041	Homo sapiens	Inhibition	%	0.18
	8147487	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.76	CHEMBL2041	Homo sapiens	Inhibition	%	3.76
	8147488	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.91	CHEMBL2041	Homo sapiens	Inhibition	%	3.91
	8147639	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	7.18	CHEMBL2041	Homo sapiens	Inhibition	%	7.18
	8147640	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.18	CHEMBL2041	Homo sapiens	Inhibition	%	3.18
	8147641	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.06	CHEMBL2041	Homo sapiens	Inhibition	%	4.06
	8147826	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	7.84	CHEMBL2041	Homo sapiens	Inhibition	%	7.84
	8147827	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	11.98	CHEMBL2041	Homo sapiens	Inhibition	%	11.98
	8147828	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.79	CHEMBL2041	Homo sapiens	Inhibition	%	5.79
	8148050	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.67	CHEMBL2041	Homo sapiens	Inhibition	%	7.67
	8148208	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	51.03	CHEMBL2041	Homo sapiens	Inhibition	%	51.03
	8148209	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.3	CHEMBL2041	Homo sapiens	Inhibition	%	3.3
	8148210	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	37.86	CHEMBL2041	Homo sapiens	Inhibition	%	37.86
	8148546	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.94	CHEMBL2041	Homo sapiens	Inhibition	%	4.94
	8148547	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.43	CHEMBL2041	Homo sapiens	Inhibition	%	4.43
	8148548	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	15.06	CHEMBL2041	Homo sapiens	Inhibition	%	15.06
	8148685	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	6.21	CHEMBL2041	Homo sapiens	Inhibition	%	6.21
	8148686	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.62	CHEMBL2041	Homo sapiens	Inhibition	%	4.62
	8148687	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	7.19	CHEMBL2041	Homo sapiens	Inhibition	%	7.19
	8149047	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.55	CHEMBL2041	Homo sapiens	Inhibition	%	1.55
	8149048	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.2	CHEMBL2041	Homo sapiens	Inhibition	%	2.2
	8149049	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.11	CHEMBL2041	Homo sapiens	Inhibition	%	3.11
	8149206	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.96	CHEMBL2041	Homo sapiens	Inhibition	%	2.96
	8149207	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	5.41	CHEMBL2041	Homo sapiens	Inhibition	%	5.41
	8149208	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.82	CHEMBL2041	Homo sapiens	Inhibition	%	2.82
	8149564	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.04	CHEMBL2041	Homo sapiens	Inhibition	%	3.04
	8149565	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	9.24	CHEMBL2041	Homo sapiens	Inhibition	%	9.24
	8149566	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	15.43	CHEMBL2041	Homo sapiens	Inhibition	%	15.43
	8149886	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-1.48	CHEMBL2041	Homo sapiens	Inhibition	%	-1.48
	8149887	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.06	CHEMBL2041	Homo sapiens	Inhibition	%	2.06
	8149888	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.2	CHEMBL2041	Homo sapiens	Inhibition	%	2.2
	8150011	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	9.6	CHEMBL2041	Homo sapiens	Inhibition	%	9.6
	8150012	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	8.22	CHEMBL2041	Homo sapiens	Inhibition	%	8.22
	8150013	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	8.66	CHEMBL2041	Homo sapiens	Inhibition	%	8.66
	8150235	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	77.67	CHEMBL2041	Homo sapiens	Inhibition	%	77.67
	8150236	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	45.58	CHEMBL2041	Homo sapiens	Inhibition	%	45.58
	8150237	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	50.9	CHEMBL2041	Homo sapiens	Inhibition	%	50.9
	8150395	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	48.65	CHEMBL2041	Homo sapiens	Inhibition	%	48.65
	8150396	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	41.02	CHEMBL2041	Homo sapiens	Inhibition	%	41.02
	8150397	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	64.75	CHEMBL2041	Homo sapiens	Inhibition	%	64.75
	8150739	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	74.14	CHEMBL2041	Homo sapiens	Inhibition	%	74.14
	8150740	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	57.96	CHEMBL2041	Homo sapiens	Inhibition	%	57.96
	8150741	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	73.87	CHEMBL2041	Homo sapiens	Inhibition	%	73.87
	8150904	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	11.93	CHEMBL2041	Homo sapiens	Inhibition	%	11.93
	8150905	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.29	CHEMBL2041	Homo sapiens	Inhibition	%	2.29
	8150906	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.79	CHEMBL2041	Homo sapiens	Inhibition	%	1.79
	8151291	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.17	CHEMBL2041	Homo sapiens	Inhibition	%	-2.17
	8151292	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.65	CHEMBL2041	Homo sapiens	Inhibition	%	-1.65
	8151293	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.09	CHEMBL2041	Homo sapiens	Inhibition	%	-3.09
	8151468	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.25	CHEMBL2041	Homo sapiens	Inhibition	%	0.25
	8151469	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.73	CHEMBL2041	Homo sapiens	Inhibition	%	3.73
	8151470	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.43	CHEMBL2041	Homo sapiens	Inhibition	%	5.43
	8151830	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.88	CHEMBL2041	Homo sapiens	Inhibition	%	2.88
	8151831	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	4.5	CHEMBL2041	Homo sapiens	Inhibition	%	4.5
	8151832	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	9.0	CHEMBL2041	Homo sapiens	Inhibition	%	9.0
	8151984	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.63	CHEMBL2041	Homo sapiens	Inhibition	%	2.63
	8151985	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.06	CHEMBL2041	Homo sapiens	Inhibition	%	2.06
	8151986	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.38	CHEMBL2041	Homo sapiens	Inhibition	%	3.38
	8152173	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.28	CHEMBL2041	Homo sapiens	Inhibition	%	7.28
	8152174	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	12.15	CHEMBL2041	Homo sapiens	Inhibition	%	12.15
	8152396	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	25.77	CHEMBL2041	Homo sapiens	Inhibition	%	25.77
	8152397	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	39.82	CHEMBL2041	Homo sapiens	Inhibition	%	39.82
	8152398	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	21.48	CHEMBL2041	Homo sapiens	Inhibition	%	21.48
	8152554	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	6.9	CHEMBL2041	Homo sapiens	Inhibition	%	6.9
	8152555	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.13	CHEMBL2041	Homo sapiens	Inhibition	%	2.13
	8152556	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.1	CHEMBL2041	Homo sapiens	Inhibition	%	5.1
	8152892	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	64.82	CHEMBL2041	Homo sapiens	Inhibition	%	64.82
	8152893	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	4.04	CHEMBL2041	Homo sapiens	Inhibition	%	4.04
	8152894	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	58.1	CHEMBL2041	Homo sapiens	Inhibition	%	58.1
	8153031	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	6.76	CHEMBL2041	Homo sapiens	Inhibition	%	6.76
	8153032	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	8.07	CHEMBL2041	Homo sapiens	Inhibition	%	8.07
	8153033	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	10.93	CHEMBL2041	Homo sapiens	Inhibition	%	10.93
	8153255	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.83	CHEMBL2041	Homo sapiens	Inhibition	%	6.83
	8153256	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.67	CHEMBL2041	Homo sapiens	Inhibition	%	3.67
	8153257	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.88	CHEMBL2041	Homo sapiens	Inhibition	%	4.88
	8153392	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.99	CHEMBL2041	Homo sapiens	Inhibition	%	2.99
	8153393	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.79	CHEMBL2041	Homo sapiens	Inhibition	%	5.79
	8153394	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.63	CHEMBL2041	Homo sapiens	Inhibition	%	3.63
	8153549	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.24	CHEMBL2041	Homo sapiens	Inhibition	%	0.24
	8153550	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.02	CHEMBL2041	Homo sapiens	Inhibition	%	1.02
	8153551	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.36	CHEMBL2041	Homo sapiens	Inhibition	%	2.36
	8153773	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.76	CHEMBL2041	Homo sapiens	Inhibition	%	2.76
	8153774	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.35	CHEMBL2041	Homo sapiens	Inhibition	%	3.35
	8153775	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.1	CHEMBL2041	Homo sapiens	Inhibition	%	3.1
	8153906	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	6.45	CHEMBL2041	Homo sapiens	Inhibition	%	6.45
	8153907	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.21	CHEMBL2041	Homo sapiens	Inhibition	%	4.21
	8153908	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	7.45	CHEMBL2041	Homo sapiens	Inhibition	%	7.45
	8154227	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.54	CHEMBL2041	Homo sapiens	Inhibition	%	2.54
	8154228	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.32	CHEMBL2041	Homo sapiens	Inhibition	%	3.32
	8154229	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.71	CHEMBL2041	Homo sapiens	Inhibition	%	2.71
	8154577	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	84.17	CHEMBL2041	Homo sapiens	Inhibition	%	84.17
	8154578	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	75.71	CHEMBL2041	Homo sapiens	Inhibition	%	75.71
	8154579	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	82.34	CHEMBL2041	Homo sapiens	Inhibition	%	82.34
	8154736	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.18	CHEMBL2041	Homo sapiens	Inhibition	%	1.18
	8154737	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.44	CHEMBL2041	Homo sapiens	Inhibition	%	2.44
	8154738	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.02	CHEMBL2041	Homo sapiens	Inhibition	%	0.02
	8155080	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.95	CHEMBL2041	Homo sapiens	Inhibition	%	1.95
	8155081	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.26	CHEMBL2041	Homo sapiens	Inhibition	%	1.26
	8155082	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.43	CHEMBL2041	Homo sapiens	Inhibition	%	-0.43
	8155256	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	14.22	CHEMBL2041	Homo sapiens	Inhibition	%	14.22
	8155257	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	13.56	CHEMBL2041	Homo sapiens	Inhibition	%	13.56
	8155258	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	7.35	CHEMBL2041	Homo sapiens	Inhibition	%	7.35
	8155641	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.48	CHEMBL2041	Homo sapiens	Inhibition	%	-0.48
	8155642	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.72	CHEMBL2041	Homo sapiens	Inhibition	%	0.72
	8155643	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.71	CHEMBL2041	Homo sapiens	Inhibition	%	-0.71
	8155819	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.64	CHEMBL2041	Homo sapiens	Inhibition	%	3.64
	8155820	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.6	CHEMBL2041	Homo sapiens	Inhibition	%	3.6
	8155821	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	5.5	CHEMBL2041	Homo sapiens	Inhibition	%	5.5
	8156181	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.9	CHEMBL2041	Homo sapiens	Inhibition	%	0.9
	8156182	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	5.38	CHEMBL2041	Homo sapiens	Inhibition	%	5.38
	8156183	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	7.78	CHEMBL2041	Homo sapiens	Inhibition	%	7.78
	8156393	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.76	CHEMBL2041	Homo sapiens	Inhibition	%	5.76
	8156394	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	14.96	CHEMBL2041	Homo sapiens	Inhibition	%	14.96
	8156395	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	10.46	CHEMBL2041	Homo sapiens	Inhibition	%	10.46
	8156767	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	33.56	CHEMBL2041	Homo sapiens	Inhibition	%	33.56
	8156768	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	28.78	CHEMBL2041	Homo sapiens	Inhibition	%	28.78
	8156769	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	39.18	CHEMBL2041	Homo sapiens	Inhibition	%	39.18
	8156910	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.66	CHEMBL2041	Homo sapiens	Inhibition	%	3.66
	8156911	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.57	CHEMBL2041	Homo sapiens	Inhibition	%	3.57
	8156912	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	0.77	CHEMBL2041	Homo sapiens	Inhibition	%	0.77
	8157254	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	7.82	CHEMBL2041	Homo sapiens	Inhibition	%	7.82
	8157255	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	12.21	CHEMBL2041	Homo sapiens	Inhibition	%	12.21
	8157256	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	10.51	CHEMBL2041	Homo sapiens	Inhibition	%	10.51
	8157619	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	7.14	CHEMBL2041	Homo sapiens	Inhibition	%	7.14
	8157620	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	16.67	CHEMBL2041	Homo sapiens	Inhibition	%	16.67
	8157621	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	8.01	CHEMBL2041	Homo sapiens	Inhibition	%	8.01
	8157749	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	90.21	CHEMBL2041	Homo sapiens	Inhibition	%	90.21
	8157750	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	78.71	CHEMBL2041	Homo sapiens	Inhibition	%	78.71
	8157751	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	87.04	CHEMBL2041	Homo sapiens	Inhibition	%	87.04
	8158134	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	9.77	CHEMBL2041	Homo sapiens	Inhibition	%	9.77
	8158135	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	9.69	CHEMBL2041	Homo sapiens	Inhibition	%	9.69
	8158136	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	4.28	CHEMBL2041	Homo sapiens	Inhibition	%	4.28
	8158384	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	22.2	CHEMBL2041	Homo sapiens	Inhibition	%	22.2
	8158385	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.41	CHEMBL2041	Homo sapiens	Inhibition	%	4.41
	8158386	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	26.64	CHEMBL2041	Homo sapiens	Inhibition	%	26.64
	8158542	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.99	CHEMBL2041	Homo sapiens	Inhibition	%	6.99
	8158543	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	8.29	CHEMBL2041	Homo sapiens	Inhibition	%	8.29
	8158544	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	10.68	CHEMBL2041	Homo sapiens	Inhibition	%	10.68
	8158766	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	9.44	CHEMBL2041	Homo sapiens	Inhibition	%	9.44
	8158767	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	9.54	CHEMBL2041	Homo sapiens	Inhibition	%	9.54
	8158768	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	11.41	CHEMBL2041	Homo sapiens	Inhibition	%	11.41
	8158935	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	6.14	CHEMBL2041	Homo sapiens	Inhibition	%	6.14
	8158936	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.33	CHEMBL2041	Homo sapiens	Inhibition	%	3.33
	8158937	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	7.68	CHEMBL2041	Homo sapiens	Inhibition	%	7.68
	8159070	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.21	CHEMBL2041	Homo sapiens	Inhibition	%	5.21
	8159071	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	9.32	CHEMBL2041	Homo sapiens	Inhibition	%	9.32
	8159072	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	8.19	CHEMBL2041	Homo sapiens	Inhibition	%	8.19
	8159294	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.0	CHEMBL2041	Homo sapiens	Inhibition	%	2.0
	8159295	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.92	CHEMBL2041	Homo sapiens	Inhibition	%	2.92
	8159296	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.36	CHEMBL2041	Homo sapiens	Inhibition	%	4.36
	8159414	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	15.23	CHEMBL2041	Homo sapiens	Inhibition	%	15.23
	8159415	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	33.33	CHEMBL2041	Homo sapiens	Inhibition	%	33.33
	8159416	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	18.15	CHEMBL2041	Homo sapiens	Inhibition	%	18.15
	8159769	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	15.54	CHEMBL2041	Homo sapiens	Inhibition	%	15.54
	8159770	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	21.27	CHEMBL2041	Homo sapiens	Inhibition	%	21.27
	8159771	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	26.24	CHEMBL2041	Homo sapiens	Inhibition	%	26.24
	8159910	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.81	CHEMBL2041	Homo sapiens	Inhibition	%	2.81
	8159911	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.37	CHEMBL2041	Homo sapiens	Inhibition	%	1.37
	8159912	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.63	CHEMBL2041	Homo sapiens	Inhibition	%	2.63
	8160134	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.44	CHEMBL2041	Homo sapiens	Inhibition	%	4.44
	8160135	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.16	CHEMBL2041	Homo sapiens	Inhibition	%	1.16
	8160136	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.82	CHEMBL2041	Homo sapiens	Inhibition	%	1.82
	8160271	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.27	CHEMBL2041	Homo sapiens	Inhibition	%	4.27
	8160272	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.54	CHEMBL2041	Homo sapiens	Inhibition	%	1.54
	8160273	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.41	CHEMBL2041	Homo sapiens	Inhibition	%	5.41
	8160421	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	4.3	CHEMBL2041	Homo sapiens	Inhibition	%	4.3
	8160422	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.58	CHEMBL2041	Homo sapiens	Inhibition	%	2.58
	8160423	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	7.68	CHEMBL2041	Homo sapiens	Inhibition	%	7.68
	8160645	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	3.09	CHEMBL2041	Homo sapiens	Inhibition	%	3.09
	8160646	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.11	CHEMBL2041	Homo sapiens	Inhibition	%	0.11
	8160647	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	3.7	CHEMBL2041	Homo sapiens	Inhibition	%	3.7
	8160715	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	8.44	CHEMBL2041	Homo sapiens	Inhibition	%	8.44
	8160716	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	6.9	CHEMBL2041	Homo sapiens	Inhibition	%	6.9
	8160717	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	8.23	CHEMBL2041	Homo sapiens	Inhibition	%	8.23
	8160939	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	27.56	CHEMBL2041	Homo sapiens	Inhibition	%	27.56
	8160940	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	13.64	CHEMBL2041	Homo sapiens	Inhibition	%	13.64
	8160941	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	12.87	CHEMBL2041	Homo sapiens	Inhibition	%	12.87
	8161089	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	16.53	CHEMBL2041	Homo sapiens	Inhibition	%	16.53
	8161090	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	13.16	CHEMBL2041	Homo sapiens	Inhibition	%	13.16
	8161091	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	29.08	CHEMBL2041	Homo sapiens	Inhibition	%	29.08
	8161232	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	7.66	CHEMBL2041	Homo sapiens	Inhibition	%	7.66
	8161233	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	10.01	CHEMBL2041	Homo sapiens	Inhibition	%	10.01
	8161234	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	7.3	CHEMBL2041	Homo sapiens	Inhibition	%	7.3
	8161456	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	5.62	CHEMBL2041	Homo sapiens	Inhibition	%	5.62
	8161457	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	5.79	CHEMBL2041	Homo sapiens	Inhibition	%	5.79
	8161458	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.73	CHEMBL2041	Homo sapiens	Inhibition	%	4.73
	8161581	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	44.25	CHEMBL2041	Homo sapiens	Inhibition	%	44.25
	8161582	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	42.19	CHEMBL2041	Homo sapiens	Inhibition	%	42.19
	8161583	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	38.09	CHEMBL2041	Homo sapiens	Inhibition	%	38.09
	8161943	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	39.07	CHEMBL2041	Homo sapiens	Inhibition	%	39.07
	8161944	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	57.4	CHEMBL2041	Homo sapiens	Inhibition	%	57.4
	8161945	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	31.78	CHEMBL2041	Homo sapiens	Inhibition	%	31.78
	8162073	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	6.25	CHEMBL2041	Homo sapiens	Inhibition	%	6.25
	8162074	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.29	CHEMBL2041	Homo sapiens	Inhibition	%	4.29
	8162075	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	8.48	CHEMBL2041	Homo sapiens	Inhibition	%	8.48
	8162297	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	12.02	CHEMBL2041	Homo sapiens	Inhibition	%	12.02
	8162298	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	13.42	CHEMBL2041	Homo sapiens	Inhibition	%	13.42
	8162299	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	14.21	CHEMBL2041	Homo sapiens	Inhibition	%	14.21
	8162457	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	76.25	CHEMBL2041	Homo sapiens	Inhibition	%	76.25
	8162458	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	38.77	CHEMBL2041	Homo sapiens	Inhibition	%	38.77
	8162459	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	65.8	CHEMBL2041	Homo sapiens	Inhibition	%	65.8
	8162710	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.56	CHEMBL2041	Homo sapiens	Inhibition	%	5.56
	8162711	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.46	CHEMBL2041	Homo sapiens	Inhibition	%	3.46
	8162712	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.17	CHEMBL2041	Homo sapiens	Inhibition	%	4.17
	8163082	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	47.66	CHEMBL2041	Homo sapiens	Inhibition	%	47.66
	8163083	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	58.98	CHEMBL2041	Homo sapiens	Inhibition	%	58.98
	8163084	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	46.11	CHEMBL2041	Homo sapiens	Inhibition	%	46.11
	8163251	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	10.26	CHEMBL2041	Homo sapiens	Inhibition	%	10.26
	8163252	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.9	CHEMBL2041	Homo sapiens	Inhibition	%	2.9
	8163253	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	11.49	CHEMBL2041	Homo sapiens	Inhibition	%	11.49
	8163609	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	10.56	CHEMBL2041	Homo sapiens	Inhibition	%	10.56
	8163610	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.95	CHEMBL2041	Homo sapiens	Inhibition	%	6.95
	8163611	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	7.29	CHEMBL2041	Homo sapiens	Inhibition	%	7.29
	8163732	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.13	CHEMBL2041	Homo sapiens	Inhibition	%	1.13
	8163733	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.1	CHEMBL2041	Homo sapiens	Inhibition	%	3.1
	8163734	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.14	CHEMBL2041	Homo sapiens	Inhibition	%	3.14
	8163956	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	7.86	CHEMBL2041	Homo sapiens	Inhibition	%	7.86
	8163957	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	6.64	CHEMBL2041	Homo sapiens	Inhibition	%	6.64
	8163958	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	7.69	CHEMBL2041	Homo sapiens	Inhibition	%	7.69
	8164090	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	8.63	CHEMBL2041	Homo sapiens	Inhibition	%	8.63
	8164091	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	10.08	CHEMBL2041	Homo sapiens	Inhibition	%	10.08
	8164092	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	8.67	CHEMBL2041	Homo sapiens	Inhibition	%	8.67
	8164454	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.92	CHEMBL2041	Homo sapiens	Inhibition	%	-0.92
	8164455	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	2.21	CHEMBL2041	Homo sapiens	Inhibition	%	2.21
	8164456	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.42	CHEMBL2041	Homo sapiens	Inhibition	%	1.42
	8164609	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	7.18	CHEMBL2041	Homo sapiens	Inhibition	%	7.18
	8164610	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	8.77	CHEMBL2041	Homo sapiens	Inhibition	%	8.77
	8164611	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	8.63	CHEMBL2041	Homo sapiens	Inhibition	%	8.63
	8164977	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	19.32	CHEMBL2041	Homo sapiens	Inhibition	%	19.32
	8164978	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	5.11	CHEMBL2041	Homo sapiens	Inhibition	%	5.11
	8164979	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	25.22	CHEMBL2041	Homo sapiens	Inhibition	%	25.22
	8165271	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.39	CHEMBL2041	Homo sapiens	Inhibition	%	7.39
	8165272	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.91	CHEMBL2041	Homo sapiens	Inhibition	%	7.91
	8165273	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.98	CHEMBL2041	Homo sapiens	Inhibition	%	7.98
	8165412	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	58.48	CHEMBL2041	Homo sapiens	Inhibition	%	58.48
	8165413	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	48.89	CHEMBL2041	Homo sapiens	Inhibition	%	48.89
	8165414	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	73.64	CHEMBL2041	Homo sapiens	Inhibition	%	73.64
	8165779	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	21.9	CHEMBL2041	Homo sapiens	Inhibition	%	21.9
	8165780	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	21.96	CHEMBL2041	Homo sapiens	Inhibition	%	21.96
	8165781	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	26.25	CHEMBL2041	Homo sapiens	Inhibition	%	26.25
	8165905	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.55	CHEMBL2041	Homo sapiens	Inhibition	%	1.55
	8165906	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.61	CHEMBL2041	Homo sapiens	Inhibition	%	3.61
	8165907	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.99	CHEMBL2041	Homo sapiens	Inhibition	%	2.99
	8166129	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	7.91	CHEMBL2041	Homo sapiens	Inhibition	%	7.91
	8166130	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.98	CHEMBL2041	Homo sapiens	Inhibition	%	2.98
	8166131	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	6.27	CHEMBL2041	Homo sapiens	Inhibition	%	6.27
	8166267	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.74	CHEMBL2041	Homo sapiens	Inhibition	%	4.74
	8166268	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	5.42	CHEMBL2041	Homo sapiens	Inhibition	%	5.42
	8166269	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.26	CHEMBL2041	Homo sapiens	Inhibition	%	3.26
	8166621	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	27.45	CHEMBL2041	Homo sapiens	Inhibition	%	27.45
	8166622	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.04	CHEMBL2041	Homo sapiens	Inhibition	%	4.04
	8166623	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	30.03	CHEMBL2041	Homo sapiens	Inhibition	%	30.03
	8166722	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	51.06	CHEMBL2041	Homo sapiens	Inhibition	%	51.06
	8166723	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	25.31	CHEMBL2041	Homo sapiens	Inhibition	%	25.31
	8166724	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	57.55	CHEMBL2041	Homo sapiens	Inhibition	%	57.55
	8166946	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	84.05	CHEMBL2041	Homo sapiens	Inhibition	%	84.05
	8166947	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	68.71	CHEMBL2041	Homo sapiens	Inhibition	%	68.71
	8166948	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	82.39	CHEMBL2041	Homo sapiens	Inhibition	%	82.39
	8167034	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.11	CHEMBL2041	Homo sapiens	Inhibition	%	4.11
	8167035	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.03	CHEMBL2041	Homo sapiens	Inhibition	%	4.03
	8167036	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	13.86	CHEMBL2041	Homo sapiens	Inhibition	%	13.86
	8167399	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	79.9	CHEMBL2041	Homo sapiens	Inhibition	%	79.9
	8167400	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	78.31	CHEMBL2041	Homo sapiens	Inhibition	%	78.31
	8167401	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	72.37	CHEMBL2041	Homo sapiens	Inhibition	%	72.37
	8167563	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.35	CHEMBL2041	Homo sapiens	Inhibition	%	5.35
	8167564	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.1	CHEMBL2041	Homo sapiens	Inhibition	%	3.1
	8167565	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.18	CHEMBL2041	Homo sapiens	Inhibition	%	5.18
	8167920	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.24	CHEMBL2041	Homo sapiens	Inhibition	%	6.24
	8167921	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.33	CHEMBL2041	Homo sapiens	Inhibition	%	3.33
	8167922	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.33	CHEMBL2041	Homo sapiens	Inhibition	%	6.33
	8168268	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	6.58	CHEMBL2041	Homo sapiens	Inhibition	%	6.58
	8168269	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	6.27	CHEMBL2041	Homo sapiens	Inhibition	%	6.27
	8168270	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	8.37	CHEMBL2041	Homo sapiens	Inhibition	%	8.37
	8168409	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	20.86	CHEMBL2041	Homo sapiens	Inhibition	%	20.86
	8168410	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	41.64	CHEMBL2041	Homo sapiens	Inhibition	%	41.64
	8168411	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	23.65	CHEMBL2041	Homo sapiens	Inhibition	%	23.65
	8168769	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.44	CHEMBL2041	Homo sapiens	Inhibition	%	-0.44
	8168770	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	2.81	CHEMBL2041	Homo sapiens	Inhibition	%	2.81
	8168771	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.67	CHEMBL2041	Homo sapiens	Inhibition	%	1.67
	8168933	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	8.71	CHEMBL2041	Homo sapiens	Inhibition	%	8.71
	8168934	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	6.87	CHEMBL2041	Homo sapiens	Inhibition	%	6.87
	8168935	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	7.91	CHEMBL2041	Homo sapiens	Inhibition	%	7.91
	8169299	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.92	CHEMBL2041	Homo sapiens	Inhibition	%	3.92
	8169300	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.24	CHEMBL2041	Homo sapiens	Inhibition	%	4.24
	8169301	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	6.88	CHEMBL2041	Homo sapiens	Inhibition	%	6.88
	8169603	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	9.1	CHEMBL2041	Homo sapiens	Inhibition	%	9.1
	8169604	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	20.39	CHEMBL2041	Homo sapiens	Inhibition	%	20.39
	8169605	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	27.15	CHEMBL2041	Homo sapiens	Inhibition	%	27.15
	8169737	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.05	CHEMBL2041	Homo sapiens	Inhibition	%	3.05
	8169738	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.66	CHEMBL2041	Homo sapiens	Inhibition	%	0.66
	8169739	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.8	CHEMBL2041	Homo sapiens	Inhibition	%	0.8
	8169961	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	5.72	CHEMBL2041	Homo sapiens	Inhibition	%	5.72
	8169962	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	17.11	CHEMBL2041	Homo sapiens	Inhibition	%	17.11
	8169963	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	14.84	CHEMBL2041	Homo sapiens	Inhibition	%	14.84
	8170106	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	76.41	CHEMBL2041	Homo sapiens	Inhibition	%	76.41
	8170107	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	38.37	CHEMBL2041	Homo sapiens	Inhibition	%	38.37
	8170108	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	60.72	CHEMBL2041	Homo sapiens	Inhibition	%	60.72
	8170455	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.83	CHEMBL2041	Homo sapiens	Inhibition	%	1.83
	8170456	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.14	CHEMBL2041	Homo sapiens	Inhibition	%	3.14
	8170457	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.74	CHEMBL2041	Homo sapiens	Inhibition	%	2.74
	8170595	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	17.92	CHEMBL2041	Homo sapiens	Inhibition	%	17.92
	8170596	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	25.3	CHEMBL2041	Homo sapiens	Inhibition	%	25.3
	8170597	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	23.65	CHEMBL2041	Homo sapiens	Inhibition	%	23.65
	8170954	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	72.85	CHEMBL2041	Homo sapiens	Inhibition	%	72.85
	8170955	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	7.21	CHEMBL2041	Homo sapiens	Inhibition	%	7.21
	8170956	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	71.22	CHEMBL2041	Homo sapiens	Inhibition	%	71.22
	8171151	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	86.23	CHEMBL2041	Homo sapiens	Inhibition	%	86.23
	8171152	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	74.92	CHEMBL2041	Homo sapiens	Inhibition	%	74.92
	8171153	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	83.89	CHEMBL2041	Homo sapiens	Inhibition	%	83.89
	8171368	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	6.91	CHEMBL2041	Homo sapiens	Inhibition	%	6.91
	8171369	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.37	CHEMBL2041	Homo sapiens	Inhibition	%	2.37
	8171370	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.99	CHEMBL2041	Homo sapiens	Inhibition	%	5.99
	8171592	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	10.43	CHEMBL2041	Homo sapiens	Inhibition	%	10.43
	8171593	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	6.08	CHEMBL2041	Homo sapiens	Inhibition	%	6.08
	8171594	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	7.86	CHEMBL2041	Homo sapiens	Inhibition	%	7.86
	8171733	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	8.13	CHEMBL2041	Homo sapiens	Inhibition	%	8.13
	8171734	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	12.88	CHEMBL2041	Homo sapiens	Inhibition	%	12.88
	8171735	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	8.97	CHEMBL2041	Homo sapiens	Inhibition	%	8.97
	8171886	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.82	CHEMBL2041	Homo sapiens	Inhibition	%	5.82
	8171887	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.6	CHEMBL2041	Homo sapiens	Inhibition	%	3.6
	8171888	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.2	CHEMBL2041	Homo sapiens	Inhibition	%	2.2
	8172110	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.64	CHEMBL2041	Homo sapiens	Inhibition	%	2.64
	8172111	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.55	CHEMBL2041	Homo sapiens	Inhibition	%	3.55
	8172112	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	4.94	CHEMBL2041	Homo sapiens	Inhibition	%	4.94
	8172242	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.07	CHEMBL2041	Homo sapiens	Inhibition	%	5.07
	8172243	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	15.82	CHEMBL2041	Homo sapiens	Inhibition	%	15.82
	8172244	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	11.26	CHEMBL2041	Homo sapiens	Inhibition	%	11.26
	8172594	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	34.95	CHEMBL2041	Homo sapiens	Inhibition	%	34.95
	8172595	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	35.46	CHEMBL2041	Homo sapiens	Inhibition	%	35.46
	8172596	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	42.42	CHEMBL2041	Homo sapiens	Inhibition	%	42.42
	8172736	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.55	CHEMBL2041	Homo sapiens	Inhibition	%	5.55
	8172737	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.73	CHEMBL2041	Homo sapiens	Inhibition	%	1.73
	8172738	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	6.62	CHEMBL2041	Homo sapiens	Inhibition	%	6.62
	8172960	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	16.62	CHEMBL2041	Homo sapiens	Inhibition	%	16.62
	8172961	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.71	CHEMBL2041	Homo sapiens	Inhibition	%	4.71
	8172962	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	19.41	CHEMBL2041	Homo sapiens	Inhibition	%	19.41
	8173096	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.41	CHEMBL2041	Homo sapiens	Inhibition	%	2.41
	8173097	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.14	CHEMBL2041	Homo sapiens	Inhibition	%	-0.14
	8173098	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.8	CHEMBL2041	Homo sapiens	Inhibition	%	-2.8
	8173261	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	37.35	CHEMBL2041	Homo sapiens	Inhibition	%	37.35
	8173262	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	43.83	CHEMBL2041	Homo sapiens	Inhibition	%	43.83
	8173263	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	37.28	CHEMBL2041	Homo sapiens	Inhibition	%	37.28
	8173485	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	9.73	CHEMBL2041	Homo sapiens	Inhibition	%	9.73
	8173486	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	7.23	CHEMBL2041	Homo sapiens	Inhibition	%	7.23
	8173487	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	18.43	CHEMBL2041	Homo sapiens	Inhibition	%	18.43
	8173626	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	6.93	CHEMBL2041	Homo sapiens	Inhibition	%	6.93
	8173627	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	8.77	CHEMBL2041	Homo sapiens	Inhibition	%	8.77
	8173628	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	6.93	CHEMBL2041	Homo sapiens	Inhibition	%	6.93
	8173937	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	15.31	CHEMBL2041	Homo sapiens	Inhibition	%	15.31
	8173938	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	42.64	CHEMBL2041	Homo sapiens	Inhibition	%	42.64
	8173939	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	22.77	CHEMBL2041	Homo sapiens	Inhibition	%	22.77
	8174293	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.45	CHEMBL2041	Homo sapiens	Inhibition	%	2.45
	8174294	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.74	CHEMBL2041	Homo sapiens	Inhibition	%	2.74
	8174295	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.65	CHEMBL2041	Homo sapiens	Inhibition	%	0.65
	8174441	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	81.39	CHEMBL2041	Homo sapiens	Inhibition	%	81.39
	8174442	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	77.0	CHEMBL2041	Homo sapiens	Inhibition	%	77.0
	8174443	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	75.62	CHEMBL2041	Homo sapiens	Inhibition	%	75.62
	8174787	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	5.76	CHEMBL2041	Homo sapiens	Inhibition	%	5.76
	8174788	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	7.11	CHEMBL2041	Homo sapiens	Inhibition	%	7.11
	8174789	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	18.79	CHEMBL2041	Homo sapiens	Inhibition	%	18.79
	8174930	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	6.89	CHEMBL2041	Homo sapiens	Inhibition	%	6.89
	8174931	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	6.2	CHEMBL2041	Homo sapiens	Inhibition	%	6.2
	8174932	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	5.3	CHEMBL2041	Homo sapiens	Inhibition	%	5.3
	8175154	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	26.28	CHEMBL2041	Homo sapiens	Inhibition	%	26.28
	8175155	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	28.46	CHEMBL2041	Homo sapiens	Inhibition	%	28.46
	8175156	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	33.53	CHEMBL2041	Homo sapiens	Inhibition	%	33.53
	8175290	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	6.8	CHEMBL2041	Homo sapiens	Inhibition	%	6.8
	8175291	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.06	CHEMBL2041	Homo sapiens	Inhibition	%	4.06
	8175292	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	5.09	CHEMBL2041	Homo sapiens	Inhibition	%	5.09
	8175546	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	15.39	CHEMBL2041	Homo sapiens	Inhibition	%	15.39
	8175547	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	20.25	CHEMBL2041	Homo sapiens	Inhibition	%	20.25
	8175548	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	12.88	CHEMBL2041	Homo sapiens	Inhibition	%	12.88
	8175933	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	11.87	CHEMBL2041	Homo sapiens	Inhibition	%	11.87
	8175934	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	5.4	CHEMBL2041	Homo sapiens	Inhibition	%	5.4
	8175935	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	12.56	CHEMBL2041	Homo sapiens	Inhibition	%	12.56
	8176086	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	14.07	CHEMBL2041	Homo sapiens	Inhibition	%	14.07
	8176087	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	38.09	CHEMBL2041	Homo sapiens	Inhibition	%	38.09
	8176088	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	18.67	CHEMBL2041	Homo sapiens	Inhibition	%	18.67
	8176459	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	18.27	CHEMBL2041	Homo sapiens	Inhibition	%	18.27
	8176460	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	9.3	CHEMBL2041	Homo sapiens	Inhibition	%	9.3
	8176461	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	19.49	CHEMBL2041	Homo sapiens	Inhibition	%	19.49
	8176591	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	23.74	CHEMBL2041	Homo sapiens	Inhibition	%	23.74
	8176592	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	32.39	CHEMBL2041	Homo sapiens	Inhibition	%	32.39
	8176593	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	25.81	CHEMBL2041	Homo sapiens	Inhibition	%	25.81
	8176815	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	61.26	CHEMBL2041	Homo sapiens	Inhibition	%	61.26
	8176816	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	75.36	CHEMBL2041	Homo sapiens	Inhibition	%	75.36
	8176817	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	67.01	CHEMBL2041	Homo sapiens	Inhibition	%	67.01
	8176945	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.0	CHEMBL2041	Homo sapiens	Inhibition	%	2.0
	8176946	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.75	CHEMBL2041	Homo sapiens	Inhibition	%	2.75
	8176947	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.44	CHEMBL2041	Homo sapiens	Inhibition	%	2.44
	8177311	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.14	CHEMBL2041	Homo sapiens	Inhibition	%	1.14
	8177312	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	8.88	CHEMBL2041	Homo sapiens	Inhibition	%	8.88
	8177313	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.32	CHEMBL2041	Homo sapiens	Inhibition	%	3.32
	8177449	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.62	CHEMBL2041	Homo sapiens	Inhibition	%	1.62
	8177450	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.66	CHEMBL2041	Homo sapiens	Inhibition	%	-1.66
	8177451	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.02	CHEMBL2041	Homo sapiens	Inhibition	%	-2.02
	8177837	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	50.26	CHEMBL2041	Homo sapiens	Inhibition	%	50.26
	8177838	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	31.08	CHEMBL2041	Homo sapiens	Inhibition	%	31.08
	8177839	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	65.89	CHEMBL2041	Homo sapiens	Inhibition	%	65.89
	8177977	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-0.83	CHEMBL2041	Homo sapiens	Inhibition	%	-0.83
	8177978	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.79	CHEMBL2041	Homo sapiens	Inhibition	%	2.79
	8177979	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	8.02	CHEMBL2041	Homo sapiens	Inhibition	%	8.02
	8178201	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	7.95	CHEMBL2041	Homo sapiens	Inhibition	%	7.95
	8178202	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	16.25	CHEMBL2041	Homo sapiens	Inhibition	%	16.25
	8178203	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.19	CHEMBL2041	Homo sapiens	Inhibition	%	1.19
	8178289	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	57.82	CHEMBL2041	Homo sapiens	Inhibition	%	57.82
	8178290	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	83.47	CHEMBL2041	Homo sapiens	Inhibition	%	83.47
	8178291	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	63.74	CHEMBL2041	Homo sapiens	Inhibition	%	63.74
	8178640	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	5.3	CHEMBL2041	Homo sapiens	Inhibition	%	5.3
	8178641	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	7.8	CHEMBL2041	Homo sapiens	Inhibition	%	7.8
	8178642	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	15.18	CHEMBL2041	Homo sapiens	Inhibition	%	15.18
	8178789	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.9	CHEMBL2041	Homo sapiens	Inhibition	%	3.9
	8178790	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.77	CHEMBL2041	Homo sapiens	Inhibition	%	1.77
	8178791	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	8.82	CHEMBL2041	Homo sapiens	Inhibition	%	8.82
	8179013	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	7.06	CHEMBL2041	Homo sapiens	Inhibition	%	7.06
	8179014	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	7.1	CHEMBL2041	Homo sapiens	Inhibition	%	7.1
	8179015	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	24.54	CHEMBL2041	Homo sapiens	Inhibition	%	24.54
	8179136	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.0	CHEMBL2041	Homo sapiens	Inhibition	%	2.0
	8179137	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.16	CHEMBL2041	Homo sapiens	Inhibition	%	2.16
	8179138	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.93	CHEMBL2041	Homo sapiens	Inhibition	%	1.93
	8179504	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	11.06	CHEMBL2041	Homo sapiens	Inhibition	%	11.06
	8179505	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	31.38	CHEMBL2041	Homo sapiens	Inhibition	%	31.38
	8179506	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	10.61	CHEMBL2041	Homo sapiens	Inhibition	%	10.61
	8179641	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	14.44	CHEMBL2041	Homo sapiens	Inhibition	%	14.44
	8179642	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	10.05	CHEMBL2041	Homo sapiens	Inhibition	%	10.05
	8179643	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	13.45	CHEMBL2041	Homo sapiens	Inhibition	%	13.45
	8179898	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	48.57	CHEMBL2041	Homo sapiens	Inhibition	%	48.57
	8179899	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	67.29	CHEMBL2041	Homo sapiens	Inhibition	%	67.29
	8179900	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	53.24	CHEMBL2041	Homo sapiens	Inhibition	%	53.24
	8180122	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.29	CHEMBL2041	Homo sapiens	Inhibition	%	1.29
	8180123	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.66	CHEMBL2041	Homo sapiens	Inhibition	%	4.66
	8180124	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.08	CHEMBL2041	Homo sapiens	Inhibition	%	3.08
	8180276	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	39.04	CHEMBL2041	Homo sapiens	Inhibition	%	39.04
	8180277	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	34.16	CHEMBL2041	Homo sapiens	Inhibition	%	34.16
	8180278	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	46.83	CHEMBL2041	Homo sapiens	Inhibition	%	46.83
	8180432	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	5.69	CHEMBL2041	Homo sapiens	Inhibition	%	5.69
	8180433	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.22	CHEMBL2041	Homo sapiens	Inhibition	%	7.22
	8180434	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.37	CHEMBL2041	Homo sapiens	Inhibition	%	7.37
	8180656	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.7	CHEMBL2041	Homo sapiens	Inhibition	%	7.7
	8180657	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	9.65	CHEMBL2041	Homo sapiens	Inhibition	%	9.65
	8180658	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.16	CHEMBL2041	Homo sapiens	Inhibition	%	7.16
	8180804	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	20.23	CHEMBL2041	Homo sapiens	Inhibition	%	20.23
	8180805	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	12.5	CHEMBL2041	Homo sapiens	Inhibition	%	12.5
	8180806	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	11.22	CHEMBL2041	Homo sapiens	Inhibition	%	11.22
	8181161	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	81.81	CHEMBL2041	Homo sapiens	Inhibition	%	81.81
	8181162	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	7.62	CHEMBL2041	Homo sapiens	Inhibition	%	7.62
	8181163	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	81.3	CHEMBL2041	Homo sapiens	Inhibition	%	81.3
	8181292	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	9.49	CHEMBL2041	Homo sapiens	Inhibition	%	9.49
	8181293	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	13.16	CHEMBL2041	Homo sapiens	Inhibition	%	13.16
	8181294	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	19.07	CHEMBL2041	Homo sapiens	Inhibition	%	19.07
	8181656	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	9.47	CHEMBL2041	Homo sapiens	Inhibition	%	9.47
	8181657	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	9.42	CHEMBL2041	Homo sapiens	Inhibition	%	9.42
	8181658	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	14.38	CHEMBL2041	Homo sapiens	Inhibition	%	14.38
	8181795	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	40.52	CHEMBL2041	Homo sapiens	Inhibition	%	40.52
	8181796	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	70.98	CHEMBL2041	Homo sapiens	Inhibition	%	70.98
	8181797	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	44.76	CHEMBL2041	Homo sapiens	Inhibition	%	44.76
	8182019	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	77.35	CHEMBL2041	Homo sapiens	Inhibition	%	77.35
	8182020	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	82.08	CHEMBL2041	Homo sapiens	Inhibition	%	82.08
	8182021	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	67.34	CHEMBL2041	Homo sapiens	Inhibition	%	67.34
	8182182	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	8.56	CHEMBL2041	Homo sapiens	Inhibition	%	8.56
	8182183	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.68	CHEMBL2041	Homo sapiens	Inhibition	%	4.68
	8182184	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	7.45	CHEMBL2041	Homo sapiens	Inhibition	%	7.45
	8182546	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	Inhibition	%	4.0
	8182547	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.24	CHEMBL2041	Homo sapiens	Inhibition	%	1.24
	8182548	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	5.34	CHEMBL2041	Homo sapiens	Inhibition	%	5.34
	8182638	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.97	CHEMBL2041	Homo sapiens	Inhibition	%	4.97
	8182639	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.2	CHEMBL2041	Homo sapiens	Inhibition	%	3.2
	8182640	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.68	CHEMBL2041	Homo sapiens	Inhibition	%	3.68
	8182862	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	19.47	CHEMBL2041	Homo sapiens	Inhibition	%	19.47
	8182863	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.12	CHEMBL2041	Homo sapiens	Inhibition	%	4.12
	8182864	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	9.1	CHEMBL2041	Homo sapiens	Inhibition	%	9.1
	8182984	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.24	CHEMBL2041	Homo sapiens	Inhibition	%	5.24
	8182985	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.47	CHEMBL2041	Homo sapiens	Inhibition	%	2.47
	8182986	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.26	CHEMBL2041	Homo sapiens	Inhibition	%	1.26
	8183357	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	21.86	CHEMBL2041	Homo sapiens	Inhibition	%	21.86
	8183358	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	7.11	CHEMBL2041	Homo sapiens	Inhibition	%	7.11
	8183359	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	22.65	CHEMBL2041	Homo sapiens	Inhibition	%	22.65
	8183486	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.91	CHEMBL2041	Homo sapiens	Inhibition	%	3.91
	8183487	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.84	CHEMBL2041	Homo sapiens	Inhibition	%	0.84
	8183488	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.83	CHEMBL2041	Homo sapiens	Inhibition	%	2.83
	8183710	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	8.08	CHEMBL2041	Homo sapiens	Inhibition	%	8.08
	8183852	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	49.27	CHEMBL2041	Homo sapiens	Inhibition	%	49.27
	8183853	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	75.21	CHEMBL2041	Homo sapiens	Inhibition	%	75.21
	8183854	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	51.9	CHEMBL2041	Homo sapiens	Inhibition	%	51.9
	8183988	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.68	CHEMBL2041	Homo sapiens	Inhibition	%	4.68
	8183989	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.01	CHEMBL2041	Homo sapiens	Inhibition	%	1.01
	8183990	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.4	CHEMBL2041	Homo sapiens	Inhibition	%	2.4
	8184212	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.59	CHEMBL2041	Homo sapiens	Inhibition	%	7.59
	8184213	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	5.01	CHEMBL2041	Homo sapiens	Inhibition	%	5.01
	8184214	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.22	CHEMBL2041	Homo sapiens	Inhibition	%	2.22
	8184478	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.61	CHEMBL2041	Homo sapiens	Inhibition	%	2.61
	8184479	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	14.66	CHEMBL2041	Homo sapiens	Inhibition	%	14.66
	8184480	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	Inhibition	%	10.0
	8184625	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	9.0	CHEMBL2041	Homo sapiens	Inhibition	%	9.0
	8184626	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.25	CHEMBL2041	Homo sapiens	Inhibition	%	3.25
	8184627	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	7.54	CHEMBL2041	Homo sapiens	Inhibition	%	7.54
	8185006	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	23.53	CHEMBL2041	Homo sapiens	Inhibition	%	23.53
	8185007	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	4.29	CHEMBL2041	Homo sapiens	Inhibition	%	4.29
	8185008	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	30.75	CHEMBL2041	Homo sapiens	Inhibition	%	30.75
	8185155	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	51.54	CHEMBL2041	Homo sapiens	Inhibition	%	51.54
	8185156	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	51.08	CHEMBL2041	Homo sapiens	Inhibition	%	51.08
	8185157	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	47.05	CHEMBL2041	Homo sapiens	Inhibition	%	47.05
	8185510	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	88.38	CHEMBL2041	Homo sapiens	Inhibition	%	88.38
	8185511	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	26.59	CHEMBL2041	Homo sapiens	Inhibition	%	26.59
	8185512	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	89.5	CHEMBL2041	Homo sapiens	Inhibition	%	89.5
	8185641	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	6.38	CHEMBL2041	Homo sapiens	Inhibition	%	6.38
	8185642	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	13.04	CHEMBL2041	Homo sapiens	Inhibition	%	13.04
	8185643	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	5.97	CHEMBL2041	Homo sapiens	Inhibition	%	5.97
	8185865	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	35.87	CHEMBL2041	Homo sapiens	Inhibition	%	35.87
	8185866	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	53.92	CHEMBL2041	Homo sapiens	Inhibition	%	53.92
	8185867	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	40.31	CHEMBL2041	Homo sapiens	Inhibition	%	40.31
	8186004	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.67	CHEMBL2041	Homo sapiens	Inhibition	%	4.67
	8186005	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.54	CHEMBL2041	Homo sapiens	Inhibition	%	1.54
	8186006	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.42	CHEMBL2041	Homo sapiens	Inhibition	%	4.42
	8186369	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.85	CHEMBL2041	Homo sapiens	Inhibition	%	4.85
	8186370	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	16.17	CHEMBL2041	Homo sapiens	Inhibition	%	16.17
	8186371	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	9.34	CHEMBL2041	Homo sapiens	Inhibition	%	9.34
	8186533	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	14.75	CHEMBL2041	Homo sapiens	Inhibition	%	14.75
	8186534	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	7.83	CHEMBL2041	Homo sapiens	Inhibition	%	7.83
	8186535	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	13.98	CHEMBL2041	Homo sapiens	Inhibition	%	13.98
	8186896	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	6.84	CHEMBL2041	Homo sapiens	Inhibition	%	6.84
	8186897	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-1.13	CHEMBL2041	Homo sapiens	Inhibition	%	-1.13
	8186898	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.13	CHEMBL2041	Homo sapiens	Inhibition	%	4.13
	8187218	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.99	CHEMBL2041	Homo sapiens	Inhibition	%	3.99
	8187219	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.84	CHEMBL2041	Homo sapiens	Inhibition	%	0.84
	8187220	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.94	CHEMBL2041	Homo sapiens	Inhibition	%	3.94
	8187342	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	14.95	CHEMBL2041	Homo sapiens	Inhibition	%	14.95
	8187343	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	7.65	CHEMBL2041	Homo sapiens	Inhibition	%	7.65
	8187344	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	18.55	CHEMBL2041	Homo sapiens	Inhibition	%	18.55
	8187566	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.2	CHEMBL2041	Homo sapiens	Inhibition	%	3.2
	8187567	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.12	CHEMBL2041	Homo sapiens	Inhibition	%	3.12
	8187568	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.41	CHEMBL2041	Homo sapiens	Inhibition	%	1.41
	8187714	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	68.53	CHEMBL2041	Homo sapiens	Inhibition	%	68.53
	8187715	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	44.13	CHEMBL2041	Homo sapiens	Inhibition	%	44.13
	8187716	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	67.08	CHEMBL2041	Homo sapiens	Inhibition	%	67.08
	8187844	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	9.12	CHEMBL2041	Homo sapiens	Inhibition	%	9.12
	8187845	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	8.67	CHEMBL2041	Homo sapiens	Inhibition	%	8.67
	8188067	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	29.18	CHEMBL2041	Homo sapiens	Inhibition	%	29.18
	8188068	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	14.26	CHEMBL2041	Homo sapiens	Inhibition	%	14.26
	8188069	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	43.93	CHEMBL2041	Homo sapiens	Inhibition	%	43.93
	8188210	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-0.09	CHEMBL2041	Homo sapiens	Inhibition	%	-0.09
	8188211	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	8.27	CHEMBL2041	Homo sapiens	Inhibition	%	8.27
	8188212	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.06	CHEMBL2041	Homo sapiens	Inhibition	%	2.06
	8188569	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	11.39	CHEMBL2041	Homo sapiens	Inhibition	%	11.39
	8188570	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	4.8	CHEMBL2041	Homo sapiens	Inhibition	%	4.8
	8188571	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	14.06	CHEMBL2041	Homo sapiens	Inhibition	%	14.06
	8188843	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.69	CHEMBL2041	Homo sapiens	Inhibition	%	5.69
	8188844	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.61	CHEMBL2041	Homo sapiens	Inhibition	%	4.61
	8188845	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.59	CHEMBL2041	Homo sapiens	Inhibition	%	3.59
	8188991	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	11.51	CHEMBL2041	Homo sapiens	Inhibition	%	11.51
	8188992	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	8.38	CHEMBL2041	Homo sapiens	Inhibition	%	8.38
	8188993	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	15.83	CHEMBL2041	Homo sapiens	Inhibition	%	15.83
	8189215	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	61.15	CHEMBL2041	Homo sapiens	Inhibition	%	61.15
	8189216	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	14.11	CHEMBL2041	Homo sapiens	Inhibition	%	14.11
	8189217	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	54.05	CHEMBL2041	Homo sapiens	Inhibition	%	54.05
	8189371	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	64.87	CHEMBL2041	Homo sapiens	Inhibition	%	64.87
	8189372	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	4.6	CHEMBL2041	Homo sapiens	Inhibition	%	4.6
	8189373	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	65.77	CHEMBL2041	Homo sapiens	Inhibition	%	65.77
	8189520	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.99	CHEMBL2041	Homo sapiens	Inhibition	%	3.99
	8189521	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.58	CHEMBL2041	Homo sapiens	Inhibition	%	2.58
	8189522	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.6	CHEMBL2041	Homo sapiens	Inhibition	%	1.6
	8189744	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	20.2	CHEMBL2041	Homo sapiens	Inhibition	%	20.2
	8189745	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	6.73	CHEMBL2041	Homo sapiens	Inhibition	%	6.73
	8189746	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.42	CHEMBL2041	Homo sapiens	Inhibition	%	3.42
	8189876	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	14.33	CHEMBL2041	Homo sapiens	Inhibition	%	14.33
	8189877	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.06	CHEMBL2041	Homo sapiens	Inhibition	%	4.06
	8189878	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	17.87	CHEMBL2041	Homo sapiens	Inhibition	%	17.87
	8190232	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.23	CHEMBL2041	Homo sapiens	Inhibition	%	2.23
	8190233	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	9.25	CHEMBL2041	Homo sapiens	Inhibition	%	9.25
	8190234	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	12.58	CHEMBL2041	Homo sapiens	Inhibition	%	12.58
	8190372	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.93	CHEMBL2041	Homo sapiens	Inhibition	%	5.93
	8190373	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	0.17	CHEMBL2041	Homo sapiens	Inhibition	%	0.17
	8190374	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	10.6	CHEMBL2041	Homo sapiens	Inhibition	%	10.6
	8190596	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.99	CHEMBL2041	Homo sapiens	Inhibition	%	6.99
	8190597	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.8	CHEMBL2041	Homo sapiens	Inhibition	%	2.8
	8190598	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.34	CHEMBL2041	Homo sapiens	Inhibition	%	6.34
	8190733	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	18.09	CHEMBL2041	Homo sapiens	Inhibition	%	18.09
	8190734	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	15.83	CHEMBL2041	Homo sapiens	Inhibition	%	15.83
	8190735	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	19.13	CHEMBL2041	Homo sapiens	Inhibition	%	19.13
	8190897	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	9.66	CHEMBL2041	Homo sapiens	Inhibition	%	9.66
	8190898	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.21	CHEMBL2041	Homo sapiens	Inhibition	%	5.21
	8190899	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.21	CHEMBL2041	Homo sapiens	Inhibition	%	6.21
	8191121	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.15	CHEMBL2041	Homo sapiens	Inhibition	%	6.15
	8191122	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	7.12	CHEMBL2041	Homo sapiens	Inhibition	%	7.12
	8191123	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	9.39	CHEMBL2041	Homo sapiens	Inhibition	%	9.39
	8191259	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	7.81	CHEMBL2041	Homo sapiens	Inhibition	%	7.81
	8191260	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.98	CHEMBL2041	Homo sapiens	Inhibition	%	4.98
	8191261	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	9.9	CHEMBL2041	Homo sapiens	Inhibition	%	9.9
	8191579	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	8.88	CHEMBL2041	Homo sapiens	Inhibition	%	8.88
	8191580	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.4	CHEMBL2041	Homo sapiens	Inhibition	%	4.4
	8191581	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	8.63	CHEMBL2041	Homo sapiens	Inhibition	%	8.63
	8191925	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	8.79	CHEMBL2041	Homo sapiens	Inhibition	%	8.79
	8191926	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	12.52	CHEMBL2041	Homo sapiens	Inhibition	%	12.52
	8191927	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	11.95	CHEMBL2041	Homo sapiens	Inhibition	%	11.95
	8192074	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	6.73	CHEMBL2041	Homo sapiens	Inhibition	%	6.73
	8192075	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1	Outside typical range	CHEMBL385426	=	Inhibition	%	-25.21	CHEMBL2041	Homo sapiens	Inhibition	%	-25.21
	8192076	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	5.49	CHEMBL2041	Homo sapiens	Inhibition	%	5.49
	8192427	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	7.22	CHEMBL2041	Homo sapiens	Inhibition	%	7.22
	8192428	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	13.99	CHEMBL2041	Homo sapiens	Inhibition	%	13.99
	8192429	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.44	CHEMBL2041	Homo sapiens	Inhibition	%	6.44
	8192571	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	14.52	CHEMBL2041	Homo sapiens	Inhibition	%	14.52
	8192572	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	41.61	CHEMBL2041	Homo sapiens	Inhibition	%	41.61
	8192573	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	22.26	CHEMBL2041	Homo sapiens	Inhibition	%	22.26
	8192795	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.93	CHEMBL2041	Homo sapiens	Inhibition	%	3.93
	8192796	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	5.6	CHEMBL2041	Homo sapiens	Inhibition	%	5.6
	8192797	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.57	CHEMBL2041	Homo sapiens	Inhibition	%	2.57
	8192931	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	30.73	CHEMBL2041	Homo sapiens	Inhibition	%	30.73
	8192932	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	8.24	CHEMBL2041	Homo sapiens	Inhibition	%	8.24
	8192933	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	26.74	CHEMBL2041	Homo sapiens	Inhibition	%	26.74
	8193203	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	14.84	CHEMBL2041	Homo sapiens	Inhibition	%	14.84
	8193204	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	10.88	CHEMBL2041	Homo sapiens	Inhibition	%	10.88
	8193205	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	17.43	CHEMBL2041	Homo sapiens	Inhibition	%	17.43
	8193572	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	85.39	CHEMBL2041	Homo sapiens	Inhibition	%	85.39
	8193573	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	53.85	CHEMBL2041	Homo sapiens	Inhibition	%	53.85
	8193574	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	78.08	CHEMBL2041	Homo sapiens	Inhibition	%	78.08
	8193729	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	7.9	CHEMBL2041	Homo sapiens	Inhibition	%	7.9
	8193730	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	11.04	CHEMBL2041	Homo sapiens	Inhibition	%	11.04
	8193731	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	10.05	CHEMBL2041	Homo sapiens	Inhibition	%	10.05
	8194102	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	4.49	CHEMBL2041	Homo sapiens	Inhibition	%	4.49
	8194103	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.68	CHEMBL2041	Homo sapiens	Inhibition	%	0.68
	8194104	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	Inhibition	%	0.0
	8194233	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	18.91	CHEMBL2041	Homo sapiens	Inhibition	%	18.91
	8194234	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	11.89	CHEMBL2041	Homo sapiens	Inhibition	%	11.89
	8194235	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	31.26	CHEMBL2041	Homo sapiens	Inhibition	%	31.26
	8194457	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	83.58	CHEMBL2041	Homo sapiens	Inhibition	%	83.58
	8194458	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.3	CHEMBL2041	Homo sapiens	Inhibition	%	3.3
	8194459	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	76.81	CHEMBL2041	Homo sapiens	Inhibition	%	76.81
	8194588	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	11.1	CHEMBL2041	Homo sapiens	Inhibition	%	11.1
	8194589	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	11.99	CHEMBL2041	Homo sapiens	Inhibition	%	11.99
	8194590	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	13.18	CHEMBL2041	Homo sapiens	Inhibition	%	13.18
	8194955	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	27.01	CHEMBL2041	Homo sapiens	Inhibition	%	27.01
	8194956	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.36	CHEMBL2041	Homo sapiens	Inhibition	%	6.36
	8194957	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	42.3	CHEMBL2041	Homo sapiens	Inhibition	%	42.3
	8195088	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.17	CHEMBL2041	Homo sapiens	Inhibition	%	1.17
	8195089	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.71	CHEMBL2041	Homo sapiens	Inhibition	%	4.71
	8195090	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.21	CHEMBL2041	Homo sapiens	Inhibition	%	5.21
	8195476	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	19.63	CHEMBL2041	Homo sapiens	Inhibition	%	19.63
	8195477	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	38.41	CHEMBL2041	Homo sapiens	Inhibition	%	38.41
	8195478	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	15.96	CHEMBL2041	Homo sapiens	Inhibition	%	15.96
	8195615	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	14.92	CHEMBL2041	Homo sapiens	Inhibition	%	14.92
	8195616	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	13.92	CHEMBL2041	Homo sapiens	Inhibition	%	13.92
	8195617	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	23.34	CHEMBL2041	Homo sapiens	Inhibition	%	23.34
	8195937	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	7.82	CHEMBL2041	Homo sapiens	Inhibition	%	7.82
	8195938	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	5.19	CHEMBL2041	Homo sapiens	Inhibition	%	5.19
	8195939	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	9.49	CHEMBL2041	Homo sapiens	Inhibition	%	9.49
	8196278	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.63	CHEMBL2041	Homo sapiens	Inhibition	%	4.63
	8196279	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.59	CHEMBL2041	Homo sapiens	Inhibition	%	2.59
	8196280	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.35	CHEMBL2041	Homo sapiens	Inhibition	%	3.35
	8196428	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	7.18	CHEMBL2041	Homo sapiens	Inhibition	%	7.18
	8196429	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.16	CHEMBL2041	Homo sapiens	Inhibition	%	3.16
	8196430	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.43	CHEMBL2041	Homo sapiens	Inhibition	%	2.43
	8196652	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	14.85	CHEMBL2041	Homo sapiens	Inhibition	%	14.85
	8196653	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.27	CHEMBL2041	Homo sapiens	Inhibition	%	1.27
	8196654	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	14.69	CHEMBL2041	Homo sapiens	Inhibition	%	14.69
	8196780	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	7.69	CHEMBL2041	Homo sapiens	Inhibition	%	7.69
	8196781	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	15.81	CHEMBL2041	Homo sapiens	Inhibition	%	15.81
	8196782	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	19.94	CHEMBL2041	Homo sapiens	Inhibition	%	19.94
	8197145	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.36	CHEMBL2041	Homo sapiens	Inhibition	%	6.36
	8197146	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	11.84	CHEMBL2041	Homo sapiens	Inhibition	%	11.84
	8197147	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	12.27	CHEMBL2041	Homo sapiens	Inhibition	%	12.27
	8197282	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.73	CHEMBL2041	Homo sapiens	Inhibition	%	2.73
	8197283	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.94	CHEMBL2041	Homo sapiens	Inhibition	%	1.94
	8197284	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.94	CHEMBL2041	Homo sapiens	Inhibition	%	2.94
	8197557	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	6.04	CHEMBL2041	Homo sapiens	Inhibition	%	6.04
	8197558	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.31	CHEMBL2041	Homo sapiens	Inhibition	%	2.31
	8197559	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.64	CHEMBL2041	Homo sapiens	Inhibition	%	4.64
	8197921	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	17.67	CHEMBL2041	Homo sapiens	Inhibition	%	17.67
	8197922	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	4.73	CHEMBL2041	Homo sapiens	Inhibition	%	4.73
	8197923	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	20.74	CHEMBL2041	Homo sapiens	Inhibition	%	20.74
	8198078	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	30.56	CHEMBL2041	Homo sapiens	Inhibition	%	30.56
	8198079	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	48.62	CHEMBL2041	Homo sapiens	Inhibition	%	48.62
	8198080	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	34.3	CHEMBL2041	Homo sapiens	Inhibition	%	34.3
	8198440	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	20.81	CHEMBL2041	Homo sapiens	Inhibition	%	20.81
	8198441	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.73	CHEMBL2041	Homo sapiens	Inhibition	%	-0.73
	8198442	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.26	CHEMBL2041	Homo sapiens	Inhibition	%	2.26
	8198794	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	89.43	CHEMBL2041	Homo sapiens	Inhibition	%	89.43
	8198795	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	11.28	CHEMBL2041	Homo sapiens	Inhibition	%	11.28
	8198796	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	90.09	CHEMBL2041	Homo sapiens	Inhibition	%	90.09
	8198925	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.35	CHEMBL2041	Homo sapiens	Inhibition	%	2.35
	8198926	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	7.17	CHEMBL2041	Homo sapiens	Inhibition	%	7.17
	8198927	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	11.45	CHEMBL2041	Homo sapiens	Inhibition	%	11.45
	8199297	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	7.21	CHEMBL2041	Homo sapiens	Inhibition	%	7.21
	8199298	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.89	CHEMBL2041	Homo sapiens	Inhibition	%	3.89
	8199299	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	6.91	CHEMBL2041	Homo sapiens	Inhibition	%	6.91
	8199431	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.73	CHEMBL2041	Homo sapiens	Inhibition	%	1.73
	8199432	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	10.78	CHEMBL2041	Homo sapiens	Inhibition	%	10.78
	8199433	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	15.15	CHEMBL2041	Homo sapiens	Inhibition	%	15.15
	8199655	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	-0.25	CHEMBL2041	Homo sapiens	Inhibition	%	-0.25
	8199656	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.31	CHEMBL2041	Homo sapiens	Inhibition	%	5.31
	8199657	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.33	CHEMBL2041	Homo sapiens	Inhibition	%	5.33
	8199818	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	58.11	CHEMBL2041	Homo sapiens	Inhibition	%	58.11
	8199819	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	74.71	CHEMBL2041	Homo sapiens	Inhibition	%	74.71
	8199820	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	54.79	CHEMBL2041	Homo sapiens	Inhibition	%	54.79
	8199956	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.72	CHEMBL2041	Homo sapiens	Inhibition	%	4.72
	8199957	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.41	CHEMBL2041	Homo sapiens	Inhibition	%	4.41
	8199958	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	12.26	CHEMBL2041	Homo sapiens	Inhibition	%	12.26
	8200180	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.99	CHEMBL2041	Homo sapiens	Inhibition	%	4.99
	8200181	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.05	CHEMBL2041	Homo sapiens	Inhibition	%	1.05
	8200182	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.59	CHEMBL2041	Homo sapiens	Inhibition	%	6.59
	8200284	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	38.61	CHEMBL2041	Homo sapiens	Inhibition	%	38.61
	8200285	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	26.6	CHEMBL2041	Homo sapiens	Inhibition	%	26.6
	8200286	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	42.95	CHEMBL2041	Homo sapiens	Inhibition	%	42.95
	8200623	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	9.44	CHEMBL2041	Homo sapiens	Inhibition	%	9.44
	8200624	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	9.82	CHEMBL2041	Homo sapiens	Inhibition	%	9.82
	8200625	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	6.8	CHEMBL2041	Homo sapiens	Inhibition	%	6.8
	8200997	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	46.65	CHEMBL2041	Homo sapiens	Inhibition	%	46.65
	8200998	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.44	CHEMBL2041	Homo sapiens	Inhibition	%	0.44
	8200999	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	50.68	CHEMBL2041	Homo sapiens	Inhibition	%	50.68
	8201127	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	11.88	CHEMBL2041	Homo sapiens	Inhibition	%	11.88
	8201128	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	7.23	CHEMBL2041	Homo sapiens	Inhibition	%	7.23
	8201129	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	15.03	CHEMBL2041	Homo sapiens	Inhibition	%	15.03
	8201486	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.04	CHEMBL2041	Homo sapiens	Inhibition	%	2.04
	8201487	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.23	CHEMBL2041	Homo sapiens	Inhibition	%	2.23
	8201488	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	5.72	CHEMBL2041	Homo sapiens	Inhibition	%	5.72
	8201619	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	13.24	CHEMBL2041	Homo sapiens	Inhibition	%	13.24
	8201620	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	5.01	CHEMBL2041	Homo sapiens	Inhibition	%	5.01
	8201621	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	5.26	CHEMBL2041	Homo sapiens	Inhibition	%	5.26
	8201843	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.66	CHEMBL2041	Homo sapiens	Inhibition	%	2.66
	8201844	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	1.07	CHEMBL2041	Homo sapiens	Inhibition	%	1.07
	8201845	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.0	CHEMBL2041	Homo sapiens	Inhibition	%	2.0
	8201898	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.69	CHEMBL2041	Homo sapiens	Inhibition	%	1.69
	8201899	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.03	CHEMBL2041	Homo sapiens	Inhibition	%	2.03
	8201900	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	8.5	CHEMBL2041	Homo sapiens	Inhibition	%	8.5
	8202122	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	6.1	CHEMBL2041	Homo sapiens	Inhibition	%	6.1
	8202123	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.9	CHEMBL2041	Homo sapiens	Inhibition	%	1.9
	8202124	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.66	CHEMBL2041	Homo sapiens	Inhibition	%	2.66
	8202262	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	60.83	CHEMBL2041	Homo sapiens	Inhibition	%	60.83
	8202263	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	26.88	CHEMBL2041	Homo sapiens	Inhibition	%	26.88
	8202264	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	60.22	CHEMBL2041	Homo sapiens	Inhibition	%	60.22
	8202429	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.05	CHEMBL2041	Homo sapiens	Inhibition	%	4.05
	8202430	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	9.59	CHEMBL2041	Homo sapiens	Inhibition	%	9.59
	8202431	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	5.15	CHEMBL2041	Homo sapiens	Inhibition	%	5.15
	8202653	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	8.81	CHEMBL2041	Homo sapiens	Inhibition	%	8.81
	8202654	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	12.64	CHEMBL2041	Homo sapiens	Inhibition	%	12.64
	8202655	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	9.79	CHEMBL2041	Homo sapiens	Inhibition	%	9.79
	8202778	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.13	CHEMBL2041	Homo sapiens	Inhibition	%	5.13
	8202779	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.33	CHEMBL2041	Homo sapiens	Inhibition	%	2.33
	8202780	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.92	CHEMBL2041	Homo sapiens	Inhibition	%	3.92
	8203132	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.46	CHEMBL2041	Homo sapiens	Inhibition	%	6.46
	8203133	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.6	CHEMBL2041	Homo sapiens	Inhibition	%	3.6
	8203134	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	11.55	CHEMBL2041	Homo sapiens	Inhibition	%	11.55
	8203263	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	10.13	CHEMBL2041	Homo sapiens	Inhibition	%	10.13
	8203264	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	9.11	CHEMBL2041	Homo sapiens	Inhibition	%	9.11
	8203265	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	10.38	CHEMBL2041	Homo sapiens	Inhibition	%	10.38
	8203487	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	44.56	CHEMBL2041	Homo sapiens	Inhibition	%	44.56
	8203488	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	10.1	CHEMBL2041	Homo sapiens	Inhibition	%	10.1
	8203489	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	60.59	CHEMBL2041	Homo sapiens	Inhibition	%	60.59
	8203633	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	13.19	CHEMBL2041	Homo sapiens	Inhibition	%	13.19
	8203634	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	7.59	CHEMBL2041	Homo sapiens	Inhibition	%	7.59
	8203635	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	27.91	CHEMBL2041	Homo sapiens	Inhibition	%	27.91
	8203991	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.48	CHEMBL2041	Homo sapiens	Inhibition	%	5.48
	8203992	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	11.87	CHEMBL2041	Homo sapiens	Inhibition	%	11.87
	8203993	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	15.13	CHEMBL2041	Homo sapiens	Inhibition	%	15.13
	8204157	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	5.39	CHEMBL2041	Homo sapiens	Inhibition	%	5.39
	8204158	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.42	CHEMBL2041	Homo sapiens	Inhibition	%	3.42
	8204159	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	4.05	CHEMBL2041	Homo sapiens	Inhibition	%	4.05
	8204518	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	84.22	CHEMBL2041	Homo sapiens	Inhibition	%	84.22
	8204519	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.72	CHEMBL2041	Homo sapiens	Inhibition	%	4.72
	8204520	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	92.29	CHEMBL2041	Homo sapiens	Inhibition	%	92.29
	8204623	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	8.76	CHEMBL2041	Homo sapiens	Inhibition	%	8.76
	8204624	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	4.29	CHEMBL2041	Homo sapiens	Inhibition	%	4.29
	8204625	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	9.6	CHEMBL2041	Homo sapiens	Inhibition	%	9.6
	8204847	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	41.97	CHEMBL2041	Homo sapiens	Inhibition	%	41.97
	8204848	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	4.92	CHEMBL2041	Homo sapiens	Inhibition	%	4.92
	8204849	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	42.16	CHEMBL2041	Homo sapiens	Inhibition	%	42.16
	8204962	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	58.98	CHEMBL2041	Homo sapiens	Inhibition	%	58.98
	8204963	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	17.75	CHEMBL2041	Homo sapiens	Inhibition	%	17.75
	8204964	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	56.68	CHEMBL2041	Homo sapiens	Inhibition	%	56.68
	8205335	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	5.62	CHEMBL2041	Homo sapiens	Inhibition	%	5.62
	8205336	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.15	CHEMBL2041	Homo sapiens	Inhibition	%	3.15
	8205337	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.04	CHEMBL2041	Homo sapiens	Inhibition	%	6.04
	8205471	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	43.5	CHEMBL2041	Homo sapiens	Inhibition	%	43.5
	8205472	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	24.73	CHEMBL2041	Homo sapiens	Inhibition	%	24.73
	8205473	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	54.53	CHEMBL2041	Homo sapiens	Inhibition	%	54.53
	8205695	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.47	CHEMBL2041	Homo sapiens	Inhibition	%	5.47
	8205696	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	8.5	CHEMBL2041	Homo sapiens	Inhibition	%	8.5
	8205697	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	9.76	CHEMBL2041	Homo sapiens	Inhibition	%	9.76
	8205834	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	8.69	CHEMBL2041	Homo sapiens	Inhibition	%	8.69
	8205835	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	5.47	CHEMBL2041	Homo sapiens	Inhibition	%	5.47
	8205836	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	8.79	CHEMBL2041	Homo sapiens	Inhibition	%	8.79
	8206190	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	22.25	CHEMBL2041	Homo sapiens	Inhibition	%	22.25
	8206191	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.78	CHEMBL2041	Homo sapiens	Inhibition	%	2.78
	8206192	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	28.29	CHEMBL2041	Homo sapiens	Inhibition	%	28.29
	8206466	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.78	CHEMBL2041	Homo sapiens	Inhibition	%	3.78
	8206467	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.58	CHEMBL2041	Homo sapiens	Inhibition	%	4.58
	8206468	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.86	CHEMBL2041	Homo sapiens	Inhibition	%	3.86
	8206609	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	7.13	CHEMBL2041	Homo sapiens	Inhibition	%	7.13
	8206610	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.75	CHEMBL2041	Homo sapiens	Inhibition	%	1.75
	8206611	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	3.97	CHEMBL2041	Homo sapiens	Inhibition	%	3.97
	8207013	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	7.25	CHEMBL2041	Homo sapiens	Inhibition	%	7.25
	8207014	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.93	CHEMBL2041	Homo sapiens	Inhibition	%	1.93
	8207015	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.47	CHEMBL2041	Homo sapiens	Inhibition	%	2.47
	8207139	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.43	CHEMBL2041	Homo sapiens	Inhibition	%	2.43
	8207140	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	8.21	CHEMBL2041	Homo sapiens	Inhibition	%	8.21
	8207141	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	13.76	CHEMBL2041	Homo sapiens	Inhibition	%	13.76
	8207363	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.79	CHEMBL2041	Homo sapiens	Inhibition	%	4.79
	8207364	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	8.87	CHEMBL2041	Homo sapiens	Inhibition	%	8.87
	8207365	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.93	CHEMBL2041	Homo sapiens	Inhibition	%	3.93
	8207493	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	10.18	CHEMBL2041	Homo sapiens	Inhibition	%	10.18
	8207494	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	8.73	CHEMBL2041	Homo sapiens	Inhibition	%	8.73
	8207495	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	21.57	CHEMBL2041	Homo sapiens	Inhibition	%	21.57
	8207849	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	77.47	CHEMBL2041	Homo sapiens	Inhibition	%	77.47
	8207850	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	37.28	CHEMBL2041	Homo sapiens	Inhibition	%	37.28
	8207851	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	80.32	CHEMBL2041	Homo sapiens	Inhibition	%	80.32
	8207994	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	4.78	CHEMBL2041	Homo sapiens	Inhibition	%	4.78
	8207995	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.98	CHEMBL2041	Homo sapiens	Inhibition	%	2.98
	8207996	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	6.04	CHEMBL2041	Homo sapiens	Inhibition	%	6.04
	8208350	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.33	CHEMBL2041	Homo sapiens	Inhibition	%	5.33
	8208351	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.29	CHEMBL2041	Homo sapiens	Inhibition	%	4.29
	8208352	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	6.24	CHEMBL2041	Homo sapiens	Inhibition	%	6.24
	8208516	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	7.34	CHEMBL2041	Homo sapiens	Inhibition	%	7.34
	8208517	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	11.58	CHEMBL2041	Homo sapiens	Inhibition	%	11.58
	8208518	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	12.06	CHEMBL2041	Homo sapiens	Inhibition	%	12.06
	8208740	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	20.39	CHEMBL2041	Homo sapiens	Inhibition	%	20.39
	8208741	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	12.38	CHEMBL2041	Homo sapiens	Inhibition	%	12.38
	8208742	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	20.06	CHEMBL2041	Homo sapiens	Inhibition	%	20.06
	8208873	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	89.75	CHEMBL2041	Homo sapiens	Inhibition	%	89.75
	8208874	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.44	CHEMBL2041	Homo sapiens	Inhibition	%	3.44
	8208875	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	93.46	CHEMBL2041	Homo sapiens	Inhibition	%	93.46
	8209202	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	15.42	CHEMBL2041	Homo sapiens	Inhibition	%	15.42
	8209203	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	3.52	CHEMBL2041	Homo sapiens	Inhibition	%	3.52
	8209204	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	10.13	CHEMBL2041	Homo sapiens	Inhibition	%	10.13
	8209318	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	83.41	CHEMBL2041	Homo sapiens	Inhibition	%	83.41
	8209319	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	68.62	CHEMBL2041	Homo sapiens	Inhibition	%	68.62
	8209320	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	80.9	CHEMBL2041	Homo sapiens	Inhibition	%	80.9
	8209542	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.19	CHEMBL2041	Homo sapiens	Inhibition	%	1.19
	8209543	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.3	CHEMBL2041	Homo sapiens	Inhibition	%	1.3
	8209544	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.3	CHEMBL2041	Homo sapiens	Inhibition	%	2.3
	8209692	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	15.62	CHEMBL2041	Homo sapiens	Inhibition	%	15.62
	8209693	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	8.37	CHEMBL2041	Homo sapiens	Inhibition	%	8.37
	8209694	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	16.25	CHEMBL2041	Homo sapiens	Inhibition	%	16.25
	8210052	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	12.26	CHEMBL2041	Homo sapiens	Inhibition	%	12.26
	8210053	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	20.24	CHEMBL2041	Homo sapiens	Inhibition	%	20.24
	8210054	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	28.67	CHEMBL2041	Homo sapiens	Inhibition	%	28.67
	8210193	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.79	CHEMBL2041	Homo sapiens	Inhibition	%	4.79
	8210194	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.68	CHEMBL2041	Homo sapiens	Inhibition	%	2.68
	8210195	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	7.7	CHEMBL2041	Homo sapiens	Inhibition	%	7.7
	8210553	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.65	CHEMBL2041	Homo sapiens	Inhibition	%	1.65
	8210554	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.08	CHEMBL2041	Homo sapiens	Inhibition	%	0.08
	8210555	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.87	CHEMBL2041	Homo sapiens	Inhibition	%	-1.87
	8210812	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	8.83	CHEMBL2041	Homo sapiens	Inhibition	%	8.83
	8210813	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.03	CHEMBL2041	Homo sapiens	Inhibition	%	2.03
	8210814	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.1	CHEMBL2041	Homo sapiens	Inhibition	%	1.1
	8210956	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	12.26	CHEMBL2041	Homo sapiens	Inhibition	%	12.26
	8210957	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	9.79	CHEMBL2041	Homo sapiens	Inhibition	%	9.79
	8210958	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	7.25	CHEMBL2041	Homo sapiens	Inhibition	%	7.25
	8211180	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	24.84	CHEMBL2041	Homo sapiens	Inhibition	%	24.84
	8211181	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	9.09	CHEMBL2041	Homo sapiens	Inhibition	%	9.09
	8211182	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	25.15	CHEMBL2041	Homo sapiens	Inhibition	%	25.15
	8211350	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	8.04	CHEMBL2041	Homo sapiens	Inhibition	%	8.04
	8211351	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.02	CHEMBL2041	Homo sapiens	Inhibition	%	2.02
	8211352	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	8.31	CHEMBL2041	Homo sapiens	Inhibition	%	8.31
	8211697	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.99	CHEMBL2041	Homo sapiens	Inhibition	%	5.99
	8211698	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	14.05	CHEMBL2041	Homo sapiens	Inhibition	%	14.05
	8211699	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	15.21	CHEMBL2041	Homo sapiens	Inhibition	%	15.21
	8211826	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	11.82	CHEMBL2041	Homo sapiens	Inhibition	%	11.82
	8211827	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.98	CHEMBL2041	Homo sapiens	Inhibition	%	5.98
	8211828	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	12.06	CHEMBL2041	Homo sapiens	Inhibition	%	12.06
	8212182	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	6.15	CHEMBL2041	Homo sapiens	Inhibition	%	6.15
	8212183	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	6.02	CHEMBL2041	Homo sapiens	Inhibition	%	6.02
	8212184	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	12.57	CHEMBL2041	Homo sapiens	Inhibition	%	12.57
	8212323	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.87	CHEMBL2041	Homo sapiens	Inhibition	%	0.87
	8212324	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.2	CHEMBL2041	Homo sapiens	Inhibition	%	2.2
	8212325	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.64	CHEMBL2041	Homo sapiens	Inhibition	%	0.64
	8212547	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.79	CHEMBL2041	Homo sapiens	Inhibition	%	2.79
	8212548	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.36	CHEMBL2041	Homo sapiens	Inhibition	%	2.36
	8212549	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.2	CHEMBL2041	Homo sapiens	Inhibition	%	4.2
	8212680	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.9	CHEMBL2041	Homo sapiens	Inhibition	%	5.9
	8212681	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.73	CHEMBL2041	Homo sapiens	Inhibition	%	5.73
	8212682	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	17.36	CHEMBL2041	Homo sapiens	Inhibition	%	17.36
	8213074	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	65.79	CHEMBL2041	Homo sapiens	Inhibition	%	65.79
	8213075	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	53.19	CHEMBL2041	Homo sapiens	Inhibition	%	53.19
	8213076	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	60.53	CHEMBL2041	Homo sapiens	Inhibition	%	60.53
	8213203	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.13	CHEMBL2041	Homo sapiens	Inhibition	%	4.13
	8213204	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.79	CHEMBL2041	Homo sapiens	Inhibition	%	4.79
	8213205	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	6.44	CHEMBL2041	Homo sapiens	Inhibition	%	6.44
	8213531	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	54.4	CHEMBL2041	Homo sapiens	Inhibition	%	54.4
	8213532	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	9.78	CHEMBL2041	Homo sapiens	Inhibition	%	9.78
	8213533	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	51.13	CHEMBL2041	Homo sapiens	Inhibition	%	51.13
	8213868	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.76	CHEMBL2041	Homo sapiens	Inhibition	%	4.76
	8213869	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.95	CHEMBL2041	Homo sapiens	Inhibition	%	5.95
	8213870	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	10.21	CHEMBL2041	Homo sapiens	Inhibition	%	10.21
	8214015	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.0	CHEMBL2041	Homo sapiens	Inhibition	%	3.0
	8214016	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.82	CHEMBL2041	Homo sapiens	Inhibition	%	2.82
	8214017	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.34	CHEMBL2041	Homo sapiens	Inhibition	%	3.34
	8214376	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	18.16	CHEMBL2041	Homo sapiens	Inhibition	%	18.16
	8214377	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	19.49	CHEMBL2041	Homo sapiens	Inhibition	%	19.49
	8214378	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	20.67	CHEMBL2041	Homo sapiens	Inhibition	%	20.67
	8214510	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	9.25	CHEMBL2041	Homo sapiens	Inhibition	%	9.25
	8214511	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	10.02	CHEMBL2041	Homo sapiens	Inhibition	%	10.02
	8214512	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	28.8	CHEMBL2041	Homo sapiens	Inhibition	%	28.8
	8214734	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	73.54	CHEMBL2041	Homo sapiens	Inhibition	%	73.54
	8214735	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	11.73	CHEMBL2041	Homo sapiens	Inhibition	%	11.73
	8214736	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	74.59	CHEMBL2041	Homo sapiens	Inhibition	%	74.59
	8214886	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	3.8	CHEMBL2041	Homo sapiens	Inhibition	%	3.8
	8214887	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.04	CHEMBL2041	Homo sapiens	Inhibition	%	-2.04
	8214888	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.99	CHEMBL2041	Homo sapiens	Inhibition	%	-0.99
	8215137	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.3	CHEMBL2041	Homo sapiens	Inhibition	%	2.3
	8215138	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.91	CHEMBL2041	Homo sapiens	Inhibition	%	2.91
	8215139	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	7.75	CHEMBL2041	Homo sapiens	Inhibition	%	7.75
	8215514	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	64.45	CHEMBL2041	Homo sapiens	Inhibition	%	64.45
	8215515	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	27.84	CHEMBL2041	Homo sapiens	Inhibition	%	27.84
	8215516	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	52.34	CHEMBL2041	Homo sapiens	Inhibition	%	52.34
	8215678	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.76	CHEMBL2041	Homo sapiens	Inhibition	%	2.76
	8215679	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.75	CHEMBL2041	Homo sapiens	Inhibition	%	2.75
	8215680	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.9	CHEMBL2041	Homo sapiens	Inhibition	%	1.9
	8216021	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	5.61	CHEMBL2041	Homo sapiens	Inhibition	%	5.61
	8216022	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	5.31	CHEMBL2041	Homo sapiens	Inhibition	%	5.31
	8216023	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	6.02	CHEMBL2041	Homo sapiens	Inhibition	%	6.02
	8216140	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	28.09	CHEMBL2041	Homo sapiens	Inhibition	%	28.09
	8216141	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	21.0	CHEMBL2041	Homo sapiens	Inhibition	%	21.0
	8216142	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	36.32	CHEMBL2041	Homo sapiens	Inhibition	%	36.32
	8216364	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.18	CHEMBL2041	Homo sapiens	Inhibition	%	1.18
	8216365	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.41	CHEMBL2041	Homo sapiens	Inhibition	%	2.41
	8216366	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.67	CHEMBL2041	Homo sapiens	Inhibition	%	3.67
	8216500	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	14.3	CHEMBL2041	Homo sapiens	Inhibition	%	14.3
	8216501	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	14.26	CHEMBL2041	Homo sapiens	Inhibition	%	14.26
	8216502	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	18.01	CHEMBL2041	Homo sapiens	Inhibition	%	18.01
	8216862	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.73	CHEMBL2041	Homo sapiens	Inhibition	%	3.73
	8216863	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.06	CHEMBL2041	Homo sapiens	Inhibition	%	3.06
	8216864	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.03	CHEMBL2041	Homo sapiens	Inhibition	%	2.03
	8216996	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.13	CHEMBL2041	Homo sapiens	Inhibition	%	4.13
	8216997	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.63	CHEMBL2041	Homo sapiens	Inhibition	%	4.63
	8216998	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.0	CHEMBL2041	Homo sapiens	Inhibition	%	5.0
	8217220	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.32	CHEMBL2041	Homo sapiens	Inhibition	%	7.32
	8217221	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	16.71	CHEMBL2041	Homo sapiens	Inhibition	%	16.71
	8217222	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	14.4	CHEMBL2041	Homo sapiens	Inhibition	%	14.4
	8217394	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	5.96	CHEMBL2041	Homo sapiens	Inhibition	%	5.96
	8217395	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.18	CHEMBL2041	Homo sapiens	Inhibition	%	4.18
	8217396	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	5.06	CHEMBL2041	Homo sapiens	Inhibition	%	5.06
	8217525	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	10.63	CHEMBL2041	Homo sapiens	Inhibition	%	10.63
	8217526	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	9.45	CHEMBL2041	Homo sapiens	Inhibition	%	9.45
	8217527	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	6.05	CHEMBL2041	Homo sapiens	Inhibition	%	6.05
	8217749	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	18.18	CHEMBL2041	Homo sapiens	Inhibition	%	18.18
	8217750	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	11.31	CHEMBL2041	Homo sapiens	Inhibition	%	11.31
	8217751	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	23.17	CHEMBL2041	Homo sapiens	Inhibition	%	23.17
	8217850	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	3.14	CHEMBL2041	Homo sapiens	Inhibition	%	3.14
	8217851	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.34	CHEMBL2041	Homo sapiens	Inhibition	%	0.34
	8217852	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.25	CHEMBL2041	Homo sapiens	Inhibition	%	0.25
	8218189	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	5.96	CHEMBL2041	Homo sapiens	Inhibition	%	5.96
	8218190	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.07	CHEMBL2041	Homo sapiens	Inhibition	%	3.07
	8218191	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.28	CHEMBL2041	Homo sapiens	Inhibition	%	2.28
	8218316	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	8.48	CHEMBL2041	Homo sapiens	Inhibition	%	8.48
	8218317	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.4	CHEMBL2041	Homo sapiens	Inhibition	%	4.4
	8218318	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	5.85	CHEMBL2041	Homo sapiens	Inhibition	%	5.85
	8218540	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	22.38	CHEMBL2041	Homo sapiens	Inhibition	%	22.38
	8218541	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	12.7	CHEMBL2041	Homo sapiens	Inhibition	%	12.7
	8218542	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	37.26	CHEMBL2041	Homo sapiens	Inhibition	%	37.26
	8218683	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	51.82	CHEMBL2041	Homo sapiens	Inhibition	%	51.82
	8218684	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	54.75	CHEMBL2041	Homo sapiens	Inhibition	%	54.75
	8218685	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	63.76	CHEMBL2041	Homo sapiens	Inhibition	%	63.76
	8219038	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	85.7	CHEMBL2041	Homo sapiens	Inhibition	%	85.7
	8219039	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	49.66	CHEMBL2041	Homo sapiens	Inhibition	%	49.66
	8219040	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	88.68	CHEMBL2041	Homo sapiens	Inhibition	%	88.68
	8219198	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	8.77	CHEMBL2041	Homo sapiens	Inhibition	%	8.77
	8219199	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	6.56	CHEMBL2041	Homo sapiens	Inhibition	%	6.56
	8219200	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	10.04	CHEMBL2041	Homo sapiens	Inhibition	%	10.04
	8219448	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.75	CHEMBL2041	Homo sapiens	Inhibition	%	4.75
	8219449	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.67	CHEMBL2041	Homo sapiens	Inhibition	%	1.67
	8219450	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.28	CHEMBL2041	Homo sapiens	Inhibition	%	2.28
	8219672	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.26	CHEMBL2041	Homo sapiens	Inhibition	%	5.26
	8219673	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.72	CHEMBL2041	Homo sapiens	Inhibition	%	4.72
	8219674	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	24.89	CHEMBL2041	Homo sapiens	Inhibition	%	24.89
	8219833	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.27	CHEMBL2041	Homo sapiens	Inhibition	%	4.27
	8219834	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.56	CHEMBL2041	Homo sapiens	Inhibition	%	4.56
	8219835	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	10.4	CHEMBL2041	Homo sapiens	Inhibition	%	10.4
	8220002	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.91	CHEMBL2041	Homo sapiens	Inhibition	%	4.91
	8220003	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.26	CHEMBL2041	Homo sapiens	Inhibition	%	4.26
	8220004	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	19.56	CHEMBL2041	Homo sapiens	Inhibition	%	19.56
	8220226	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.45	CHEMBL2041	Homo sapiens	Inhibition	%	5.45
	8220227	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.53	CHEMBL2041	Homo sapiens	Inhibition	%	3.53
	8220228	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.61	CHEMBL2041	Homo sapiens	Inhibition	%	4.61
	8220355	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	8.19	CHEMBL2041	Homo sapiens	Inhibition	%	8.19
	8220356	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	18.38	CHEMBL2041	Homo sapiens	Inhibition	%	18.38
	8220357	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	13.87	CHEMBL2041	Homo sapiens	Inhibition	%	13.87
	8220693	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.33	CHEMBL2041	Homo sapiens	Inhibition	%	4.33
	8220694	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.36	CHEMBL2041	Homo sapiens	Inhibition	%	3.36
	8220695	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	11.12	CHEMBL2041	Homo sapiens	Inhibition	%	11.12
	8220831	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	22.98	CHEMBL2041	Homo sapiens	Inhibition	%	22.98
	8220832	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	36.08	CHEMBL2041	Homo sapiens	Inhibition	%	36.08
	8220833	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	25.76	CHEMBL2041	Homo sapiens	Inhibition	%	25.76
	8221055	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	66.34	CHEMBL2041	Homo sapiens	Inhibition	%	66.34
	8221056	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	73.64	CHEMBL2041	Homo sapiens	Inhibition	%	73.64
	8221057	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	64.63	CHEMBL2041	Homo sapiens	Inhibition	%	64.63
	8221191	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.16	CHEMBL2041	Homo sapiens	Inhibition	%	4.16
	8221192	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.57	CHEMBL2041	Homo sapiens	Inhibition	%	3.57
	8221193	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.27	CHEMBL2041	Homo sapiens	Inhibition	%	5.27
	8221548	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.88	CHEMBL2041	Homo sapiens	Inhibition	%	4.88
	8221549	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.85	CHEMBL2041	Homo sapiens	Inhibition	%	3.85
	8221550	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.5	CHEMBL2041	Homo sapiens	Inhibition	%	4.5
	8221713	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.49	CHEMBL2041	Homo sapiens	Inhibition	%	3.49
	8221714	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	6.54	CHEMBL2041	Homo sapiens	Inhibition	%	6.54
	8221715	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	6.74	CHEMBL2041	Homo sapiens	Inhibition	%	6.74
	8222068	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	63.73	CHEMBL2041	Homo sapiens	Inhibition	%	63.73
	8222069	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	53.59	CHEMBL2041	Homo sapiens	Inhibition	%	53.59
	8222070	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	59.06	CHEMBL2041	Homo sapiens	Inhibition	%	59.06
	8222166	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.98	CHEMBL2041	Homo sapiens	Inhibition	%	2.98
	8222167	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.69	CHEMBL2041	Homo sapiens	Inhibition	%	-0.69
	8222168	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.73	CHEMBL2041	Homo sapiens	Inhibition	%	-1.73
	8222390	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	7.26	CHEMBL2041	Homo sapiens	Inhibition	%	7.26
	8222391	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	5.03	CHEMBL2041	Homo sapiens	Inhibition	%	5.03
	8222392	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	6.91	CHEMBL2041	Homo sapiens	Inhibition	%	6.91
	8222524	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	7.06	CHEMBL2041	Homo sapiens	Inhibition	%	7.06
	8222525	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	6.45	CHEMBL2041	Homo sapiens	Inhibition	%	6.45
	8222526	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	20.19	CHEMBL2041	Homo sapiens	Inhibition	%	20.19
	8222866	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	66.9	CHEMBL2041	Homo sapiens	Inhibition	%	66.9
	8222867	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	50.41	CHEMBL2041	Homo sapiens	Inhibition	%	50.41
	8222868	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	72.37	CHEMBL2041	Homo sapiens	Inhibition	%	72.37
	8223010	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	88.96	CHEMBL2041	Homo sapiens	Inhibition	%	88.96
	8223011	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	69.46	CHEMBL2041	Homo sapiens	Inhibition	%	69.46
	8223012	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	74.4	CHEMBL2041	Homo sapiens	Inhibition	%	74.4
	8223234	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	93.61	CHEMBL2041	Homo sapiens	Inhibition	%	93.61
	8223235	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	87.82	CHEMBL2041	Homo sapiens	Inhibition	%	87.82
	8223236	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	94.67	CHEMBL2041	Homo sapiens	Inhibition	%	94.67
	8223363	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	62.6	CHEMBL2041	Homo sapiens	Inhibition	%	62.6
	8223364	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	25.35	CHEMBL2041	Homo sapiens	Inhibition	%	25.35
	8223365	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	38.63	CHEMBL2041	Homo sapiens	Inhibition	%	38.63
	8223524	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	11.1	CHEMBL2041	Homo sapiens	Inhibition	%	11.1
	8223525	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.32	CHEMBL2041	Homo sapiens	Inhibition	%	4.32
	8223526	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	12.93	CHEMBL2041	Homo sapiens	Inhibition	%	12.93
	8223748	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	9.65	CHEMBL2041	Homo sapiens	Inhibition	%	9.65
	8223749	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	6.53	CHEMBL2041	Homo sapiens	Inhibition	%	6.53
	8223750	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	12.39	CHEMBL2041	Homo sapiens	Inhibition	%	12.39
	8223998	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.93	CHEMBL2041	Homo sapiens	Inhibition	%	4.93
	8223999	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.68	CHEMBL2041	Homo sapiens	Inhibition	%	2.68
	8224000	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.67	CHEMBL2041	Homo sapiens	Inhibition	%	3.67
	8224160	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	11.67	CHEMBL2041	Homo sapiens	Inhibition	%	11.67
	8224161	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.32	CHEMBL2041	Homo sapiens	Inhibition	%	5.32
	8224162	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	10.98	CHEMBL2041	Homo sapiens	Inhibition	%	10.98
	8224554	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	7.45	CHEMBL2041	Homo sapiens	Inhibition	%	7.45
	8224555	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.15	CHEMBL2041	Homo sapiens	Inhibition	%	1.15
	8224556	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	9.38	CHEMBL2041	Homo sapiens	Inhibition	%	9.38
	8224689	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.92	CHEMBL2041	Homo sapiens	Inhibition	%	5.92
	8224690	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.63	CHEMBL2041	Homo sapiens	Inhibition	%	3.63
	8224691	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.73	CHEMBL2041	Homo sapiens	Inhibition	%	4.73
	8225027	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.22	CHEMBL2041	Homo sapiens	Inhibition	%	4.22
	8225028	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.98	CHEMBL2041	Homo sapiens	Inhibition	%	4.98
	8225029	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.42	CHEMBL2041	Homo sapiens	Inhibition	%	2.42
	8225385	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.46	CHEMBL2041	Homo sapiens	Inhibition	%	6.46
	8225386	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	9.69	CHEMBL2041	Homo sapiens	Inhibition	%	9.69
	8225387	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	13.41	CHEMBL2041	Homo sapiens	Inhibition	%	13.41
	8225523	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.77	CHEMBL2041	Homo sapiens	Inhibition	%	0.77
	8225524	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	6.56	CHEMBL2041	Homo sapiens	Inhibition	%	6.56
	8225525	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.67	CHEMBL2041	Homo sapiens	Inhibition	%	3.67
	8225882	CHEMBL1962161	GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.6	CHEMBL2041	Homo sapiens	Inhibition	%	5.6
	8225883	CHEMBL1962163	GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	12.13	CHEMBL2041	Homo sapiens	Inhibition	%	12.13
	8225884	CHEMBL1962165	GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	11.56	CHEMBL2041	Homo sapiens	Inhibition	%	11.56
	8226040	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.86	CHEMBL2041	Homo sapiens	Inhibition	%	2.86
	8226041	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.71	CHEMBL2041	Homo sapiens	Inhibition	%	2.71
	8226042	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.84	CHEMBL2041	Homo sapiens	Inhibition	%	3.84
	8226389	CHEMBL1962160	GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.17	CHEMBL2041	Homo sapiens	Inhibition	%	1.17
	8226390	CHEMBL1962162	GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	10.11	CHEMBL2041	Homo sapiens	Inhibition	%	10.11
	8226391	CHEMBL1962164	GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.88	CHEMBL2041	Homo sapiens	Inhibition	%	4.88
inactive	9532856	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532857	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	10.0	CHEMBL2041	Homo sapiens	pKi		8.0
active	9532858	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	Ki	nM	50.12	CHEMBL2041	Homo sapiens	pKi		7.3
inactive	9532859	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532860	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532861	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	12.59	CHEMBL2041	Homo sapiens	pKi		7.9
inactive	9532862	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532863	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	3.162	CHEMBL2041	Homo sapiens	pKi		8.5
inactive	9532864	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532865	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	5.012	CHEMBL2041	Homo sapiens	pKi		8.3
active	9532866	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	=	Ki	nM	79.43	CHEMBL2041	Homo sapiens	pKi		7.1
inactive	9532867	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532868	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532869	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532870	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	=	Ki	nM	1584.89	CHEMBL2041	Homo sapiens	pKi		5.8
inactive	9532871	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532872	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	251.19	CHEMBL2041	Homo sapiens	pKi		6.6
inactive	9532873	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	15848.93	CHEMBL2041	Homo sapiens	pKi		4.8
inactive	9532874	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532875	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	79.43	CHEMBL2041	Homo sapiens	pKi		7.1
inactive	9532876	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532877	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532878	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532879	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	<	Ki	nM	19952.62	CHEMBL2041	Homo sapiens	pKi		4.7
inactive	9532880	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532881	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532882	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
inactive	9532883	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532884	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532885	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532886	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532887	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Fc1ccc(-c2ccc3nccn3n2)cn1		CHEMBL1967211	=	Ki	nM	79432.82	CHEMBL2041	Homo sapiens	pKi		4.1
inactive	9532888	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532889	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9532890	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532891	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
active	9532892	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	3.162	CHEMBL2041	Homo sapiens	pKi		8.5
inactive	9532893	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
inactive	9532894	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532895	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	63095.73	CHEMBL2041	Homo sapiens	pKi		4.2
active	9532896	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	12589.25	CHEMBL2041	Homo sapiens	pKi		4.9
active	9532897	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
active	9532898	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9532899	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
active	9532900	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	31.62	CHEMBL2041	Homo sapiens	pKi		7.5
active	9532901	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOC(=O)Cc1nc2c3cc(Br)ccc3[nH]c(=O)n2n1		CHEMBL1974480	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532902	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2000934	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532903	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
inactive	9532904	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532905	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532906	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532907	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	199.53	CHEMBL2041	Homo sapiens	pKi		6.7
inactive	9532908	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	<	Ki	nM	31622.78	CHEMBL2041	Homo sapiens	pKi		4.5
inactive	9532909	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532910	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
inactive	9532911	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532912	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532913	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532914	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	15.85	CHEMBL2041	Homo sapiens	pKi		7.8
active	9532915	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
inactive	9532916	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532917	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	39810.72	CHEMBL2041	Homo sapiens	pKi		4.4
active	9532918	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
active	9532919	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	630.96	CHEMBL2041	Homo sapiens	pKi		6.2
inactive	9532920	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532921	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532922	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532923	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532924	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532925	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Ki	nM	1584.89	CHEMBL2041	Homo sapiens	pKi		5.8
active	9532926	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1966842	=	Ki	nM	630.96	CHEMBL2041	Homo sapiens	pKi		6.2
inactive	9532927	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532928	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	=	Ki	nM	7.943	CHEMBL2041	Homo sapiens	pKi		8.1
active	9532929	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	10.0	CHEMBL2041	Homo sapiens	pKi		8.0
inactive	9532930	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532931	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	12.59	CHEMBL2041	Homo sapiens	pKi		7.9
inactive	9532932	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1977619	<	Ki	nM	12589.25	CHEMBL2041	Homo sapiens	pKi		4.9
active	9532933	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9532934	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
active	9532935	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9532936	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532937	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	=	Ki	nM	125.89	CHEMBL2041	Homo sapiens	pKi		6.9
active	9532938	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	19.95	CHEMBL2041	Homo sapiens	pKi		7.7
active	9532939	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	10.0	CHEMBL2041	Homo sapiens	pKi		8.0
active	9532940	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	19952.62	CHEMBL2041	Homo sapiens	pKi		4.7
active	9532941	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	=	Ki	nM	501.19	CHEMBL2041	Homo sapiens	pKi		6.3
active	9532942	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	398.11	CHEMBL2041	Homo sapiens	pKi		6.4
active	9532943	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	63.1	CHEMBL2041	Homo sapiens	pKi		7.2
active	9532944	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	79.43	CHEMBL2041	Homo sapiens	pKi		7.1
inactive	9532945	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532946	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	=	Ki	nM	19.95	CHEMBL2041	Homo sapiens	pKi		7.7
active	9532947	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	=	Ki	nM	501.19	CHEMBL2041	Homo sapiens	pKi		6.3
inactive	9532948	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532949	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	398.11	CHEMBL2041	Homo sapiens	pKi		6.4
inactive	9532950	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532951	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	3.981	CHEMBL2041	Homo sapiens	pKi		8.4
inactive	9532952	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532953	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532954	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532955	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Ki	nM	19.95	CHEMBL2041	Homo sapiens	pKi		7.7
active	9532956	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
inactive	9532957	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532958	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Ki	nM	79.43	CHEMBL2041	Homo sapiens	pKi		7.1
active	9532959	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
inactive	9532960	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532961	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9532962	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9532963	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	=	Ki	nM	251.19	CHEMBL2041	Homo sapiens	pKi		6.6
inactive	9532964	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532965	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9532966	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532967	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532968	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532969	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)Nc1cc2ccccn2n1		CHEMBL1976872	<	Ki	nM	12589.25	CHEMBL2041	Homo sapiens	pKi		4.9
active	9532970	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	=	Ki	nM	19952.62	CHEMBL2041	Homo sapiens	pKi		4.7
active	9532971	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	25.12	CHEMBL2041	Homo sapiens	pKi		7.6
inactive	9532972	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
inactive	9532973	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532974	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532975	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532976	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532977	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	=	Ki	nM	31622.78	CHEMBL2041	Homo sapiens	pKi		4.5
active	9532978	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	501.19	CHEMBL2041	Homo sapiens	pKi		6.3
inactive	9532979	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532980	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532981	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532982	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532983	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	1.585	CHEMBL2041	Homo sapiens	pKi		8.8
inactive	9532984	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532985	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F		CHEMBL2001228	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
active	9532986	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1CN=C(c2ccc(F)cc2)c2cn[nH]c2N1		CHEMBL1994056	=	Ki	nM	79432.82	CHEMBL2041	Homo sapiens	pKi		4.1
active	9532987	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
inactive	9532988	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532989	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Ki	nM	6.31	CHEMBL2041	Homo sapiens	pKi		8.2
inactive	9532990	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532991	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9532992	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9532993	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	158.49	CHEMBL2041	Homo sapiens	pKi		6.8
inactive	9532994	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532995	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532996	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9532997	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9532998	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	=	Ki	nM	15.85	CHEMBL2041	Homo sapiens	pKi		7.8
inactive	9532999	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533000	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	125.89	CHEMBL2041	Homo sapiens	pKi		6.9
inactive	9533001	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9533002	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1		CHEMBL1997924	=	Ki	nM	7.943	CHEMBL2041	Homo sapiens	pKi		8.1
inactive	9533003	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533004	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533005	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	25.12	CHEMBL2041	Homo sapiens	pKi		7.6
active	9533006	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)c1c(NC(=O)Cc2ccccc2)cccc1-c1nc2sccn2c1-c1ccnc(Nc2cccc(N3CCOCC3)c2)n1		CHEMBL1971485	=	Ki	nM	630.96	CHEMBL2041	Homo sapiens	pKi		6.2
inactive	9533007	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)c1ccccc1		CHEMBL1978267	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9533008	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533009	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	100.0	CHEMBL2041	Homo sapiens	pKi		7.0
inactive	9533010	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533011	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533012	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533013	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533014	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533015	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533016	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	19.95	CHEMBL2041	Homo sapiens	pKi		7.7
active	9533017	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	31622.78	CHEMBL2041	Homo sapiens	pKi		4.5
inactive	9533018	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533019	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533020	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	<	Ki	nM	1584.89	CHEMBL2041	Homo sapiens	pKi		5.8
active	9533021	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	=	Ki	nM	199.53	CHEMBL2041	Homo sapiens	pKi		6.7
inactive	9533022	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9533023	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533024	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	63095.73	CHEMBL2041	Homo sapiens	pKi		4.2
inactive	9533025	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9533026	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533027	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	100.0	CHEMBL2041	Homo sapiens	pKi		7.0
active	9533028	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nc2ncc(-c3ccccc3)cn2n1		CHEMBL2002480	=	Ki	nM	25118.86	CHEMBL2041	Homo sapiens	pKi		4.6
active	9533029	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	251.19	CHEMBL2041	Homo sapiens	pKi		6.6
active	9533030	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	=	Ki	nM	199.53	CHEMBL2041	Homo sapiens	pKi		6.7
inactive	9533031	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9533032	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533033	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533034	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	31.62	CHEMBL2041	Homo sapiens	pKi		7.5
inactive	9533035	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533036	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533037	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9533038	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9533039	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	199.53	CHEMBL2041	Homo sapiens	pKi		6.7
active	9533040	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	50118.72	CHEMBL2041	Homo sapiens	pKi		4.3
inactive	9533041	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533042	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533043	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	1584.89	CHEMBL2041	Homo sapiens	pKi		5.8
active	9533044	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	=	Ki	nM	199.53	CHEMBL2041	Homo sapiens	pKi		6.7
inactive	9533045	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533046	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533047	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	50.12	CHEMBL2041	Homo sapiens	pKi		7.3
active	9533048	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	19.95	CHEMBL2041	Homo sapiens	pKi		7.7
active	9533049	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1NS(=O)(=O)c2ccc(Cl)cc21		CHEMBL1967612	=	Ki	nM	100000.0	CHEMBL2041	Homo sapiens	pKi		4.0
inactive	9533050	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533051	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533052	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533053	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	2.512	CHEMBL2041	Homo sapiens	pKi		8.6
inactive	9533054	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533055	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	=	Ki	nM	398.11	CHEMBL2041	Homo sapiens	pKi		6.4
inactive	9533056	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533057	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	5.012	CHEMBL2041	Homo sapiens	pKi		8.3
inactive	9533058	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533059	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9533060	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533061	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(F)cc12		CHEMBL2007603	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9533062	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533063	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9533064	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	10000.0	CHEMBL2041	Homo sapiens	pKi		5.0
inactive	9533065	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533066	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
active	9533067	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	19.95	CHEMBL2041	Homo sapiens	pKi		7.7
active	9533068	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9533069	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533070	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533071	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533072	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	10.0	CHEMBL2041	Homo sapiens	pKi		8.0
inactive	9533073	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533074	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	5011.87	CHEMBL2041	Homo sapiens	pKi		5.3
inactive	9533075	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533076	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533077	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9533078	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	7943.28	CHEMBL2041	Homo sapiens	pKi		5.1
inactive	9533079	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9533080	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533081	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	=	Ki	nM	15.85	CHEMBL2041	Homo sapiens	pKi		7.8
inactive	9533082	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9533083	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	39.81	CHEMBL2041	Homo sapiens	pKi		7.4
active	9533084	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	10.0	CHEMBL2041	Homo sapiens	pKi		8.0
inactive	9533085	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533086	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	50.12	CHEMBL2041	Homo sapiens	pKi		7.3
inactive	9533087	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9533088	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9533089	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	50.12	CHEMBL2041	Homo sapiens	pKi		7.3
active	9536987	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	7.943	CHEMBL2041	Homo sapiens	pKi		8.1
inactive	9536988	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9536989	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	31.62	CHEMBL2041	Homo sapiens	pKi		7.5
active	9536990	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
inactive	9536991	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
inactive	9536992	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9536993	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
inactive	9536994	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9536995	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	5.012	CHEMBL2041	Homo sapiens	pKi		8.3
active	9536996	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)c1cccc(-c2ccc3nccn3n2)c1		CHEMBL1994159	=	Ki	nM	63095.73	CHEMBL2041	Homo sapiens	pKi		4.2
inactive	9536997	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9536998	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	0.631	CHEMBL2041	Homo sapiens	pKi		9.2
inactive	9536999	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537000	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537001	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537002	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(CCN(C)C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1992354	=	Ki	nM	1584.89	CHEMBL2041	Homo sapiens	pKi		5.8
inactive	9537003	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537004	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537005	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537006	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	19952.62	CHEMBL2041	Homo sapiens	pKi		4.7
active	9537007	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	125.89	CHEMBL2041	Homo sapiens	pKi		6.9
inactive	9537008	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537009	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	19.95	CHEMBL2041	Homo sapiens	pKi		7.7
inactive	9537010	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537011	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537012	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	398.11	CHEMBL2041	Homo sapiens	pKi		6.4
inactive	9537013	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537014	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537015	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537016	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537017	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537018	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537019	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	100.0	CHEMBL2041	Homo sapiens	pKi		7.0
active	9537020	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	100.0	CHEMBL2041	Homo sapiens	pKi		7.0
inactive	9537021	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537022	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	63.1	CHEMBL2041	Homo sapiens	pKi		7.2
active	9537023	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	251.19	CHEMBL2041	Homo sapiens	pKi		6.6
inactive	9537024	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537025	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1		CHEMBL2002346	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9537026	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537027	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537028	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
inactive	9537029	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537030	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537031	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1cc2nc(-c3ccccc3)cn2cn1		CHEMBL1972365	=	Ki	nM	6309.57	CHEMBL2041	Homo sapiens	pKi		5.2
inactive	9537032	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537033	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	7.943	CHEMBL2041	Homo sapiens	pKi		8.1
inactive	9537034	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537035	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	3.162	CHEMBL2041	Homo sapiens	pKi		8.5
inactive	9537036	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537037	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537038	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537039	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	125.89	CHEMBL2041	Homo sapiens	pKi		6.9
inactive	9537040	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537041	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	=	Ki	nM	3.981	CHEMBL2041	Homo sapiens	pKi		8.4
active	9537042	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
active	9537043	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	50.12	CHEMBL2041	Homo sapiens	pKi		7.3
active	9537044	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	125.89	CHEMBL2041	Homo sapiens	pKi		6.9
inactive	9537045	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537046	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537047	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	=	Ki	nM	1584.89	CHEMBL2041	Homo sapiens	pKi		5.8
active	9537048	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537049	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	25118.86	CHEMBL2041	Homo sapiens	pKi		4.6
inactive	9537050	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
active	9537051	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9537052	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
inactive	9537053	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537054	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537055	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	100.0	CHEMBL2041	Homo sapiens	pKi		7.0
inactive	9537056	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537057	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
active	9537058	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	10.0	CHEMBL2041	Homo sapiens	pKi		8.0
inactive	9537059	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537060	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	15.85	CHEMBL2041	Homo sapiens	pKi		7.8
inactive	9537061	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537062	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
inactive	9537063	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537064	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
active	9537065	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	=	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
active	9537066	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1987815	=	Ki	nM	50118.72	CHEMBL2041	Homo sapiens	pKi		4.3
active	9537067	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9537068	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537069	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	=	Ki	nM	39.81	CHEMBL2041	Homo sapiens	pKi		7.4
inactive	9537070	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537071	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537072	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537073	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	12589.25	CHEMBL2041	Homo sapiens	pKi		4.9
active	9537074	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	39.81	CHEMBL2041	Homo sapiens	pKi		7.4
active	9537075	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
inactive	9537076	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537077	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	=	Ki	nM	63095.73	CHEMBL2041	Homo sapiens	pKi		4.2
active	9537078	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	199.53	CHEMBL2041	Homo sapiens	pKi		6.7
active	9537079	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	=	Ki	nM	398.11	CHEMBL2041	Homo sapiens	pKi		6.4
inactive	9537080	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537081	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537082	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537083	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	1584.89	CHEMBL2041	Homo sapiens	pKi		5.8
active	9537084	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537085	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537086	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537087	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537088	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537089	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537090	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	31.62	CHEMBL2041	Homo sapiens	pKi		7.5
inactive	9537091	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537092	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537093	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
inactive	9537094	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537095	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	125.89	CHEMBL2041	Homo sapiens	pKi		6.9
inactive	9537096	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
active	9537097	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	=	Ki	nM	79.43	CHEMBL2041	Homo sapiens	pKi		7.1
inactive	9537098	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537099	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537100	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537101	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	10.0	CHEMBL2041	Homo sapiens	pKi		8.0
active	9537102	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4c(F)cccc4F)c3)nc3sccn23)n1		CHEMBL1997051	=	Ki	nM	31.62	CHEMBL2041	Homo sapiens	pKi		7.5
active	9537103	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	=	Ki	nM	630.96	CHEMBL2041	Homo sapiens	pKi		6.2
inactive	9537104	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537105	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537106	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537107	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	630.96	CHEMBL2041	Homo sapiens	pKi		6.2
active	9537108	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	3.981	CHEMBL2041	Homo sapiens	pKi		8.4
active	9537109	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	100.0	CHEMBL2041	Homo sapiens	pKi		7.0
inactive	9537110	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537111	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	50.12	CHEMBL2041	Homo sapiens	pKi		7.3
active	9537112	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	10000.0	CHEMBL2041	Homo sapiens	pKi		5.0
inactive	9537113	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537114	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	=	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537115	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	7.943	CHEMBL2041	Homo sapiens	pKi		8.1
inactive	9537116	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	<	Ki	nM	12589.25	CHEMBL2041	Homo sapiens	pKi		4.9
inactive	9537117	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537118	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC1=CN2CC(=O)NN=C2C=C1		CHEMBL1964718	=	Ki	nM	50118.72	CHEMBL2041	Homo sapiens	pKi		4.3
inactive	9537119	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9537120	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	=	Ki	nM	25.12	CHEMBL2041	Homo sapiens	pKi		7.6
inactive	9537121	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537122	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(C(N)=O)n2nc(C(C)(C)C)cc2n1		CHEMBL1986684	=	Ki	nM	79432.82	CHEMBL2041	Homo sapiens	pKi		4.1
active	9537123	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9537124	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	398.11	CHEMBL2041	Homo sapiens	pKi		6.4
active	9537125	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537126	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537127	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537128	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	=	Ki	nM	501.19	CHEMBL2041	Homo sapiens	pKi		6.3
inactive	9537129	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
active	9537130	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	2.512	CHEMBL2041	Homo sapiens	pKi		8.6
inactive	9537131	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537132	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	25118.86	CHEMBL2041	Homo sapiens	pKi		4.6
active	9537133	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
active	9537134	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	79.43	CHEMBL2041	Homo sapiens	pKi		7.1
active	9537135	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	10.0	CHEMBL2041	Homo sapiens	pKi		8.0
active	9537136	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	39.81	CHEMBL2041	Homo sapiens	pKi		7.4
inactive	9537137	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537138	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537139	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537140	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537141	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	=	Ki	nM	630.96	CHEMBL2041	Homo sapiens	pKi		6.2
active	9537142	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
inactive	9537143	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537144	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537145	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9537146	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
inactive	9537147	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537148	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	398.11	CHEMBL2041	Homo sapiens	pKi		6.4
active	9537149	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	25.12	CHEMBL2041	Homo sapiens	pKi		7.6
active	9537150	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1ccc(C2CCc3[nH]ncc3C2)cc1		CHEMBL2000879	=	Ki	nM	39810.72	CHEMBL2041	Homo sapiens	pKi		4.4
inactive	9537151	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	1584.89	CHEMBL2041	Homo sapiens	pKi		5.8
inactive	9537152	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL1969483	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537153	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	100.0	CHEMBL2041	Homo sapiens	pKi		7.0
active	9537154	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9537155	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	7.943	CHEMBL2041	Homo sapiens	pKi		8.1
inactive	9537156	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537157	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537158	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Ki	nM	199.53	CHEMBL2041	Homo sapiens	pKi		6.7
inactive	9537159	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537160	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537161	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
inactive	9537162	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537163	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537164	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	501.19	CHEMBL2041	Homo sapiens	pKi		6.3
active	9537165	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	79.43	CHEMBL2041	Homo sapiens	pKi		7.1
inactive	9537166	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537167	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537168	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
inactive	9537169	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537170	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	125.89	CHEMBL2041	Homo sapiens	pKi		6.9
inactive	9537171	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9537172	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
active	9537173	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	1.585	CHEMBL2041	Homo sapiens	pKi		8.8
inactive	9537174	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537175	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
active	9537176	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	=	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
inactive	9537177	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537178	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537179	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537180	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537181	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537182	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537183	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9537184	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537185	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537186	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOc1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL2000078	=	Ki	nM	125.89	CHEMBL2041	Homo sapiens	pKi		6.9
active	9537187	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	398.11	CHEMBL2041	Homo sapiens	pKi		6.4
active	9537188	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	12.59	CHEMBL2041	Homo sapiens	pKi		7.9
active	9537189	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	7.943	CHEMBL2041	Homo sapiens	pKi		8.1
active	9537190	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	=	Ki	nM	1584.89	CHEMBL2041	Homo sapiens	pKi		5.8
active	9537191	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
inactive	9537192	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9537193	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Cc1ccccc1)Nc1cc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)ccc1Cl		CHEMBL2005482	=	Ki	nM	12.59	CHEMBL2041	Homo sapiens	pKi		7.9
active	9537194	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	=	Ki	nM	630.96	CHEMBL2041	Homo sapiens	pKi		6.2
active	9537195	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	12.59	CHEMBL2041	Homo sapiens	pKi		7.9
active	9537196	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1997909	=	Ki	nM	199.53	CHEMBL2041	Homo sapiens	pKi		6.7
active	9537197	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9537198	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
active	9537199	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	251.19	CHEMBL2041	Homo sapiens	pKi		6.6
active	9537200	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	79.43	CHEMBL2041	Homo sapiens	pKi		7.1
active	9537201	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	100.0	CHEMBL2041	Homo sapiens	pKi		7.0
active	9537202	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	12.59	CHEMBL2041	Homo sapiens	pKi		7.9
active	9537203	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9537204	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
inactive	9537205	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9537206	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	12589.25	CHEMBL2041	Homo sapiens	pKi		4.9
inactive	9537207	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537208	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	=	Ki	nM	501.19	CHEMBL2041	Homo sapiens	pKi		6.3
inactive	9537209	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537210	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537211	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537212	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
inactive	9537213	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537214	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	79.43	CHEMBL2041	Homo sapiens	pKi		7.1
active	9537215	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	6.31	CHEMBL2041	Homo sapiens	pKi		8.2
inactive	9537216	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	<	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
inactive	9537217	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537218	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	398.11	CHEMBL2041	Homo sapiens	pKi		6.4
active	9537219	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9537220	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN1c2cc(N)ccc2-c2ccc(N)cc2C1(O)c1ccccc1		CHEMBL1991818	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9537221	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	1.259	CHEMBL2041	Homo sapiens	pKi		8.9
active	9537222	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	=	Ki	nM	1.0	CHEMBL2041	Homo sapiens	pKi		9.0
inactive	9537223	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9537224	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9537225	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	25.12	CHEMBL2041	Homo sapiens	pKi		7.6
inactive	9537226	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541141	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541142	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	=	Ki	nM	3.162	CHEMBL2041	Homo sapiens	pKi		8.5
active	9541143	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	25118.86	CHEMBL2041	Homo sapiens	pKi		4.6
active	9541144	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
inactive	9541145	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541146	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541147	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541148	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541149	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541150	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
active	9541151	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	125.89	CHEMBL2041	Homo sapiens	pKi		6.9
active	9541152	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	10.0	CHEMBL2041	Homo sapiens	pKi		8.0
inactive	9541153	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541154	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541155	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541156	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	158.49	CHEMBL2041	Homo sapiens	pKi		6.8
active	9541157	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	501.19	CHEMBL2041	Homo sapiens	pKi		6.3
active	9541158	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	=	Ki	nM	12.59	CHEMBL2041	Homo sapiens	pKi		7.9
active	9541159	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	100.0	CHEMBL2041	Homo sapiens	pKi		7.0
inactive	9541160	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541161	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541162	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541163	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541164	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541165	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541166	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541167	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	=	Ki	nM	125.89	CHEMBL2041	Homo sapiens	pKi		6.9
inactive	9541168	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541169	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	39810.72	CHEMBL2041	Homo sapiens	pKi		4.4
inactive	9541170	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541171	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541172	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541173	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2F)c1		CHEMBL1986851	=	Ki	nM	1.0	CHEMBL2041	Homo sapiens	pKi		9.0
active	9541174	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
active	9541175	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	31.62	CHEMBL2041	Homo sapiens	pKi		7.5
active	9541176	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	0.631	CHEMBL2041	Homo sapiens	pKi		9.2
inactive	9541177	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541178	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
active	9541179	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1NS(=O)(=O)c2cccc(Cl)c21		CHEMBL1987003	=	Ki	nM	100000.0	CHEMBL2041	Homo sapiens	pKi		4.0
active	9541180	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	12589.25	CHEMBL2041	Homo sapiens	pKi		4.9
active	9541181	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	251.19	CHEMBL2041	Homo sapiens	pKi		6.6
inactive	9541182	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541183	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541184	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	=	Ki	nM	63.1	CHEMBL2041	Homo sapiens	pKi		7.2
inactive	9541185	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541186	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541187	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541188	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541189	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541190	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541191	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541192	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
active	9541193	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1CN2C(=NN1)COc1ccccc12		CHEMBL1968515	=	Ki	nM	50118.72	CHEMBL2041	Homo sapiens	pKi		4.3
active	9541194	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	630.96	CHEMBL2041	Homo sapiens	pKi		6.2
active	9541195	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Ki	nM	158.49	CHEMBL2041	Homo sapiens	pKi		6.8
inactive	9541196	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541197	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	50.12	CHEMBL2041	Homo sapiens	pKi		7.3
active	9541198	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
active	9541199	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	50.12	CHEMBL2041	Homo sapiens	pKi		7.3
active	9541200	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
active	9541201	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541202	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541203	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	1584.89	CHEMBL2041	Homo sapiens	pKi		5.8
active	9541204	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	=	Ki	nM	7.943	CHEMBL2041	Homo sapiens	pKi		8.1
active	9541205	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nnc2ccc(-c3ccccc3)cn12		CHEMBL1987143	=	Ki	nM	10000.0	CHEMBL2041	Homo sapiens	pKi		5.0
inactive	9541206	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541207	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541208	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
inactive	9541209	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541210	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	=	Ki	nM	25.12	CHEMBL2041	Homo sapiens	pKi		7.6
inactive	9541211	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541212	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541213	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541214	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541215	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541216	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	199.53	CHEMBL2041	Homo sapiens	pKi		6.7
active	9541217	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	1.259	CHEMBL2041	Homo sapiens	pKi		8.9
active	9541218	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	=	Ki	nM	501.19	CHEMBL2041	Homo sapiens	pKi		6.3
inactive	9541219	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541220	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541221	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541222	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	25118.86	CHEMBL2041	Homo sapiens	pKi		4.6
inactive	9541223	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541224	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	=	Ki	nM	199.53	CHEMBL2041	Homo sapiens	pKi		6.7
active	9541225	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	3.162	CHEMBL2041	Homo sapiens	pKi		8.5
inactive	9541226	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541227	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541228	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	199.53	CHEMBL2041	Homo sapiens	pKi		6.7
active	9541229	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	100.0	CHEMBL2041	Homo sapiens	pKi		7.0
active	9541230	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	C=Cc1ccc(-c2cccc3nnc(N)n23)cc1		CHEMBL1983573	=	Ki	nM	50118.72	CHEMBL2041	Homo sapiens	pKi		4.3
inactive	9541231	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541232	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	50.12	CHEMBL2041	Homo sapiens	pKi		7.3
active	9541233	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	=	Ki	nM	19.95	CHEMBL2041	Homo sapiens	pKi		7.7
inactive	9541234	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541235	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541236	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4ccccc4)c3)nc3sccn23)n1		CHEMBL1988076	=	Ki	nM	63.1	CHEMBL2041	Homo sapiens	pKi		7.2
inactive	9541237	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541238	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541239	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541240	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	31.62	CHEMBL2041	Homo sapiens	pKi		7.5
active	9541241	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	39.81	CHEMBL2041	Homo sapiens	pKi		7.4
inactive	9541242	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541243	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541244	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
inactive	9541245	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541246	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
inactive	9541247	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541248	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	63.1	CHEMBL2041	Homo sapiens	pKi		7.2
inactive	9541249	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541250	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541251	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541252	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541253	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541254	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1		CHEMBL385478	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541255	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	19.95	CHEMBL2041	Homo sapiens	pKi		7.7
inactive	9541256	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541257	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541258	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	19.95	CHEMBL2041	Homo sapiens	pKi		7.7
active	9541259	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	50.12	CHEMBL2041	Homo sapiens	pKi		7.3
active	9541260	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)CCCCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2001451	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
inactive	9541261	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541262	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541263	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	=	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
inactive	9541264	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541265	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541266	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541267	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541268	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541269	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(SCC1CCC2CC1C2(C)C)C(N)=O		CHEMBL1966976	=	Ki	nM	100000.0	CHEMBL2041	Homo sapiens	pKi		4.0
inactive	9541270	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541271	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	<	Ki	nM	12589.25	CHEMBL2041	Homo sapiens	pKi		4.9
active	9541272	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	7943.28	CHEMBL2041	Homo sapiens	pKi		5.1
inactive	9541273	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541274	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541275	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9541276	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
inactive	9541277	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541278	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	158.49	CHEMBL2041	Homo sapiens	pKi		6.8
inactive	9541279	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541280	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541281	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2c1C(=O)NCCN2		CHEMBL1992607	=	Ki	nM	31622.78	CHEMBL2041	Homo sapiens	pKi		4.5
inactive	9541282	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541283	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541284	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	39.81	CHEMBL2041	Homo sapiens	pKi		7.4
inactive	9541285	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541286	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541287	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Ki	nM	398.11	CHEMBL2041	Homo sapiens	pKi		6.4
inactive	9541288	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541289	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	=	Ki	nM	100.0	CHEMBL2041	Homo sapiens	pKi		7.0
active	9541290	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	2.512	CHEMBL2041	Homo sapiens	pKi		8.6
inactive	9541291	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541292	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541293	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541294	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	=	Ki	nM	63.1	CHEMBL2041	Homo sapiens	pKi		7.2
inactive	9541295	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541296	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	630.96	CHEMBL2041	Homo sapiens	pKi		6.2
active	9541297	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	15.85	CHEMBL2041	Homo sapiens	pKi		7.8
inactive	9541298	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541299	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	3.162	CHEMBL2041	Homo sapiens	pKi		8.5
active	9541300	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
active	9541301	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541302	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	5.012	CHEMBL2041	Homo sapiens	pKi		8.3
inactive	9541303	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3981.07	CHEMBL2041	Homo sapiens	pKi		5.4
active	9541304	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9541305	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541306	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	31.62	CHEMBL2041	Homo sapiens	pKi		7.5
active	9541307	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	=	Ki	nM	79.43	CHEMBL2041	Homo sapiens	pKi		7.1
active	9541308	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	501.19	CHEMBL2041	Homo sapiens	pKi		6.3
inactive	9541309	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541310	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	63.1	CHEMBL2041	Homo sapiens	pKi		7.2
active	9541311	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	1.585	CHEMBL2041	Homo sapiens	pKi		8.8
active	9541312	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
inactive	9541313	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541314	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541315	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541316	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	50118.72	CHEMBL2041	Homo sapiens	pKi		4.3
active	9541317	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	63.1	CHEMBL2041	Homo sapiens	pKi		7.2
inactive	9541318	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541319	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	199.53	CHEMBL2041	Homo sapiens	pKi		6.7
inactive	9541320	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541321	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541322	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	=	Ki	nM	316.23	CHEMBL2041	Homo sapiens	pKi		6.5
inactive	9541323	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541324	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	3.162	CHEMBL2041	Homo sapiens	pKi		8.5
inactive	9541325	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541326	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541327	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	12589.25	CHEMBL2041	Homo sapiens	pKi		4.9
inactive	9541328	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541329	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541330	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
inactive	9541331	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
inactive	9541332	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541333	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541334	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	=	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
active	9541335	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNC(=O)c1cc(-c2ccccc2)[nH]n1		CHEMBL1995916	=	Ki	nM	79432.82	CHEMBL2041	Homo sapiens	pKi		4.1
inactive	9541336	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541337	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
active	9541338	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	=	Ki	nM	19952.62	CHEMBL2041	Homo sapiens	pKi		4.7
inactive	9541339	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541340	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541341	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	=	Ki	nM	50.12	CHEMBL2041	Homo sapiens	pKi		7.3
active	9541342	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(-c2ccc(N)cc2)c2cnoc12		CHEMBL2002450	=	Ki	nM	39810.72	CHEMBL2041	Homo sapiens	pKi		4.4
inactive	9541343	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541344	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541345	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	10.0	CHEMBL2041	Homo sapiens	pKi		8.0
inactive	9541346	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541347	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541348	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541349	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541350	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541351	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	=	Ki	nM	794.33	CHEMBL2041	Homo sapiens	pKi		6.1
inactive	9541352	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541353	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541354	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541355	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)N(CCN)CCO)c2)n1		CHEMBL1993634	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541356	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541357	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=c1[nH]nc2c(-c3ccccc3)cccn12		CHEMBL2002182	=	Ki	nM	50118.72	CHEMBL2041	Homo sapiens	pKi		4.3
active	9541358	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	158.49	CHEMBL2041	Homo sapiens	pKi		6.8
active	9541359	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	50.12	CHEMBL2041	Homo sapiens	pKi		7.3
inactive	9541360	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541361	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541362	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541363	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	=	Ki	nM	1584.89	CHEMBL2041	Homo sapiens	pKi		5.8
inactive	9541364	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541365	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541366	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	=	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
active	9541367	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	=	Ki	nM	398.11	CHEMBL2041	Homo sapiens	pKi		6.4
active	9541368	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	39810.72	CHEMBL2041	Homo sapiens	pKi		4.4
active	9541369	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	501.19	CHEMBL2041	Homo sapiens	pKi		6.3
inactive	9541370	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9541371	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	=	Ki	nM	630.96	CHEMBL2041	Homo sapiens	pKi		6.2
inactive	9541372	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541373	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541374	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9541375	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	=	Ki	nM	630.96	CHEMBL2041	Homo sapiens	pKi		6.2
active	9541376	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	3.162	CHEMBL2041	Homo sapiens	pKi		8.5
inactive	9541377	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9541378	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541379	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9541380	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
inactive	9545281	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9545282	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9545283	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	1995.26	CHEMBL2041	Homo sapiens	pKi		5.7
inactive	9545284	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9545285	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3981.07	CHEMBL2041	Homo sapiens	pKi		5.4
active	9545286	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Ki	nM	158.49	CHEMBL2041	Homo sapiens	pKi		6.8
active	9545287	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	251.19	CHEMBL2041	Homo sapiens	pKi		6.6
active	9545288	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	63.1	CHEMBL2041	Homo sapiens	pKi		7.2
active	9545289	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	10.0	CHEMBL2041	Homo sapiens	pKi		8.0
inactive	9545290	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9545291	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	7.943	CHEMBL2041	Homo sapiens	pKi		8.1
active	9545292	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
inactive	9545293	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9545294	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
inactive	9545295	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	3162.28	CHEMBL2041	Homo sapiens	pKi		5.5
active	9545296	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9545297	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	2.512	CHEMBL2041	Homo sapiens	pKi		8.6
active	9545298	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	79.43	CHEMBL2041	Homo sapiens	pKi		7.1
active	9545299	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9545300	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	=	Ki	nM	1000.0	CHEMBL2041	Homo sapiens	pKi		6.0
active	9545301	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	=	Ki	nM	63.1	CHEMBL2041	Homo sapiens	pKi		7.2
active	9545302	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	63.1	CHEMBL2041	Homo sapiens	pKi		7.2
inactive	9545303	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	2511.89	CHEMBL2041	Homo sapiens	pKi		5.6
active	9545304	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	3.981	CHEMBL2041	Homo sapiens	pKi		8.4
inactive	9545305	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	1258.93	CHEMBL2041	Homo sapiens	pKi		5.9
active	9545306	CHEMBL1963706	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	12.59	CHEMBL2041	Homo sapiens	pKi		7.9
	10838625	CHEMBL2014503	Inhibition of RET at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	11.0	CHEMBL2041	Homo sapiens	INH	%	11.0
	10838626	CHEMBL2014504	Inhibition of RET M918T mutant at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	9.0	CHEMBL2041	Homo sapiens	INH	%	9.0
	10843851	CHEMBL2016117	Inhibition of human RET using ATP as substrate	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010872	=	IC50	nM	5.0	CHEMBL2041	Homo sapiens	IC50	nM	5.0
	10850687	CHEMBL2019807	Inhibition of human Ret at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	10863748	CHEMBL2024903	Inhibition of RET by TR-FRET assay	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	7.0	CHEMBL2041	Homo sapiens	IC50	nM	7.0
	10886522	CHEMBL2033427	Inhibition of Ret in human HEK293 cells after 1 hr by competition binding assay	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	2.0	CHEMBL2041	Homo sapiens	Kd	nM	2.0
	10889038	CHEMBL2032477	Inhibition of RET	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	25000.0	CHEMBL2041	Homo sapiens	IC50	uM	25.0
	10889065	CHEMBL2032477	Inhibition of RET	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC		CHEMBL2031893	=	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	uM	0.01
	10903525	CHEMBL2037938	Inhibition of Ret at 10 times IC50 concentration after 90 mins in presence of ATP	B	N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1		CHEMBL2036807	=	Inhibition	%	79.0	CHEMBL2041	Homo sapiens	INH	%	79.0
	10903526	CHEMBL2037938	Inhibition of Ret at 10 times IC50 concentration after 90 mins in presence of ATP	B	CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1		CHEMBL2036808	=	Inhibition	%	59.0	CHEMBL2041	Homo sapiens	INH	%	59.0
	10903527	CHEMBL2037939	Inhibition of Ret Y791F mutant at 10 times IC50 concentration after 90 mins in presence of ATP	B	N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1		CHEMBL2036807	=	Inhibition	%	67.0	CHEMBL2041	Homo sapiens	INH	%	67.0
	10903528	CHEMBL2037939	Inhibition of Ret Y791F mutant at 10 times IC50 concentration after 90 mins in presence of ATP	B	CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1		CHEMBL2036808	=	Inhibition	%	56.0	CHEMBL2041	Homo sapiens	INH	%	56.0
	10936275	CHEMBL2050068	Inhibition of human Ret	B	Cc1ccc(NC(=O)Nc2nnc(Sc3ncnc4cc(OCCCN5CCOCC5)ccc34)s2)cc1		CHEMBL2046883	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	10952729	CHEMBL2060517	Inhibition of RET	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	37.0	CHEMBL2041	Homo sapiens	IC50	nM	37.0
	10962846	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	<	Activity	%	20.0	CHEMBL2041	Homo sapiens	Activity	%	20.0
	10962847	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	CC(C)n1nc(C#Cc2ccc(F)cc2)c2c(N)ncnc21		CHEMBL2058539	<	Activity	%	20.0	CHEMBL2041	Homo sapiens	Activity	%	20.0
	10962848	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	CC(C)n1nc(C#Cc2cccc(N)c2)c2c(N)ncnc21		CHEMBL2058540	<	Activity	%	20.0	CHEMBL2041	Homo sapiens	Activity	%	20.0
	10962849	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	CC(C)n1nc(C#Cc2ccccc2N)c2c(N)ncnc21		CHEMBL2058541	<	Activity	%	20.0	CHEMBL2041	Homo sapiens	Activity	%	20.0
	10962850	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	Cc1ccc(C)c(C#Cc2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL2058542	<	Activity	%	20.0	CHEMBL2041	Homo sapiens	Activity	%	20.0
	10962851	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	CC(C)n1nc(/C=C/c2ccccc2)c2c(N)ncnc21		CHEMBL2058543	<	Activity	%	20.0	CHEMBL2041	Homo sapiens	Activity	%	20.0
Not Active	10962852	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	CC(C)n1nc(C#Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL2058544		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	10962853	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	COc1ccc2cc(C#Cc3nn(C(C)C)c4ncnc(N)c34)ccc2c1		CHEMBL2058545		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	10962854	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	CC(C)n1nc(C#Cc2cncn2C)c2c(N)ncnc21		CHEMBL2058546		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	10962855	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	C=C(C)C#Cc1nn(C(C)C)c2ncnc(N)c12		CHEMBL2058547		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	10962856	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	CC(C)n1nc(C#CC(C)(C)C)c2c(N)ncnc21		CHEMBL2058548		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	10962857	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	CC(C)n1nc(CCc2ccccc2)c2c(N)ncnc21		CHEMBL2058549		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	10962858	CHEMBL2060377	Inhibition of RET at 300 nM assessed as remaining enzyme activity by cell-free enzyme inhibition assay	B	CC(C)n1nc(CCc2ccc(F)cc2)c2c(N)ncnc21		CHEMBL2058550		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	10962859	CHEMBL2060378	Inhibition of RET by commercial radiometric assay	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	IC50	nM	8.0	CHEMBL2041	Homo sapiens	IC50	nM	8.0
	10962860	CHEMBL2060378	Inhibition of RET by commercial radiometric assay	B	CC(C)n1nc(C#Cc2ccc(F)cc2)c2c(N)ncnc21		CHEMBL2058539	=	IC50	nM	43.0	CHEMBL2041	Homo sapiens	IC50	nM	43.0
	10962861	CHEMBL2060378	Inhibition of RET by commercial radiometric assay	B	CC(C)n1nc(C#Cc2cccc(N)c2)c2c(N)ncnc21		CHEMBL2058540	=	IC50	nM	110.0	CHEMBL2041	Homo sapiens	IC50	nM	110.0
	10962862	CHEMBL2060378	Inhibition of RET by commercial radiometric assay	B	CC(C)n1nc(C#Cc2ccccc2N)c2c(N)ncnc21		CHEMBL2058541	=	IC50	nM	195.0	CHEMBL2041	Homo sapiens	IC50	nM	195.0
	10962863	CHEMBL2060378	Inhibition of RET by commercial radiometric assay	B	Cc1ccc(C)c(C#Cc2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL2058542	=	IC50	nM	83.0	CHEMBL2041	Homo sapiens	IC50	nM	83.0
	10962864	CHEMBL2060378	Inhibition of RET by commercial radiometric assay	B	CC(C)n1nc(/C=C/c2ccccc2)c2c(N)ncnc21		CHEMBL2058543	=	IC50	nM	50.0	CHEMBL2041	Homo sapiens	IC50	nM	50.0
	10962874	CHEMBL2060388	Inhibition of RET assessed as remaining enzyme activity at 0.4 uM	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	Activity	%	0.0	CHEMBL2041	Homo sapiens	Activity	%	0.0
Active	10962880	CHEMBL2060394	Inhibition of RET in serum starved human MCF7 cells assessed as reduction in GDNF-induced ERK1/2 phosphorylation at 100 nM added 30 mins before GDNF stimulation and incubated for further 45 mins by Western blotting	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	10962881	CHEMBL2060395	Inhibition of RET in human TPC1 cells expressing constitutively active RET fusion protein assessed as reduction in ERK1/2 phosphorylation at 50 to 200 nM by Western blotting	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	10962883	CHEMBL2060397	Inhibition of RET in human TPC1 cells expressing constitutively active RET fusion protein assessed as reduction in nuclear translocation of ERK1/2 at 200 nM by immunofluorescence microscopy	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	10983102	CHEMBL2072605	Inhibition of RET	B	C[C@H](NC(=O)c1cc(-c2cnn(C3CCOCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2071457	=	IC50	nM	210.0	CHEMBL2041	Homo sapiens	IC50	uM	0.21
	10984772	CHEMBL2072068	Inhibition of human Ret at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	>	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	10993506	CHEMBL2073082	Inhibition of Ret at 10 uM	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Inhibition	%	5.0	CHEMBL2041	Homo sapiens	INH	%	5.0
	11017229	CHEMBL2092477	Inhibition of RET	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1c(F)cn2c(C(C)(C)C)nnc2c1F		CHEMBL2087742	=	IC50	nM	2000.0	CHEMBL2041	Homo sapiens	IC50	uM	2.0
	11017231	CHEMBL2092479	Inhibition of RET at 10 uM	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccn2c(C(C)(C)C)nnc2c1		CHEMBL2087501	=	Inhibition	%	66.0	CHEMBL2041	Homo sapiens	INH	%	66.0
	12047336	CHEMBL2157613	Inhibition of Ret at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	12051580	CHEMBL2154720	Inhibition of Ret	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	<	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	12108539	CHEMBL2173414	Inhibition of Ret in human SK-N-SH cells	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	EC50	nM	80.0	CHEMBL2041	Homo sapiens	EC50	nM	80.0
	12108540	CHEMBL2173012	Inhibition of Ret by biochemical assay	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	IC50	nM	5.0	CHEMBL2041	Homo sapiens	IC50	nM	5.0
	12112576	CHEMBL2174409	Inhibition of RET at 1 uM by 33P kinase hotspot assay	B	NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170414	=	Inhibition	%	70.0	CHEMBL2041	Homo sapiens	INH	%	70.0
	12112577	CHEMBL2174409	Inhibition of RET at 1 uM by 33P kinase hotspot assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Inhibition	%	96.0	CHEMBL2041	Homo sapiens	INH	%	96.0
	12116234	CHEMBL2172940	Inhibition of RET	B	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL2171124	=	IC50	nM	1215.0	CHEMBL2041	Homo sapiens	IC50	nM	1215.0
	12138514	CHEMBL2185926	Inhibition of RET	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2180602	=	IC50	nM	5.0	CHEMBL2041	Homo sapiens	IC50	nM	5.0
	12145253	CHEMBL2182676	Inhibition of RET using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL2041	Homo sapiens	INH	%	25.0
	12145254	CHEMBL2182676	Inhibition of RET using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL2041	Homo sapiens	INH	%	25.0
	12172234	CHEMBL2212014	Inhibition of RET V804M mutant assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	93.0	CHEMBL2041	Homo sapiens	Activity	%	93.0
	12172235	CHEMBL2212015	Inhibition of RET V804L mutant assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	12172236	CHEMBL2212017	Inhibition of RET M918T mutant assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	12172237	CHEMBL2212016	Inhibition of RET assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	93.0	CHEMBL2041	Homo sapiens	Activity	%	93.0
	12175339	CHEMBL2211563	Inhibition of RET at 1 uM	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207503	=	Inhibition	%	1.8	CHEMBL2041	Homo sapiens	INH	%	1.8
	12183821	CHEMBL2214439	Inhibition of RET	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	pIC50		5.0
	12193496	CHEMBL2215276	Inhibition of RET at 100 uM	B	O=C1CC(c2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2207940	=	Inhibition	%	55.2	CHEMBL2041	Homo sapiens	INH	%	55.2
	12272388	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	101.0	CHEMBL2041	Homo sapiens	Residual Activity	%	101.0
	12272389	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	79.0	CHEMBL2041	Homo sapiens	Residual Activity	%	79.0
	12272390	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	89.0	CHEMBL2041	Homo sapiens	Residual Activity	%	89.0
	12272391	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	93.0	CHEMBL2041	Homo sapiens	Residual Activity	%	93.0
	12272392	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	67.0	CHEMBL2041	Homo sapiens	Residual Activity	%	67.0
	12272393	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	101.0	CHEMBL2041	Homo sapiens	Residual Activity	%	101.0
	12272394	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	1.0
	12272395	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	39.0	CHEMBL2041	Homo sapiens	Residual Activity	%	39.0
	12272396	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	65.0	CHEMBL2041	Homo sapiens	Residual Activity	%	65.0
	12272397	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	66.0	CHEMBL2041	Homo sapiens	Residual Activity	%	66.0
	12272398	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	100.0	CHEMBL2041	Homo sapiens	Residual Activity	%	100.0
	12272399	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	88.0	CHEMBL2041	Homo sapiens	Residual Activity	%	88.0
	12272400	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	86.0	CHEMBL2041	Homo sapiens	Residual Activity	%	86.0
	12272401	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	11.0	CHEMBL2041	Homo sapiens	Residual Activity	%	11.0
	12272402	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	83.0	CHEMBL2041	Homo sapiens	Residual Activity	%	83.0
	12272403	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	24.0	CHEMBL2041	Homo sapiens	Residual Activity	%	24.0
	12272404	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	96.0	CHEMBL2041	Homo sapiens	Residual Activity	%	96.0
	12272405	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	86.0	CHEMBL2041	Homo sapiens	Residual Activity	%	86.0
	12272406	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	93.0	CHEMBL2041	Homo sapiens	Residual Activity	%	93.0
	12272407	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	18.0	CHEMBL2041	Homo sapiens	Residual Activity	%	18.0
	12272408	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	94.0	CHEMBL2041	Homo sapiens	Residual Activity	%	94.0
	12272409	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	91.0	CHEMBL2041	Homo sapiens	Residual Activity	%	91.0
	12272410	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	96.0	CHEMBL2041	Homo sapiens	Residual Activity	%	96.0
	12272411	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	53.0	CHEMBL2041	Homo sapiens	Residual Activity	%	53.0
	12272412	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	100.0	CHEMBL2041	Homo sapiens	Residual Activity	%	100.0
	12272413	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	30.0	CHEMBL2041	Homo sapiens	Residual Activity	%	30.0
	12272414	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	8.0	CHEMBL2041	Homo sapiens	Residual Activity	%	8.0
	12272415	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	23.0	CHEMBL2041	Homo sapiens	Residual Activity	%	23.0
	12272416	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	101.0	CHEMBL2041	Homo sapiens	Residual Activity	%	101.0
	12272417	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	102.0	CHEMBL2041	Homo sapiens	Residual Activity	%	102.0
	12272418	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	104.0	CHEMBL2041	Homo sapiens	Residual Activity	%	104.0
	12272419	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	0.0	CHEMBL2041	Homo sapiens	Residual Activity	%	0.0
	12272420	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	99.0	CHEMBL2041	Homo sapiens	Residual Activity	%	99.0
	12272421	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	99.0	CHEMBL2041	Homo sapiens	Residual Activity	%	99.0
	12272422	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	92.0	CHEMBL2041	Homo sapiens	Residual Activity	%	92.0
	12272423	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	102.0	CHEMBL2041	Homo sapiens	Residual Activity	%	102.0
	12272424	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	64.0	CHEMBL2041	Homo sapiens	Residual Activity	%	64.0
	12272425	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	102.0	CHEMBL2041	Homo sapiens	Residual Activity	%	102.0
	12272426	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	98.0	CHEMBL2041	Homo sapiens	Residual Activity	%	98.0
	12272427	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	74.0	CHEMBL2041	Homo sapiens	Residual Activity	%	74.0
	12272428	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	108.0	CHEMBL2041	Homo sapiens	Residual Activity	%	108.0
	12272429	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	99.0	CHEMBL2041	Homo sapiens	Residual Activity	%	99.0
	12272430	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	-1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	-1.0
	12272431	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	13.0	CHEMBL2041	Homo sapiens	Residual Activity	%	13.0
	12272432	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	75.0	CHEMBL2041	Homo sapiens	Residual Activity	%	75.0
	12272433	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	103.0	CHEMBL2041	Homo sapiens	Residual Activity	%	103.0
	12272434	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	96.0	CHEMBL2041	Homo sapiens	Residual Activity	%	96.0
	12272435	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	12.0	CHEMBL2041	Homo sapiens	Residual Activity	%	12.0
	12272436	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	105.0	CHEMBL2041	Homo sapiens	Residual Activity	%	105.0
	12272437	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	101.0	CHEMBL2041	Homo sapiens	Residual Activity	%	101.0
	12272438	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	75.0	CHEMBL2041	Homo sapiens	Residual Activity	%	75.0
	12272439	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	0.0	CHEMBL2041	Homo sapiens	Residual Activity	%	0.0
	12272440	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	9.0	CHEMBL2041	Homo sapiens	Residual Activity	%	9.0
	12272441	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	91.0	CHEMBL2041	Homo sapiens	Residual Activity	%	91.0
	12272442	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	99.0	CHEMBL2041	Homo sapiens	Residual Activity	%	99.0
	12272443	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	89.0	CHEMBL2041	Homo sapiens	Residual Activity	%	89.0
	12272444	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	56.0	CHEMBL2041	Homo sapiens	Residual Activity	%	56.0
	12272445	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	104.0	CHEMBL2041	Homo sapiens	Residual Activity	%	104.0
	12272446	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	74.0	CHEMBL2041	Homo sapiens	Residual Activity	%	74.0
	12272447	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	92.0	CHEMBL2041	Homo sapiens	Residual Activity	%	92.0
	12272448	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	91.0	CHEMBL2041	Homo sapiens	Residual Activity	%	91.0
	12272449	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	8.0	CHEMBL2041	Homo sapiens	Residual Activity	%	8.0
	12272450	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	93.0	CHEMBL2041	Homo sapiens	Residual Activity	%	93.0
	12272451	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	94.0	CHEMBL2041	Homo sapiens	Residual Activity	%	94.0
	12272452	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	102.0	CHEMBL2041	Homo sapiens	Residual Activity	%	102.0
	12272453	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	66.0	CHEMBL2041	Homo sapiens	Residual Activity	%	66.0
	12272454	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	108.0	CHEMBL2041	Homo sapiens	Residual Activity	%	108.0
	12272455	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	108.0	CHEMBL2041	Homo sapiens	Residual Activity	%	108.0
	12272456	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	98.0	CHEMBL2041	Homo sapiens	Residual Activity	%	98.0
	12272457	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	25.0	CHEMBL2041	Homo sapiens	Residual Activity	%	25.0
	12272458	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	96.0	CHEMBL2041	Homo sapiens	Residual Activity	%	96.0
	12272459	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	74.0	CHEMBL2041	Homo sapiens	Residual Activity	%	74.0
	12272460	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	95.0	CHEMBL2041	Homo sapiens	Residual Activity	%	95.0
	12272461	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	75.0	CHEMBL2041	Homo sapiens	Residual Activity	%	75.0
	12272462	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	82.0	CHEMBL2041	Homo sapiens	Residual Activity	%	82.0
	12272463	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	20.0	CHEMBL2041	Homo sapiens	Residual Activity	%	20.0
	12272464	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	91.0	CHEMBL2041	Homo sapiens	Residual Activity	%	91.0
	12272465	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	-1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	-1.0
	12272466	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	94.0	CHEMBL2041	Homo sapiens	Residual Activity	%	94.0
	12272467	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	3.0	CHEMBL2041	Homo sapiens	Residual Activity	%	3.0
	12272468	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	107.0	CHEMBL2041	Homo sapiens	Residual Activity	%	107.0
	12272469	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	53.0	CHEMBL2041	Homo sapiens	Residual Activity	%	53.0
	12272470	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	91.0	CHEMBL2041	Homo sapiens	Residual Activity	%	91.0
	12272471	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	122.0	CHEMBL2041	Homo sapiens	Residual Activity	%	122.0
	12272472	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	22.0	CHEMBL2041	Homo sapiens	Residual Activity	%	22.0
	12272473	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	91.0	CHEMBL2041	Homo sapiens	Residual Activity	%	91.0
	12272474	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	66.0	CHEMBL2041	Homo sapiens	Residual Activity	%	66.0
	12272475	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	90.0	CHEMBL2041	Homo sapiens	Residual Activity	%	90.0
	12272476	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	102.0	CHEMBL2041	Homo sapiens	Residual Activity	%	102.0
	12272477	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	1.0
	12272478	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	110.0	CHEMBL2041	Homo sapiens	Residual Activity	%	110.0
	12272479	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	108.0	CHEMBL2041	Homo sapiens	Residual Activity	%	108.0
	12272480	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	2.0	CHEMBL2041	Homo sapiens	Residual Activity	%	2.0
	12272481	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	96.0	CHEMBL2041	Homo sapiens	Residual Activity	%	96.0
	12272482	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	93.0	CHEMBL2041	Homo sapiens	Residual Activity	%	93.0
	12272483	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	53.0	CHEMBL2041	Homo sapiens	Residual Activity	%	53.0
	12272484	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	111.0	CHEMBL2041	Homo sapiens	Residual Activity	%	111.0
	12272485	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	115.0	CHEMBL2041	Homo sapiens	Residual Activity	%	115.0
	12272486	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	109.0	CHEMBL2041	Homo sapiens	Residual Activity	%	109.0
	12272487	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	102.0	CHEMBL2041	Homo sapiens	Residual Activity	%	102.0
	12272488	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	59.0	CHEMBL2041	Homo sapiens	Residual Activity	%	59.0
	12272489	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	2.0	CHEMBL2041	Homo sapiens	Residual Activity	%	2.0
	12272490	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	114.0	CHEMBL2041	Homo sapiens	Residual Activity	%	114.0
	12272491	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	37.0	CHEMBL2041	Homo sapiens	Residual Activity	%	37.0
	12272492	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	103.0	CHEMBL2041	Homo sapiens	Residual Activity	%	103.0
	12272493	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	96.0	CHEMBL2041	Homo sapiens	Residual Activity	%	96.0
	12272494	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	100.0	CHEMBL2041	Homo sapiens	Residual Activity	%	100.0
	12272495	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	89.0	CHEMBL2041	Homo sapiens	Residual Activity	%	89.0
	12272496	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	99.0	CHEMBL2041	Homo sapiens	Residual Activity	%	99.0
	12272497	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	93.0	CHEMBL2041	Homo sapiens	Residual Activity	%	93.0
	12272498	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	78.0	CHEMBL2041	Homo sapiens	Residual Activity	%	78.0
	12272499	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	11.0	CHEMBL2041	Homo sapiens	Residual Activity	%	11.0
	12272500	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	80.0	CHEMBL2041	Homo sapiens	Residual Activity	%	80.0
	12272501	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	108.0	CHEMBL2041	Homo sapiens	Residual Activity	%	108.0
	12272502	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	105.0	CHEMBL2041	Homo sapiens	Residual Activity	%	105.0
	12272503	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	94.0	CHEMBL2041	Homo sapiens	Residual Activity	%	94.0
	12272504	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	30.0	CHEMBL2041	Homo sapiens	Residual Activity	%	30.0
	12272505	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	105.0	CHEMBL2041	Homo sapiens	Residual Activity	%	105.0
	12272506	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	97.0	CHEMBL2041	Homo sapiens	Residual Activity	%	97.0
	12272507	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	98.0	CHEMBL2041	Homo sapiens	Residual Activity	%	98.0
	12272508	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	45.0	CHEMBL2041	Homo sapiens	Residual Activity	%	45.0
	12272509	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	61.0	CHEMBL2041	Homo sapiens	Residual Activity	%	61.0
	12272510	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	93.0	CHEMBL2041	Homo sapiens	Residual Activity	%	93.0
	12272511	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	93.0	CHEMBL2041	Homo sapiens	Residual Activity	%	93.0
	12272512	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	2.0	CHEMBL2041	Homo sapiens	Residual Activity	%	2.0
	12274155	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	104.0	CHEMBL2041	Homo sapiens	Residual Activity	%	104.0
	12274156	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	91.0	CHEMBL2041	Homo sapiens	Residual Activity	%	91.0
	12274157	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	97.0	CHEMBL2041	Homo sapiens	Residual Activity	%	97.0
	12274158	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	45.0	CHEMBL2041	Homo sapiens	Residual Activity	%	45.0
	12274159	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	2.0	CHEMBL2041	Homo sapiens	Residual Activity	%	2.0
	12274160	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	108.0	CHEMBL2041	Homo sapiens	Residual Activity	%	108.0
	12274161	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	92.0	CHEMBL2041	Homo sapiens	Residual Activity	%	92.0
	12274162	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	43.0	CHEMBL2041	Homo sapiens	Residual Activity	%	43.0
	12274163	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	102.0	CHEMBL2041	Homo sapiens	Residual Activity	%	102.0
	12274164	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	2.0	CHEMBL2041	Homo sapiens	Residual Activity	%	2.0
	12274165	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	83.0	CHEMBL2041	Homo sapiens	Residual Activity	%	83.0
	12274166	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	100.0	CHEMBL2041	Homo sapiens	Residual Activity	%	100.0
	12274167	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	3.0	CHEMBL2041	Homo sapiens	Residual Activity	%	3.0
	12274168	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	1.0
	12274169	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	93.0	CHEMBL2041	Homo sapiens	Residual Activity	%	93.0
	12274170	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	109.0	CHEMBL2041	Homo sapiens	Residual Activity	%	109.0
	12274171	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	108.0	CHEMBL2041	Homo sapiens	Residual Activity	%	108.0
	12274172	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	97.0	CHEMBL2041	Homo sapiens	Residual Activity	%	97.0
	12274173	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	51.0	CHEMBL2041	Homo sapiens	Residual Activity	%	51.0
	12274174	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	104.0	CHEMBL2041	Homo sapiens	Residual Activity	%	104.0
	12274175	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	103.0	CHEMBL2041	Homo sapiens	Residual Activity	%	103.0
	12274176	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	6.0	CHEMBL2041	Homo sapiens	Residual Activity	%	6.0
	12274177	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	63.0	CHEMBL2041	Homo sapiens	Residual Activity	%	63.0
	12274178	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	72.0	CHEMBL2041	Homo sapiens	Residual Activity	%	72.0
	12274179	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	106.0	CHEMBL2041	Homo sapiens	Residual Activity	%	106.0
	12274180	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	57.0	CHEMBL2041	Homo sapiens	Residual Activity	%	57.0
	12274181	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	103.0	CHEMBL2041	Homo sapiens	Residual Activity	%	103.0
	12274182	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	108.0	CHEMBL2041	Homo sapiens	Residual Activity	%	108.0
	12274183	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	82.0	CHEMBL2041	Homo sapiens	Residual Activity	%	82.0
	12274184	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	101.0	CHEMBL2041	Homo sapiens	Residual Activity	%	101.0
	12274185	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	76.0	CHEMBL2041	Homo sapiens	Residual Activity	%	76.0
	12274186	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	101.0	CHEMBL2041	Homo sapiens	Residual Activity	%	101.0
	12274187	CHEMBL2219155	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	88.0	CHEMBL2041	Homo sapiens	Residual Activity	%	88.0
	12274188	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	108.0	CHEMBL2041	Homo sapiens	Residual Activity	%	108.0
	12274189	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	28.0	CHEMBL2041	Homo sapiens	Residual Activity	%	28.0
	12274190	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	95.0	CHEMBL2041	Homo sapiens	Residual Activity	%	95.0
	12274191	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	87.0	CHEMBL2041	Homo sapiens	Residual Activity	%	87.0
	12274192	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	75.0	CHEMBL2041	Homo sapiens	Residual Activity	%	75.0
	12274193	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	91.0	CHEMBL2041	Homo sapiens	Residual Activity	%	91.0
	12274194	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	1.0
	12274195	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	6.0	CHEMBL2041	Homo sapiens	Residual Activity	%	6.0
	12274196	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	35.0	CHEMBL2041	Homo sapiens	Residual Activity	%	35.0
	12274197	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	65.0	CHEMBL2041	Homo sapiens	Residual Activity	%	65.0
	12274198	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	104.0	CHEMBL2041	Homo sapiens	Residual Activity	%	104.0
	12274199	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	101.0	CHEMBL2041	Homo sapiens	Residual Activity	%	101.0
	12274200	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	103.0	CHEMBL2041	Homo sapiens	Residual Activity	%	103.0
	12274201	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	1.0
	12274202	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	44.0	CHEMBL2041	Homo sapiens	Residual Activity	%	44.0
	12274203	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	14.0	CHEMBL2041	Homo sapiens	Residual Activity	%	14.0
	12274204	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	100.0	CHEMBL2041	Homo sapiens	Residual Activity	%	100.0
	12274205	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	106.0	CHEMBL2041	Homo sapiens	Residual Activity	%	106.0
	12274206	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	113.0	CHEMBL2041	Homo sapiens	Residual Activity	%	113.0
	12274207	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	36.0	CHEMBL2041	Homo sapiens	Residual Activity	%	36.0
	12274208	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	115.0	CHEMBL2041	Homo sapiens	Residual Activity	%	115.0
	12274209	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	86.0	CHEMBL2041	Homo sapiens	Residual Activity	%	86.0
	12274210	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	108.0	CHEMBL2041	Homo sapiens	Residual Activity	%	108.0
	12274211	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	6.0	CHEMBL2041	Homo sapiens	Residual Activity	%	6.0
	12274212	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	95.0	CHEMBL2041	Homo sapiens	Residual Activity	%	95.0
	12274213	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	1.0
	12274214	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	0.0	CHEMBL2041	Homo sapiens	Residual Activity	%	0.0
	12274215	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	1.0
	12274216	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	82.0	CHEMBL2041	Homo sapiens	Residual Activity	%	82.0
	12274217	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	70.0	CHEMBL2041	Homo sapiens	Residual Activity	%	70.0
	12274218	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	91.0	CHEMBL2041	Homo sapiens	Residual Activity	%	91.0
	12274219	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	-1.0
	12274220	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	83.0	CHEMBL2041	Homo sapiens	Residual Activity	%	83.0
	12274221	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	107.0	CHEMBL2041	Homo sapiens	Residual Activity	%	107.0
	12274222	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	92.0	CHEMBL2041	Homo sapiens	Residual Activity	%	92.0
	12274223	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	97.0	CHEMBL2041	Homo sapiens	Residual Activity	%	97.0
	12274224	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	19.0	CHEMBL2041	Homo sapiens	Residual Activity	%	19.0
	12274225	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	107.0	CHEMBL2041	Homo sapiens	Residual Activity	%	107.0
	12274226	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	107.0	CHEMBL2041	Homo sapiens	Residual Activity	%	107.0
	12274227	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	69.0	CHEMBL2041	Homo sapiens	Residual Activity	%	69.0
	12274228	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	117.0	CHEMBL2041	Homo sapiens	Residual Activity	%	117.0
	12274229	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	109.0	CHEMBL2041	Homo sapiens	Residual Activity	%	109.0
	12274230	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	1.0
	12274231	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	0.0	CHEMBL2041	Homo sapiens	Residual Activity	%	0.0
	12274232	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	78.0	CHEMBL2041	Homo sapiens	Residual Activity	%	78.0
	12274233	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	101.0	CHEMBL2041	Homo sapiens	Residual Activity	%	101.0
	12274234	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	110.0	CHEMBL2041	Homo sapiens	Residual Activity	%	110.0
	12274235	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	10.0	CHEMBL2041	Homo sapiens	Residual Activity	%	10.0
	12274236	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	114.0	CHEMBL2041	Homo sapiens	Residual Activity	%	114.0
	12274237	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	110.0	CHEMBL2041	Homo sapiens	Residual Activity	%	110.0
	12274238	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	45.0	CHEMBL2041	Homo sapiens	Residual Activity	%	45.0
	12274239	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	-1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	-1.0
	12274240	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	0.0	CHEMBL2041	Homo sapiens	Residual Activity	%	0.0
	12274241	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	90.0	CHEMBL2041	Homo sapiens	Residual Activity	%	90.0
	12274242	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	120.0	CHEMBL2041	Homo sapiens	Residual Activity	%	120.0
	12274243	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	99.0	CHEMBL2041	Homo sapiens	Residual Activity	%	99.0
	12274244	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	12.0	CHEMBL2041	Homo sapiens	Residual Activity	%	12.0
	12274245	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	108.0	CHEMBL2041	Homo sapiens	Residual Activity	%	108.0
	12274246	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	47.0	CHEMBL2041	Homo sapiens	Residual Activity	%	47.0
	12274247	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	116.0	CHEMBL2041	Homo sapiens	Residual Activity	%	116.0
	12274248	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	77.0	CHEMBL2041	Homo sapiens	Residual Activity	%	77.0
	12274249	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	5.0	CHEMBL2041	Homo sapiens	Residual Activity	%	5.0
	12274250	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	109.0	CHEMBL2041	Homo sapiens	Residual Activity	%	109.0
	12274251	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	100.0	CHEMBL2041	Homo sapiens	Residual Activity	%	100.0
	12274252	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	87.0	CHEMBL2041	Homo sapiens	Residual Activity	%	87.0
	12274253	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	32.0	CHEMBL2041	Homo sapiens	Residual Activity	%	32.0
	12274254	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	106.0	CHEMBL2041	Homo sapiens	Residual Activity	%	106.0
	12274255	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	103.0	CHEMBL2041	Homo sapiens	Residual Activity	%	103.0
	12274256	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	96.0	CHEMBL2041	Homo sapiens	Residual Activity	%	96.0
	12274257	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	7.0	CHEMBL2041	Homo sapiens	Residual Activity	%	7.0
	12274258	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	104.0	CHEMBL2041	Homo sapiens	Residual Activity	%	104.0
	12274259	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	81.0	CHEMBL2041	Homo sapiens	Residual Activity	%	81.0
	12274260	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	64.0	CHEMBL2041	Homo sapiens	Residual Activity	%	64.0
	12274261	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	89.0	CHEMBL2041	Homo sapiens	Residual Activity	%	89.0
	12274262	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	37.0	CHEMBL2041	Homo sapiens	Residual Activity	%	37.0
	12274263	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	18.0	CHEMBL2041	Homo sapiens	Residual Activity	%	18.0
	12274264	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	98.0	CHEMBL2041	Homo sapiens	Residual Activity	%	98.0
	12274265	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	-1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	-1.0
	12274266	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	92.0	CHEMBL2041	Homo sapiens	Residual Activity	%	92.0
	12274267	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	9.0	CHEMBL2041	Homo sapiens	Residual Activity	%	9.0
	12274268	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	100.0	CHEMBL2041	Homo sapiens	Residual Activity	%	100.0
	12274269	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	5.0	CHEMBL2041	Homo sapiens	Residual Activity	%	5.0
	12274270	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	77.0	CHEMBL2041	Homo sapiens	Residual Activity	%	77.0
	12274271	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	116.0	CHEMBL2041	Homo sapiens	Residual Activity	%	116.0
	12274272	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	37.0	CHEMBL2041	Homo sapiens	Residual Activity	%	37.0
	12274273	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	86.0	CHEMBL2041	Homo sapiens	Residual Activity	%	86.0
	12274274	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	28.0	CHEMBL2041	Homo sapiens	Residual Activity	%	28.0
	12274275	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	46.0	CHEMBL2041	Homo sapiens	Residual Activity	%	46.0
	12274276	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	83.0	CHEMBL2041	Homo sapiens	Residual Activity	%	83.0
	12274277	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	0.0	CHEMBL2041	Homo sapiens	Residual Activity	%	0.0
	12274278	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	96.0	CHEMBL2041	Homo sapiens	Residual Activity	%	96.0
	12274279	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	58.0	CHEMBL2041	Homo sapiens	Residual Activity	%	58.0
	12274280	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	0.0	CHEMBL2041	Homo sapiens	Residual Activity	%	0.0
	12274281	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	76.0	CHEMBL2041	Homo sapiens	Residual Activity	%	76.0
	12274282	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	55.0	CHEMBL2041	Homo sapiens	Residual Activity	%	55.0
	12274283	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	39.0	CHEMBL2041	Homo sapiens	Residual Activity	%	39.0
	12274284	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	86.0	CHEMBL2041	Homo sapiens	Residual Activity	%	86.0
	12274285	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	90.0	CHEMBL2041	Homo sapiens	Residual Activity	%	90.0
	12274286	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	97.0	CHEMBL2041	Homo sapiens	Residual Activity	%	97.0
	12274287	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	80.0	CHEMBL2041	Homo sapiens	Residual Activity	%	80.0
	12274288	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	33.0	CHEMBL2041	Homo sapiens	Residual Activity	%	33.0
	12274289	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	1.0
	12274290	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	83.0	CHEMBL2041	Homo sapiens	Residual Activity	%	83.0
	12274291	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	34.0	CHEMBL2041	Homo sapiens	Residual Activity	%	34.0
	12274292	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	79.0	CHEMBL2041	Homo sapiens	Residual Activity	%	79.0
	12274293	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	92.0	CHEMBL2041	Homo sapiens	Residual Activity	%	92.0
	12274294	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	84.0	CHEMBL2041	Homo sapiens	Residual Activity	%	84.0
	12274295	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	75.0	CHEMBL2041	Homo sapiens	Residual Activity	%	75.0
	12274296	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	92.0	CHEMBL2041	Homo sapiens	Residual Activity	%	92.0
	12274297	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	72.0	CHEMBL2041	Homo sapiens	Residual Activity	%	72.0
	12274298	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	73.0	CHEMBL2041	Homo sapiens	Residual Activity	%	73.0
	12274299	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	7.0	CHEMBL2041	Homo sapiens	Residual Activity	%	7.0
	12274300	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	49.0	CHEMBL2041	Homo sapiens	Residual Activity	%	49.0
	12274301	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	82.0	CHEMBL2041	Homo sapiens	Residual Activity	%	82.0
	12274302	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	85.0	CHEMBL2041	Homo sapiens	Residual Activity	%	85.0
	12274303	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	94.0	CHEMBL2041	Homo sapiens	Residual Activity	%	94.0
	12274304	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	1.0
	12274305	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	87.0	CHEMBL2041	Homo sapiens	Residual Activity	%	87.0
	12274306	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	52.0	CHEMBL2041	Homo sapiens	Residual Activity	%	52.0
	12274307	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	83.0	CHEMBL2041	Homo sapiens	Residual Activity	%	83.0
	12274308	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	48.0	CHEMBL2041	Homo sapiens	Residual Activity	%	48.0
	12274309	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	25.0	CHEMBL2041	Homo sapiens	Residual Activity	%	25.0
	12274310	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	40.0	CHEMBL2041	Homo sapiens	Residual Activity	%	40.0
	12274311	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	74.0	CHEMBL2041	Homo sapiens	Residual Activity	%	74.0
	12274312	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	-1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	-1.0
	12274313	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	89.0	CHEMBL2041	Homo sapiens	Residual Activity	%	89.0
	12274314	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	27.0	CHEMBL2041	Homo sapiens	Residual Activity	%	27.0
	12274315	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	87.0	CHEMBL2041	Homo sapiens	Residual Activity	%	87.0
	12274316	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	63.0	CHEMBL2041	Homo sapiens	Residual Activity	%	63.0
	12274317	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	-1.0
	12274318	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	97.0	CHEMBL2041	Homo sapiens	Residual Activity	%	97.0
	12274319	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	78.0	CHEMBL2041	Homo sapiens	Residual Activity	%	78.0
	12274320	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	11.0	CHEMBL2041	Homo sapiens	Residual Activity	%	11.0
	12274321	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	86.0	CHEMBL2041	Homo sapiens	Residual Activity	%	86.0
	12274322	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	0.0	CHEMBL2041	Homo sapiens	Residual Activity	%	0.0
	12274323	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	21.0	CHEMBL2041	Homo sapiens	Residual Activity	%	21.0
	12274324	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	82.0	CHEMBL2041	Homo sapiens	Residual Activity	%	82.0
	12274325	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	0.0	CHEMBL2041	Homo sapiens	Residual Activity	%	0.0
	12274326	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	0.0	CHEMBL2041	Homo sapiens	Residual Activity	%	0.0
	12274327	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	63.0	CHEMBL2041	Homo sapiens	Residual Activity	%	63.0
	12274328	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	90.0	CHEMBL2041	Homo sapiens	Residual Activity	%	90.0
	12274329	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	82.0	CHEMBL2041	Homo sapiens	Residual Activity	%	82.0
	12274330	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	61.0	CHEMBL2041	Homo sapiens	Residual Activity	%	61.0
	12274331	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	5.0	CHEMBL2041	Homo sapiens	Residual Activity	%	5.0
	12274332	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	91.0	CHEMBL2041	Homo sapiens	Residual Activity	%	91.0
	12274333	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	92.0	CHEMBL2041	Homo sapiens	Residual Activity	%	92.0
	12274334	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	-1.0	CHEMBL2041	Homo sapiens	Residual Activity	%	-1.0
	12274335	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	47.0	CHEMBL2041	Homo sapiens	Residual Activity	%	47.0
	12274336	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	18.0	CHEMBL2041	Homo sapiens	Residual Activity	%	18.0
	12274337	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	80.0	CHEMBL2041	Homo sapiens	Residual Activity	%	80.0
	12274338	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	9.0	CHEMBL2041	Homo sapiens	Residual Activity	%	9.0
	12274339	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	103.0	CHEMBL2041	Homo sapiens	Residual Activity	%	103.0
	12274340	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	105.0	CHEMBL2041	Homo sapiens	Residual Activity	%	105.0
	12274341	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	81.0	CHEMBL2041	Homo sapiens	Residual Activity	%	81.0
	12274342	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	91.0	CHEMBL2041	Homo sapiens	Residual Activity	%	91.0
	12274343	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	55.0	CHEMBL2041	Homo sapiens	Residual Activity	%	55.0
	12274344	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	47.0	CHEMBL2041	Homo sapiens	Residual Activity	%	47.0
	12274345	CHEMBL2219156	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	62.0	CHEMBL2041	Homo sapiens	Residual Activity	%	62.0
Not Active	12623297	CHEMBL2318777	Binding affinity to RET (unknown origin) at 10 nM after 2 hrs by FRET assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1		CHEMBL2316582		Activity			CHEMBL2041	Homo sapiens	Activity		
	12626733	CHEMBL2317004	Inhibition of RET (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>	Inhibition	%	95.0	CHEMBL2041	Homo sapiens	INH	%	95.0
	12668240	CHEMBL2345060	Inhibition of RET (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(N3CCOCC3)ccc12		CHEMBL2333120	=	Inhibition	%	83.0	CHEMBL2041	Homo sapiens	INH	%	83.0
	12668241	CHEMBL2345060	Inhibition of RET (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333115	=	Inhibition	%	99.0	CHEMBL2041	Homo sapiens	INH	%	99.0
	12668242	CHEMBL2345060	Inhibition of RET (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3ccncc3)cc12		CHEMBL2333114	=	Inhibition	%	93.0	CHEMBL2041	Homo sapiens	INH	%	93.0
	12668243	CHEMBL2345060	Inhibition of RET (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(-c3ccncc3)ccc12		CHEMBL2333112	=	Inhibition	%	96.0	CHEMBL2041	Homo sapiens	INH	%	96.0
	12668244	CHEMBL2345060	Inhibition of RET (unknown origin) at 10 uM relative to control	B	CS(=O)(=O)c1ccc(-c2ccc3c(NC4CCC4)c(C(N)=O)nnc3c2)cc1		CHEMBL2333129	=	Inhibition	%	62.0	CHEMBL2041	Homo sapiens	INH	%	62.0
	12668245	CHEMBL2345060	Inhibition of RET (unknown origin) at 10 uM relative to control	B	C[C@@H](Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12)C1CC1		CHEMBL2333128	=	Inhibition	%	57.0	CHEMBL2041	Homo sapiens	INH	%	57.0
	12668246	CHEMBL2345060	Inhibition of RET (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2333125	=	Inhibition	%	73.0	CHEMBL2041	Homo sapiens	INH	%	73.0
	12693176	CHEMBL2345778	Inhibition of RET (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	12700131	CHEMBL2342670	Inhibition of recombinant RET (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	21.0	CHEMBL2041	Homo sapiens	INH	%	21.0
	12723642	CHEMBL2350474	Inhibition of RET (unknown origin) at 10 uM by single point assay	B	C[C@@H](Nc1c(C#N)cnc2cc(-c3ccc(-n4ccoc4=O)cc3)ccc12)C1CC1		CHEMBL2347818	=	Inhibition	%	12.0	CHEMBL2041	Homo sapiens	INH	%	12.0
	12723688	CHEMBL2350781	Inhibition of RET (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3cnn(C)c3)ccc12		CHEMBL2347824	=	Inhibition	%	41.0	CHEMBL2041	Homo sapiens	INH	%	41.0
	12723689	CHEMBL2350781	Inhibition of RET (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2347823	=	Inhibition	%	43.0	CHEMBL2041	Homo sapiens	INH	%	43.0
	12727660	CHEMBL2351124	Inhibition of RET Y791F mutant (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	81.0	CHEMBL2041	Homo sapiens	Activity	%	81.0
	12727661	CHEMBL2351125	Inhibition of RET V804L mutant (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	82.0	CHEMBL2041	Homo sapiens	Activity	%	82.0
	12727662	CHEMBL2351126	Inhibition of RET (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	86.0	CHEMBL2041	Homo sapiens	Activity	%	86.0
	12728946	CHEMBL2353064	Inhibition of RET Y791F mutant (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL2041	Homo sapiens	Activity	%	96.0
	12728947	CHEMBL2353066	Inhibition of RET V804L mutant (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	103.0	CHEMBL2041	Homo sapiens	Activity	%	103.0
	12728948	CHEMBL2353065	Inhibition of RET (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL2041	Homo sapiens	Activity	%	98.0
	12729344	CHEMBL2351442	Inhibition of Ret (unknown origin) at 1 uM	B	FC(F)(F)c1cccc(Sc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL2348936	>	Inhibition	%	18.0	CHEMBL2041	Homo sapiens	INH	%	18.0
	12729768	CHEMBL2349766	Inhibition of RET V804M mutant (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	91.0	CHEMBL2041	Homo sapiens	Activity	%	91.0
	12729769	CHEMBL2349767	Inhibition of RET V804L mutant (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	94.0	CHEMBL2041	Homo sapiens	Activity	%	94.0
	12729835	CHEMBL2352167	Inhibition of RET (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	94.0	CHEMBL2041	Homo sapiens	Activity	%	94.0
	12730089	CHEMBL2351124	Inhibition of RET Y791F mutant (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	83.0	CHEMBL2041	Homo sapiens	Activity	%	83.0
	12730090	CHEMBL2351125	Inhibition of RET V804L mutant (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	87.0	CHEMBL2041	Homo sapiens	Activity	%	87.0
	12730091	CHEMBL2351126	Inhibition of RET (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	78.0	CHEMBL2041	Homo sapiens	Activity	%	78.0
	12730624	CHEMBL2353583	Inhibition of human RET	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	=	IC50	nM	18.0	CHEMBL2041	Homo sapiens	IC50	nM	18.0
	13293015	CHEMBL2379871	Inhibition of RET (unknown origin)	B	C[C@@H](Oc1c[nH]c(=O)c(C(=O)Nc2ccc(N3CCN(C)CC3)cc2)c1)c1c(Cl)ccc(F)c1Cl		CHEMBL2376650	>	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	13301305	CHEMBL2382838	Inhibition of Ret (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)cc1C(F)(F)F		CHEMBL2380834	=	IC50	nM	706.0	CHEMBL2041	Homo sapiens	IC50	nM	706.0
	13301306	CHEMBL2382838	Inhibition of Ret (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1		CHEMBL2380845	=	IC50	nM	15.0	CHEMBL2041	Homo sapiens	IC50	nM	15.0
	13327638	CHEMBL2389812	Inhibition of RET (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	97.0	CHEMBL2041	Homo sapiens	INH	%	97.0
	13327639	CHEMBL2389812	Inhibition of RET (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	99.0	CHEMBL2041	Homo sapiens	INH	%	99.0
	13365833	CHEMBL2405537	Inhibition of TEL-fused RET (unknown origin) by cell-based assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2304.0	CHEMBL2041	Homo sapiens	IC50	nM	2304.0
	13367220	CHEMBL2406325	Inhibition of RET (unknown origin) after 60 mins	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	400.0	CHEMBL2041	Homo sapiens	IC50	uM	0.4
	13371353	CHEMBL2403998	Inhibition of RET (unknown origin) at 10 uM by Z'-LYTE kinase assay	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261	=	Inhibition	%	1.86	CHEMBL2041	Homo sapiens	INH	%	1.86
	13374362	CHEMBL2406306	Inhibition of RET Y791F mutant (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-1.0	CHEMBL2041	Homo sapiens	INH	%	-1.0
	13374363	CHEMBL2406308	Inhibition of RET V804L mutant (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	6.0	CHEMBL2041	Homo sapiens	INH	%	6.0
	13374364	CHEMBL2406307	Inhibition of RET (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	6.0	CHEMBL2041	Homo sapiens	INH	%	6.0
	13379727	CHEMBL2406180	Inhibition of RET (unknown origin)	B	CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc([N+](=O)[O-])cc43)cc2C1		CHEMBL2403378	=	IC50	nM	73.0	CHEMBL2041	Homo sapiens	IC50	uM	0.073
	13379728	CHEMBL2406180	Inhibition of RET (unknown origin)	B	CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(C#N)cc43)cc2C1		CHEMBL2403377	=	IC50	nM	4.0	CHEMBL2041	Homo sapiens	IC50	uM	0.004
	13379729	CHEMBL2406180	Inhibition of RET (unknown origin)	B	CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(C(F)(F)F)cc43)cc2C1		CHEMBL2403376	=	IC50	nM	300.0	CHEMBL2041	Homo sapiens	IC50	uM	0.3
	13379730	CHEMBL2406180	Inhibition of RET (unknown origin)	B	CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(OC(C)C)cc43)cc2C1		CHEMBL2403375	=	IC50	nM	150.0	CHEMBL2041	Homo sapiens	IC50	uM	0.15
	13379731	CHEMBL2406180	Inhibition of RET (unknown origin)	B	CC(=O)Nc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)N1CCOCC1)C3)C(=O)N2		CHEMBL2403374	=	IC50	nM	25.0	CHEMBL2041	Homo sapiens	IC50	uM	0.025
	13379732	CHEMBL2406180	Inhibition of RET (unknown origin)	B	CN1CCC(Nc2ccc3c(c2)/C(=C/c2cc4c([nH]2)CCN(C(=O)N2CCOCC2)C4)C(=O)N3)CC1		CHEMBL2403373	=	IC50	nM	5.0	CHEMBL2041	Homo sapiens	IC50	uM	0.005
	13379733	CHEMBL2406180	Inhibition of RET (unknown origin)	B	O=C1Nc2ccc(C(F)(F)F)cc2/C1=C/c1cc2c([nH]1)CCN(C(=O)N1CCOCC1)C2		CHEMBL2403372	=	IC50	nM	140.0	CHEMBL2041	Homo sapiens	IC50	uM	0.14
	13379734	CHEMBL2406180	Inhibition of RET (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1[nH]c3c(c1Cl)CN(C(C)=O)CC3)C(=O)N2		CHEMBL2403371	=	IC50	nM	34.0	CHEMBL2041	Homo sapiens	IC50	uM	0.034
	13379735	CHEMBL2406180	Inhibition of RET (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)N1CCOCC1)C3)C(=O)N2		CHEMBL2403370	=	IC50	nM	25.0	CHEMBL2041	Homo sapiens	IC50	uM	0.025
	13379736	CHEMBL2406180	Inhibition of RET (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)N1CCN(C)CC1)C3)C(=O)N2		CHEMBL2403369	=	IC50	nM	6.0	CHEMBL2041	Homo sapiens	IC50	uM	0.006
	13379737	CHEMBL2406180	Inhibition of RET (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)c1cnoc1C)C3)C(=O)N2		CHEMBL2403368	=	IC50	nM	75.0	CHEMBL2041	Homo sapiens	IC50	uM	0.075
	13379738	CHEMBL2406180	Inhibition of RET (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(C)=O)C3)C(=O)N2		CHEMBL2403367	=	IC50	nM	54.0	CHEMBL2041	Homo sapiens	IC50	uM	0.054
	13379739	CHEMBL2406180	Inhibition of RET (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)CCN)C3)C(=O)N2		CHEMBL2403366	=	IC50	nM	4.0	CHEMBL2041	Homo sapiens	IC50	uM	0.004
	13379740	CHEMBL2406180	Inhibition of RET (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1[nH]c(C)c(C(=O)NCCCN)c1C)C(=O)N2		CHEMBL2403365	<	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	uM	1.0
	13439764	CHEMBL2429005	Competitive binding affinity to RET M918T mutant (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	13439765	CHEMBL2429006	Competitive binding affinity to RET (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	13442610	CHEMBL2429006	Competitive binding affinity to RET (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	94.0	CHEMBL2041	Homo sapiens	INH	%	94.0
	13445597	CHEMBL2429005	Competitive binding affinity to RET M918T mutant (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	13445598	CHEMBL2429006	Competitive binding affinity to RET (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	13451584	CHEMBL2429005	Competitive binding affinity to RET M918T mutant (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	13451585	CHEMBL2429006	Competitive binding affinity to RET (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	13461861	CHEMBL2434168	Inhibition of RET (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2180602	=	IC50	nM	1.3	CHEMBL2041	Homo sapiens	IC50	nM	1.3
	13499585	CHEMBL2447151	Inhibition of RET (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Sc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2442124	>	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	13506617	CHEMBL2443978	Inhibition of RET (unknown origin)	B	CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1		CHEMBL2443026	>	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	nM	10.0
	13506618	CHEMBL2443978	Inhibition of RET (unknown origin)	B	CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1		CHEMBL2443139	>	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	nM	10.0
	13506619	CHEMBL2443978	Inhibition of RET (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1		CHEMBL2443138	>	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	nM	10.0
	13506620	CHEMBL2443978	Inhibition of RET (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1		CHEMBL2443044	>	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	nM	10.0
Active	13826419	CHEMBL3088487	Binding affinity to RET (unknown origin)	B	C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1		CHEMBL3086102		Activity			CHEMBL2041	Homo sapiens	Activity		
	13851903	CHEMBL3095048	Inhibition of recombinant RET (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CCN(CC)CCCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL3092314	=	IC50	nM	347.0	CHEMBL2041	Homo sapiens	IC50	uM	0.347
	13851904	CHEMBL3095048	Inhibition of recombinant RET (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	O=C(NCCN1CCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL3092308	=	IC50	nM	223.0	CHEMBL2041	Homo sapiens	IC50	uM	0.223
	13871760	CHEMBL3100925	Inhibition of human Ret assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	107.0	CHEMBL2041	Homo sapiens	Activity	%	107.0
	13872217	CHEMBL3102404	Inhibition of RET (unknown origin) assessed as residual activity at 10 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	97.0	CHEMBL2041	Homo sapiens	Activity	%	97.0
	13872247	CHEMBL3102553	Inhibition of RET (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	97.0	CHEMBL2041	Homo sapiens	Activity	%	97.0
	13899592	CHEMBL3111857	Inhibition of human recombinant RET expressed in insect cells using ATP/biotinyl-betaAbetaAbetaAAEEEEYFELVAKKK as substrate at 1 uM after 30 mins by HTRF assay	B	Cc1nn(-c2ccc(Cl)cc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110144	<	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	INH	%	10.0
	13918698	CHEMBL3118218	Inhibition of human Ret	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2cc[nH]c2n1)c1ncc(F)cn1		CHEMBL3116050	=	IC50	nM	46.0	CHEMBL2041	Homo sapiens	IC50	uM	0.046
	13945298	CHEMBL3130574	Inhibition of recombinant human RET at 100 uM incubated for 5 mins with substrate prior to protein addition by fluorescence assay relative to control	B	COc1ccc(S(=O)(=O)Nc2cccc(CNc3ncnc4c3cnn4CCc3ccccc3)c2)cc1OC		CHEMBL3128225	=	Inhibition	%	8.0	CHEMBL2041	Homo sapiens	INH	%	8.0
	13945303	CHEMBL3130570	Inhibition of RET phosphorylation in human TT cells assessed as ratio of phosphorylated RET to total RET level at IC50 determined from antiproliferative assay after 72 hrs by ELISA relative to control	B	O=S(=O)(Cc1ccccc1)Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1		CHEMBL3128226	=	Inhibition	%	68.9	CHEMBL2041	Homo sapiens	INH	%	68.9
	13945304	CHEMBL3130570	Inhibition of RET phosphorylation in human TT cells assessed as ratio of phosphorylated RET to total RET level at IC50 determined from antiproliferative assay after 72 hrs by ELISA relative to control	B	O=S(=O)(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccccc1		CHEMBL3128220	=	Inhibition	%	88.7	CHEMBL2041	Homo sapiens	INH	%	88.7
	13945305	CHEMBL3130570	Inhibition of RET phosphorylation in human TT cells assessed as ratio of phosphorylated RET to total RET level at IC50 determined from antiproliferative assay after 72 hrs by ELISA relative to control	B	O=C(Nc1ccccc1)Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1		CHEMBL3128235	=	Inhibition	%	64.5	CHEMBL2041	Homo sapiens	INH	%	64.5
	13945306	CHEMBL3130570	Inhibition of RET phosphorylation in human TT cells assessed as ratio of phosphorylated RET to total RET level at IC50 determined from antiproliferative assay after 72 hrs by ELISA relative to control	B	O=C(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL3128231	=	Inhibition	%	66.4	CHEMBL2041	Homo sapiens	INH	%	66.4
	13945339	CHEMBL3130573	Inhibition of recombinant human RET V804L mutant incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=S(=O)(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccc(F)cc1		CHEMBL3128222	=	IC50	nM	5470.0	CHEMBL2041	Homo sapiens	IC50	uM	5.47
	13945340	CHEMBL3130573	Inhibition of recombinant human RET V804L mutant incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=C(Nc1ccc(F)cc1)Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1		CHEMBL3128237	=	IC50	nM	7960.0	CHEMBL2041	Homo sapiens	IC50	uM	7.96
	13945341	CHEMBL3130573	Inhibition of recombinant human RET V804L mutant incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=C(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccc(Br)cc1		CHEMBL3128229	=	IC50	nM	9310.0	CHEMBL2041	Homo sapiens	IC50	uM	9.31
	13945342	CHEMBL3130574	Inhibition of recombinant human RET at 100 uM incubated for 5 mins with substrate prior to protein addition by fluorescence assay relative to control	B	C[C@@H](Nc1ncnc2c1cnn2CCc1ccccc1)c1ccccc1		CHEMBL3128227	=	Inhibition	%	48.0	CHEMBL2041	Homo sapiens	INH	%	48.0
	13945343	CHEMBL3130574	Inhibition of recombinant human RET at 100 uM incubated for 5 mins with substrate prior to protein addition by fluorescence assay relative to control	B	O=[N+]([O-])c1ccc(S(=O)(=O)Nc2cccc(CNc3ncnc4c3cnn4CCc3ccccc3)c2)cc1		CHEMBL3128223	=	Inhibition	%	57.0	CHEMBL2041	Homo sapiens	INH	%	57.0
	13945344	CHEMBL3130574	Inhibition of recombinant human RET at 100 uM incubated for 5 mins with substrate prior to protein addition by fluorescence assay relative to control	B	O=C(Nc1ccc([N+](=O)[O-])cc1)Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1		CHEMBL3128238	=	Inhibition	%	37.0	CHEMBL2041	Homo sapiens	INH	%	37.0
	13945345	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=S(=O)(Cc1ccccc1)Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1		CHEMBL3128226	=	IC50	nM	58600.0	CHEMBL2041	Homo sapiens	IC50	uM	58.6
	13945346	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	COc1ccc(S(=O)(=O)Nc2cccc(CNc3ncnc4c3cnn4CCc3ccccc3)c2)cc1		CHEMBL3128224	=	IC50	nM	57200.0	CHEMBL2041	Homo sapiens	IC50	uM	57.2
	13945347	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=S(=O)(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccc(F)cc1		CHEMBL3128222	=	IC50	nM	4830.0	CHEMBL2041	Homo sapiens	IC50	uM	4.83
	13945348	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=S(=O)(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccc(Br)cc1		CHEMBL3128221	=	IC50	nM	12850.0	CHEMBL2041	Homo sapiens	IC50	uM	12.85
	13945349	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=S(=O)(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccccc1		CHEMBL3128220	=	IC50	nM	7900.0	CHEMBL2041	Homo sapiens	IC50	uM	7.9
	13945350	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=C(NCc1ccccc1)Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1		CHEMBL3128219	=	IC50	nM	10300.0	CHEMBL2041	Homo sapiens	IC50	uM	10.3
	13945351	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	COc1ccc(NC(=O)Nc2cccc(CNc3ncnc4c3cnn4CCc3ccccc3)c2)cc1OC		CHEMBL3128218	=	IC50	nM	15300.0	CHEMBL2041	Homo sapiens	IC50	uM	15.3
	13945352	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	COc1ccc(NC(=O)Nc2cccc(CNc3ncnc4c3cnn4CCc3ccccc3)c2)cc1		CHEMBL3128239	=	IC50	nM	9260.0	CHEMBL2041	Homo sapiens	IC50	uM	9.26
	13945353	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=C(Nc1ccc(F)cc1)Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1		CHEMBL3128237	=	IC50	nM	4800.0	CHEMBL2041	Homo sapiens	IC50	uM	4.8
	13945354	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=C(Nc1ccc(Br)cc1)Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1		CHEMBL3128236	=	IC50	nM	9070.0	CHEMBL2041	Homo sapiens	IC50	uM	9.07
	13945355	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=C(Nc1ccccc1)Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1		CHEMBL3128235	=	IC50	nM	7040.0	CHEMBL2041	Homo sapiens	IC50	uM	7.04
	13945356	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=C(Cc1ccccc1)Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1		CHEMBL3128234	=	IC50	nM	22600.0	CHEMBL2041	Homo sapiens	IC50	uM	22.6
	13945357	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c3cnn4CCc3ccccc3)c2)cc1OC		CHEMBL3128233	=	IC50	nM	28100.0	CHEMBL2041	Homo sapiens	IC50	uM	28.1
	13945358	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c3cnn4CCc3ccccc3)c2)cc1		CHEMBL3128232	=	IC50	nM	24100.0	CHEMBL2041	Homo sapiens	IC50	uM	24.1
	13945359	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=C(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL3128231	=	IC50	nM	17100.0	CHEMBL2041	Homo sapiens	IC50	uM	17.1
	13945360	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=C(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccc(F)cc1		CHEMBL3128230	=	IC50	nM	9640.0	CHEMBL2041	Homo sapiens	IC50	uM	9.64
	13945361	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=C(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccc(Br)cc1		CHEMBL3128229	=	IC50	nM	4260.0	CHEMBL2041	Homo sapiens	IC50	uM	4.26
	13945362	CHEMBL3130575	Inhibition of recombinant human RET incubated for 5 mins with substrate prior to protein addition by fluorescence assay	B	O=C(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccccc1		CHEMBL3128228	=	IC50	nM	22400.0	CHEMBL2041	Homo sapiens	IC50	uM	22.4
	13954583	CHEMBL3132504	Inhibition of human RET V804L mutant assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	13.0	CHEMBL2041	Homo sapiens	Activity	%	13.0
	13954585	CHEMBL3132505	Inhibition of human RET assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	10.0	CHEMBL2041	Homo sapiens	Activity	%	10.0
	13954587	CHEMBL3132501	Inhibition of human RET V804M mutant assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	9.0	CHEMBL2041	Homo sapiens	Activity	%	9.0
	13954794	CHEMBL3132501	Inhibition of human RET V804M mutant assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	24.0	CHEMBL2041	Homo sapiens	Activity	%	24.0
	13954802	CHEMBL3132501	Inhibition of human RET V804M mutant assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	15.0	CHEMBL2041	Homo sapiens	Activity	%	15.0
	13954809	CHEMBL3132504	Inhibition of human RET V804L mutant assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	8.0	CHEMBL2041	Homo sapiens	Activity	%	8.0
	13954811	CHEMBL3132505	Inhibition of human RET assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	7.0	CHEMBL2041	Homo sapiens	Activity	%	7.0
	13954815	CHEMBL3132505	Inhibition of human RET assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	6.0	CHEMBL2041	Homo sapiens	Activity	%	6.0
	13954818	CHEMBL3132504	Inhibition of human RET V804L mutant assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	5.0	CHEMBL2041	Homo sapiens	Activity	%	5.0
	14553629	CHEMBL3225768	Inhibition of RET (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	83.3	CHEMBL2041	Homo sapiens	Activity	%	83.3
	14585320	CHEMBL3241836	Inhibition of human Ret assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	98.5	CHEMBL2041	Homo sapiens	Activity	%	98.5
	14589529	CHEMBL3239033	Inhibition of recombinant RET (unknown origin) using Poly(Glu:Tyr)4:1 after 60 mins by ELISA	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3233767	=	IC50	nM	1626.0	CHEMBL2041	Homo sapiens	IC50	uM	1.626
	14589530	CHEMBL3239033	Inhibition of recombinant RET (unknown origin) using Poly(Glu:Tyr)4:1 after 60 mins by ELISA	B	O=C(/C=C/CN1CC2CCC1C(=O)C2)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3233785	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	14645521	CHEMBL3269110	Inhibition of RET (unknown origin)	B	N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1		CHEMBL3262356	=	IC50	nM	20.0	CHEMBL2041	Homo sapiens	IC50	nM	20.0
Not Active	14652732	CHEMBL3270637	Inhibition of human Ret kinase at 1 uM	B	CCN(Cc1ccc(C)cc1)C(=O)c1nc(-c2ccccc2Cl)c2ccccc2n1		CHEMBL3261905		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	14652733	CHEMBL3270638	Inhibition of human Ret kinase at 10 uM	B	CCN(Cc1ccc(C)cc1)C(=O)c1nc(-c2ccccc2Cl)c2ccccc2n1		CHEMBL3261905		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	14653548	CHEMBL3267435	Inhibition of recombinant RET (unknown origin) at 1 uM	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cccc(-c5ccsc5)c4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL3263964	>	Inhibition	%	70.0	CHEMBL2041	Homo sapiens	INH	%	70.0
Active	14653672	CHEMBL3267807	Inhibition of purified recombinant RET (unknown origin) at 1 uM after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(c2ccccc2)CN(C)CC3)ncc1Cl		CHEMBL3263970		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	14653673	CHEMBL3267807	Inhibition of purified recombinant RET (unknown origin) at 1 uM after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)ncc1Cl		CHEMBL3263971		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	14659381	CHEMBL3267956	Inhibition of RET (unknown origin) at 1 uM	B	CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1		CHEMBL3264107	=	Inhibition	%	34.0	CHEMBL2041	Homo sapiens	INH	%	34.0
	14659382	CHEMBL3267956	Inhibition of RET (unknown origin) at 1 uM	B	CCCP(=O)(Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1)OCC		CHEMBL3264108	=	Inhibition	%	16.0	CHEMBL2041	Homo sapiens	INH	%	16.0
	14661110	CHEMBL3267597	Inhibition of RET (unknown origin) at 100 times Ki	B	N#Cc1cccc(Cn2cc(NC(=O)c3n[nH]c4ccccc34)cn2)c1		CHEMBL3262780	>	Inhibition	%	85.0	CHEMBL2041	Homo sapiens	INH	%	85.0
	14672072	CHEMBL3270318	Inhibition of Ret in human SK-M-MC cells assessed as assessed as phosphorylation after 1 hr incubation	B	c1cn2cc(-c3ccc4cn[nH]c4c3)nc(Nc3ccc(N4CCOCC4)cc3)c2n1		CHEMBL3265032	>	EC50	nM	1000.0	CHEMBL2041	Homo sapiens	EC50	nM	1000.0
	14672073	CHEMBL3270318	Inhibition of Ret in human SK-M-MC cells assessed as assessed as phosphorylation after 1 hr incubation	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	EC50	nM	36.0	CHEMBL2041	Homo sapiens	EC50	nM	36.0
	14713693	CHEMBL3296761	Binding affinity to RET (unknown origin)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Ki	nM	18.0	CHEMBL2041	Homo sapiens	Ki	uM	0.018
	14713749	CHEMBL3296850	Inhibition of RET (unknown origin) at 1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Inhibition	%	99.0	CHEMBL2041	Homo sapiens	INH	%	99.0
Not Determined	14713754	CHEMBL3296761	Binding affinity to RET (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Ki			CHEMBL2041	Homo sapiens	Ki		
	14746935	CHEMBL3295616	Inhibition of recombinant RET (unknown origin) using poly (4 Glu, Tyr) as substrate after 60 mins by ELISA	B	Nc1ncnc2scc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)c12		CHEMBL3288526	=	IC50	nM	20.2	CHEMBL2041	Homo sapiens	IC50	nM	20.2
	14751815	CHEMBL3300856	Inhibition of RET (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	14751816	CHEMBL3300856	Inhibition of RET (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	14977877	CHEMBL3377247	Inhibition of human RET kinase cytoplasmic domain by Time-Resolved fluorescence reader assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)on2)c(F)c1		CHEMBL3355009	<=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	14977878	CHEMBL3377248	Inhibition of human RET kinase in TT cells by TRET Kinase cell-based mechanistic assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)on2)c(F)c1		CHEMBL3355009	<=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	14977879	CHEMBL3377249	Inhibition of RET kinase-mediated proliferative activity against human TT cells by cell-based proliferation assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)on2)c(F)c1		CHEMBL3355009	<=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	14977880	CHEMBL3377247	Inhibition of human RET kinase cytoplasmic domain by Time-Resolved fluorescence reader assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)no2)c(F)c1		CHEMBL3355010	<=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	14977881	CHEMBL3377248	Inhibition of human RET kinase in TT cells by TRET Kinase cell-based mechanistic assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)no2)c(F)c1		CHEMBL3355010	<=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	14977882	CHEMBL3377249	Inhibition of RET kinase-mediated proliferative activity against human TT cells by cell-based proliferation assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)no2)c(F)c1		CHEMBL3355010	<=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	14977883	CHEMBL3377249	Inhibition of RET kinase-mediated proliferative activity against human TT cells by cell-based proliferation assay	B	CCOc1cc(-c2ccc(CC(=O)Nc3ccc(Cl)c(Cl)c3)c(F)c2)c[nH]c1=O		CHEMBL3355008	>	IC50	nM	500.0	CHEMBL2041	Homo sapiens	IC50	uM	0.5
	14977884	CHEMBL3377248	Inhibition of human RET kinase in TT cells by TRET Kinase cell-based mechanistic assay	B	CCOc1cc(-c2ccc(CC(=O)Nc3ccc(Cl)c(Cl)c3)c(F)c2)c[nH]c1=O		CHEMBL3355008	>	IC50	nM	500.0	CHEMBL2041	Homo sapiens	IC50	uM	0.5
	14977885	CHEMBL3377247	Inhibition of human RET kinase cytoplasmic domain by Time-Resolved fluorescence reader assay	B	CCOc1cc(-c2ccc(CC(=O)Nc3ccc(Cl)c(Cl)c3)c(F)c2)c[nH]c1=O		CHEMBL3355008	>=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	14977886	CHEMBL3377249	Inhibition of RET kinase-mediated proliferative activity against human TT cells by cell-based proliferation assay	B	CCOc1cc(-c2ccc(CC(=O)Nc3ccc(OCCO)c(C(F)(F)F)c3)c(F)c2F)c[nH]c1=O		CHEMBL3355007	>=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	14977887	CHEMBL3377248	Inhibition of human RET kinase in TT cells by TRET Kinase cell-based mechanistic assay	B	CCOc1cc(-c2ccc(CC(=O)Nc3ccc(OCCO)c(C(F)(F)F)c3)c(F)c2F)c[nH]c1=O		CHEMBL3355007	>=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	14977888	CHEMBL3377247	Inhibition of human RET kinase cytoplasmic domain by Time-Resolved fluorescence reader assay	B	CCOc1cc(-c2ccc(CC(=O)Nc3ccc(OCCO)c(C(F)(F)F)c3)c(F)c2F)c[nH]c1=O		CHEMBL3355007	<=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	14979242	CHEMBL3379611	Inhibition of RET (unknown origin) at 1 uM	B	CNc1cc2ccc(C#CCOc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2cn1		CHEMBL3355065	=	Inhibition	%	98.0	CHEMBL2041	Homo sapiens	INH	%	98.0
	14979243	CHEMBL3379612	Inhibition of RET (unknown origin)	B	CNc1cc2ccc(C#CCOc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2cn1		CHEMBL3355065	=	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	nM	10.0
	14983169	CHEMBL3385030	Inhibition of RET (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	96.0	CHEMBL2041	Homo sapiens	INH	%	96.0
	14984411	CHEMBL3384380	Inhibition of RET (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	71.0	CHEMBL2041	Homo sapiens	INH	%	71.0
	15005105	CHEMBL3366513	Inhibition of RET (unknown origin) at 0.1 nM after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357439	=	Inhibition	%	43.0	CHEMBL2041	Homo sapiens	INH	%	43.0
	15008102	CHEMBL3369111	Inhibition of human Ret at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	62.0	CHEMBL2041	Homo sapiens	INH	%	62.0
	15008103	CHEMBL3369111	Inhibition of human Ret at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	53.0	CHEMBL2041	Homo sapiens	INH	%	53.0
	15008104	CHEMBL3369111	Inhibition of human Ret at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	76.0	CHEMBL2041	Homo sapiens	INH	%	76.0
	15018684	CHEMBL3361576	Inhibition of RET (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	9.7	CHEMBL2041	Homo sapiens	INH	%	9.7
	15019875	CHEMBL3372652	Inhibition of RET (unknown origin)	B	COc1cc(=O)n(-c2ccc(Oc3ccnc(N)c3Cl)c(F)c2)cc1C(=O)NCc1ccc(F)cc1		CHEMBL3309965	>	IC50	nM	25000.0	CHEMBL2041	Homo sapiens	IC50	uM	25.0
	15019876	CHEMBL3372652	Inhibition of RET (unknown origin)	B	COc1cc(=O)n(-c2ccc(Oc3ccnc(N)c3I)c(F)c2)cc1C(=O)NCc1ccc(F)cc1		CHEMBL3309969	>	IC50	nM	25000.0	CHEMBL2041	Homo sapiens	IC50	uM	25.0
	15019877	CHEMBL3372652	Inhibition of RET (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	16.0	CHEMBL2041	Homo sapiens	IC50	uM	0.016
	15036933	CHEMBL3381102	Inhibition of RET (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	15036934	CHEMBL3381102	Inhibition of RET (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	15036935	CHEMBL3381102	Inhibition of RET (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	15036936	CHEMBL3381102	Inhibition of RET (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	15036937	CHEMBL3381102	Inhibition of RET (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	15055351	CHEMBL3380483	Inhibition of RET (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	5.0	CHEMBL2041	Homo sapiens	Activity	%	5.0
	15085840	CHEMBL3383514	Inhibition of purified RET (unknown origin) at 1 uM after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859	=	Inhibition	%	77.0	CHEMBL2041	Homo sapiens	INH	%	77.0
	15085897	CHEMBL3383514	Inhibition of purified RET (unknown origin) at 1 uM after 60 mins by ELISA kinase assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCNCC3)ncc1Cl		CHEMBL3330850	=	Inhibition	%	81.5	CHEMBL2041	Homo sapiens	INH	%	81.5
	15138126	CHEMBL3378916	Inhibition of RET C634R mutant (unknown origin) expressed in rat RAT1 cells assessed as reduction in Tyr905 phosphorylation at 0.5 to 10 uM incubated for 2 hrs by immunoblotting method	B	CC(C)(C)c1cc(NC(=O)Cc2cccc(Oc3ccc4nccn4n3)c2)no1		CHEMBL3329404	=	IC50	nM	2500.0	CHEMBL2041	Homo sapiens	IC50	uM	2.5
	15138127	CHEMBL3378916	Inhibition of RET C634R mutant (unknown origin) expressed in rat RAT1 cells assessed as reduction in Tyr905 phosphorylation at 0.5 to 10 uM incubated for 2 hrs by immunoblotting method	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-c3ccc4nccn4c3)cc2)no1		CHEMBL3329397	=	IC50	nM	250.0	CHEMBL2041	Homo sapiens	IC50	uM	0.25
	15138128	CHEMBL3378915	Inhibition of RET (unknown origin) pre-incubated for 20 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-c3ccc4nccn4c3)cc2)no1		CHEMBL3329397	=	IC50	nM	380.0	CHEMBL2041	Homo sapiens	IC50	uM	0.38
	15138129	CHEMBL3378914	Inhibition of RET (unknown origin) pre-incubated for 3 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-c3ccc4nccn4c3)cc2)no1		CHEMBL3329397	=	IC50	nM	420.0	CHEMBL2041	Homo sapiens	IC50	uM	0.42
	15138130	CHEMBL3378366	Inhibition of RET (unknown origin) pre-incubated for 0 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-c3ccc4nccn4c3)cc2)no1		CHEMBL3329397	=	IC50	nM	440.0	CHEMBL2041	Homo sapiens	IC50	uM	0.44
	15138131	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	102.0	CHEMBL2041	Homo sapiens	IC50	uM	0.102
	15138132	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2cccc(Oc3ccc4nccn4n3)c2)no1		CHEMBL3329404	=	IC50	nM	750.0	CHEMBL2041	Homo sapiens	IC50	uM	0.75
	15138133	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	O=C(Cc1cccc(Oc2ccc3nccn3n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL3329403	=	IC50	nM	9100.0	CHEMBL2041	Homo sapiens	IC50	uM	9.1
	15138134	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	O=C(Cc1cccc(Oc2ccc3nccn3n2)c1)Nc1ccccc1		CHEMBL3329402	=	IC50	nM	14300.0	CHEMBL2041	Homo sapiens	IC50	uM	14.3
	15138135	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	O=C(Cc1cccc(Oc2ccc3nccn3n2)c1)Nc1cccc(Cl)c1		CHEMBL3329401	=	IC50	nM	17200.0	CHEMBL2041	Homo sapiens	IC50	uM	17.2
	15138136	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	O=C(Cc1cccc(Oc2ccc3nccn3n2)c1)Nc1cccc(F)c1		CHEMBL3329400	=	IC50	nM	19300.0	CHEMBL2041	Homo sapiens	IC50	uM	19.3
	15138137	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	Cc1cccc(NC(=O)Cc2cccc(Oc3ccc4nccn4n3)c2)c1		CHEMBL3329399	=	IC50	nM	20400.0	CHEMBL2041	Homo sapiens	IC50	uM	20.4
	15138138	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	O=C(Cc1cccc(Oc2ccc3nccn3n2)c1)Nc1cccc(Br)c1		CHEMBL3329398	=	IC50	nM	22300.0	CHEMBL2041	Homo sapiens	IC50	uM	22.3
	15138139	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-c3ccc4nccn4c3)cc2)no1		CHEMBL3329397	=	IC50	nM	210.0	CHEMBL2041	Homo sapiens	IC50	uM	0.21
	15138140	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	O=C(Cc1ccc(-c2ccc3nccn3c2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL3329396	=	IC50	nM	15700.0	CHEMBL2041	Homo sapiens	IC50	uM	15.7
	15138141	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	O=C(Cc1ccc(-c2ccc3nccn3c2)cc1)Nc1ccccc1		CHEMBL3329395	=	IC50	nM	18800.0	CHEMBL2041	Homo sapiens	IC50	uM	18.8
	15138142	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	O=C(Cc1ccc(-c2ccc3nccn3c2)cc1)Nc1cccc(Cl)c1		CHEMBL3329394	=	IC50	nM	67800.0	CHEMBL2041	Homo sapiens	IC50	uM	67.8
	15138143	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	O=C(Cc1ccc(-c2ccc3nccn3c2)cc1)Nc1cccc(F)c1		CHEMBL3329393	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	15138144	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	Cc1cccc(NC(=O)Cc2ccc(-c3ccc4nccn4c3)cc2)c1		CHEMBL3329392	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	15138145	CHEMBL3378365	Inhibition of RET (unknown origin) pre-incubated for 60 mins before substrate addition in presence of 9 uM ATP by microfluidic assay	B	O=C(Cc1ccc(-c2ccc3nccn3c2)cc1)Nc1cccc(Br)c1		CHEMBL3329391	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	15138146	CHEMBL3378917	Inhibition of RET C634R mutant (unknown origin) expressed in rat RAT1 cells assessed as reduction in Tyr1062 phosphorylation at 0.5 to 10 uM incubated for 2 hrs by immunoblotting method	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-c3ccc4nccn4c3)cc2)no1		CHEMBL3329397	=	IC50	nM	250.0	CHEMBL2041	Homo sapiens	IC50	uM	0.25
	15138147	CHEMBL3378917	Inhibition of RET C634R mutant (unknown origin) expressed in rat RAT1 cells assessed as reduction in Tyr1062 phosphorylation at 0.5 to 10 uM incubated for 2 hrs by immunoblotting method	B	CC(C)(C)c1cc(NC(=O)Cc2cccc(Oc3ccc4nccn4n3)c2)no1		CHEMBL3329404	=	IC50	nM	2500.0	CHEMBL2041	Homo sapiens	IC50	uM	2.5
	15143827	CHEMBL3396213	Inhibition of purified RET (unknown origin) at 1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469	=	Inhibition	%	66.1	CHEMBL2041	Homo sapiens	INH	%	66.1
Not Determined	15143842	CHEMBL3396228	Inhibition of purified RET (unknown origin) at 0.1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Determined	15143857	CHEMBL3396243	Inhibition of purified RET (unknown origin) at 0.01 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	15150133	CHEMBL3396181	Inhibition of RET (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	15150134	CHEMBL3396181	Inhibition of RET (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	15150135	CHEMBL3396181	Inhibition of RET (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	15150136	CHEMBL3396181	Inhibition of RET (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	15150137	CHEMBL3396181	Inhibition of RET (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	15188671	CHEMBL3411312	Inhibition of human RET using KKKSPGEYVNIEFG substrate, ATP and [gamma33P]ATP at 1 uM	B	Cc1c[nH]c2ncnc(-c3ccc(NC(=O)N(CCO)c4ccccc4)cc3)c12		CHEMBL3410036	>	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	15237682	CHEMBL3423965	Inhibition of human Ret V804L mutant by millipore radiometric assay	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4[C@H]5CC[C@H]4CC(O)C5)cc3)c2c1		CHEMBL3422092	=	IC50	nM	250.0	CHEMBL2041	Homo sapiens	IC50	nM	250.0
	15237683	CHEMBL3423966	Inhibition of human Ret V804M mutant by millipore radiometric assay	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4[C@H]5CC[C@H]4CC(O)C5)cc3)c2c1		CHEMBL3422092	=	IC50	nM	280.0	CHEMBL2041	Homo sapiens	IC50	nM	280.0
	15237684	CHEMBL3423967	Inhibition of human Ret by millipore radiometric assay	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4[C@H]5CC[C@H]4CC(O)C5)cc3)c2c1		CHEMBL3422092	=	IC50	nM	2800.0	CHEMBL2041	Homo sapiens	IC50	nM	2800.0
	15247900	CHEMBL3428795	Inhibition of RET (unknown origin)	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	15247901	CHEMBL3428795	Inhibition of RET (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	5.0	CHEMBL2041	Homo sapiens	IC50	nM	5.0
	15247902	CHEMBL3428795	Inhibition of RET (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	6.0	CHEMBL2041	Homo sapiens	IC50	nM	6.0
	15247903	CHEMBL3428795	Inhibition of RET (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	220.0	CHEMBL2041	Homo sapiens	IC50	nM	220.0
	15247904	CHEMBL3428795	Inhibition of RET (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Ki	nM	1.5	CHEMBL2041	Homo sapiens	Ki	nM	1.5
	15247905	CHEMBL3428795	Inhibition of RET (unknown origin)	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	IC50	nM	90.0	CHEMBL2041	Homo sapiens	IC50	nM	90.0
	15247906	CHEMBL3428795	Inhibition of RET (unknown origin)	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	25.8	CHEMBL2041	Homo sapiens	IC50	nM	25.8
	15247910	CHEMBL3428926	Inhibition of RET (unknown origin) assessed as decrease in autophoshorylation	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	224.0	CHEMBL2041	Homo sapiens	IC50	nM	224.0
	15247911	CHEMBL3428927	Inhibition of RET (unknown origin) V804 mutant	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	33.9	CHEMBL2041	Homo sapiens	IC50	nM	33.9
	15247912	CHEMBL3428928	Inhibition of wild type RET (unknown origin) by cellular phosphorylation assay	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	IC50	nM	66.0	CHEMBL2041	Homo sapiens	IC50	nM	66.0
	15616216	CHEMBL3583139	Inhibition of Tel-fused RET (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	OC1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582442	=	IC50	nM	6000.0	CHEMBL2041	Homo sapiens	IC50	uM	6.0
	15616217	CHEMBL3583139	Inhibition of Tel-fused RET (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582441	=	IC50	nM	3700.0	CHEMBL2041	Homo sapiens	IC50	uM	3.7
	15616218	CHEMBL3583139	Inhibition of Tel-fused RET (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	Fc1cccc([C@H]2CCCN2c2ccc3ncc(-c4ccccn4)n3n2)c1		CHEMBL3582439	=	IC50	nM	8000.0	CHEMBL2041	Homo sapiens	IC50	uM	8.0
	15616219	CHEMBL3583139	Inhibition of Tel-fused RET (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1		CHEMBL3582427	=	IC50	nM	4900.0	CHEMBL2041	Homo sapiens	IC50	uM	4.9
	15649711	CHEMBL3595394	Inhibition of human RET Y791F mutant at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	86.0	CHEMBL2041	Homo sapiens	INH	%	86.0
	15649715	CHEMBL3595390	Inhibition of human RET V804L mutant at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	65.0	CHEMBL2041	Homo sapiens	INH	%	65.0
	15649719	CHEMBL3595386	Inhibition of human RET at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	95.0	CHEMBL2041	Homo sapiens	INH	%	95.0
	15655414	CHEMBL3598605	Inhibition of RET (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	COc1ccc(-c2cncc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)n2)cc1		CHEMBL3596862	=	IC50	nM	140.0	CHEMBL2041	Homo sapiens	IC50	uM	0.14
	15655415	CHEMBL3598605	Inhibition of RET (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cncc(-c4ccsc4)n3)c2)no1		CHEMBL3596868	=	IC50	nM	120.0	CHEMBL2041	Homo sapiens	IC50	uM	0.12
	15655416	CHEMBL3598605	Inhibition of RET (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cncc(-c4ccc(S(C)(=O)=O)cc4)n3)c2)no1		CHEMBL3596873	=	IC50	nM	210.0	CHEMBL2041	Homo sapiens	IC50	uM	0.21
	15655417	CHEMBL3598605	Inhibition of RET (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	Cn1cc(-c2cncc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)n2)cn1		CHEMBL3596879	=	IC50	nM	330.0	CHEMBL2041	Homo sapiens	IC50	uM	0.33
	15655418	CHEMBL3598605	Inhibition of RET (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cncc(-c4ccc(F)cc4)n3)c2)no1		CHEMBL3596889	=	IC50	nM	56.0	CHEMBL2041	Homo sapiens	IC50	uM	0.056
	15655419	CHEMBL3598605	Inhibition of RET (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	Cn1cc(-c2cncc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)no4)cc3)n2)cn1		CHEMBL3596892	=	IC50	nM	63.0	CHEMBL2041	Homo sapiens	IC50	uM	0.063
	15655420	CHEMBL3598605	Inhibition of RET (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	Cn1cc(-c2cncc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4C)cc3)n2)cn1		CHEMBL3596893	=	IC50	nM	64.0	CHEMBL2041	Homo sapiens	IC50	uM	0.064
	15656303	CHEMBL3598817	Inhibition of RET (unknown origin) at 0.1 uM	B	CN1CCc2cc(-c3cnc4[nH]cc(C(=O)c5ccccc5Cl)c4c3)ccc2C1		CHEMBL3597011	>	Inhibition	%	95.0	CHEMBL2041	Homo sapiens	INH	%	95.0
Active	15666677	CHEMBL3603424	Inhibition of RET (unknown origin)	B	Cc1cc(Nc2cc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)cn2)cc(C)n1		CHEMBL3601196		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	15685916	CHEMBL3606459	Inhibition of human RET	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
Not Determined	15736012	CHEMBL3627025	Inhibition of human RET pre-incubated for 30 mins at room temperature before substrate addition and measured 1 hr after substrate addition by cell free kinase assay	B	Cc1cc(C)cc(Nc2nccc(-n3cc(C)c(CN4CC[C@@H](O)C4)c3)n2)c1		CHEMBL3622924		IC50			CHEMBL2041	Homo sapiens	IC50		
	15736013	CHEMBL3627025	Inhibition of human RET pre-incubated for 30 mins at room temperature before substrate addition and measured 1 hr after substrate addition by cell free kinase assay	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622956	=	IC50	nM	67.8	CHEMBL2041	Homo sapiens	IC50	nM	67.8
	15736014	CHEMBL3627025	Inhibition of human RET pre-incubated for 30 mins at room temperature before substrate addition and measured 1 hr after substrate addition by cell free kinase assay	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC[C@@H](O)C1		CHEMBL3622957	=	IC50	nM	9594.0	CHEMBL2041	Homo sapiens	IC50	nM	9594.0
Not Determined	15736015	CHEMBL3627025	Inhibition of human RET pre-incubated for 30 mins at room temperature before substrate addition and measured 1 hr after substrate addition by cell free kinase assay	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(C)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622958		IC50			CHEMBL2041	Homo sapiens	IC50		
	15736131	CHEMBL3627528	Inhibition of human Ret V804L mutant at 0.1 uM	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622956	>	Inhibition	%	70.0	CHEMBL2041	Homo sapiens	INH	%	70.0
	15736132	CHEMBL3627529	Inhibition of human Ret V804M mutant at 0.1 uM	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622956	>	Inhibition	%	70.0	CHEMBL2041	Homo sapiens	INH	%	70.0
	15736147	CHEMBL3627544	Inhibition of human Ret V804L mutant at 0.01 uM	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622956	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	15736148	CHEMBL3627545	Inhibition of human Ret V804M mutant at 0.01 uM	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622956	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	15736630	CHEMBL3625821	Inhibition of human recombinant Ret	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	=	IC50	nM	986.0	CHEMBL2041	Homo sapiens	IC50	uM	0.986
	15754265	CHEMBL3631691	Inhibition of Ret (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	29.6	CHEMBL2041	Homo sapiens	INH	%	29.6
	15755927	CHEMBL3631578	Inhibition of RET (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	74.0	CHEMBL2041	Homo sapiens	Activity	%	74.0
	15756831	CHEMBL3631111	Inhibition of RET (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	99.2	CHEMBL2041	Homo sapiens	INH	%	99.2
	15757892	CHEMBL3631111	Inhibition of RET (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	97.96	CHEMBL2041	Homo sapiens	INH	%	97.96
	15758871	CHEMBL3631111	Inhibition of RET (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	35.95	CHEMBL2041	Homo sapiens	INH	%	35.95
263074	16258773	CHEMBL3707688	In Vitro Kinase Activity Assay: Compounds to be tested were dissolved in 100% DMSO in a range of concentrations from 10-8 to 10-3 M including negative control (DMSO), then diluted with Kinase Buffer (50 mM HEPES, pH 7.5, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, and 2 mM DTT, added fresh) to 4x the final concentration. The final curve included 11 concentrations (10-11 to 10-5 M) plus negative control DMSO tested in triplicate.Kinase and ATP concentrations necessary for optimal activity were determined in separate experiments. (Table 2). Briefly, increasing concentrations of kinase were incubated in a fixed concentration of ATP (200 uM) in Kinase Buffer to determine maximal activity at various time points (30-120 min). The concentration of kinase that resulted in maximal activity with the shortest incubation time was then incubated in Kinase Buffer with increasing concentrations of ATP.	B	C[C@@H](Cc1c(F)c(F)cc(F)c1F)Nc1cc[nH]c(=O)c1-c1nc2cc3c(cc2[nH]1)CN(CCN(C)C)C3=O		CHEMBL3671311	=	IC50	nM	3.527	CHEMBL2041	Homo sapiens	IC50	nM	3.527
263075	16263727	CHEMBL3707688	In Vitro Kinase Activity Assay: Compounds to be tested were dissolved in 100% DMSO in a range of concentrations from 10-8 to 10-3 M including negative control (DMSO), then diluted with Kinase Buffer (50 mM HEPES, pH 7.5, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, and 2 mM DTT, added fresh) to 4x the final concentration. The final curve included 11 concentrations (10-11 to 10-5 M) plus negative control DMSO tested in triplicate.Kinase and ATP concentrations necessary for optimal activity were determined in separate experiments. (Table 2). Briefly, increasing concentrations of kinase were incubated in a fixed concentration of ATP (200 uM) in Kinase Buffer to determine maximal activity at various time points (30-120 min). The concentration of kinase that resulted in maximal activity with the shortest incubation time was then incubated in Kinase Buffer with increasing concentrations of ATP.	B	CC(Cc1cc(F)ccc1F)Nc1cc[nH]c(=O)c1-c1nc2cc3c(cc2[nH]1)C(=O)N(CCN(C)C)C3		CHEMBL3671318	=	IC50	nM	13.07	CHEMBL2041	Homo sapiens	IC50	nM	13.07
263073	16292547	CHEMBL3707688	In Vitro Kinase Activity Assay: Compounds to be tested were dissolved in 100% DMSO in a range of concentrations from 10-8 to 10-3 M including negative control (DMSO), then diluted with Kinase Buffer (50 mM HEPES, pH 7.5, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, and 2 mM DTT, added fresh) to 4x the final concentration. The final curve included 11 concentrations (10-11 to 10-5 M) plus negative control DMSO tested in triplicate.Kinase and ATP concentrations necessary for optimal activity were determined in separate experiments. (Table 2). Briefly, increasing concentrations of kinase were incubated in a fixed concentration of ATP (200 uM) in Kinase Buffer to determine maximal activity at various time points (30-120 min). The concentration of kinase that resulted in maximal activity with the shortest incubation time was then incubated in Kinase Buffer with increasing concentrations of ATP.	B	C[C@@H](Cc1c(F)c(F)cc(F)c1F)Nc1cc[nH]c(=O)c1-c1nc2cc3c(cc2[nH]1)C(=O)N(CCN(C)C)C3=O		CHEMBL3671310	=	IC50	nM	25.82	CHEMBL2041	Homo sapiens	IC50	nM	25.82
254322	16293970	CHEMBL3707654	Kinase Screen Assay: KINOMEscan (Ambit Biosciences, San Diego, Calif.), a high-throughput method for screening small molecular agents against a large panel of human kinases, was utilized for compound 2. The technology is a competition binding assay that profiled the selectivity of compound 2 against 350 kinases, each fused to a proprietary tag. The quantity of each kinase bound to an immobilized, active site-directed ligand was measured in the presence and absence of compound 2.	B	Cc1nc(Nc2nc3ccc(-c4cccc(C(=O)Nc5cccc(C(F)(F)F)c5)c4)nc3s2)cc(N2CCNCC2)n1		CHEMBL2148120	=	Kd	nM	5.6	CHEMBL2041	Homo sapiens	Kd	nM	5.6
263072	16304347	CHEMBL3707688	In Vitro Kinase Activity Assay: Compounds to be tested were dissolved in 100% DMSO in a range of concentrations from 10-8 to 10-3 M including negative control (DMSO), then diluted with Kinase Buffer (50 mM HEPES, pH 7.5, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, and 2 mM DTT, added fresh) to 4x the final concentration. The final curve included 11 concentrations (10-11 to 10-5 M) plus negative control DMSO tested in triplicate.Kinase and ATP concentrations necessary for optimal activity were determined in separate experiments. (Table 2). Briefly, increasing concentrations of kinase were incubated in a fixed concentration of ATP (200 uM) in Kinase Buffer to determine maximal activity at various time points (30-120 min). The concentration of kinase that resulted in maximal activity with the shortest incubation time was then incubated in Kinase Buffer with increasing concentrations of ATP.	B	C[C@@H](Cc1c(F)c(F)cc(F)c1F)Nc1cc[nH]c(=O)c1-c1nc2cc3c(cc2[nH]1)CN(C1CCN(C)CC1)C3=O		CHEMBL3671309	=	IC50	nM	5.977	CHEMBL2041	Homo sapiens	IC50	nM	5.977
263076	16312727	CHEMBL3707688	In Vitro Kinase Activity Assay: Compounds to be tested were dissolved in 100% DMSO in a range of concentrations from 10-8 to 10-3 M including negative control (DMSO), then diluted with Kinase Buffer (50 mM HEPES, pH 7.5, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, and 2 mM DTT, added fresh) to 4x the final concentration. The final curve included 11 concentrations (10-11 to 10-5 M) plus negative control DMSO tested in triplicate.Kinase and ATP concentrations necessary for optimal activity were determined in separate experiments. (Table 2). Briefly, increasing concentrations of kinase were incubated in a fixed concentration of ATP (200 uM) in Kinase Buffer to determine maximal activity at various time points (30-120 min). The concentration of kinase that resulted in maximal activity with the shortest incubation time was then incubated in Kinase Buffer with increasing concentrations of ATP.	B	Cc1c2c(cc3[nH]c(-c4c(NC(C)Cc5c(F)c(F)cc(F)c5F)cc[nH]c4=O)nc13)C(=O)N(C1CCN(C)CC1)C2		CHEMBL3671320	=	IC50	nM	11.15	CHEMBL2041	Homo sapiens	IC50	nM	11.15
263071	16336969	CHEMBL3707688	In Vitro Kinase Activity Assay: Compounds to be tested were dissolved in 100% DMSO in a range of concentrations from 10-8 to 10-3 M including negative control (DMSO), then diluted with Kinase Buffer (50 mM HEPES, pH 7.5, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, and 2 mM DTT, added fresh) to 4x the final concentration. The final curve included 11 concentrations (10-11 to 10-5 M) plus negative control DMSO tested in triplicate.Kinase and ATP concentrations necessary for optimal activity were determined in separate experiments. (Table 2). Briefly, increasing concentrations of kinase were incubated in a fixed concentration of ATP (200 uM) in Kinase Buffer to determine maximal activity at various time points (30-120 min). The concentration of kinase that resulted in maximal activity with the shortest incubation time was then incubated in Kinase Buffer with increasing concentrations of ATP.	B	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	IC50	nM	2.195	CHEMBL2041	Homo sapiens	IC50	nM	2.195
	16396083	CHEMBL3742491	Inhibition of human recombinant RET using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5ccccc5)cccc4c3)n2)c1		CHEMBL3740721	=	IC50	nM	59.2	CHEMBL2041	Homo sapiens	IC50	nM	59.2
	16396084	CHEMBL3742491	Inhibition of human recombinant RET using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccc(F)c5)cccc4c3)n2)c1		CHEMBL3740487	=	IC50	nM	22.8	CHEMBL2041	Homo sapiens	IC50	nM	22.8
	16396085	CHEMBL3742491	Inhibition of human recombinant RET using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccnc5)cccc4c3)n2)c1		CHEMBL3739732	=	IC50	nM	167.1	CHEMBL2041	Homo sapiens	IC50	nM	167.1
	16413510	CHEMBL3743744	Inhibition of RET (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	16417295	CHEMBL3750773	Inhibition of RET (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21		CHEMBL3747699	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	16417296	CHEMBL3750773	Inhibition of RET (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21		CHEMBL3746959	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	16417297	CHEMBL3750773	Inhibition of RET (unknown origin) at 10 uM	B	CN1CCN(CCCNc2ncc3cc(Oc4ccc(F)cc4F)c(=O)n(C)c3n2)CC1		CHEMBL3746022	=	Inhibition	%	24.0	CHEMBL2041	Homo sapiens	INH	%	24.0
	16417298	CHEMBL3750773	Inhibition of RET (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3745734	=	Inhibition	%	98.0	CHEMBL2041	Homo sapiens	INH	%	98.0
	16417299	CHEMBL3750773	Inhibition of RET (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2c(Cl)cccc2Cl)cc2cnc(NC3CCOCC3)nc21		CHEMBL3747351	=	Inhibition	%	2.0	CHEMBL2041	Homo sapiens	INH	%	2.0
	16417300	CHEMBL3750773	Inhibition of RET (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3747023	=	Inhibition	%	43.0	CHEMBL2041	Homo sapiens	INH	%	43.0
	16417301	CHEMBL3750773	Inhibition of RET (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCCc3ccccn3)nc21		CHEMBL3746951	=	Inhibition	%	11.0	CHEMBL2041	Homo sapiens	INH	%	11.0
	16417302	CHEMBL3750773	Inhibition of RET (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCCCC4)cc3)nc21		CHEMBL3746973	=	Inhibition	%	46.0	CHEMBL2041	Homo sapiens	INH	%	46.0
	16417303	CHEMBL3750773	Inhibition of RET (unknown origin) at 10 uM	B	CN(C)CCNc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL3745857	=	Inhibition	%	1.0	CHEMBL2041	Homo sapiens	INH	%	1.0
	16421942	CHEMBL3748459	Inhibition of RET (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	16425383	CHEMBL3751209	Inhibition of Ret (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	14.9	CHEMBL2041	Homo sapiens	INH	%	14.9
	16425953	CHEMBL3748751	Inhibition of RET (unknown origin) expressed in BaF3 cells assessed as inhibition of cell proliferation after 72 hrs by CelltiterGlo assay	B	CN(C)CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3745919	=	GI50	nM	650.0	CHEMBL2041	Homo sapiens	GI50	uM	0.65
	16425966	CHEMBL3749076	Inhibition of RET (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CN(C)CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3745919	=	Activity	%	0.4	CHEMBL2041	Homo sapiens	Activity	%	0.4
	16428154	CHEMBL3748850	Inhibition of RET (unknown origin)	B	CCc1cc2c(cc1-c1cnn(CCCN(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3746678	=	IC50	nM	2.0	CHEMBL2041	Homo sapiens	IC50	nM	2.0
	16428155	CHEMBL3748850	Inhibition of RET (unknown origin)	B	CCc1cc2c(cc1-c1cnn(CC(=O)N(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735401	=	IC50	nM	3.0	CHEMBL2041	Homo sapiens	IC50	nM	3.0
	16428156	CHEMBL3749183	Inhibition of Ret V804L (unknown origin)	B	CCc1cc2c(cc1-c1cnn(CCCN(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3746678	=	IC50	nM	9.0	CHEMBL2041	Homo sapiens	IC50	nM	9.0
	16428157	CHEMBL3749183	Inhibition of Ret V804L (unknown origin)	B	CCc1cc2c(cc1-c1cnn(CC(=O)N(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735401	=	IC50	nM	13.0	CHEMBL2041	Homo sapiens	IC50	nM	13.0
	16428158	CHEMBL3749237	Inhibition of Ret V804M (unknown origin)	B	CCc1cc2c(cc1-c1cnn(CCCN(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3746678	=	IC50	nM	23.0	CHEMBL2041	Homo sapiens	IC50	nM	23.0
	16428159	CHEMBL3749237	Inhibition of Ret V804M (unknown origin)	B	CCc1cc2c(cc1-c1cnn(CC(=O)N(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735401	=	IC50	nM	12.0	CHEMBL2041	Homo sapiens	IC50	nM	12.0
	16428376	CHEMBL3749608	Inhibition of Ret (unknown origin)	B	C[C@H]1Cc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cc(C4(C)CC4)[nH]n3)c2)CN1		CHEMBL3746776	=	IC50	nM	66.0	CHEMBL2041	Homo sapiens	IC50	uM	0.066
	16428377	CHEMBL3749608	Inhibition of Ret (unknown origin)	B	O=C(Nc1cc(C2CC2)on1)n1ccc2cc(Oc3ncnc4c3CNC4)ccc21		CHEMBL3746122	=	IC50	nM	500.0	CHEMBL2041	Homo sapiens	IC50	uM	0.5
	16429070	CHEMBL3750808	Inhibition of RET (unknown origin) at 1 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(N)(=O)=O)CC3)nc21		CHEMBL3747489	=	Inhibition	%	30.0	CHEMBL2041	Homo sapiens	INH	%	30.0
	16431987	CHEMBL3750026	Inhibition of human RET using [KKKSPGEYVNIEFG] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	16445690	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2C1CCCCC1		CHEMBL3753512	=	IC50	nM	14.0	CHEMBL2041	Homo sapiens	IC50	uM	0.014
	16445691	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2C1CCOCC1		CHEMBL3751904	=	IC50	nM	41.0	CHEMBL2041	Homo sapiens	IC50	uM	0.041
	16445692	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(/C=N/O)c2c(N)ncnc21		CHEMBL3753503	=	IC50	nM	3680.0	CHEMBL2041	Homo sapiens	IC50	uM	3.68
	16445693	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(C2=NOC(c3ccccc3)C2)c2c(N)ncnc21		CHEMBL3752736	=	IC50	nM	5680.0	CHEMBL2041	Homo sapiens	IC50	uM	5.68
	16445694	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(Cc3ccccc3)on2)c2c(N)ncnc21		CHEMBL3753714	=	IC50	nM	1990.0	CHEMBL2041	Homo sapiens	IC50	uM	1.99
	16445695	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(-c3ccccn3)on2)c2c(N)ncnc21		CHEMBL3754247	=	IC50	nM	5880.0	CHEMBL2041	Homo sapiens	IC50	uM	5.88
	16445696	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CCc1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL3753958	=	IC50	nM	531.0	CHEMBL2041	Homo sapiens	IC50	uM	0.531
	16445697	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL3752395	=	IC50	nM	355.0	CHEMBL2041	Homo sapiens	IC50	uM	0.355
	16445698	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C(C)(C)C)on2)c2c(N)ncnc21		CHEMBL3751965	=	IC50	nM	2100.0	CHEMBL2041	Homo sapiens	IC50	uM	2.1
	16445699	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	IC50	nM	4.0	CHEMBL2041	Homo sapiens	IC50	uM	0.004
	16445700	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CCCC3)on2)c2c(N)ncnc21		CHEMBL3753903	=	IC50	nM	1570.0	CHEMBL2041	Homo sapiens	IC50	uM	1.57
	16445701	CHEMBL3756069	Inhibition of human Ret V804M mutant at 10 uM by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(/C=N/OCc2ccccc2)c2c(N)ncnc21		CHEMBL3754195	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	16445702	CHEMBL3756069	Inhibition of human Ret V804M mutant at 10 uM by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(-c3ccccc3)on2)c2c(N)ncnc21		CHEMBL3754442	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	16445703	CHEMBL3756069	Inhibition of human Ret V804M mutant at 10 uM by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(-c3ccc(F)cc3)on2)c2c(N)ncnc21		CHEMBL3754092	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	16445704	CHEMBL3756069	Inhibition of human Ret V804M mutant at 10 uM by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CCCCC3)on2)c2c(N)ncnc21		CHEMBL3752827	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	16445705	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(-c2ccon2)c2c(N)ncnc21		CHEMBL3752025	=	GI50	nM	7920.0	CHEMBL2041	Homo sapiens	GI50	uM	7.92
	16445706	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	Nc1ncnc2[nH]nc(-c3cc(C4CC4)on3)c12		CHEMBL3752879	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445707	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	Cn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3752118	=	GI50	nM	3510.0	CHEMBL2041	Homo sapiens	GI50	uM	3.51
	16445708	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2Cc1ccccc1		CHEMBL3754346	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445709	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CCCCCCCn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753242	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445710	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)(O)Cn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3752712	=	GI50	nM	4250.0	CHEMBL2041	Homo sapiens	GI50	uM	4.25
	16445711	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2C1CCCCC1		CHEMBL3753512	=	GI50	nM	290.0	CHEMBL2041	Homo sapiens	GI50	uM	0.29
	16445712	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2C1CCOCC1		CHEMBL3751904	=	GI50	nM	940.0	CHEMBL2041	Homo sapiens	GI50	uM	0.94
	16445713	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(/C=N/O)c2c(N)ncnc21		CHEMBL3753503	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445714	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(/C=N/OCc2ccccc2)c2c(N)ncnc21		CHEMBL3754195	=	GI50	nM	9270.0	CHEMBL2041	Homo sapiens	GI50	uM	9.27
	16445715	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(C2=NOC(c3ccccc3)C2)c2c(N)ncnc21		CHEMBL3752736	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445716	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(-c2cc(-c3ccccc3)on2)c2c(N)ncnc21		CHEMBL3754442	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445717	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(-c2cc(Cc3ccccc3)on2)c2c(N)ncnc21		CHEMBL3753714	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445718	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(-c2cc(-c3ccc(F)cc3)on2)c2c(N)ncnc21		CHEMBL3754092	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445719	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(-c2cc(-c3ccccn3)on2)c2c(N)ncnc21		CHEMBL3754247	=	GI50	nM	9260.0	CHEMBL2041	Homo sapiens	GI50	uM	9.26
	16445720	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CCc1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL3753958	=	GI50	nM	2610.0	CHEMBL2041	Homo sapiens	GI50	uM	2.61
	16445721	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL3752395	=	GI50	nM	5130.0	CHEMBL2041	Homo sapiens	GI50	uM	5.13
	16445722	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(-c2cc(C(C)(C)C)on2)c2c(N)ncnc21		CHEMBL3751965	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445723	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	GI50	nM	240.0	CHEMBL2041	Homo sapiens	GI50	uM	0.24
	16445724	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(-c2cc(C3CCCC3)on2)c2c(N)ncnc21		CHEMBL3753903	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445725	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(-c2cc(C3CCCCC3)on2)c2c(N)ncnc21		CHEMBL3752827	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445726	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	GI50	nM	2540.0	CHEMBL2041	Homo sapiens	GI50	uM	2.54
	16445727	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)(O)Cn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3752712	=	IC50	nM	217.0	CHEMBL2041	Homo sapiens	IC50	uM	0.217
	16445728	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CCCCCCCn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753242	=	IC50	nM	927.0	CHEMBL2041	Homo sapiens	IC50	uM	0.927
	16445729	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2Cc1ccccc1		CHEMBL3754346	=	IC50	nM	557.0	CHEMBL2041	Homo sapiens	IC50	uM	0.557
	16445730	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	Cn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3752118	=	IC50	nM	182.0	CHEMBL2041	Homo sapiens	IC50	uM	0.182
	16445731	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	Nc1ncnc2[nH]nc(-c3cc(C4CC4)on3)c12		CHEMBL3752879	=	IC50	nM	354.0	CHEMBL2041	Homo sapiens	IC50	uM	0.354
	16445732	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2ccon2)c2c(N)ncnc21		CHEMBL3752025	=	IC50	nM	903.0	CHEMBL2041	Homo sapiens	IC50	uM	0.903
	16445733	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CCCCC3)on2)c2c(N)ncnc21		CHEMBL3752827	=	IC50	nM	910.0	CHEMBL2041	Homo sapiens	IC50	uM	0.91
	16445734	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CCCC3)on2)c2c(N)ncnc21		CHEMBL3753903	=	IC50	nM	241.0	CHEMBL2041	Homo sapiens	IC50	uM	0.241
	16445735	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	IC50	nM	1.4	CHEMBL2041	Homo sapiens	IC50	uM	0.0014
	16445736	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C(C)(C)C)on2)c2c(N)ncnc21		CHEMBL3751965	=	IC50	nM	210.0	CHEMBL2041	Homo sapiens	IC50	uM	0.21
	16445737	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL3752395	=	IC50	nM	41.0	CHEMBL2041	Homo sapiens	IC50	uM	0.041
	16445738	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CCc1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL3753958	=	IC50	nM	41.0	CHEMBL2041	Homo sapiens	IC50	uM	0.041
	16445739	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(-c3ccccn3)on2)c2c(N)ncnc21		CHEMBL3754247	=	IC50	nM	910.0	CHEMBL2041	Homo sapiens	IC50	uM	0.91
	16445740	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(-c3ccc(F)cc3)on2)c2c(N)ncnc21		CHEMBL3754092	=	IC50	nM	150.0	CHEMBL2041	Homo sapiens	IC50	uM	0.15
	16445741	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(Cc3ccccc3)on2)c2c(N)ncnc21		CHEMBL3753714	=	IC50	nM	241.0	CHEMBL2041	Homo sapiens	IC50	uM	0.241
	16445742	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(-c3ccccc3)on2)c2c(N)ncnc21		CHEMBL3754442	=	IC50	nM	190.0	CHEMBL2041	Homo sapiens	IC50	uM	0.19
	16445743	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(C2=NOC(c3ccccc3)C2)c2c(N)ncnc21		CHEMBL3752736	=	IC50	nM	583.0	CHEMBL2041	Homo sapiens	IC50	uM	0.583
	16445744	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(/C=N/OCc2ccccc2)c2c(N)ncnc21		CHEMBL3754195	=	IC50	nM	8330.0	CHEMBL2041	Homo sapiens	IC50	uM	8.33
	16445745	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(/C=N/O)c2c(N)ncnc21		CHEMBL3753503	=	IC50	nM	4900.0	CHEMBL2041	Homo sapiens	IC50	uM	4.9
	16445746	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2C1CCOCC1		CHEMBL3751904	=	IC50	nM	5.0	CHEMBL2041	Homo sapiens	IC50	uM	0.005
	16445747	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2C1CCCCC1		CHEMBL3753512	=	IC50	nM	2.0	CHEMBL2041	Homo sapiens	IC50	uM	0.002
	16445748	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)(O)Cn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3752712	=	IC50	nM	68.0	CHEMBL2041	Homo sapiens	IC50	uM	0.068
	16445749	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CCCCCCCn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753242	=	IC50	nM	96.0	CHEMBL2041	Homo sapiens	IC50	uM	0.096
	16445750	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2Cc1ccccc1		CHEMBL3754346	=	IC50	nM	74.0	CHEMBL2041	Homo sapiens	IC50	uM	0.074
	16445751	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	Cn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3752118	=	IC50	nM	27.0	CHEMBL2041	Homo sapiens	IC50	uM	0.027
	16445752	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	Nc1ncnc2[nH]nc(-c3cc(C4CC4)on3)c12		CHEMBL3752879	=	IC50	nM	52.0	CHEMBL2041	Homo sapiens	IC50	uM	0.052
	16445753	CHEMBL3756067	Inhibition of human wild type RET by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2ccon2)c2c(N)ncnc21		CHEMBL3752025	=	IC50	nM	213.0	CHEMBL2041	Homo sapiens	IC50	uM	0.213
	16445776	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2ccon2)c2c(N)ncnc21		CHEMBL3752025	=	GI50	nM	3210.0	CHEMBL2041	Homo sapiens	GI50	uM	3.21
	16445777	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	Nc1ncnc2[nH]nc(-c3cc(C4CC4)on3)c12		CHEMBL3752879	=	GI50	nM	5340.0	CHEMBL2041	Homo sapiens	GI50	uM	5.34
	16445778	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	Cn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3752118	=	GI50	nM	2670.0	CHEMBL2041	Homo sapiens	GI50	uM	2.67
	16445779	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2Cc1ccccc1		CHEMBL3754346	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445780	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CCCCCCCn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753242	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445781	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)(O)Cn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3752712	=	GI50	nM	1770.0	CHEMBL2041	Homo sapiens	GI50	uM	1.77
	16445782	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2C1CCCCC1		CHEMBL3753512	=	GI50	nM	520.0	CHEMBL2041	Homo sapiens	GI50	uM	0.52
	16445783	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2C1CCOCC1		CHEMBL3751904	=	GI50	nM	440.0	CHEMBL2041	Homo sapiens	GI50	uM	0.44
	16445784	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(/C=N/O)c2c(N)ncnc21		CHEMBL3753503	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445785	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(/C=N/OCc2ccccc2)c2c(N)ncnc21		CHEMBL3754195	=	GI50	nM	7410.0	CHEMBL2041	Homo sapiens	GI50	uM	7.41
	16445786	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(C2=NOC(c3ccccc3)C2)c2c(N)ncnc21		CHEMBL3752736	=	GI50	nM	6240.0	CHEMBL2041	Homo sapiens	GI50	uM	6.24
	16445787	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(-c3ccccc3)on2)c2c(N)ncnc21		CHEMBL3754442	=	GI50	nM	3460.0	CHEMBL2041	Homo sapiens	GI50	uM	3.46
	16445788	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(Cc3ccccc3)on2)c2c(N)ncnc21		CHEMBL3753714	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445789	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(-c3ccc(F)cc3)on2)c2c(N)ncnc21		CHEMBL3754092	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445790	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(-c3ccccn3)on2)c2c(N)ncnc21		CHEMBL3754247	=	GI50	nM	1110.0	CHEMBL2041	Homo sapiens	GI50	uM	1.11
	16445791	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CCc1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL3753958	=	GI50	nM	1560.0	CHEMBL2041	Homo sapiens	GI50	uM	1.56
	16445792	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL3752395	=	GI50	nM	2400.0	CHEMBL2041	Homo sapiens	GI50	uM	2.4
	16445793	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(C(C)(C)C)on2)c2c(N)ncnc21		CHEMBL3751965	=	GI50	nM	6120.0	CHEMBL2041	Homo sapiens	GI50	uM	6.12
	16445794	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	GI50	nM	80.0	CHEMBL2041	Homo sapiens	GI50	uM	0.08
	16445795	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(C3CCCC3)on2)c2c(N)ncnc21		CHEMBL3753903	=	GI50	nM	7120.0	CHEMBL2041	Homo sapiens	GI50	uM	7.12
	16445796	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(C3CCCCC3)on2)c2c(N)ncnc21		CHEMBL3752827	=	GI50	nM	9500.0	CHEMBL2041	Homo sapiens	GI50	uM	9.5
	16445797	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	GI50	nM	610.0	CHEMBL2041	Homo sapiens	GI50	uM	0.61
	16445798	CHEMBL3756061	Inhibition of wild type TEL-fused RET (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	GI50	nM	50.0	CHEMBL2041	Homo sapiens	GI50	uM	0.05
	16445799	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2ccon2)c2c(N)ncnc21		CHEMBL3752025	=	GI50	nM	8940.0	CHEMBL2041	Homo sapiens	GI50	uM	8.94
	16445800	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	Nc1ncnc2[nH]nc(-c3cc(C4CC4)on3)c12		CHEMBL3752879	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445801	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	Cn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3752118	=	GI50	nM	5560.0	CHEMBL2041	Homo sapiens	GI50	uM	5.56
	16445802	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2Cc1ccccc1		CHEMBL3754346	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445803	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CCCCCCCn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753242	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445804	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)(O)Cn1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3752712	=	GI50	nM	6750.0	CHEMBL2041	Homo sapiens	GI50	uM	6.75
	16445805	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2C1CCCCC1		CHEMBL3753512	=	GI50	nM	2000.0	CHEMBL2041	Homo sapiens	GI50	uM	2.0
	16445806	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	Nc1ncnc2c1c(-c1cc(C3CC3)on1)nn2C1CCOCC1		CHEMBL3751904	=	GI50	nM	1930.0	CHEMBL2041	Homo sapiens	GI50	uM	1.93
	16445807	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(/C=N/O)c2c(N)ncnc21		CHEMBL3753503	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445808	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(/C=N/OCc2ccccc2)c2c(N)ncnc21		CHEMBL3754195	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445809	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(C2=NOC(c3ccccc3)C2)c2c(N)ncnc21		CHEMBL3752736	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445810	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(-c3ccccc3)on2)c2c(N)ncnc21		CHEMBL3754442	=	GI50	nM	4970.0	CHEMBL2041	Homo sapiens	GI50	uM	4.97
	16445811	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(Cc3ccccc3)on2)c2c(N)ncnc21		CHEMBL3753714	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445812	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(-c3ccc(F)cc3)on2)c2c(N)ncnc21		CHEMBL3754092	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445813	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(-c3ccccn3)on2)c2c(N)ncnc21		CHEMBL3754247	=	GI50	nM	700.0	CHEMBL2041	Homo sapiens	GI50	uM	0.7
	16445814	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CCc1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL3753958	=	GI50	nM	5770.0	CHEMBL2041	Homo sapiens	GI50	uM	5.77
	16445815	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL3752395	=	GI50	nM	5900.0	CHEMBL2041	Homo sapiens	GI50	uM	5.9
	16445816	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(C(C)(C)C)on2)c2c(N)ncnc21		CHEMBL3751965	=	GI50	nM	7310.0	CHEMBL2041	Homo sapiens	GI50	uM	7.31
	16445817	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	GI50	nM	320.0	CHEMBL2041	Homo sapiens	GI50	uM	0.32
	16445818	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(C3CCCC3)on2)c2c(N)ncnc21		CHEMBL3753903	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	16445819	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(C3CCCCC3)on2)c2c(N)ncnc21		CHEMBL3752827	=	GI50	nM	4730.0	CHEMBL2041	Homo sapiens	GI50	uM	4.73
	16445820	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	GI50	nM	2600.0	CHEMBL2041	Homo sapiens	GI50	uM	2.6
	16445821	CHEMBL3756058	Inhibition of TEL-fused Ret V804M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	GI50	nM	890.0	CHEMBL2041	Homo sapiens	GI50	uM	0.89
	16446697	CHEMBL3756072	Inhibition of human Ret G691S mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	nM	10.0
	16446698	CHEMBL3756072	Inhibition of human Ret G691S mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	IC50	nM	75.0	CHEMBL2041	Homo sapiens	IC50	nM	75.0
	16446699	CHEMBL3756072	Inhibition of human Ret G691S mutant by radiometric assay in presence of [gamma-33P]-ATP	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	14.0	CHEMBL2041	Homo sapiens	IC50	nM	14.0
	16446700	CHEMBL3756073	Inhibition of human Ret Y791F mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	IC50	nM	3.0	CHEMBL2041	Homo sapiens	IC50	nM	3.0
	16446701	CHEMBL3756073	Inhibition of human Ret Y791F mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	IC50	nM	14.0	CHEMBL2041	Homo sapiens	IC50	nM	14.0
	16446702	CHEMBL3756073	Inhibition of human Ret Y791F mutant by radiometric assay in presence of [gamma-33P]-ATP	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	7.0	CHEMBL2041	Homo sapiens	IC50	nM	7.0
	16446703	CHEMBL3756074	Inhibition of human Ret V804L mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	IC50	nM	21.0	CHEMBL2041	Homo sapiens	IC50	nM	21.0
	16446704	CHEMBL3756074	Inhibition of human Ret V804L mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	IC50	nM	3130.0	CHEMBL2041	Homo sapiens	IC50	nM	3130.0
	16446705	CHEMBL3756074	Inhibition of human Ret V804L mutant by radiometric assay in presence of [gamma-33P]-ATP	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	230.0	CHEMBL2041	Homo sapiens	IC50	nM	230.0
	16446706	CHEMBL3756075	Inhibition of human Ret S891A mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	IC50	nM	2.0	CHEMBL2041	Homo sapiens	IC50	nM	2.0
	16446707	CHEMBL3756075	Inhibition of human Ret S891A mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	IC50	nM	54.0	CHEMBL2041	Homo sapiens	IC50	nM	54.0
	16446708	CHEMBL3756075	Inhibition of human Ret S891A mutant by radiometric assay in presence of [gamma-33P]-ATP	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	5.0	CHEMBL2041	Homo sapiens	IC50	nM	5.0
	16446709	CHEMBL3756076	Inhibition of human Ret M918T mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	IC50	nM	6.0	CHEMBL2041	Homo sapiens	IC50	nM	6.0
	16446710	CHEMBL3756076	Inhibition of human Ret M918T mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	IC50	nM	57.0	CHEMBL2041	Homo sapiens	IC50	nM	57.0
	16446711	CHEMBL3756076	Inhibition of human Ret M918T mutant by radiometric assay in presence of [gamma-33P]-ATP	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	18.0	CHEMBL2041	Homo sapiens	IC50	nM	18.0
	16446712	CHEMBL3756077	Inhibition of TEL-fused Ret V804L mutant (unknown origin) expressed in mouse BaF3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	GI50	nM	500.0	CHEMBL2041	Homo sapiens	GI50	uM	0.5
	16446713	CHEMBL3756077	Inhibition of TEL-fused Ret V804L mutant (unknown origin) expressed in mouse BaF3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	GI50	nM	5430.0	CHEMBL2041	Homo sapiens	GI50	uM	5.43
	16446714	CHEMBL3756077	Inhibition of TEL-fused Ret V804L mutant (unknown origin) expressed in mouse BaF3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	GI50	nM	910.0	CHEMBL2041	Homo sapiens	GI50	uM	0.91
	16446715	CHEMBL3756078	Inhibition of TEL-fused Ret S891A mutant (unknown origin) expressed in mouse BaF3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	GI50	nM	90.0	CHEMBL2041	Homo sapiens	GI50	uM	0.09
	16446716	CHEMBL3756078	Inhibition of TEL-fused Ret S891A mutant (unknown origin) expressed in mouse BaF3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	GI50	nM	350.0	CHEMBL2041	Homo sapiens	GI50	uM	0.35
	16446717	CHEMBL3756078	Inhibition of TEL-fused Ret S891A mutant (unknown origin) expressed in mouse BaF3 cells assessed as cell growth inhibition after 48 hrs by MTT assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	GI50	nM	10.0	CHEMBL2041	Homo sapiens	GI50	uM	0.01
	16446718	CHEMBL3756079	Potency index, ratio of IC50 for cabozantinib to IC50 for test compound for inhibition of Ret V804L mutant (unknown origin) by radiometric kinase assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	Ratio IC50		10.0	CHEMBL2041	Homo sapiens	Ratio IC50		10.0
Active	16446737	CHEMBL3756064	Inhibition of TEL-fused wild type Ret (unknown origin) phosphorylation at Y1062/Y905 expressed in mouse BAF3 cells at 0.01 to 10 uM after 1 hr by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	16446738	CHEMBL3756064	Inhibition of TEL-fused wild type Ret (unknown origin) phosphorylation at Y1062/Y905 expressed in mouse BAF3 cells at 0.01 to 10 uM after 1 hr by Western blot analysis	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446739	CHEMBL3756064	Inhibition of TEL-fused wild type Ret (unknown origin) phosphorylation at Y1062/Y905 expressed in mouse BAF3 cells at 0.01 to 10 uM after 1 hr by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	16446740	CHEMBL3757326	Inhibition of TEL-fused wild type Ret (unknown origin) expressed in mouse BAF3 assessed as suppression of phosphorylation of PLCgamma at Y783 at 0.01 to 10 uM after 1 hr by Western blot analysis	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	16446741	CHEMBL3757327	Inhibition of TEL-fused wild type Ret (unknown origin) expressed in mouse BAF3 assessed as suppression of phosphorylation of Shc at Y317 at 0.01 to 10 uM after 1 hr by Western blot analysis	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446742	CHEMBL3757139	Inhibition of TEL-fused Ret S891A mutant (unknown origin) phosphorylation at Y1062/Y905 expressed in mouse BAF3 cells at 0.01 to 10 uM after 1 hr by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	16446743	CHEMBL3757139	Inhibition of TEL-fused Ret S891A mutant (unknown origin) phosphorylation at Y1062/Y905 expressed in mouse BAF3 cells at 0.01 to 10 uM after 1 hr by Western blot analysis	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446744	CHEMBL3757139	Inhibition of TEL-fused Ret S891A mutant (unknown origin) phosphorylation at Y1062/Y905 expressed in mouse BAF3 cells at 0.01 to 10 uM after 1 hr by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446745	CHEMBL3757328	Inhibition of TEL-fused Ret S891A mutant (unknown origin) expressed in mouse BAF3 cells assessed as suppression of phosphorylation of PLCgamma at Y783 at 0.01 to 10 uM after 1 hr by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	16446746	CHEMBL3757328	Inhibition of TEL-fused Ret S891A mutant (unknown origin) expressed in mouse BAF3 cells assessed as suppression of phosphorylation of PLCgamma at Y783 at 0.01 to 10 uM after 1 hr by Western blot analysis	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446747	CHEMBL3757328	Inhibition of TEL-fused Ret S891A mutant (unknown origin) expressed in mouse BAF3 cells assessed as suppression of phosphorylation of PLCgamma at Y783 at 0.01 to 10 uM after 1 hr by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446748	CHEMBL3757329	Inhibition of TEL-fused Ret S891A mutant (unknown origin) expressed in mouse BAF3 cells assessed as suppression of phosphorylation of Shc at Y317 at 0.01 to 10 uM after 1 hr by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	16446749	CHEMBL3757329	Inhibition of TEL-fused Ret S891A mutant (unknown origin) expressed in mouse BAF3 cells assessed as suppression of phosphorylation of Shc at Y317 at 0.01 to 10 uM after 1 hr by Western blot analysis	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446750	CHEMBL3757329	Inhibition of TEL-fused Ret S891A mutant (unknown origin) expressed in mouse BAF3 cells assessed as suppression of phosphorylation of Shc at Y317 at 0.01 to 10 uM after 1 hr by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Dose-dependent effect	16446751	CHEMBL3757330	Inhibition of TEL-fused Ret V804L/M (unknown origin) expressed in mouse BAF3 after 1 hr by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Dose-dependent effect	16446752	CHEMBL3757330	Inhibition of TEL-fused Ret V804L/M (unknown origin) expressed in mouse BAF3 after 1 hr by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	16446753	CHEMBL3757332	Inhibition of TEL-fused Ret V804L/M (unknown origin) expressed in mouse BAF3 at 10 uM after 1 hr by Western blot analysis	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446754	CHEMBL3756066	Inhibition of autophosphorylation of RET C634W mutant at Y905 in human TT cells at 1 uM after 4 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	16446755	CHEMBL3756066	Inhibition of autophosphorylation of RET C634W mutant at Y905 in human TT cells at 1 uM after 4 hrs by Western blot analysis	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446756	CHEMBL3756066	Inhibition of autophosphorylation of RET C634W mutant at Y905 in human TT cells at 1 uM after 4 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446757	CHEMBL3757333	Inhibition of autophosphorylation of RET C634W mutant at Y1062 in human TT cells at 1 uM after 4 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	16446758	CHEMBL3757333	Inhibition of autophosphorylation of RET C634W mutant at Y1062 in human TT cells at 1 uM after 4 hrs by Western blot analysis	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446759	CHEMBL3757333	Inhibition of autophosphorylation of RET C634W mutant at Y1062 in human TT cells at 1 uM after 4 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446760	CHEMBL3757337	Inhibition of RET C634W mutant in human TT cells assessed as suppression of PLCgamma phosphorylation at Y783 at 1 to 10 uM after 4 hrs by Western blot analysis	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446761	CHEMBL3757337	Inhibition of RET C634W mutant in human TT cells assessed as suppression of PLCgamma phosphorylation at Y783 at 1 to 10 uM after 4 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446762	CHEMBL3757338	Inhibition of RET C634W mutant in human TT cells assessed as suppression of AKT phosphorylation at T308/S473 at 1 to 10 uM after 4 hrs by Western blot analysis	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446763	CHEMBL3757338	Inhibition of RET C634W mutant in human TT cells assessed as suppression of AKT phosphorylation at T308/S473 at 1 to 10 uM after 4 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446764	CHEMBL3757339	Inhibition of RET C634W mutant in human TT cells assessed as suppression of ERK phosphorylation at T202/Y204 at 1 to 10 uM after 4 hrs by Western blot analysis	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446765	CHEMBL3757339	Inhibition of RET C634W mutant in human TT cells assessed as suppression of ERK phosphorylation at T202/Y204 at 1 to 10 uM after 4 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446768	CHEMBL3757342	Inhibition of RET in human MCF7 cells assessed as suppression of GDNF-induced phosphorylation of ERK1/ERK2 at 100 nM by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	16446769	CHEMBL3757331	Potency index, ratio of IC50 for cabozantinib to IC50 for test compound for inhibition of Ret V804M mutant (unknown origin) by radiometric kinase assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	Ratio IC50		90.0	CHEMBL2041	Homo sapiens	Ratio IC50		90.0
Active	16446784	CHEMBL3757353	Inhibition of Ret-driven oncogenic transformation of human TT cells at 0.3 uM by soft agar assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446785	CHEMBL3757354	Inhibition of Ret-driven oncogenic transformation of human TT cells at 1 uM by soft agar assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	16446800	CHEMBL3756080	Inhibition of human RET assessed as residual activity at 1 uM by radiometric assay in presence of [gamma-33P]-ATP relative to control	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	Activity	%	1.62	CHEMBL2041	Homo sapiens	Activity	%	1.62
Active	16446801	CHEMBL3757334	Inhibition of RET C634W mutant in human TT cells assessed as suppression of PLCgamma phosphorylation at Y783 at 0.1 to 10 uM after 4 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446802	CHEMBL3757335	Inhibition of RET C634W mutant in human TT cells assessed as suppression of AKT phosphorylation at T308/S473 at 0.1 to 10 uM after 4 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	16446803	CHEMBL3757336	Inhibition of RET C634W mutant in human TT cells assessed as suppression of ERK phosphorylation at T202/Y204 at 0.1 to 10 uM after 4 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	16446804	CHEMBL3756070	Inhibition of RET C634W mutant in human TT cells assessed as cell growth inhibition after 10 days by MTT assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	GI50	nM	120.0	CHEMBL2041	Homo sapiens	GI50	uM	0.12
	16446806	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	358.0	CHEMBL2041	Homo sapiens	IC50	nM	358.0
	16446807	CHEMBL3756068	Inhibition of human Ret V804M mutant by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	IC50	nM	2650.0	CHEMBL2041	Homo sapiens	IC50	nM	2650.0
	16451603	CHEMBL3761184	Inhibition of RET (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	98.2	CHEMBL2041	Homo sapiens	INH	%	98.2
	16458636	CHEMBL3761602	Inhibition of RET (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	-5.0	CHEMBL2041	Homo sapiens	INH	%	-5.0
	16458637	CHEMBL3761602	Inhibition of RET (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	-2.0	CHEMBL2041	Homo sapiens	INH	%	-2.0
	16458638	CHEMBL3761602	Inhibition of RET (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	20.0	CHEMBL2041	Homo sapiens	INH	%	20.0
	16458639	CHEMBL3761602	Inhibition of RET (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	5.0	CHEMBL2041	Homo sapiens	INH	%	5.0
	16458640	CHEMBL3761602	Inhibition of RET (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	7.0	CHEMBL2041	Homo sapiens	INH	%	7.0
	16458641	CHEMBL3761602	Inhibition of RET (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	5.0	CHEMBL2041	Homo sapiens	INH	%	5.0
	16458642	CHEMBL3761602	Inhibition of RET (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	9.0	CHEMBL2041	Homo sapiens	INH	%	9.0
	16458643	CHEMBL3761602	Inhibition of RET (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	26.0	CHEMBL2041	Homo sapiens	INH	%	26.0
	16458644	CHEMBL3761602	Inhibition of RET (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	16458645	CHEMBL3761602	Inhibition of RET (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	16.0	CHEMBL2041	Homo sapiens	INH	%	16.0
	16458646	CHEMBL3761602	Inhibition of RET (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	64.0	CHEMBL2041	Homo sapiens	INH	%	64.0
	16465573	CHEMBL3766479	Inhibition of human RET using poly(Glu, Tyr) as substrate by Luciferase-Coupled Chemiluminescence assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	5.2	CHEMBL2041	Homo sapiens	IC50	nM	5.2
	16486386	CHEMBL3771952	Inhibition of human recombinant RET assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	16495206	CHEMBL3777748	Inhibition of N-terminal His6-tagged recombinant human RET expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	1.0	CHEMBL2041	Homo sapiens	Activity	%	1.0
	16495207	CHEMBL3777749	Inhibition of N-terminal His6-tagged recombinant human RET V804L mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-6.0	CHEMBL2041	Homo sapiens	Activity	%	-6.0
	16495208	CHEMBL3777750	Inhibition of N-terminal His6-tagged recombinant human RET V804M mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-1.0	CHEMBL2041	Homo sapiens	Activity	%	-1.0
	16496125	CHEMBL3777748	Inhibition of N-terminal His6-tagged recombinant human RET expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	3.0	CHEMBL2041	Homo sapiens	Activity	%	3.0
	16496126	CHEMBL3777749	Inhibition of N-terminal His6-tagged recombinant human RET V804L mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-3.0	CHEMBL2041	Homo sapiens	Activity	%	-3.0
	16496127	CHEMBL3777750	Inhibition of N-terminal His6-tagged recombinant human RET V804M mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-14.0	CHEMBL2041	Homo sapiens	Activity	%	-14.0
	16498856	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(N3CCCc4c(O)cccc43)c2cc1OC		CHEMBL3774623	=	IC50	nM	4100.0	CHEMBL2041	Homo sapiens	IC50	nM	4100.0
	16498857	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(N3CCc4c(O)cccc43)c2cc1OC		CHEMBL3774430	=	IC50	nM	60.0	CHEMBL2041	Homo sapiens	IC50	nM	60.0
	16498858	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Sc3cccc(O)c3)c2cc1OC		CHEMBL3775376	=	IC50	nM	23.0	CHEMBL2041	Homo sapiens	IC50	nM	23.0
	16498859	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Oc3cccc(O)c3)c2cc1OC		CHEMBL3775672	=	IC50	nM	16.0	CHEMBL2041	Homo sapiens	IC50	nM	16.0
	16498860	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(N(C)c3cccc(O)c3)c2cc1OC		CHEMBL3774935	=	IC50	nM	210.0	CHEMBL2041	Homo sapiens	IC50	nM	210.0
	16498861	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3c(F)ccc(O)c3Cl)c2cc1OC		CHEMBL3774953	=	IC50	nM	3.9	CHEMBL2041	Homo sapiens	IC50	nM	3.9
	16498862	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3c(Cl)ccc(O)c3Cl)c2cc1OC		CHEMBL3775585	=	IC50	nM	9.7	CHEMBL2041	Homo sapiens	IC50	nM	9.7
	16498863	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3Cl)c2cc1OC		CHEMBL3775560	=	IC50	nM	9.3	CHEMBL2041	Homo sapiens	IC50	nM	9.3
	16498864	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3c(Cl)ccc(O)c3C)c2cc1OC		CHEMBL3774697	=	IC50	nM	120.0	CHEMBL2041	Homo sapiens	IC50	nM	120.0
	16498865	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3c(F)ccc(O)c3C)c2cc1OC		CHEMBL3775940	=	IC50	nM	44.0	CHEMBL2041	Homo sapiens	IC50	nM	44.0
	16498866	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cc(F)cc(O)c3C)c2cc1OC		CHEMBL3774913	=	IC50	nM	21.0	CHEMBL2041	Homo sapiens	IC50	nM	21.0
	16498867	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3c(Cl)ccc(O)c3F)c2cc1OC		CHEMBL3775511	=	IC50	nM	4.8	CHEMBL2041	Homo sapiens	IC50	nM	4.8
	16498868	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3c(F)ccc(O)c3F)c2cc1OC		CHEMBL3775557	=	IC50	nM	1.7	CHEMBL2041	Homo sapiens	IC50	nM	1.7
	16498869	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccc(F)c(O)c3F)c2cc1OC		CHEMBL3775336	=	IC50	nM	2.0	CHEMBL2041	Homo sapiens	IC50	nM	2.0
	16498870	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cc(O)c(C)cc3Cl)c2cc1OC		CHEMBL3775415	=	IC50	nM	13.0	CHEMBL2041	Homo sapiens	IC50	nM	13.0
	16498871	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cc(O)c(C)cc3F)c2cc1OC		CHEMBL440727	=	IC50	nM	0.75	CHEMBL2041	Homo sapiens	IC50	nM	0.75
	16498872	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cc(O)c(Cl)cc3Cl)c2cc1OC		CHEMBL3775190	=	IC50	nM	5.0	CHEMBL2041	Homo sapiens	IC50	nM	5.0
	16498873	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cc(O)c(F)cc3F)c2cc1OC		CHEMBL3775169	=	IC50	nM	0.41	CHEMBL2041	Homo sapiens	IC50	nM	0.41
	16498874	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cc(O)ccc3C)c2cc1OC		CHEMBL3774951	=	IC50	nM	8.4	CHEMBL2041	Homo sapiens	IC50	nM	8.4
	16498875	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cc(O)ccc3Cl)c2cc1OC		CHEMBL3774489	=	IC50	nM	2.6	CHEMBL2041	Homo sapiens	IC50	nM	2.6
	16498876	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cc(O)ccc3F)c2cc1OC		CHEMBL3774904	=	IC50	nM	1.1	CHEMBL2041	Homo sapiens	IC50	nM	1.1
	16498877	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cc(C)cc(O)c3)c2cc1OC		CHEMBL3775086	=	IC50	nM	29.0	CHEMBL2041	Homo sapiens	IC50	nM	29.0
	16498878	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cc(O)cc(F)c3)c2cc1OC		CHEMBL3775934	=	IC50	nM	2.6	CHEMBL2041	Homo sapiens	IC50	nM	2.6
	16498879	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1O		CHEMBL3774563	=	IC50	nM	11.0	CHEMBL2041	Homo sapiens	IC50	nM	11.0
	16498880	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccc(Cl)c(O)c3)c2cc1OC		CHEMBL235851	=	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	nM	10.0
	16498881	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC		CHEMBL478442	=	IC50	nM	4.6	CHEMBL2041	Homo sapiens	IC50	nM	4.6
	16498882	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccc(F)c(O)c3)c2cc1OC		CHEMBL3775879	=	IC50	nM	3.2	CHEMBL2041	Homo sapiens	IC50	nM	3.2
	16498883	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cccc(O)c3C#N)c2cc1OC		CHEMBL3774643	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	16498884	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cccc(O)c3C(F)(F)F)c2cc1OC		CHEMBL3774720	=	IC50	nM	5500.0	CHEMBL2041	Homo sapiens	IC50	nM	5500.0
	16498885	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	CCc1c(O)cccc1Nc1ncnc2cc(OC)c(OC)cc12		CHEMBL3775240	=	IC50	nM	3800.0	CHEMBL2041	Homo sapiens	IC50	nM	3800.0
	16498886	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cccc(O)c3OC)c2cc1OC		CHEMBL3775660	=	IC50	nM	1100.0	CHEMBL2041	Homo sapiens	IC50	nM	1100.0
	16498887	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cccc(O)c3F)c2cc1OC		CHEMBL3775903	=	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	nM	10.0
	16498888	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cccc(O)c3C)c2cc1OC		CHEMBL3775569	=	IC50	nM	190.0	CHEMBL2041	Homo sapiens	IC50	nM	190.0
	16498889	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cccc(O)c3Cl)c2cc1OC		CHEMBL3775840	=	IC50	nM	19.0	CHEMBL2041	Homo sapiens	IC50	nM	19.0
	16498890	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cccc(O)c3Br)c2cc1OC		CHEMBL3775164	=	IC50	nM	23.0	CHEMBL2041	Homo sapiens	IC50	nM	23.0
	16498891	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cccc(O)c3O)c2cc1OC		CHEMBL3774580	=	IC50	nM	3.9	CHEMBL2041	Homo sapiens	IC50	nM	3.9
	16498892	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL169473	=	IC50	nM	1200.0	CHEMBL2041	Homo sapiens	IC50	nM	1200.0
	16498893	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cccc(N)c3)c2cc1OC		CHEMBL3220401	=	IC50	nM	590.0	CHEMBL2041	Homo sapiens	IC50	nM	590.0
	16498894	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	=	IC50	nM	720.0	CHEMBL2041	Homo sapiens	IC50	nM	720.0
	16498895	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	IC50	nM	4.5	CHEMBL2041	Homo sapiens	IC50	nM	4.5
	16498896	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccccc3O)c2cc1OC		CHEMBL3774450	=	IC50	nM	1600.0	CHEMBL2041	Homo sapiens	IC50	nM	1600.0
	16498897	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1OC		CHEMBL1277620	=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
	16498898	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	650.0	CHEMBL2041	Homo sapiens	IC50	nM	650.0
	16498899	CHEMBL3778237	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	49.0	CHEMBL2041	Homo sapiens	IC50	nM	49.0
	16508915	CHEMBL3777748	Inhibition of N-terminal His6-tagged recombinant human RET expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	11.0	CHEMBL2041	Homo sapiens	Activity	%	11.0
	16508916	CHEMBL3777749	Inhibition of N-terminal His6-tagged recombinant human RET V804L mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	10.0	CHEMBL2041	Homo sapiens	Activity	%	10.0
	16508917	CHEMBL3777750	Inhibition of N-terminal His6-tagged recombinant human RET V804M mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-6.0	CHEMBL2041	Homo sapiens	Activity	%	-6.0
Not Active	16515651	CHEMBL3782392	Inhibition of partial length human RET expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	16525670	CHEMBL3790306	Inhibition of RET (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	=	IC50	nM	3300.0	CHEMBL2041	Homo sapiens	IC50	uM	3.3
	16525671	CHEMBL3790306	Inhibition of RET (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	=	IC50	nM	4400.0	CHEMBL2041	Homo sapiens	IC50	uM	4.4
	16525672	CHEMBL3790306	Inhibition of RET (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	8.0	CHEMBL2041	Homo sapiens	IC50	uM	0.008
	16525673	CHEMBL3790306	Inhibition of RET (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	16525674	CHEMBL3790306	Inhibition of RET (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	=	IC50	nM	9300.0	CHEMBL2041	Homo sapiens	IC50	uM	9.3
	16525675	CHEMBL3790306	Inhibition of RET (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	=	IC50	nM	6000.0	CHEMBL2041	Homo sapiens	IC50	uM	6.0
	16539463	CHEMBL3789403	Inhibition of Ret (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	=	IC50	nM	3300.0	CHEMBL2041	Homo sapiens	IC50	uM	3.3
	16539464	CHEMBL3789403	Inhibition of Ret (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	8.0	CHEMBL2041	Homo sapiens	IC50	uM	0.008
	16539465	CHEMBL3789403	Inhibition of Ret (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	=	IC50	nM	4400.0	CHEMBL2041	Homo sapiens	IC50	uM	4.4
	16539466	CHEMBL3789403	Inhibition of Ret (unknown origin)	B	CC1(C)CC[C@@H](COc2cccc(-c3cn([C@H]4C[C@@H](CN5CCC5)C4)c4ncnc(N)c34)c2)O1		CHEMBL3786567	=	IC50	nM	970.0	CHEMBL2041	Homo sapiens	IC50	uM	0.97
	16563354	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2F)ccn1		CHEMBL3798751	=	Inhibition	%	74.1	CHEMBL2041	Homo sapiens	INH	%	74.1
	16563355	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ccn1		CHEMBL3800078	=	Inhibition	%	77.7	CHEMBL2041	Homo sapiens	INH	%	77.7
	16563356	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccccc3C(F)(F)F)cc2F)ccn1		CHEMBL3797345	=	Inhibition	%	43.0	CHEMBL2041	Homo sapiens	INH	%	43.0
	16563357	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(F)c(F)c3)cc2F)ccn1		CHEMBL3797892	=	Inhibition	%	17.6	CHEMBL2041	Homo sapiens	INH	%	17.6
	16563358	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(F)c(Cl)c3)cc2F)ccn1		CHEMBL3799169	=	Inhibition	%	63.3	CHEMBL2041	Homo sapiens	INH	%	63.3
Not Determined	16563359	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)cc3Cl)cc2F)ccn1		CHEMBL3797423		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	16563360	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CCN(CC)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2F)ccn1		CHEMBL3798176	=	Inhibition	%	84.4	CHEMBL2041	Homo sapiens	INH	%	84.4
	16563361	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CCN(CC)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ccn1		CHEMBL3798031	=	Inhibition	%	72.1	CHEMBL2041	Homo sapiens	INH	%	72.1
Not Determined	16563362	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CCN(CC)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccccc3C(F)(F)F)cc2F)ccn1		CHEMBL3800022		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	16563363	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CCN(CC)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(F)c(F)c3)cc2F)ccn1		CHEMBL3797607	=	Inhibition	%	7.1	CHEMBL2041	Homo sapiens	INH	%	7.1
	16563364	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CCN(CC)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(F)c(Cl)c3)cc2F)ccn1		CHEMBL3797930	=	Inhibition	%	1.9	CHEMBL2041	Homo sapiens	INH	%	1.9
Not Determined	16563365	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CCN(CC)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)cc3Cl)cc2F)ccn1		CHEMBL3798131		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	16563366	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CN(C)CCCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2F)ccn1		CHEMBL3798042	=	Inhibition	%	79.3	CHEMBL2041	Homo sapiens	INH	%	79.3
	16563367	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CN(C)CCCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ccn1		CHEMBL3800152	=	Inhibition	%	85.6	CHEMBL2041	Homo sapiens	INH	%	85.6
Not Determined	16563368	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CN(C)CCCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccccc3C(F)(F)F)cc2F)ccn1		CHEMBL3800096		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	16563369	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CN(C)CCCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(F)c(F)c3)cc2F)ccn1		CHEMBL3798667	=	Inhibition	%	30.9	CHEMBL2041	Homo sapiens	INH	%	30.9
	16563370	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CN(C)CCCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(F)c(Cl)c3)cc2F)ccn1		CHEMBL3797614	=	Inhibition	%	45.5	CHEMBL2041	Homo sapiens	INH	%	45.5
Not Determined	16563371	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CN(C)CCCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)cc3Cl)cc2F)ccn1		CHEMBL3798456		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	16563372	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	O=C(Nc1ccc(Oc2ccnc(-c3nncn3CCCN3CCOCC3)c2)c(F)c1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL3799650	=	Inhibition	%	42.3	CHEMBL2041	Homo sapiens	INH	%	42.3
	16563373	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	O=C(Nc1ccc(Oc2ccnc(-c3nncn3CCCN3CCOCC3)c2)c(F)c1)Nc1ccc(Cl)cc1Cl		CHEMBL3797752	=	Inhibition	%	45.6	CHEMBL2041	Homo sapiens	INH	%	45.6
	16563374	CHEMBL3801447	Inhibition of RET (unknown origin) at 10 uM after 1 hr by mobility shift assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Inhibition	%	97.0	CHEMBL2041	Homo sapiens	INH	%	97.0
	16563789	CHEMBL3802296	Inhibition of RET (unknown origin) by Z-LYTE assay	B	CC(NC(=O)c1ccc2[nH]nc(-c3ccncc3)c2c1)c1cccc(Cl)c1		CHEMBL3798631	>	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	16563790	CHEMBL3802296	Inhibition of RET (unknown origin) by Z-LYTE assay	B	Cc1cc(-c2n[nH]c3ccc(C(=O)NC(C)c4c(Cl)cncc4Cl)cc23)ccn1		CHEMBL3798257	>	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	16566747	CHEMBL3802996	Inhibition of human RET using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	CCOC(Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21)OCC		CHEMBL3799221	=	IC50	nM	598.0	CHEMBL2041	Homo sapiens	IC50	nM	598.0
	16566764	CHEMBL3802996	Inhibition of human RET using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	CCOC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OCC		CHEMBL3800481	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	10'5nM	1.0
	16566814	CHEMBL3802996	Inhibition of human RET using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	Nc1nc2cc(-c3nn(CC4OCCO4)c4ncnc(N)c34)ccc2o1		CHEMBL3797590	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	10'5nM	1.0
	16566828	CHEMBL3802996	Inhibition of human RET using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	COC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OC		CHEMBL3800138	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	10'5nM	1.0
	16574808	CHEMBL3802400	Inhibition of recombinant RET (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1000 nM incubated for 60 mins by ELISA relative to control	B	Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1		CHEMBL3797579	=	Inhibition	%	29.9	CHEMBL2041	Homo sapiens	INH	%	29.9
	16579358	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COCCCOc1cc2ncnc(Nc3c(F)ccc(O)c3C)c2cc1OC		CHEMBL3797684	=	IC50	nM	38.0	CHEMBL2041	Homo sapiens	IC50	uM	0.038
	16579359	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COCCOc1cc2ncnc(Nc3c(F)ccc(O)c3C)c2cc1OC		CHEMBL3797413	=	IC50	nM	14.0	CHEMBL2041	Homo sapiens	IC50	uM	0.014
	16579360	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCC1CCCO1		CHEMBL3800155	=	IC50	nM	18.0	CHEMBL2041	Homo sapiens	IC50	uM	0.018
	16579361	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCC1CCN(C)CC1		CHEMBL3799843	=	IC50	nM	78.0	CHEMBL2041	Homo sapiens	IC50	uM	0.078
	16579362	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCc1noc(C)n1		CHEMBL3798119	=	IC50	nM	24.0	CHEMBL2041	Homo sapiens	IC50	uM	0.024
	16579363	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCc1nccn1C		CHEMBL3797991	=	IC50	nM	110.0	CHEMBL2041	Homo sapiens	IC50	uM	0.11
	16579364	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCc1cccnc1		CHEMBL3800346	=	IC50	nM	12.0	CHEMBL2041	Homo sapiens	IC50	uM	0.012
	16579365	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN1CCCC1C(F)(F)F		CHEMBL3798883	=	IC50	nM	62.0	CHEMBL2041	Homo sapiens	IC50	uM	0.062
	16579366	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCCC1C(F)(F)F		CHEMBL3798349	=	IC50	nM	150.0	CHEMBL2041	Homo sapiens	IC50	uM	0.15
	16579367	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCC(F)C1		CHEMBL3800250	=	IC50	nM	30.0	CHEMBL2041	Homo sapiens	IC50	uM	0.03
	16579368	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN1CCS(=O)(=O)CC1		CHEMBL3798584	=	IC50	nM	9.0	CHEMBL2041	Homo sapiens	IC50	uM	0.009
	16579369	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCS(=O)(=O)CC1		CHEMBL3797561	=	IC50	nM	14.0	CHEMBL2041	Homo sapiens	IC50	uM	0.014
	16579370	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN1CCOCC1		CHEMBL3799933	=	IC50	nM	11.0	CHEMBL2041	Homo sapiens	IC50	uM	0.011
	16579371	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCOCC1		CHEMBL3797688	=	IC50	nM	14.0	CHEMBL2041	Homo sapiens	IC50	uM	0.014
	16579372	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL3800348	=	IC50	nM	29.0	CHEMBL2041	Homo sapiens	IC50	uM	0.029
	16579373	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCN(C)CC1		CHEMBL3798442	=	IC50	nM	44.0	CHEMBL2041	Homo sapiens	IC50	uM	0.044
	16579374	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN1CCCNCC1		CHEMBL3799971	=	IC50	nM	11.0	CHEMBL2041	Homo sapiens	IC50	uM	0.011
	16579375	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCCNCC1		CHEMBL3799969	=	IC50	nM	65.0	CHEMBL2041	Homo sapiens	IC50	uM	0.065
	16579376	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN1CCNCC1		CHEMBL3797261	=	IC50	nM	5.0	CHEMBL2041	Homo sapiens	IC50	uM	0.005
	16579377	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCNCC1		CHEMBL3798033	=	IC50	nM	17.0	CHEMBL2041	Homo sapiens	IC50	uM	0.017
	16579378	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN1CCCCC1		CHEMBL3799244	=	IC50	nM	15.0	CHEMBL2041	Homo sapiens	IC50	uM	0.015
	16579379	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCCCC1		CHEMBL3799867	=	IC50	nM	120.0	CHEMBL2041	Homo sapiens	IC50	uM	0.12
	16579380	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN1CCCC1		CHEMBL3800542	=	IC50	nM	15.0	CHEMBL2041	Homo sapiens	IC50	uM	0.015
	16579381	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCCC1		CHEMBL3797895	=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	uM	0.1
	16579382	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN(C)C		CHEMBL3799523	=	IC50	nM	7.0	CHEMBL2041	Homo sapiens	IC50	uM	0.007
	16579383	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN(C)C		CHEMBL3799264	=	IC50	nM	350.0	CHEMBL2041	Homo sapiens	IC50	uM	0.35
	16579384	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	CNCCCOc1cc2ncnc(Nc3c(F)ccc(O)c3C)c2cc1OC		CHEMBL3799756	=	IC50	nM	23.0	CHEMBL2041	Homo sapiens	IC50	uM	0.023
	16579385	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	CNCCOc1cc2ncnc(Nc3c(F)ccc(O)c3C)c2cc1OC		CHEMBL3800408	=	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	uM	0.1
	16579386	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN		CHEMBL3798215	=	IC50	nM	48.0	CHEMBL2041	Homo sapiens	IC50	uM	0.048
	16579387	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN		CHEMBL3797288	=	IC50	nM	130.0	CHEMBL2041	Homo sapiens	IC50	uM	0.13
	16579388	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2ncnc(Nc3cccc4[nH]ncc34)c2cc1OC		CHEMBL3800327	=	IC50	nM	140.0	CHEMBL2041	Homo sapiens	IC50	uM	0.14
	16579389	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2ncnc(Nc3ccc4[nH]ncc4c3)c2cc1OC		CHEMBL3798986	=	IC50	nM	600.0	CHEMBL2041	Homo sapiens	IC50	uM	0.6
	16579390	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2ncnc(Nc3ccc4cn[nH]c4c3)c2cc1OC		CHEMBL3800021	=	IC50	nM	280.0	CHEMBL2041	Homo sapiens	IC50	uM	0.28
	16579391	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2ncnc(Nc3cccc4cn[nH]c34)c2cc1OC		CHEMBL3797215	=	IC50	nM	3300.0	CHEMBL2041	Homo sapiens	IC50	uM	3.3
	16579392	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2ncnc(Nc3cccc4[nH]cnc34)c2cc1OC		CHEMBL3798102	=	IC50	nM	4300.0	CHEMBL2041	Homo sapiens	IC50	uM	4.3
	16579393	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2ncnc(Nc3ccc4[nH]cnc4c3)c2cc1OC		CHEMBL2333995	>	IC50	nM	30000.0	CHEMBL2041	Homo sapiens	IC50	uM	30.0
	16579394	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2ncnc(Nc3cccc4[nH]ccc34)c2cc1OC		CHEMBL3799979	=	IC50	nM	9100.0	CHEMBL2041	Homo sapiens	IC50	uM	9.1
	16579395	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2ncnc(Nc3ccc4cc[nH]c4c3)c2cc1OC		CHEMBL3799035	=	IC50	nM	1700.0	CHEMBL2041	Homo sapiens	IC50	uM	1.7
	16579396	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2ncnc(Nc3cccc(C(F)F)c3)c2cc1OC		CHEMBL3798019	=	IC50	nM	2900.0	CHEMBL2041	Homo sapiens	IC50	uM	2.9
	16579397	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2ncnc(Nc3cccc(NS(C)(=O)=O)c3)c2cc1OC		CHEMBL3800128	=	IC50	nM	7700.0	CHEMBL2041	Homo sapiens	IC50	uM	7.7
	16579398	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2ncnc(Nc3ccccc3)c2cc1OC		CHEMBL94191	=	IC50	nM	1700.0	CHEMBL2041	Homo sapiens	IC50	uM	1.7
	16579399	CHEMBL3804157	Inhibition of N-terminal GST fused human RET (658 to 1114 amino acid residue) using CSKtide as substrate expressed in baculovirus preincubated for 15 mins followed by substrate addition measured after 20 mins by FRET assay	B	COc1cc2ncnc(Nc3c(F)ccc(O)c3C)c2cc1OC		CHEMBL3775940	=	IC50	nM	44.0	CHEMBL2041	Homo sapiens	IC50	uM	0.044
	16587009	CHEMBL3807421	Inhibition of RET (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	IC50	nM	393.0	CHEMBL2041	Homo sapiens	IC50	uM	0.393
	16588214	CHEMBL3806822	Inhibition of human recombinant RET expressed in sf21 cells using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CCN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805771	=	IC50	nM	7.0	CHEMBL2041	Homo sapiens	IC50	uM	0.007
	16588215	CHEMBL3806822	Inhibition of human recombinant RET expressed in sf21 cells using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3F)cc2C(F)(F)F)CC1		CHEMBL3806189	=	IC50	nM	1.0	CHEMBL2041	Homo sapiens	IC50	uM	0.001
	16588275	CHEMBL3806846	Inhibition of human recombinant RET expressed in sf21 cells at 1 uM using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CCN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805771	>	Inhibition	%	99.0	CHEMBL2041	Homo sapiens	INH	%	99.0
	16588276	CHEMBL3806846	Inhibition of human recombinant RET expressed in sf21 cells at 1 uM using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3F)cc2C(F)(F)F)CC1		CHEMBL3806189	>	Inhibition	%	99.0	CHEMBL2041	Homo sapiens	INH	%	99.0
	16593597	CHEMBL3811554	Inhibition of GST-tagged human recombinant RET (658 to 1114 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL2041	Homo sapiens	INH	%	40.0
	16594843	CHEMBL3812894	Inhibition of human RET (713 to 1014 amino acid residues) expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	16614615	CHEMBL3816761	Inhibition of human RET at 1 uM using [KKKSPGEYVNIEFG] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	2.0	CHEMBL2041	Homo sapiens	INH	%	2.0
	16618135	CHEMBL3816521	Inhibition of recombinant human GST-tagged cytoplasmic RET (658 to 1114 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	16619694	CHEMBL3820361	Inhibition of recombinant human full length GST-tagged RET expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL2041	Homo sapiens	INH	%	75.0
	16621531	CHEMBL3820670	Inhibition of RET (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL2041	Homo sapiens	IC50	nM	30000.0
	16622238	CHEMBL3820670	Inhibition of RET (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	4.6	CHEMBL2041	Homo sapiens	IC50	nM	4.6
	16627570	CHEMBL3820502	Inhibition of recombinant human N-terminal GST-tagged RET (658-end residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	-3.0	CHEMBL2041	Homo sapiens	INH	%	-3.0
	16627571	CHEMBL3820502	Inhibition of recombinant human N-terminal GST-tagged RET (658-end residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	26.0	CHEMBL2041	Homo sapiens	INH	%	26.0
	16640015	CHEMBL3826743	Inhibition of human RET using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	Cc1ccc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)cc1		CHEMBL3823212	=	IC50	nM	6584.0	CHEMBL2041	Homo sapiens	IC50	nM	6584.0
	16640016	CHEMBL3826743	Inhibition of human RET using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	Cc1ccc(-c2nn(CCN3CCC(CN(C)C)CC3)c3ncnc(N)c23)cc1		CHEMBL3823849	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	10'4nM	1.0
	16640017	CHEMBL3826743	Inhibition of human RET using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	Cc1ccc(-c2nn(CCN3CCC(CCN(C)C)CC3)c3ncnc(N)c23)cc1		CHEMBL3822591	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	10'4nM	1.0
	16640018	CHEMBL3826743	Inhibition of human RET using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	CCOC(Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21)OCC		CHEMBL3799221	=	IC50	nM	598.0	CHEMBL2041	Homo sapiens	IC50	nM	598.0
	16640019	CHEMBL3826743	Inhibition of human RET using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	IC50	nM	11.0	CHEMBL2041	Homo sapiens	IC50	nM	11.0
	16640020	CHEMBL3826743	Inhibition of human RET using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	CN(C)CC1CCN(CCn2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)CC1		CHEMBL3823861	=	IC50	nM	289.0	CHEMBL2041	Homo sapiens	IC50	nM	289.0
	16640021	CHEMBL3826743	Inhibition of human RET using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL3824089	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	10'4nM	1.0
	16640022	CHEMBL3826743	Inhibition of human RET using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	433.0	CHEMBL2041	Homo sapiens	IC50	nM	433.0
	16653346	CHEMBL3830182	Inhibition of recombinant human RET using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178	>	IC50	nM	100.0	CHEMBL2041	Homo sapiens	IC50	nM	100.0
Dose-dependent effect	16655134	CHEMBL3830903	Inhibition of RET (unknown origin) phosphorylation at T905 residue in mouse BaF3/CCDC6-RET cells after 1 hr by Western blot analysis	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Dose-dependent effect	16655135	CHEMBL3830904	Inhibition of RET (unknown origin) in mouse BaF3/CCDC6-RET cells assessed as suppression of ERK1/2 phosphorylation at T202/Y204 residue after 1 hr by Western blot analysis	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Dose-dependent effect	16655136	CHEMBL3830905	Inhibition of RET (unknown origin) in mouse BaF3/CCDC6-RET cells assessed as suppression of AKT phosphorylation at S473 residue after 1 hr by Western blot analysis	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Dose-dependent effect	16655137	CHEMBL3830906	Inhibition of RET (unknown origin) in mouse BaF3/CCDC6-RET cells assessed as suppression of STAT3 phosphorylation at Y705 residue after 1 hr by Western blot analysis	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	16655138	CHEMBL3830907	Inhibition of wild type N-terminal GST-tagged recombinant human RET (658 residues) expressed in insect Sf21 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	1.6	CHEMBL2041	Homo sapiens	IC50	nM	1.6
	16655139	CHEMBL3831010	Inhibition of N-terminal GST-tagged recombinant human RET V804M mutant (658 residues) expressed in insect Sf21 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	10.4	CHEMBL2041	Homo sapiens	IC50	nM	10.4
	16655171	CHEMBL3831011	Inhibition of wild type recombinant human RET using Biotin-EGPWLEEEEEAYGWMDF as substrate incubated for 60 mins by TR-FRET assay	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	4.8	CHEMBL2041	Homo sapiens	IC50	nM	4.8
	16655172	CHEMBL3831012	Inhibition of recombinant human RET V804M mutant using Biotin-EGPWLEEEEEAYGWMDF as substrate incubated for 60 mins by TR-FRET assay	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	39.8	CHEMBL2041	Homo sapiens	IC50	nM	39.8
	16655178	CHEMBL3830907	Inhibition of wild type N-terminal GST-tagged recombinant human RET (658 residues) expressed in insect Sf21 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	3.0	CHEMBL2041	Homo sapiens	IC50	nM	3.0
	16655179	CHEMBL3831010	Inhibition of N-terminal GST-tagged recombinant human RET V804M mutant (658 residues) expressed in insect Sf21 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	811.0	CHEMBL2041	Homo sapiens	IC50	nM	811.0
	16737968	CHEMBL3856685	Inhibition of recombinant human RET expressed in insect Sf21 cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by poly(Glu:Tyr) substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	42.0	CHEMBL2041	Homo sapiens	Activity	%	42.0
	16739534	CHEMBL3857077	Inhibition of GST tagged recombinant human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	11.0	CHEMBL2041	Homo sapiens	INH	%	11.0
	16739535	CHEMBL3857077	Inhibition of GST tagged recombinant human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	11.0	CHEMBL2041	Homo sapiens	INH	%	11.0
	16739536	CHEMBL3857077	Inhibition of GST tagged recombinant human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	64.0	CHEMBL2041	Homo sapiens	INH	%	64.0
	16742601	CHEMBL3857910	Inhibition of RET (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	4.0	CHEMBL2041	Homo sapiens	IC50	nM	4.0
	16759057	CHEMBL3861658	Binding affinity to of human partial length RET expressed in bacterial system by active site-directed competition binding assay	B	Cn1ccc(-c2ccc3c(c2)ncn3-c2ccc(CC(=O)Nc3cc(C(C)(C)C)on3)cc2)c1		CHEMBL3957061	<	Kd	nM	1.0	CHEMBL2041	Homo sapiens	Kd	uM	0.001
	16759058	CHEMBL3861657	Inhibition of human recombinant RET assessed as residual activity at 100 uM by microfluidics separation based assay	B	Brc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL3902643	=	Activity	%	28.0	CHEMBL2041	Homo sapiens	Activity	%	28.0
	16797827	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(-c4noc(-c5cccnc5)n4)c3)cc2C(F)(F)F)CC1		CHEMBL3961612	=	IC50	nM	7.3	CHEMBL2041	Homo sapiens	IC50	nM	7.3
	16797828	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(-c4nnc(-c5cccnc5)o4)c3)cc2C(F)(F)F)CC1		CHEMBL3915551	=	IC50	nM	137.8	CHEMBL2041	Homo sapiens	IC50	nM	137.8
	16797829	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(-c4nc(-c5cccnc5)no4)c3)cc2C(F)(F)F)CC1		CHEMBL3985315	=	IC50	nM	12.4	CHEMBL2041	Homo sapiens	IC50	nM	12.4
	16797830	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(-c4nc(-c5cccnc5)co4)c3)cc2C(F)(F)F)CC1		CHEMBL3925190	=	IC50	nM	21.4	CHEMBL2041	Homo sapiens	IC50	nM	21.4
	16797831	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(-c4cnc(-c5cccnc5)o4)c3)cc2C(F)(F)F)CC1		CHEMBL3952889	=	IC50	nM	19.4	CHEMBL2041	Homo sapiens	IC50	nM	19.4
	16797832	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL3916184	=	IC50	nM	2.5	CHEMBL2041	Homo sapiens	IC50	nM	2.5
	16797833	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	0.9	CHEMBL2041	Homo sapiens	IC50	nM	0.9
	16797834	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3cccc(-c4noc(-c5cccnc5)n4)c3)cc2C(F)(F)F)CC1		CHEMBL3943036	=	IC50	nM	17.9	CHEMBL2041	Homo sapiens	IC50	nM	17.9
	16797835	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1-c1noc(-c2cccnc2)n1		CHEMBL3972633	=	IC50	nM	107.6	CHEMBL2041	Homo sapiens	IC50	nM	107.6
	16797836	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(-c4noc(-c5ccncc5)n4)c3)cc2C(F)(F)F)CC1		CHEMBL3913553	=	IC50	nM	26.6	CHEMBL2041	Homo sapiens	IC50	nM	26.6
	16797837	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	COc1ccc(-c2nc(-c3cc(C(=O)Nc4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc3Cl)no2)cn1		CHEMBL3961567	=	IC50	nM	341.9	CHEMBL2041	Homo sapiens	IC50	nM	341.9
	16797838	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	COCCOc1cncc(-c2nc(-c3cc(C(=O)Nc4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc3Cl)no2)c1		CHEMBL3987007	=	IC50	nM	11.4	CHEMBL2041	Homo sapiens	IC50	nM	11.4
	16797839	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(-c4noc(-c5cncc(N6CCOCC6)c5)n4)c3)cc2C(F)(F)F)CC1		CHEMBL3947880	=	IC50	nM	2.1	CHEMBL2041	Homo sapiens	IC50	nM	2.1
	16797840	CHEMBL3868194	Inhibition of RET (unknown origin) using poly[Glu:Tyr] (4:1) as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(-c4noc(-c5cncc(-c6cnn(C)c6)c5)n4)c3)cc2C(F)(F)F)CC1		CHEMBL3906151	=	IC50	nM	1.8	CHEMBL2041	Homo sapiens	IC50	nM	1.8
	16804142	CHEMBL3869731	Inhibition of human recombinant GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	IC50	nM	19.0	CHEMBL2041	Homo sapiens	IC50	nM	19.0
	16804144	CHEMBL3869736	Inhibition of human recombinant N-terminal GST-tagged RET V804L mutant cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	IC50	nM	8.4	CHEMBL2041	Homo sapiens	IC50	nM	8.4
	16804191	CHEMBL3869782	Inhibition of human recombinant GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	103.0	CHEMBL2041	Homo sapiens	INH	%	103.0
	16804192	CHEMBL3869783	Inhibition of human recombinant N-terminal GST-tagged RET V804L mutant cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	99.0	CHEMBL2041	Homo sapiens	INH	%	99.0
	16815466	CHEMBL3871628	Inhibition of human recombinant GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 1 uM	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	Inhibition	%	61.0	CHEMBL2041	Homo sapiens	INH	%	61.0
	16844154	CHEMBL3877191	Inhibition of RET (unknown origin)	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	IC50	nM	48.0	CHEMBL2041	Homo sapiens	IC50	nM	48.0
	16894635	CHEMBL3882045	Inhibition of Ret (unknown origin) at 5 uM relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	=	Inhibition	%	93.0	CHEMBL2041	Homo sapiens	INH	%	93.0
234049	17622012	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	CN(C)CCC=C1c2ccccc2C=Cc2ccccc21		CHEMBL669	=	IC50	nM	300.0	CHEMBL2041	Homo sapiens	IC50	nM	300.0
234050	17622013	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	CN(C)CCC=C1c2ccccc2CCc2ccccc21		CHEMBL629	=	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
234051	17622014	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	CNCCC=C1c2ccccc2CCc2ccccc21		CHEMBL445	=	IC50	nM	1500.0	CHEMBL2041	Homo sapiens	IC50	nM	1500.0
234052	17622015	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	CN(C)CCOC1c2ccccc2C=Cc2ccccc21		CHEMBL1906929	=	IC50	nM	2500.0	CHEMBL2041	Homo sapiens	IC50	nM	2500.0
234053	17622016	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	CCN(CC)CCCOC(=O)CC1c2ccccc2C=Cc2ccccc21		CHEMBL3693950	=	IC50	nM	4000.0	CHEMBL2041	Homo sapiens	IC50	nM	4000.0
234054	17622017	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	NCC1c2ccccc2CCc2ccccc21		CHEMBL44819	=	IC50	nM	5000.0	CHEMBL2041	Homo sapiens	IC50	nM	5000.0
234055	17622018	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	CNCCC=C1c2ccccc2CCc2ccccc21		CHEMBL445	=	IC50	nM	5000.0	CHEMBL2041	Homo sapiens	IC50	nM	5000.0
234056	17622019	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21		CHEMBL627	=	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
234057	17622020	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	CN(C)CCCC1(O)c2ccccc2C=Cc2ccccc21		CHEMBL1454772	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
234058	17622021	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1		CHEMBL87708	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	nM	20000.0
234059	17622022	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	CN(C)CC/C=C1\c2ccccc2COc2ccccc21		CHEMBL860	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	nM	20000.0
234060	17622023	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	CN(C)CCNC1c2ccccc2-c2ccccc21		CHEMBL3693951	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	nM	20000.0
234061	17622024	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	NCCCC1(CCCN)c2ccccc2-c2ccccc21		CHEMBL3693952	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	nM	20000.0
234062	17622025	CHEMBL3706031	Kinase Assay: Approximately 5-20 μg of purified GST-RET proteins were incubated with 1 mM ATP in 20 μL kinase buffer (10 mM Tris-HCl, 5 mM MgCl2, pH 7.4), at 30° C. for 30 minutes. The kinase reactions were terminated by boiling the samples in SDS-PAGE sample buffer. Samples were resolved on 10% acrylamide gels by SDS-PAGE followed by Western blotting. Phosphorylation was detected using a pan-phosphotyrosine pY99 antibody (available from Santa Cruz Biotechnology) or RET phospho-specific antibody (pY905, available from Cell Signaling, Beverly, Mass., USA).	B	CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21		CHEMBL110094	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	nM	20000.0
280622	17662967	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687191	=	IC50	nM	1.1	CHEMBL2041	Homo sapiens	IC50	nM	1.1
280623	17662968	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687194	=	IC50	nM	0.95	CHEMBL2041	Homo sapiens	IC50	nM	0.95
280624	17662969	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687195	=	IC50	nM	1.7	CHEMBL2041	Homo sapiens	IC50	nM	1.7
280625	17662970	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687200	=	IC50	nM	1.5	CHEMBL2041	Homo sapiens	IC50	nM	1.5
280626	17662971	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687202	=	IC50	nM	1.0	CHEMBL2041	Homo sapiens	IC50	nM	1.0
280627	17662972	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687205	=	IC50	nM	2.3	CHEMBL2041	Homo sapiens	IC50	nM	2.3
280628	17662973	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@@](C)(O)CC1		CHEMBL3687207	=	IC50	nM	1.1	CHEMBL2041	Homo sapiens	IC50	nM	1.1
280629	17662974	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C(C)C)CC3)c(C)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687210	=	IC50	nM	1.3	CHEMBL2041	Homo sapiens	IC50	nM	1.3
280630	17662975	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@](C)(O)CC1		CHEMBL3687212	=	IC50	nM	1.0	CHEMBL2041	Homo sapiens	IC50	nM	1.0
280631	17662976	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCOCC1		CHEMBL3687215	=	IC50	nM	1.0	CHEMBL2041	Homo sapiens	IC50	nM	1.0
280632	17662977	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	Cc1cc(Nc2nc(N[C@H]3CC[C@H](O)CC3)c(Cl)nc2C(N)=O)ccc1N1CCC(N2CCN(C)CC2)CC1		CHEMBL3687217	=	IC50	nM	1.3	CHEMBL2041	Homo sapiens	IC50	nM	1.3
280633	17662978	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1NC1CCOCC1		CHEMBL3687220	=	IC50	nM	1.3	CHEMBL2041	Homo sapiens	IC50	nM	1.3
280634	17662979	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	IC50	nM	3.4	CHEMBL2041	Homo sapiens	IC50	nM	3.4
280635	17662980	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1NC1CCOCC1		CHEMBL3687221	=	IC50	nM	1.5	CHEMBL2041	Homo sapiens	IC50	nM	1.5
280636	17662981	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)c(F)c2)nc1NC1CCOCC1		CHEMBL3687222	=	IC50	nM	1.1	CHEMBL2041	Homo sapiens	IC50	nM	1.1
280637	17662982	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	COc1cc(Nc2nc(NC3CCOCC3)c(C(C)C)nc2C(N)=O)ccc1N1CCN(C)CC1		CHEMBL3687223	=	IC50	nM	3.6	CHEMBL2041	Homo sapiens	IC50	nM	3.6
280638	17662983	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1NC1CCOCC1		CHEMBL3687224	=	IC50	nM	2.9	CHEMBL2041	Homo sapiens	IC50	nM	2.9
280639	17662984	CHEMBL3706336	Inhibition Assay: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 µM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition. In the absence of the test compound, the phosphorylation peptide peak without ATP addition and with ATP addition was assumed to be 100% inhibition and 0% inhibition, respectively.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCOCC1		CHEMBL3687225	=	IC50	nM	1.1	CHEMBL2041	Homo sapiens	IC50	nM	1.1
342804	17720195	CHEMBL3887560	Kinase Inhibition Assay: This example shows that the inhibitory activity of the compound, N1'-[3-fluoro-4-[[7-[4-(hydroxyamino)-4-oxobutoxy]-6-methoxy-4-quinolyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide prepared in Example 9 in cells against kinases including ALK, AXL, FLT3, VEGFR2, c-KIT, c-MET, PDGFR-beta, RET and SRC (tested by Advanced Cellular Dynamics, 3550 General Atomics Court, Building 2, Room 639, San Diego, CA 92121. www.advancedcelldynamics.com and Carna Biosciences, Inc.(www.carnabio.com)) measured according to the method described in the literature (Reference: Daley, G. Q.; Baltimore, D. Proc. Natl. Acd. Sci. USA 1988, 85(23), 9312). Specific steps were as follows: The compound of the present invention was dissolved in dimethyl sulfoxide (DMSO) to make a stock solution of 2 mM, then the stock solution was diluted with DMSO following a 7 half-log series to concentrations ranging from 2 uM to 600 pM.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCC(=O)NO		CHEMBL3981567	=	IC50	nM	154.0	CHEMBL2041	Homo sapiens	IC50	nM	154.0
364065	17739258	CHEMBL3887942	Competitive Binding Assay (KINOMEscan): For the competitive binding assay, test compounds were screened at 10 uM against 70 diverse kinase targets for competitive binding using the KINOMEscan technology (Ambit Biosciences) (Karaman, et al. (2008) Nature biotechnology 26:127-132). 11-point Kd curves were determined for hits identified during the initial screen.	B	CSc1nc(N)cc(Oc2ccc(-c3nnc(Nc4cccc(C(F)(F)F)c4)[nH]3)cc2)n1		CHEMBL3932957	>	Kd	nM	10000.0	CHEMBL2041	Homo sapiens	Kd	nM	10000.0
431440	17791548	CHEMBL3889050	In Vitro Inhibition Assay: In Vitro Inhibition of Tyrosine Kinases using a 10-point Titration Curve.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	11.1	CHEMBL2041	Homo sapiens	IC50	nM	11.1
Inactive	17935009	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935010	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935011	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935012	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935013	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17935014	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	=	Kd	nM	2549.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	2549.0
Active	17935015	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	18050.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	18050.0
Active	17935016	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	111.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	111.0
Inactive	17935017	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935018	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	2178.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	2178.0
Inactive	17935019	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935020	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935021	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	=	Kd	nM	390.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	390.0
Inactive	17935022	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935023	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	50.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	50.0
Active	17935024	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	172.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	172.0
Inactive	17935025	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935026	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	9.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	9.0
Active	17935027	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	955.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	955.0
Inactive	17935028	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935029	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935030	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935031	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935032	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	=	Kd	nM	7483.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	7483.0
Inactive	17935033	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935034	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935035	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	17.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	17.0
Inactive	17935036	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935037	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935038	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	39.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	39.0
Inactive	17935039	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935040	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935041	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935042	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	1603.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1603.0
Inactive	17935043	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935044	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	973.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	973.0
Inactive	17935045	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935046	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935047	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935048	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935049	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	=	Kd	nM	1328.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1328.0
Inactive	17935050	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935051	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	1231.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1231.0
Inactive	17935052	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935053	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935054	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	427.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	427.0
Inactive	17935055	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935056	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	1215.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1215.0
Active	17935057	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	67.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	67.0
Inactive	17935058	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935059	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	11.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	11.0
Inactive	17935060	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935061	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935062	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935063	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	19822.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	19822.0
Active	17935064	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	810.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	810.0
Inactive	17935065	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935066	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935067	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935068	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935069	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935070	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	6.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	6.0
Active	17935071	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	23.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	23.0
Inactive	17935072	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935073	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	27.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	27.0
Inactive	17935074	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935075	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935076	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935077	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935078	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935079	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	292.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	292.0
Active	17935080	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	=	Kd	nM	93.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	93.0
Inactive	17935081	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935082	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	11.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	11.0
Inactive	17935083	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935084	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	728.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	728.0
Active	17935085	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	=	Kd	nM	111.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	111.0
Active	17935086	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	=	Kd	nM	1028.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1028.0
Active	17935087	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	Kd	nM	783.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	783.0
Active	17935088	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	Kd	nM	5.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	5.0
Active	17935089	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	105.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	105.0
Inactive	17935090	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935091	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	23.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	23.0
Active	17935092	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	117.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	117.0
Active	17935093	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Kd	nM	126.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	126.0
Inactive	17935094	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935095	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935096	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935097	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935098	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935099	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935100	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935101	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935102	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935103	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935104	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	=	Kd	nM	1107.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1107.0
Inactive	17935105	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935106	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935107	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935108	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	=	Kd	nM	29.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	29.0
Inactive	17935109	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935110	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	669.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	669.0
Inactive	17935111	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935112	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935113	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	388.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	388.0
Active	17935114	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	28.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	28.0
Active	17935115	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	33.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	33.0
Inactive	17935116	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935117	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935118	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935119	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935120	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	9.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	9.0
Active	17935121	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	=	Kd	nM	1185.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1185.0
Inactive	17935122	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935123	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935124	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935125	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	=	Kd	nM	388.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	388.0
Active	17935126	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	81.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	81.0
Inactive	17935127	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935128	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	1200.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1200.0
Inactive	17935129	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935130	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935131	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935132	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935133	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1438.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1438.0
Inactive	17935134	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935135	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	=	Kd	nM	1147.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1147.0
Active	17935136	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	405.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	405.0
Active	17935137	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	=	Kd	nM	675.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	675.0
Inactive	17935138	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935139	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935140	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935141	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935142	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	Kd	nM	369.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	369.0
Inactive	17935143	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935144	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935145	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935146	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	2416.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	2416.0
Inactive	17935147	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935148	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	=	Kd	nM	1382.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1382.0
Inactive	17935149	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935150	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935151	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935152	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	23155.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	23155.0
Inactive	17935153	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935154	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	2860.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	2860.0
Inactive	17935155	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935156	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	=	Kd	nM	10.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	10.0
Inactive	17935157	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935158	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	1322.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1322.0
Active	17935159	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Kd	nM	209.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	209.0
Inactive	17935160	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935161	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	205.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	205.0
Inactive	17935162	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935163	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935164	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2485.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	2485.0
Inactive	17935165	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935166	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	86.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	86.0
Inactive	17935167	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935168	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	521.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	521.0
Inactive	17935169	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935170	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	=	Kd	nM	57.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	57.0
Active	17935171	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	Kd	nM	487.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	487.0
Inactive	17935172	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935173	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	=	Kd	nM	21887.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	21887.0
Active	17935174	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	25.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	25.0
Inactive	17935175	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935176	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	10.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	10.0
Active	17935177	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	518.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	518.0
Active	17935178	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1349.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1349.0
Inactive	17935179	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935180	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935181	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935182	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935183	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17935184	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	21858.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	21858.0
Active	17935185	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	316.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	316.0
Inactive	17935186	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935187	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935188	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935189	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935190	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	1139.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1139.0
Active	17935191	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	33.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	33.0
Active	17935192	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1638.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1638.0
Inactive	17935193	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935194	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	1.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1.0
Inactive	17935195	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935196	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935197	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935198	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935199	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935200	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935201	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935202	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935203	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	341.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	341.0
Inactive	17935204	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935205	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935206	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935207	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	175.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	175.0
Inactive	17935208	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935209	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935210	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935211	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935212	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935213	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935214	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935215	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935216	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935217	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935218	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	227.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	227.0
Inactive	17935219	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935220	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935221	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935222	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	1558.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1558.0
Active	17935223	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	6.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	6.0
Inactive	17935224	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935225	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	=	Kd	nM	3217.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	3217.0
Inactive	17935226	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935227	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	12.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	12.0
Inactive	17935228	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935229	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	=	Kd	nM	238.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	238.0
Inactive	17935230	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935231	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935232	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935233	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935234	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935235	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935236	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17935237	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	178.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	178.0
Inactive	17935238	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935239	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935240	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	34.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	34.0
Active	17935241	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	Kd	nM	27542.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	27542.0
Inactive	17935242	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935243	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935244	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	1278.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	1278.0
Inactive	17935245	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935246	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	=	Kd	nM	2416.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	2416.0
Inactive	17935247	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935248	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935249	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	30000.0
Active	17935250	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	3.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	3.0
Active	17935251	CHEMBL3991867	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	64.0	CHEMBL2041	Homo sapiens	Kd apparent	nM	64.0
	17964946	CHEMBL3995055	Inhibition of human RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	50.0	CHEMBL2041	Homo sapiens	Activity	%	50.0
	17979270	CHEMBL3998074	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 10 uM relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	7.0	CHEMBL2041	Homo sapiens	INH	%	7.0
	17993917	CHEMBL4000806	Inhibition of human RET (E713 to D1014 residues) expressed in bacterial expression system at 1 uM by KinomeScan assay relative to control	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213	>	Inhibition	%	90.0	CHEMBL2041	Homo sapiens	INH	%	90.0
	17993918	CHEMBL4000789	Inhibition of human RET V804M mutant using peptide substrate KKKVSRSGLYRSPS MPENLNRPR in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(-c3ccsc3)on2)c(C(N)=O)c1N		CHEMBL4060622	=	IC50	nM	2902.0	CHEMBL2041	Homo sapiens	IC50	uM	2.902
	17993919	CHEMBL4000789	Inhibition of human RET V804M mutant using peptide substrate KKKVSRSGLYRSPS MPENLNRPR in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(-c3cccs3)on2)c(C(N)=O)c1N		CHEMBL4094670	=	IC50	nM	1218.0	CHEMBL2041	Homo sapiens	IC50	uM	1.218
	17993920	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2ccon2)c2c(N)ncnc21		CHEMBL3752025	=	IC50	nM	213.0	CHEMBL2041	Homo sapiens	IC50	uM	0.213
	17993921	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	Nc1ncnc2[nH]nc(-c3cc(C4CC4)on3)c12		CHEMBL3752879	=	IC50	nM	52.0	CHEMBL2041	Homo sapiens	IC50	uM	0.052
Dose-dependent effect	17993930	CHEMBL4000799	Inhibition of RET V804M mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in Shc phosphorylation at Tyr-317 residue after 3 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Dose-dependent effect	17993931	CHEMBL4000784	Inhibition of RET V804M mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in PLCgamma phosphorylation at Tyr-783 residue after 3 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Dose-dependent effect	17993932	CHEMBL4000782	Inhibition of RET (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in Shc phosphorylation at Tyr-317 residue after 3 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Dose-dependent effect	17993933	CHEMBL4000786	Inhibition of RET (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in PLCgamma phosphorylation at Tyr-783 residue after 3 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Dose-dependent effect	17993934	CHEMBL4000787	Inhibition of RET V804M mutant (unknown origin) autophosphorylation at Tyrosine 905 residue transfected in mouse Ba/F3 cells after 3 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Dose-dependent effect	17993935	CHEMBL4000788	Inhibition of RET (unknown origin) autophosphorylation at Tyrosine 905 residue transfected in mouse Ba/F3 cells after 3 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	17993940	CHEMBL4000798	Inhibition of RET C634W mutant in human TT cells assessed as reduction in cell viability by CellTiter-Glo luminescence assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	GI50	nM	260.0	CHEMBL2041	Homo sapiens	GI50	uM	0.26
	17993941	CHEMBL4000798	Inhibition of RET C634W mutant in human TT cells assessed as reduction in cell viability by CellTiter-Glo luminescence assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213	=	GI50	nM	1660.0	CHEMBL2041	Homo sapiens	GI50	uM	1.66
	17993942	CHEMBL4000798	Inhibition of RET C634W mutant in human TT cells assessed as reduction in cell viability by CellTiter-Glo luminescence assay	B	CC(C)n1nc(-c2cc(-c3ccsc3)on2)c(C(N)=O)c1N		CHEMBL4060622	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	17993943	CHEMBL4000798	Inhibition of RET C634W mutant in human TT cells assessed as reduction in cell viability by CellTiter-Glo luminescence assay	B	CC(C)n1nc(-c2cc(-c3cccs3)on2)c(C(N)=O)c1N		CHEMBL4094670	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	17993948	CHEMBL4000796	Inhibition of RET V804M mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability by CellTiter-Glo luminescence assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	GI50	nM	740.0	CHEMBL2041	Homo sapiens	GI50	uM	0.74
	17993949	CHEMBL4000796	Inhibition of RET V804M mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability by CellTiter-Glo luminescence assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213	=	GI50	nM	6980.0	CHEMBL2041	Homo sapiens	GI50	uM	6.98
	17993950	CHEMBL4000796	Inhibition of RET V804M mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability by CellTiter-Glo luminescence assay	B	CC(C)n1nc(-c2cc(-c3ccsc3)on2)c(C(N)=O)c1N		CHEMBL4060622	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	17993951	CHEMBL4000796	Inhibition of RET V804M mutant (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability by CellTiter-Glo luminescence assay	B	CC(C)n1nc(-c2cc(-c3cccs3)on2)c(C(N)=O)c1N		CHEMBL4094670	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	17993952	CHEMBL4000794	Inhibition of RET (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability by CellTiter-Glo luminescence assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	GI50	nM	70.0	CHEMBL2041	Homo sapiens	GI50	uM	0.07
	17993953	CHEMBL4000794	Inhibition of RET (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability by CellTiter-Glo luminescence assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213	=	GI50	nM	870.0	CHEMBL2041	Homo sapiens	GI50	uM	0.87
	17993954	CHEMBL4000794	Inhibition of RET (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability by CellTiter-Glo luminescence assay	B	CC(C)n1nc(-c2cc(-c3ccsc3)on2)c(C(N)=O)c1N		CHEMBL4060622	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	17993955	CHEMBL4000794	Inhibition of RET (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability by CellTiter-Glo luminescence assay	B	CC(C)n1nc(-c2cc(-c3cccs3)on2)c(C(N)=O)c1N		CHEMBL4094670	>	GI50	nM	10000.0	CHEMBL2041	Homo sapiens	GI50	uM	10.0
	17993960	CHEMBL4000789	Inhibition of human RET V804M mutant using peptide substrate KKKVSRSGLYRSPS MPENLNRPR in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213	=	IC50	nM	252.0	CHEMBL2041	Homo sapiens	IC50	uM	0.252
	17993961	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(C3CCCCC3)on2)c(C(N)=O)c1N		CHEMBL4069150	=	IC50	nM	2695.0	CHEMBL2041	Homo sapiens	IC50	uM	2.695
	17993962	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213	=	IC50	nM	44.0	CHEMBL2041	Homo sapiens	IC50	uM	0.044
	17993963	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(C(C)(C)C)on2)c(C(N)=O)c1N		CHEMBL4079894	=	IC50	nM	2224.0	CHEMBL2041	Homo sapiens	IC50	uM	2.224
	17993964	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)c1cc(-c2nn(C(C)C)c(N)c2C(N)=O)no1		CHEMBL4097921	=	IC50	nM	1259.0	CHEMBL2041	Homo sapiens	IC50	uM	1.259
	17993965	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CCc1cc(-c2nn(C(C)C)c(N)c2C(N)=O)no1		CHEMBL4082500	=	IC50	nM	631.0	CHEMBL2041	Homo sapiens	IC50	uM	0.631
	17993966	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(-c3ccsc3)on2)c(C(N)=O)c1N		CHEMBL4060622	=	IC50	nM	162.0	CHEMBL2041	Homo sapiens	IC50	uM	0.162
	17993967	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(-c3cccs3)on2)c(C(N)=O)c1N		CHEMBL4094670	=	IC50	nM	78.0	CHEMBL2041	Homo sapiens	IC50	uM	0.078
	17993968	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(-c3ccccn3)on2)c(C(N)=O)c1N		CHEMBL4074164	=	IC50	nM	4803.0	CHEMBL2041	Homo sapiens	IC50	uM	4.803
	17993969	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(-c3cccnc3)on2)c(C(N)=O)c1N		CHEMBL4086972	=	IC50	nM	3395.0	CHEMBL2041	Homo sapiens	IC50	uM	3.395
	17993970	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(-c3ccc(F)cc3)on2)c(C(N)=O)c1N		CHEMBL4065543	=	IC50	nM	416.0	CHEMBL2041	Homo sapiens	IC50	uM	0.416
	17993971	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	Cc1ccc(-c2cc(-c3nn(C(C)C)c(N)c3C(N)=O)no2)cc1		CHEMBL4079119	=	IC50	nM	1661.0	CHEMBL2041	Homo sapiens	IC50	uM	1.661
	17993972	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(Cc3ccccc3)on2)c(C(N)=O)c1N		CHEMBL4103365	=	IC50	nM	1639.0	CHEMBL2041	Homo sapiens	IC50	uM	1.639
	17993973	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2cc(-c3ccccc3)on2)c(C(N)=O)c1N		CHEMBL4068248	=	IC50	nM	236.0	CHEMBL2041	Homo sapiens	IC50	uM	0.236
	17993974	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)n1nc(-c2coc(C3CC3)n2)c2c(N)ncnc21		CHEMBL4095617	=	IC50	nM	139.0	CHEMBL2041	Homo sapiens	IC50	uM	0.139
	17993975	CHEMBL4000785	Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay	B	CC(C)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL3752395	=	IC50	nM	41.0	CHEMBL2041	Homo sapiens	IC50	uM	0.041
Active	17993993	CHEMBL4000804	Inhibition of RET (unknown origin) autophosphorylation at Tyrosine 1062 residue transfected in mouse Ba/F3 cells after 3 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	17993994	CHEMBL4000805	Inhibition of RET V804M mutant (unknown origin) autophosphorylation at Tyrosine 1062 residue transfected in mouse Ba/F3 cells after 3 hrs by Western blot analysis	B	CC(C)n1nc(-c2cc(C3CC3)on2)c(C(N)=O)c1N		CHEMBL4090213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	18002357	CHEMBL4002769	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628	=	IC50	nM	1.3	CHEMBL2041	Homo sapiens	IC50	nM	1.3
	18002375	CHEMBL4002769	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	0.3	CHEMBL2041	Homo sapiens	IC50	nM	0.3
	18031847	CHEMBL4007741	Inhibition of RET (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	132.0	CHEMBL2041	Homo sapiens	IC50	uM	0.132
	18031848	CHEMBL4007741	Inhibition of RET (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	=	IC50	nM	1510.0	CHEMBL2041	Homo sapiens	IC50	uM	1.51
	18031849	CHEMBL4007741	Inhibition of RET (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	=	IC50	nM	3500.0	CHEMBL2041	Homo sapiens	IC50	uM	3.5
	18031850	CHEMBL4007741	Inhibition of RET (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	=	IC50	nM	379.0	CHEMBL2041	Homo sapiens	IC50	uM	0.379
	18031851	CHEMBL4007741	Inhibition of RET (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	=	IC50	nM	2950.0	CHEMBL2041	Homo sapiens	IC50	uM	2.95
	18033100	CHEMBL4007916	Inhibition of human RET at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	88.0	CHEMBL2041	Homo sapiens	INH	%	88.0
	18048977	CHEMBL4011144	Inhibition of recombinant human GST-tagged RET cytoplasmic domain expressed in baculovirus expression system	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1		CHEMBL1642655	=	IC50	nM	11481.54	CHEMBL2041	Homo sapiens	pIC50		4.94
	18048978	CHEMBL4011144	Inhibition of recombinant human GST-tagged RET cytoplasmic domain expressed in baculovirus expression system	B	COCCn1cc(NC(=O)c2csc(-c3nncn3C(C)C)n2)cn1		CHEMBL4073198	=	IC50	nM	616.6	CHEMBL2041	Homo sapiens	pIC50		6.21
	18053039	CHEMBL4011886	Inhibition of RET (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	3.3	CHEMBL2041	Homo sapiens	INH	%	3.3
	18053040	CHEMBL4011887	Inhibition of RET G691S mutant (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-7.7	CHEMBL2041	Homo sapiens	INH	%	-7.7
	18053041	CHEMBL4011888	Inhibition of RET M918T mutant (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-6.2	CHEMBL2041	Homo sapiens	INH	%	-6.2
	18053042	CHEMBL4011889	Inhibition of RET S891A mutant (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-3.5	CHEMBL2041	Homo sapiens	INH	%	-3.5
	18053043	CHEMBL4011890	Inhibition of RET Y791F mutant (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O	Outside typical range	CHEMBL4089159	=	Inhibition	%	-13.6	CHEMBL2041	Homo sapiens	INH	%	-13.6
	18057661	CHEMBL4012668	Inhibition of human GST-tagged RET (658 to 1114 residues) expressed in baculovirus by ELISA	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	>	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	18057669	CHEMBL4012667	Inhibition of human GST-tagged RET (658 to 1114 residues) expressed in baculovirus assessed as activity remaining at 1 uM by ELISA relative to control	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	=	Activity	%	8.0	CHEMBL2041	Homo sapiens	Activity	%	8.0
	18085944	CHEMBL4018630	Inhibition of recombinant Ret (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4105329	=	IC50	nM	0.7	CHEMBL2041	Homo sapiens	IC50	nM	0.7
	18085945	CHEMBL4018630	Inhibition of recombinant Ret (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1		CHEMBL4067871	=	IC50	nM	0.04	CHEMBL2041	Homo sapiens	IC50	nM	0.04
	18085946	CHEMBL4018630	Inhibition of recombinant Ret (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	0.2	CHEMBL2041	Homo sapiens	IC50	nM	0.2
	18085947	CHEMBL4018630	Inhibition of recombinant Ret (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12		CHEMBL4075917	=	IC50	nM	0.4	CHEMBL2041	Homo sapiens	IC50	nM	0.4
	18086087	CHEMBL4018693	Inhibition of CCDC6-fused RET (unknown origin) expressed in mouse Ba/F3 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	315.7	CHEMBL2041	Homo sapiens	IC50	nM	315.7
Active	18086111	CHEMBL4018706	Inhibition of CCDC6-fused RET (unknown origin) phosphorylation expressed in mouse Ba/F3 cells at 0.25 to 1 uM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	18086123	CHEMBL4018723	Inhibition of CCDC6-fused RET (unknown origin) expressed in mouse Ba/F3 cells assessed as decrease in STAT3 phosphorylation at 0.25 to 1 uM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	18086124	CHEMBL4018724	Inhibition of CCDC6-fused RET (unknown origin) expressed in mouse Ba/F3 cells assessed as decrease in AKT phosphorylation at 0.25 to 1 uM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	18086125	CHEMBL4018725	Inhibition of CCDC6-fused RET (unknown origin) expressed in mouse Ba/F3 cells assessed as decrease in ERK phosphorylation at 0.25 to 1 uM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	18096341	CHEMBL4021228	Inhibition of RET (unknown origin) using FAM-labeled peptide as substrate preincubated for 5 to 10 mins followed by substrate/ATP addition measured after 30 to 60 mins by mobility shift assay	B	CC(c1cc2cc(-c3cnn(C)c3)cnc2cc1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21		CHEMBL4074262	>	IC50	nM	30000.0	CHEMBL2041	Homo sapiens	IC50	nM	30000.0
	18096404	CHEMBL4021260	Inhibition of RET (unknown origin) by HTRF method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	4.7	CHEMBL2041	Homo sapiens	IC50	nM	4.7
	18096405	CHEMBL4021260	Inhibition of RET (unknown origin) by HTRF method	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	10.1	CHEMBL2041	Homo sapiens	IC50	nM	10.1
	18096406	CHEMBL4021260	Inhibition of RET (unknown origin) by HTRF method	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	IC50	nM	594.0	CHEMBL2041	Homo sapiens	IC50	nM	594.0
	18096407	CHEMBL4021260	Inhibition of RET (unknown origin) by HTRF method	B	Nc1nccc(Oc2ccc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)c1Cl		CHEMBL4104302	=	IC50	nM	387.0	CHEMBL2041	Homo sapiens	IC50	nM	387.0
	18114824	CHEMBL4025354	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	87.0	CHEMBL2041	Homo sapiens	Activity	%	87.0
	18114825	CHEMBL4025355	Inhibition of human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	18114826	CHEMBL4025356	Inhibition of human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	18114827	CHEMBL4025357	Inhibition of human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	96.0	CHEMBL2041	Homo sapiens	Activity	%	96.0
	18121144	CHEMBL4026807	Inhibition of human RET (E713 to D1014 residues) expressed in bacterial expression system assessed as percent enzyme activity at 1 uM relative to control	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Activity	%	3.3	CHEMBL2041	Homo sapiens	Activity	%	3.3
	18136374	CHEMBL4029919	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CO)on2)c2c(N)ncnc21		CHEMBL4088300	=	IC50	nM	410.0	CHEMBL2041	Homo sapiens	IC50	nM	410.0
	18136375	CHEMBL4029919	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate after 60 mins by ELISA	B	CC(O)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL4096031	=	IC50	nM	61.2	CHEMBL2041	Homo sapiens	IC50	nM	61.2
	18136384	CHEMBL4029922	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 15 nM after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CO)on2)c2c(N)ncnc21		CHEMBL4088300	=	Inhibition	%	18.0	CHEMBL2041	Homo sapiens	INH	%	18.0
	18136385	CHEMBL4029921	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 250 nM after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CO)on2)c2c(N)ncnc21		CHEMBL4088300	=	Inhibition	%	43.0	CHEMBL2041	Homo sapiens	INH	%	43.0
	18136386	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CCCC(=O)N3CCCC3)on2)c2c(N)ncnc21		CHEMBL4090206	=	Inhibition	%	11.0	CHEMBL2041	Homo sapiens	INH	%	11.0
	18136387	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CCC(=O)N3CCOCC3)on2)c2c(N)ncnc21		CHEMBL4075817	=	Inhibition	%	7.0	CHEMBL2041	Homo sapiens	INH	%	7.0
	18136388	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CCN3CCOCC3)on2)c2c(N)ncnc21		CHEMBL4105687	=	Inhibition	%	24.0	CHEMBL2041	Homo sapiens	INH	%	24.0
	18136389	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CN3CCOCC3)on2)c2c(N)ncnc21		CHEMBL4079528	=	Inhibition	%	0.8	CHEMBL2041	Homo sapiens	INH	%	0.8
	18136390	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CCOC(=O)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL4103782	=	Inhibition	%	5.4	CHEMBL2041	Homo sapiens	INH	%	5.4
	18136391	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CCO)on2)c2c(N)ncnc21		CHEMBL4068719	=	Inhibition	%	34.0	CHEMBL2041	Homo sapiens	INH	%	34.0
	18136392	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(O)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL4096031	=	Inhibition	%	45.0	CHEMBL2041	Homo sapiens	INH	%	45.0
	18136393	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	COCc1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL4060063	=	Inhibition	%	22.0	CHEMBL2041	Homo sapiens	INH	%	22.0
	18136394	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	COc1ccc(-c2cc(C(=O)Nc3nn(C(C)C)c4ncnc(N)c34)no2)cc1		CHEMBL4104434	=	Inhibition	%	3.0	CHEMBL2041	Homo sapiens	INH	%	3.0
	18136395	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2cc(-c3ccccc3)on2)c2c(N)ncnc21		CHEMBL4080948	=	Inhibition	%	16.0	CHEMBL2041	Homo sapiens	INH	%	16.0
	18136396	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2cc(-c3cccs3)on2)c2c(N)ncnc21		CHEMBL4076621	=	Inhibition	%	13.0	CHEMBL2041	Homo sapiens	INH	%	13.0
	18136397	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2cc(-c3ccco3)on2)c2c(N)ncnc21		CHEMBL4076126	=	Inhibition	%	54.0	CHEMBL2041	Homo sapiens	INH	%	54.0
	18136398	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2noc3ccccc23)c2c(N)ncnc21		CHEMBL4089790	=	Inhibition	%	1.0	CHEMBL2041	Homo sapiens	INH	%	1.0
	18136399	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL4072832	=	Inhibition	%	57.0	CHEMBL2041	Homo sapiens	INH	%	57.0
	18136400	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2nccs2)c2c(N)ncnc21		CHEMBL4097516	=	Inhibition	%	51.0	CHEMBL2041	Homo sapiens	INH	%	51.0
	18136401	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2cscn2)c2c(N)ncnc21		CHEMBL4070341	=	Inhibition	%	48.0	CHEMBL2041	Homo sapiens	INH	%	48.0
	18136402	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2ccco2)c2c(N)ncnc21		CHEMBL4071388	=	Inhibition	%	56.0	CHEMBL2041	Homo sapiens	INH	%	56.0
	18136403	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2cccs2)c2c(N)ncnc21		CHEMBL4092178	=	Inhibition	%	57.0	CHEMBL2041	Homo sapiens	INH	%	57.0
	18136404	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2ccccn2)c2c(N)ncnc21		CHEMBL4081929	=	Inhibition	%	44.0	CHEMBL2041	Homo sapiens	INH	%	44.0
	18136405	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL4099926	=	Inhibition	%	11.0	CHEMBL2041	Homo sapiens	INH	%	11.0
	18136406	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	Cc1ccc(C2(C(=O)Nc3nn(C(C)C)c4ncnc(N)c34)CC2)cc1		CHEMBL4068132	=	Inhibition	%	9.0	CHEMBL2041	Homo sapiens	INH	%	9.0
	18136407	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)C2(c3ccc(Cl)cc3)CC2)c2c(N)ncnc21		CHEMBL4095521	=	Inhibition	%	3.0	CHEMBL2041	Homo sapiens	INH	%	3.0
	18136408	CHEMBL4029920	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 10 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)C2(c3ccccc3)CC2)c2c(N)ncnc21		CHEMBL4101353	=	Inhibition	%	-4.0	CHEMBL2041	Homo sapiens	INH	%	-4.0
	18136409	CHEMBL4029919	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate after 60 mins by ELISA	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	IC50	nM	56.5	CHEMBL2041	Homo sapiens	IC50	nM	56.5
	18136410	CHEMBL4029919	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate after 60 mins by ELISA	B	CCc1ccc(C#Cc2c3n(c4ncnc(N)c24)C(C)CC3)cc1		CHEMBL4063276	=	IC50	nM	62.5	CHEMBL2041	Homo sapiens	IC50	nM	62.5
	18136411	CHEMBL4029919	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate after 60 mins by ELISA	B	CCc1ccc(C#Cc2c3n(c4ncnc(N)c24)CCCC3)cc1		CHEMBL4091151	=	IC50	nM	102.0	CHEMBL2041	Homo sapiens	IC50	nM	102.0
Not Determined	18136412	CHEMBL4029919	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate after 60 mins by ELISA	B	C=C1CCn2c1c(C#Cc1ccc(CC)cc1)c1c(N)ncnc12		CHEMBL4071908		IC50			CHEMBL2041	Homo sapiens	IC50		
	18136413	CHEMBL4029919	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate after 60 mins by ELISA	B	C=C1CCn2c1c(C#Cc1ccccc1)c1c(N)ncnc12		CHEMBL4098899	=	IC50	nM	104.0	CHEMBL2041	Homo sapiens	IC50	nM	104.0
	18136414	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CCCC(=O)N3CCCC3)on2)c2c(N)ncnc21		CHEMBL4090206	=	Inhibition	%	29.0	CHEMBL2041	Homo sapiens	INH	%	29.0
	18136415	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CCC(=O)N3CCOCC3)on2)c2c(N)ncnc21		CHEMBL4075817	=	Inhibition	%	23.0	CHEMBL2041	Homo sapiens	INH	%	23.0
	18136416	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CCN3CCOCC3)on2)c2c(N)ncnc21		CHEMBL4105687	=	Inhibition	%	42.0	CHEMBL2041	Homo sapiens	INH	%	42.0
	18136417	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CN3CCOCC3)on2)c2c(N)ncnc21	Outside typical range	CHEMBL4079528	=	Inhibition	%	-21.0	CHEMBL2041	Homo sapiens	INH	%	-21.0
	18136418	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CCOC(=O)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL4103782	=	Inhibition	%	37.0	CHEMBL2041	Homo sapiens	INH	%	37.0
	18136419	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(-c2cc(CCO)on2)c2c(N)ncnc21		CHEMBL4068719	=	Inhibition	%	42.0	CHEMBL2041	Homo sapiens	INH	%	42.0
	18136420	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(O)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL4096031	=	Inhibition	%	73.0	CHEMBL2041	Homo sapiens	INH	%	73.0
	18136421	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	COCc1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1		CHEMBL4060063	=	Inhibition	%	51.0	CHEMBL2041	Homo sapiens	INH	%	51.0
	18136422	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	COc1ccc(-c2cc(C(=O)Nc3nn(C(C)C)c4ncnc(N)c34)no2)cc1		CHEMBL4104434	=	Inhibition	%	13.0	CHEMBL2041	Homo sapiens	INH	%	13.0
	18136423	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2cc(-c3ccccc3)on2)c2c(N)ncnc21		CHEMBL4080948	=	Inhibition	%	30.0	CHEMBL2041	Homo sapiens	INH	%	30.0
	18136424	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2cc(-c3cccs3)on2)c2c(N)ncnc21		CHEMBL4076621	=	Inhibition	%	44.0	CHEMBL2041	Homo sapiens	INH	%	44.0
	18136425	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2cc(-c3ccco3)on2)c2c(N)ncnc21		CHEMBL4076126	=	Inhibition	%	57.0	CHEMBL2041	Homo sapiens	INH	%	57.0
	18136426	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2noc3ccccc23)c2c(N)ncnc21		CHEMBL4089790	=	Inhibition	%	25.0	CHEMBL2041	Homo sapiens	INH	%	25.0
	18136427	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL4072832	=	Inhibition	%	60.0	CHEMBL2041	Homo sapiens	INH	%	60.0
	18136428	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2nccs2)c2c(N)ncnc21		CHEMBL4097516	=	Inhibition	%	51.0	CHEMBL2041	Homo sapiens	INH	%	51.0
	18136429	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2cscn2)c2c(N)ncnc21		CHEMBL4070341	=	Inhibition	%	61.0	CHEMBL2041	Homo sapiens	INH	%	61.0
	18136430	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2ccco2)c2c(N)ncnc21		CHEMBL4071388	=	Inhibition	%	63.0	CHEMBL2041	Homo sapiens	INH	%	63.0
	18136431	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2cccs2)c2c(N)ncnc21		CHEMBL4092178	=	Inhibition	%	67.0	CHEMBL2041	Homo sapiens	INH	%	67.0
	18136432	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)c2ccccn2)c2c(N)ncnc21		CHEMBL4081929	=	Inhibition	%	53.0	CHEMBL2041	Homo sapiens	INH	%	53.0
	18136433	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL4099926	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	INH	%	4.0
	18136434	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	Cc1ccc(C2(C(=O)Nc3nn(C(C)C)c4ncnc(N)c34)CC2)cc1	Outside typical range	CHEMBL4068132	=	Inhibition	%	-16.0	CHEMBL2041	Homo sapiens	INH	%	-16.0
	18136435	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)C2(c3ccc(Cl)cc3)CC2)c2c(N)ncnc21	Outside typical range	CHEMBL4095521	=	Inhibition	%	-15.0	CHEMBL2041	Homo sapiens	INH	%	-15.0
	18136436	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(NC(=O)C2(c3ccccc3)CC2)c2c(N)ncnc21		CHEMBL4101353	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	INH	%	4.0
	18136437	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	Inhibition	%	75.1	CHEMBL2041	Homo sapiens	INH	%	75.1
	18136438	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CCc1ccc(C#Cc2c3n(c4ncnc(N)c24)C(C)CC3)cc1		CHEMBL4063276	=	Inhibition	%	77.6	CHEMBL2041	Homo sapiens	INH	%	77.6
	18136439	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	CCc1ccc(C#Cc2c3n(c4ncnc(N)c24)CCCC3)cc1		CHEMBL4091151	=	Inhibition	%	63.6	CHEMBL2041	Homo sapiens	INH	%	63.6
	18136440	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	C=C1CCn2c1c(C#Cc1ccc(CC)cc1)c1c(N)ncnc12		CHEMBL4071908	=	Inhibition	%	23.0	CHEMBL2041	Homo sapiens	INH	%	23.0
	18136441	CHEMBL4029918	Inhibition of recombinant RET (unknown origin) using poly (Glu,Tyr) 4:1 substrate at 100 nM after 60 mins by ELISA	B	C=C1CCn2c1c(C#Cc1ccccc1)c1c(N)ncnc12		CHEMBL4098899	=	Inhibition	%	49.0	CHEMBL2041	Homo sapiens	INH	%	49.0
	18141791	CHEMBL4031406	Inhibition of human RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	Activity	%	0.0	CHEMBL2041	Homo sapiens	Activity	%	0.0
	18141800	CHEMBL4031414	Inhibition of RET (unknown origin) using poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo kinase assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	IC50	nM	32.0	CHEMBL2041	Homo sapiens	IC50	nM	32.0
	18141849	CHEMBL4031447	Binding affinity to RET (unknown origin) by KinomeSCan assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	9.9	CHEMBL2041	Homo sapiens	Kd	nM	9.9
	18172344	CHEMBL4038038	Inhibition of human RET (E713 to D1014 residues) expressed in bacterial expression system at 100 nM by KINOMEscan assay relative to control	B	CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C6COC6)CC5)c(C)c4)nc32)C1		CHEMBL4066141	>	Inhibition	%	90.0	CHEMBL2041	Homo sapiens	INH	%	90.0
	18203878	CHEMBL4044165	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	8.1	CHEMBL2041	Homo sapiens	Activity	%	8.1
	18203879	CHEMBL4044166	Inhibition of human partial length RET M918T mutant (E713 to D1014 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	7.1	CHEMBL2041	Homo sapiens	Activity	%	7.1
	18203880	CHEMBL4044167	Inhibition of human partial length RET V804L mutant (E713 to D1014 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	94.0	CHEMBL2041	Homo sapiens	Activity	%	94.0
	18203881	CHEMBL4044168	Inhibition of human partial length RET V804M mutant (E713 to D1014 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	52.0	CHEMBL2041	Homo sapiens	Activity	%	52.0
	18225217	CHEMBL4048649	Inhibition of RET (unknown origin) at 1 uM relative to control	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCCC2)NC3=O)ncn1		CHEMBL4076439	=	Inhibition	%	55.0	CHEMBL2041	Homo sapiens	INH	%	55.0
	18225246	CHEMBL4048649	Inhibition of RET (unknown origin) at 1 uM relative to control	B	CC1(C)NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21		CHEMBL4086319	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	INH	%	4.0
	18225255	CHEMBL4048649	Inhibition of RET (unknown origin) at 1 uM relative to control	B	CC1(c2cccc(Cl)c2)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21		CHEMBL4064839	=	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	INH	%	10.0
	18225358	CHEMBL4048649	Inhibition of RET (unknown origin) at 1 uM relative to control	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCC2)NC3=O)ncn1		CHEMBL4094975	=	Inhibition	%	87.0	CHEMBL2041	Homo sapiens	INH	%	87.0
	18250463	CHEMBL4054280	Inhibition of Ret (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 100 uM after 1 hr by ELISA relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1	Outside typical range	CHEMBL4081419	=	Inhibition	%	-10.4	CHEMBL2041	Homo sapiens	INH	%	-10.4
	18250464	CHEMBL4054281	Inhibition of Ret (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	2.4	CHEMBL2041	Homo sapiens	IC50	nM	2.4
	18253939	CHEMBL4055254	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	18253940	CHEMBL4055254	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	92.0	CHEMBL2041	Homo sapiens	Activity	%	92.0
	18265934	CHEMBL4057384	Inhibition of RET (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	59.0	CHEMBL2041	Homo sapiens	INH	%	59.0
	18265935	CHEMBL4057385	Inhibition of RET M918T mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	57.7	CHEMBL2041	Homo sapiens	INH	%	57.7
	18265936	CHEMBL4057386	Inhibition of Ret V804L mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	21.3	CHEMBL2041	Homo sapiens	INH	%	21.3
	18265937	CHEMBL4057387	Inhibition of RET Y791F mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	58.7	CHEMBL2041	Homo sapiens	INH	%	58.7
	18266150	CHEMBL4057600	Inhibition of RET (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	15.0	CHEMBL2041	Homo sapiens	INH	%	15.0
	18266151	CHEMBL4057601	Inhibition of RET M918T mutant (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	1.0	CHEMBL2041	Homo sapiens	INH	%	1.0
	18266152	CHEMBL4057602	Inhibition of Ret V804L mutant (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-0.7	CHEMBL2041	Homo sapiens	INH	%	-0.7
	18266153	CHEMBL4057603	Inhibition of RET Y791F mutant (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	18269007	CHEMBL4058108	Inhibition of recombinant human N-terminal GST-tagged RET (658 to end residues) expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by biotinyl-beta Abeta Abeta AAEEEEYFELVAKKK substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	=	IC50	nM	89.5	CHEMBL2041	Homo sapiens	IC50	nM	89.5
	18274246	CHEMBL4059317	Inhibition of human RET	B	CC(=O)N1Cc2ncnc(Oc3ccc4c(ccn4C(=O)Nc4cc(C5CC5)on4)c3)c2C[C@@H]1C		CHEMBL4077373	<	IC50	nM	500.0	CHEMBL2041	Homo sapiens	IC50	nM	500.0
	18282208	CHEMBL4120163	Inhibition of recombinant N-terminal GST-tagged human Ret cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	9.1	CHEMBL2041	Homo sapiens	INH	%	9.1
	18282527	CHEMBL4120163	Inhibition of recombinant N-terminal GST-tagged human Ret cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	17.7	CHEMBL2041	Homo sapiens	INH	%	17.7
	18282695	CHEMBL4120280	Inhibition of RET (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	59.0	CHEMBL2041	Homo sapiens	INH	%	59.0
	18282699	CHEMBL4120284	Inhibition of RET Y791F mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	58.7	CHEMBL2041	Homo sapiens	INH	%	58.7
	18282775	CHEMBL4120360	Inhibition of Ret V804L mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	21.3	CHEMBL2041	Homo sapiens	INH	%	21.3
	18282878	CHEMBL4120463	Inhibition of RET M918T mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	57.7	CHEMBL2041	Homo sapiens	INH	%	57.7
	18282922	CHEMBL4120507	Inhibition of RET (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	47.3	CHEMBL2041	Homo sapiens	INH	%	47.3
	18282926	CHEMBL4120511	Inhibition of RET Y791F mutant (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	40.0	CHEMBL2041	Homo sapiens	INH	%	40.0
	18283002	CHEMBL4120587	Inhibition of Ret V804L mutant (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	7.0	CHEMBL2041	Homo sapiens	INH	%	7.0
	18283092	CHEMBL4120677	Inhibition of RET M918T mutant (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	41.0	CHEMBL2041	Homo sapiens	INH	%	41.0
	18283146	CHEMBL4120731	Inhibition of RET (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	7.3	CHEMBL2041	Homo sapiens	INH	%	7.3
	18283150	CHEMBL4120735	Inhibition of RET Y791F mutant (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	6.0	CHEMBL2041	Homo sapiens	INH	%	6.0
	18283168	CHEMBL4120753	Inhibition of Ret V804L mutant (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	0.7	CHEMBL2041	Homo sapiens	INH	%	0.7
	18283307	CHEMBL4120892	Inhibition of RET M918T mutant (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	6.7	CHEMBL2041	Homo sapiens	INH	%	6.7
	18286349	CHEMBL4121599	Inhibition of recombinant GST-tagged human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	-3.0	CHEMBL2041	Homo sapiens	INH	%	-3.0
	18309586	CHEMBL4131858	Inhibition of recombinant human full length RET using poly (Glu, Tyr) as substrate by alpha screen assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	5.2	CHEMBL2041	Homo sapiens	IC50	nM	5.2
	18309612	CHEMBL4131868	Inhibition of human GST-tagged RET at 3 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-SpotSM kinase assay	B	CN1CCC(Nc2ccc(-c3n[nH]c4c3CN(S(=O)(=O)c3c(Cl)cccc3Cl)CC4)cc2)CC1		CHEMBL4168618	=	Inhibition	%	33.54	CHEMBL2041	Homo sapiens	INH	%	33.54
	18330800	CHEMBL4136295	Inhibition of recombinant RET (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CCOCC1)CC2)c1ccccc1		CHEMBL4168811	=	IC50	nM	7.6	CHEMBL2041	Homo sapiens	IC50	nM	7.6
	18330818	CHEMBL4136280	Inhibition of recombinant RET (unknown origin) at 1 uM by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	18330819	CHEMBL4136280	Inhibition of recombinant RET (unknown origin) at 1 uM by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CCOCC1)CC2)c1ccccc1		CHEMBL4168811	=	Inhibition	%	99.0	CHEMBL2041	Homo sapiens	INH	%	99.0
	18379942	CHEMBL4145843	Inhibition of RET (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	6.0	CHEMBL2041	Homo sapiens	INH	%	6.0
	18379994	CHEMBL4145895	Inhibition of RET (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.69	CHEMBL2041	Homo sapiens	IC50	nM	1.69
	18390491	CHEMBL4147640	Inhibition of RET (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	37.0	CHEMBL2041	Homo sapiens	IC50	umol/L	0.037
	18390492	CHEMBL4147640	Inhibition of RET (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)c(F)c3)ccnc2cc1OCCCN1CCCC1		CHEMBL4171115	=	IC50	nM	152.0	CHEMBL2041	Homo sapiens	IC50	umol/L	0.152
	18431081	CHEMBL4155762	Inhibition of recombinant N-terminal GST-tagged human Ret cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	18434148	CHEMBL4156130	Inhibition of recombinant human GST-tagged RET cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	12.0	CHEMBL2041	Homo sapiens	INH	%	12.0
	18434196	CHEMBL4156130	Inhibition of recombinant human GST-tagged RET cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	23.0	CHEMBL2041	Homo sapiens	INH	%	23.0
	18434256	CHEMBL4156130	Inhibition of recombinant human GST-tagged RET cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	93.0	CHEMBL2041	Homo sapiens	INH	%	93.0
	18434328	CHEMBL4156130	Inhibition of recombinant human GST-tagged RET cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	41.0	CHEMBL2041	Homo sapiens	INH	%	41.0
	18440420	CHEMBL4157244	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	18440421	CHEMBL4157245	Binding affinity to human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	77.0	CHEMBL2041	Homo sapiens	Activity	%	77.0
	18440422	CHEMBL4157246	Binding affinity to human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	82.0	CHEMBL2041	Homo sapiens	Activity	%	82.0
	18440423	CHEMBL4157247	Binding affinity to human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	18463799	CHEMBL4181215	Inhibition of recombinant human N-Terminal GST-tagged RET (658 to end residues) expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	7.0	CHEMBL2041	Homo sapiens	INH	%	7.0
	18484376	CHEMBL4186023	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	86.0	CHEMBL2041	Homo sapiens	Activity	%	86.0
	18484377	CHEMBL4186024	Binding affinity to human partial length RET M918T mutant (E713 to D1014 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	87.0	CHEMBL2041	Homo sapiens	Activity	%	87.0
	18484378	CHEMBL4186025	Binding affinity to human partial length RET V804L mutant (E713 to D1014 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	84.0	CHEMBL2041	Homo sapiens	Activity	%	84.0
	18484379	CHEMBL4186026	Binding affinity to human partial length RET V804M mutant (E713 to D1014 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	68.0	CHEMBL2041	Homo sapiens	Activity	%	68.0
	18484860	CHEMBL4186023	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	88.0	CHEMBL2041	Homo sapiens	Activity	%	88.0
	18484861	CHEMBL4186024	Binding affinity to human partial length RET M918T mutant (E713 to D1014 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	71.0	CHEMBL2041	Homo sapiens	Activity	%	71.0
	18484862	CHEMBL4186025	Binding affinity to human partial length RET V804L mutant (E713 to D1014 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	63.0	CHEMBL2041	Homo sapiens	Activity	%	63.0
	18484863	CHEMBL4186026	Binding affinity to human partial length RET V804M mutant (E713 to D1014 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	70.0	CHEMBL2041	Homo sapiens	Activity	%	70.0
	18489560	CHEMBL4187301	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	96.0	CHEMBL2041	Homo sapiens	Activity	%	96.0
	18499394	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4204515	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	18499395	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CCN1CCN(c2ccc(-c3nn(CC4CCCC4)c4nc(NC)ncc34)cn2)CC1		CHEMBL4213775	=	IC50	nM	440.0	CHEMBL2041	Homo sapiens	IC50	uM	0.44
	18499396	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4208852	=	IC50	nM	60.0	CHEMBL2041	Homo sapiens	IC50	uM	0.06
	18499397	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1		CHEMBL4218175	=	IC50	nM	6.0	CHEMBL2041	Homo sapiens	IC50	uM	0.006
	18499398	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	=	IC50	nM	3.0	CHEMBL2041	Homo sapiens	IC50	uM	0.003
	18499399	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4207004	=	IC50	nM	4000.0	CHEMBL2041	Homo sapiens	IC50	uM	4.0
	18499400	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CCN1CCN(c2ccc(-c3nn(Cc4cn(Cc5ccccc5)nn4)c4nc(NC)ncc34)cn2)CC1		CHEMBL4217649	=	IC50	nM	6200.0	CHEMBL2041	Homo sapiens	IC50	uM	6.2
	18499401	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4218369	=	IC50	nM	900.0	CHEMBL2041	Homo sapiens	IC50	uM	0.9
	18499402	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4211308	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	18499403	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(-c4ccsc4C(=O)OC)nn3)c2n1		CHEMBL4205191	=	IC50	nM	430.0	CHEMBL2041	Homo sapiens	IC50	uM	0.43
	18499404	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4210084	=	IC50	nM	600.0	CHEMBL2041	Homo sapiens	IC50	uM	0.6
	18499405	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(OC)cc3)nn(CC3OCCO3)c2n1		CHEMBL4209569	=	IC50	nM	1200.0	CHEMBL2041	Homo sapiens	IC50	uM	1.2
	18499406	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3OCCO3)c2n1		CHEMBL4214476	=	IC50	nM	160.0	CHEMBL2041	Homo sapiens	IC50	uM	0.16
	18499407	CHEMBL4188980	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4213003	=	IC50	nM	50.0	CHEMBL2041	Homo sapiens	IC50	uM	0.05
	18501913	CHEMBL4189549	Inhibition of human RET (E713 to D1014 residues) expressed in bacterial expression system at 1 uM by KINOMEscan assay relative to control	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	>	Inhibition	%	99.0	CHEMBL2041	Homo sapiens	INH	%	99.0
	18502853	CHEMBL4189696	Inhibition of recombinant human RET using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	5.2	CHEMBL2041	Homo sapiens	IC50	nM	5.2
	18502854	CHEMBL4189696	Inhibition of recombinant human RET using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA	B	C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1=C		CHEMBL4211949	=	IC50	nM	20.3	CHEMBL2041	Homo sapiens	IC50	nM	20.3
Active	18504082	CHEMBL4189912	Inhibition of DNA-tagged human partial length RET expressed in bacterial expression system at 100 nM by qPCR method	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	18504083	CHEMBL4189912	Inhibition of DNA-tagged human partial length RET expressed in bacterial expression system at 100 nM by qPCR method	B	CN1CCN(c2cc(Nc3cc(-c4cccc(F)c4)[nH]n3)nc(Sc3ccccc3)n2)CC1		CHEMBL4216563		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	18507626	CHEMBL4191166	Inhibition of recombinant human RET V804M mutant (658 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	14.0	CHEMBL2041	Homo sapiens	INH	%	14.0
	18507627	CHEMBL4191164	Inhibition of recombinant human RET (658 to end residues) at 1 uM using KKKSPGEYVNIEFG as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	95.0	CHEMBL2041	Homo sapiens	INH	%	95.0
	18507628	CHEMBL4191163	Inhibition of recombinant human RET V804L mutant (658 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	20.0	CHEMBL2041	Homo sapiens	INH	%	20.0
	18523810	CHEMBL4194206	Inhibition of RET (unknown origin)	B	COc1cc2c(cc1OC)Nc1ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c1NC2		CHEMBL4210100	=	IC50	nM	162.8	CHEMBL2041	Homo sapiens	IC50	nM	162.8
	18551680	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(-c4ccnc(NC)c4)cc3)cc2C(F)(F)F)CC1		CHEMBL4215099	=	IC50	nM	22.2	CHEMBL2041	Homo sapiens	IC50	nM	22.2
	18551681	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(-c4ccc(NC)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL4205803	=	IC50	nM	0.7	CHEMBL2041	Homo sapiens	IC50	nM	0.7
	18551682	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(-c4ccc(=O)[nH]c4)cc3)cc2C(F)(F)F)CC1		CHEMBL4210670	=	IC50	nM	1.2	CHEMBL2041	Homo sapiens	IC50	nM	1.2
	18551683	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCOc1cc(-c2ccc(NC(=O)Nc3ccc(CN4CCN(CC)CC4)c(C(F)(F)F)c3)c(F)c2)c[nH]c1=O		CHEMBL4218013	=	IC50	nM	0.1	CHEMBL2041	Homo sapiens	IC50	nM	0.1
	18551684	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cccc(C(F)(F)F)c2)c(F)c1		CHEMBL4206308	=	IC50	nM	1.7	CHEMBL2041	Homo sapiens	IC50	nM	1.7
	18551685	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2ccc(CN(C)C)c(C(F)(F)F)c2)c(F)c1		CHEMBL4213626	=	IC50	nM	0.8	CHEMBL2041	Homo sapiens	IC50	nM	0.8
	18551686	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2ccc(CC(C)(C)N)c(C(F)(F)F)c2)c(F)c1		CHEMBL4218563	=	IC50	nM	0.2	CHEMBL2041	Homo sapiens	IC50	nM	0.2
	18551687	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(F)(F)F)cc(CN(C)C)c2F)c(F)c1		CHEMBL4209229	=	IC50	nM	2.8	CHEMBL2041	Homo sapiens	IC50	nM	2.8
	18551688	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2ccc(C(C)C#N)c(C(F)(F)F)c2)c(F)c1		CHEMBL4214146	=	IC50	nM	0.7	CHEMBL2041	Homo sapiens	IC50	nM	0.7
	18551689	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2ccc(CC(C)(C)O)c(C(F)(F)F)c2)c(F)c1		CHEMBL4218127	=	IC50	nM	0.4	CHEMBL2041	Homo sapiens	IC50	nM	0.4
	18551690	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2ccc(CC(C)(C)CO)c(C(F)(F)F)c2)c(F)c1		CHEMBL4205243	=	IC50	nM	0.4	CHEMBL2041	Homo sapiens	IC50	nM	0.4
	18551691	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2ccc(CC(C)(C)CS(C)(=O)=O)c(C(F)(F)F)c2)c(F)c1		CHEMBL4203429	=	IC50	nM	0.6	CHEMBL2041	Homo sapiens	IC50	nM	0.6
	18551692	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(-c3nnc(C)o3)cc(C(F)(F)F)c2)c(F)c1		CHEMBL4212513	=	IC50	nM	0.4	CHEMBL2041	Homo sapiens	IC50	nM	0.4
	18551693	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)no2)c(F)c1		CHEMBL3355010	=	IC50	nM	0.4	CHEMBL2041	Homo sapiens	IC50	nM	0.4
	18551694	CHEMBL4199570	Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)on2)c(F)c1		CHEMBL3355009	=	IC50	nM	0.4	CHEMBL2041	Homo sapiens	IC50	nM	0.4
	18551721	CHEMBL4199574	Inhibition of RET phosphorylation in human TT cells after 2 hrs by ELISA	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cccc(C(F)(F)F)c2)c(F)c1		CHEMBL4206308	=	IC50	nM	111.1	CHEMBL2041	Homo sapiens	IC50	nM	111.1
	18551722	CHEMBL4199574	Inhibition of RET phosphorylation in human TT cells after 2 hrs by ELISA	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2ccc(CN(C)C)c(C(F)(F)F)c2)c(F)c1		CHEMBL4213626	=	IC50	nM	20.7	CHEMBL2041	Homo sapiens	IC50	nM	20.7
	18551723	CHEMBL4199574	Inhibition of RET phosphorylation in human TT cells after 2 hrs by ELISA	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2ccc(CC(C)(C)N)c(C(F)(F)F)c2)c(F)c1		CHEMBL4218563	=	IC50	nM	6.5	CHEMBL2041	Homo sapiens	IC50	nM	6.5
	18551724	CHEMBL4199574	Inhibition of RET phosphorylation in human TT cells after 2 hrs by ELISA	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(F)(F)F)cc(CN(C)C)c2F)c(F)c1		CHEMBL4209229	=	IC50	nM	70.2	CHEMBL2041	Homo sapiens	IC50	nM	70.2
	18551725	CHEMBL4199574	Inhibition of RET phosphorylation in human TT cells after 2 hrs by ELISA	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2ccc(C(C)C#N)c(C(F)(F)F)c2)c(F)c1		CHEMBL4214146	=	IC50	nM	63.1	CHEMBL2041	Homo sapiens	IC50	nM	63.1
	18551726	CHEMBL4199574	Inhibition of RET phosphorylation in human TT cells after 2 hrs by ELISA	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2ccc(CC(C)(C)O)c(C(F)(F)F)c2)c(F)c1		CHEMBL4218127	=	IC50	nM	6.7	CHEMBL2041	Homo sapiens	IC50	nM	6.7
	18551727	CHEMBL4199574	Inhibition of RET phosphorylation in human TT cells after 2 hrs by ELISA	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2ccc(CC(C)(C)CO)c(C(F)(F)F)c2)c(F)c1		CHEMBL4205243	=	IC50	nM	9.4	CHEMBL2041	Homo sapiens	IC50	nM	9.4
	18551728	CHEMBL4199574	Inhibition of RET phosphorylation in human TT cells after 2 hrs by ELISA	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2ccc(CC(C)(C)CS(C)(=O)=O)c(C(F)(F)F)c2)c(F)c1		CHEMBL4203429	=	IC50	nM	3.9	CHEMBL2041	Homo sapiens	IC50	nM	3.9
	18551729	CHEMBL4199574	Inhibition of RET phosphorylation in human TT cells after 2 hrs by ELISA	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(-c3nnc(C)o3)cc(C(F)(F)F)c2)c(F)c1		CHEMBL4212513	=	IC50	nM	29.5	CHEMBL2041	Homo sapiens	IC50	nM	29.5
	18551730	CHEMBL4199574	Inhibition of RET phosphorylation in human TT cells after 2 hrs by ELISA	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)no2)c(F)c1		CHEMBL3355010	=	IC50	nM	3.4	CHEMBL2041	Homo sapiens	IC50	nM	3.4
	18551731	CHEMBL4199574	Inhibition of RET phosphorylation in human TT cells after 2 hrs by ELISA	B	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)on2)c(F)c1		CHEMBL3355009	=	IC50	nM	11.1	CHEMBL2041	Homo sapiens	IC50	nM	11.1
	18556332	CHEMBL4200481	Inhibition of recombinant human N-terminal GST-tagged RET (658 to end residues) expressed in baculovirus infected Sf21 cells at 1 uM relative to control	B	CNC(=O)c1nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc2c1N[C@@H](C)C1CCOCC1		CHEMBL4218854	=	Inhibition	%	59.0	CHEMBL2041	Homo sapiens	INH	%	59.0
	18558661	CHEMBL4201057	Inhibition of human RET at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	98.7	CHEMBL2041	Homo sapiens	INH	%	98.7
	18571114	CHEMBL4221047	Inhibition of RET (unknown origin) after 40 mins in presence of [gamma-33P]-ATP by liquid scintillation counting method	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(C4=Nc5cscc5NC(=O)C4)cc3)cc2C(F)(F)F)CC1		CHEMBL4228601	=	IC50	nM	71.6	CHEMBL2041	Homo sapiens	IC50	nM	71.6
Active	18571118	CHEMBL4221044	Inhibition of human RET using KKKVSRSGLYRSPSMPENLNRPR as substrate at 10 uM after 40 mins in presence of [gamma-33P]-ATP by liquid scintillation counting method	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(C4=Nc5cscc5NC(=O)C4)cc3)cc2C(F)(F)F)CC1		CHEMBL4228601		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	18653391	CHEMBL4230210	Inhibition of RET (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	18653392	CHEMBL4230210	Inhibition of RET (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	98.0	CHEMBL2041	Homo sapiens	INH	%	98.0
	18655309	CHEMBL4230926	Binding affinity to human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	96.0	CHEMBL2041	Homo sapiens	Activity	%	96.0
	18655310	CHEMBL4230925	Binding affinity to human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	97.0	CHEMBL2041	Homo sapiens	Activity	%	97.0
	18655311	CHEMBL4230924	Binding affinity to human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	85.0	CHEMBL2041	Homo sapiens	Activity	%	85.0
	18655312	CHEMBL4230923	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	80.0	CHEMBL2041	Homo sapiens	Activity	%	80.0
Not Active	18656413	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	OC(CNCCNc1nccc(C(F)(F)F)n1)c1ccccc1		CHEMBL4243247		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656414	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Clc1ccc(SCc2n[nH]c(-c3ccc(OCc4ccccc4)cc3)n2)cc1		CHEMBL4251263		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656415	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=S(=O)(Cc1n[nH]c(-c2ccc(Cl)cc2)n1)c1ccc(Cl)cc1		CHEMBL4247863		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656416	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Clc1ccc(CCc2n[nH]c(-c3ccc(Cl)cc3)n2)cc1		CHEMBL4243650		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656417	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Clc1ccc(OCc2n[nH]c(-c3ccccc3)n2)cc1		CHEMBL4238328		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	18656418	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	Clc1ccc(SCc2n[n-]c(-c3ccc(Cl)cc3)n2)cc1.[K+]		CHEMBL4238596		IC50			CHEMBL2041	Homo sapiens	IC50		
	18656419	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	950.0	CHEMBL2041	Homo sapiens	IC50	uM	0.95
	18656420	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	CC(C)(CC(=O)O)CC(=O)Nc1cc(-c2ccccc2)[nH]n1		CHEMBL1704021	=	IC50	nM	82600.0	CHEMBL2041	Homo sapiens	IC50	uM	82.6
	18656421	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	IC50	nM	78100.0	CHEMBL2041	Homo sapiens	IC50	uM	78.1
	18656422	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	CCOc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1		CHEMBL172517	=	IC50	nM	68400.0	CHEMBL2041	Homo sapiens	IC50	uM	68.4
	18656423	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	Nc1ccccc1SCc1nc2ccccc2c(=O)[nH]1		CHEMBL4239930	=	IC50	nM	63800.0	CHEMBL2041	Homo sapiens	IC50	uM	63.8
	18656424	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	O=C1NCCN1CCN(CC(O)c1ccccc1)CC(O)c1ccccc1		CHEMBL4237913	=	IC50	nM	54000.0	CHEMBL2041	Homo sapiens	IC50	uM	54.0
	18656425	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	Cc1ccc(-c2oc3ccccc3c(=O)c2O)cc1		CHEMBL273103	=	IC50	nM	20900.0	CHEMBL2041	Homo sapiens	IC50	uM	20.9
	18656426	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	O=C1c2ccccc2O[C@@H](c2ccc(Cl)cc2)[C@@H]1O		CHEMBL4241633	=	IC50	nM	12100.0	CHEMBL2041	Homo sapiens	IC50	uM	12.1
	18656427	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	COc1ccc(OC)c(NC(=O)Nc2ccc(SCc3n[nH]c(-c4ccc(Cl)cc4)n3)cc2)c1		CHEMBL4249671	=	IC50	nM	5510.0	CHEMBL2041	Homo sapiens	IC50	uM	5.51
	18656428	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	CC(=O)c1cccc(NC(=O)Nc2ccc(SCc3n[nH]c(-c4ccccc4)n3)cc2)c1		CHEMBL4249208	=	IC50	nM	6070.0	CHEMBL2041	Homo sapiens	IC50	uM	6.07
	18656429	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	CN1CCN(c2ccc(-c3nc(CSc4ccc(Cl)cc4)n[nH]3)cc2)CC1		CHEMBL4238220	=	IC50	nM	19000.0	CHEMBL2041	Homo sapiens	IC50	uM	19.0
	18656430	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	Oc1ccc(-c2nc(CSc3ccc(Cl)cc3)n[nH]2)cc1		CHEMBL4244888	=	IC50	nM	32500.0	CHEMBL2041	Homo sapiens	IC50	uM	32.5
	18656431	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	O=C1Nc2ccccc2/C1=C/c1ccc(-c2cccs2)s1		CHEMBL47173	=	IC50	nM	9400.0	CHEMBL2041	Homo sapiens	IC50	uM	9.4
	18656432	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	Clc1ccc(SCc2n[nH]c(-c3ccc(Cl)cc3)n2)cc1		CHEMBL4238771	=	IC50	nM	9380.0	CHEMBL2041	Homo sapiens	IC50	uM	9.38
	18656433	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	Nc1c(-c2ccc(Cl)cc2)oc2ccccc2c1=O		CHEMBL4242953	=	IC50	nM	6470.0	CHEMBL2041	Homo sapiens	IC50	uM	6.47
	18656434	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	Cc1ccc(Cc2cc(-c3ccc(F)cc3)nnc2O)cc1		CHEMBL1488812	=	IC50	nM	6160.0	CHEMBL2041	Homo sapiens	IC50	uM	6.16
	18656435	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=c1[nH]nc(CSc2ccc(Cl)cc2)n1-c1ccccc1		CHEMBL4241719	=	Inhibition	%	12.0	CHEMBL2041	Homo sapiens	INH	%	12.0
	18656436	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Nc1ncc(OCc2ccccc2)c(O)n1		CHEMBL4239465	=	Inhibition	%	15.0	CHEMBL2041	Homo sapiens	INH	%	15.0
	18656437	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	CC(Oc1ccc(Cl)cc1Cl)c1n[nH]c(=S)n1-c1ccccc1		CHEMBL4243704	=	Inhibition	%	20.0	CHEMBL2041	Homo sapiens	INH	%	20.0
	18656438	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	CCOC(=O)c1c(C)n[nH]c1/N=C/c1ccncc1		CHEMBL4242898	=	Inhibition	%	27.0	CHEMBL2041	Homo sapiens	INH	%	27.0
	18656439	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Nc1ncc(C(=O)Nc2cccc(F)c2)c(C(F)(F)F)n1		CHEMBL4238715	=	Inhibition	%	27.0	CHEMBL2041	Homo sapiens	INH	%	27.0
	18656440	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=C1NC(Cc2ccccc2)C(=O)C1c1ccccc1		CHEMBL4240764	=	Inhibition	%	28.0	CHEMBL2041	Homo sapiens	INH	%	28.0
	18656441	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	S=C(Nc1ccc(Cl)c(Cl)c1)Nc1cc(-c2cccs2)n[nH]1		CHEMBL4250872	=	Inhibition	%	30.0	CHEMBL2041	Homo sapiens	INH	%	30.0
	18656442	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Cc1sc(N)c(C(=O)c2ccc(Cl)cc2)c1C		CHEMBL58369	=	Inhibition	%	42.0	CHEMBL2041	Homo sapiens	INH	%	42.0
	18656443	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Nc1[nH]nc(-c2ccccc2)c1-c1ccccc1		CHEMBL1531879	=	Inhibition	%	55.0	CHEMBL2041	Homo sapiens	INH	%	55.0
	18656444	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	CC(=O)Nc1ccc(NC(=O)c2ccccc2)cn1		CHEMBL4247493	=	Inhibition	%	55.0	CHEMBL2041	Homo sapiens	INH	%	55.0
	18656445	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=C(O)CCCc1nc(-c2ccccn2)no1		CHEMBL4243259	=	Inhibition	%	52.0	CHEMBL2041	Homo sapiens	INH	%	52.0
	18656446	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Nc1ccc(-c2nc(CSc3ccc(Cl)cc3)n[nH]2)cc1		CHEMBL4248228	=	Inhibition	%	45.7	CHEMBL2041	Homo sapiens	INH	%	45.7
	18656447	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Clc1ccc(SCc2n[nH]c(-c3ccc(Oc4ccncc4)cc3)n2)cc1		CHEMBL4241143	=	Inhibition	%	33.0	CHEMBL2041	Homo sapiens	INH	%	33.0
	18656448	CHEMBL4231189	Inhibition of wild type recombinant human RET at 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Clc1ccc(SCc2n[nH]c(-c3ccc(Br)cc3)n2)cc1		CHEMBL4240696	=	Inhibition	%	30.0	CHEMBL2041	Homo sapiens	INH	%	30.0
Not Active	18656449	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=C1NC(=S)NC(=O)C1=C/C=N/Nc1ccccc1		CHEMBL4250493		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656450	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=c1nc(-c2ccccc2)[nH]nc1/C=C/c1ccccc1		CHEMBL4246223		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656451	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Cc1ncc(CSc2ccccc2N)c(CO)c1O		CHEMBL1604036		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656452	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Cc1ccccc1-c1n[nH]c(=O)c2ccccc12		CHEMBL4250020		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656453	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Oc1nnc(-c2ccc(Cl)cc2)c2ccccc12		CHEMBL4242884		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656454	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Cc1ccc(-c2n[nH]c(=O)c3ccccc23)cc1		CHEMBL4242535		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656455	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	Cc1ccc(-c2n[nH]c(=O)c3ccccc23)cc1C		CHEMBL4240027		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656456	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	CN1N=CC2C(N/N=C/c3ccccc3)=NC=NC21		CHEMBL4244242		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656457	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	C(=N/Nc1nccc(-c2cccnc2)n1)\c1ccccc1		CHEMBL3196474		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656458	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=c1[nH]nc(-c2ccc(F)c(Cl)c2)c2ccccc12		CHEMBL4250823		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656459	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=c1[nH]c2ccccc2c(O)c1/C=N/Cc1ccccc1		CHEMBL4246791		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656460	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=C(O)CCCc1nc(-c2cnc3n(c2=O)CCS3)no1		CHEMBL562004		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656461	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=C1NN=C(c2cccs2)CC1c1ccccc1		CHEMBL4243597		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656462	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(SCc1ccccc1)SCc1ccccc1		CHEMBL4247234		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656463	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	N#CC1C(=O)N(N)C(c2ccccc2)=CC1C(F)(F)F		CHEMBL4238598		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	18656464	CHEMBL4231190	Inhibition of wild type recombinant human RET up to 100 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=C(O)CSCC(=O)Nc1ccc(-c2nc3ccccc3s2)cc1		CHEMBL1541244		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	18656465	CHEMBL4231192	Inhibition of recombinant human RET V804L mutant using peptide as substrate by fluorimetric analysis	B	Cc1ccc(Cc2cc(-c3ccc(F)cc3)nnc2O)cc1		CHEMBL1488812	=	IC50	nM	66200.0	CHEMBL2041	Homo sapiens	IC50	uM	66.2
	18656466	CHEMBL4231192	Inhibition of recombinant human RET V804L mutant using peptide as substrate by fluorimetric analysis	B	Clc1ccc(SCc2n[nH]c(-c3ccc(Cl)cc3)n2)cc1		CHEMBL4238771	=	IC50	nM	10300.0	CHEMBL2041	Homo sapiens	IC50	uM	10.3
Not Active	18656467	CHEMBL4231193	Inhibition of recombinant human RET V804L mutant up to 100 uM using peptide as substrate by fluorimetric analysis	B	Nc1c(-c2ccc(Cl)cc2)oc2ccccc2c1=O		CHEMBL4242953		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	18656512	CHEMBL4231191	Inhibition of wild type recombinant human RET at 10 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=C(Nc1ccccc1)Nc1ccc(SCc2n[nH]c(-c3ccc(Cl)cc3)n2)cc1		CHEMBL4239122	=	Inhibition	%	15.2	CHEMBL2041	Homo sapiens	INH	%	15.2
	18656513	CHEMBL4231191	Inhibition of wild type recombinant human RET at 10 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=C(Nc1ccc(SCc2n[nH]c(-c3ccc(Cl)cc3)n2)cc1)c1ccc(Cl)cc1		CHEMBL4245411	=	Inhibition	%	11.5	CHEMBL2041	Homo sapiens	INH	%	11.5
	18656514	CHEMBL4231191	Inhibition of wild type recombinant human RET at 10 uM using peptide as substrate by fluorimetric analysis relative to control	B	O=S(=O)(Nc1ccc(SCc2n[nH]c(-c3ccc(Cl)cc3)n2)cc1)c1ccccc1		CHEMBL4245870	=	Inhibition	%	33.9	CHEMBL2041	Homo sapiens	INH	%	33.9
Not Determined	18656515	CHEMBL4231192	Inhibition of recombinant human RET V804L mutant using peptide as substrate by fluorimetric analysis	B	O=C1Nc2ccccc2/C1=C/c1ccc(-c2cccs2)s1		CHEMBL47173		IC50			CHEMBL2041	Homo sapiens	IC50		
	18656516	CHEMBL4231188	Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis	B	Oc1ccc(-c2nc(CSc3ccc(Cl)cc3)n[nH]2)cc1		CHEMBL4244888	=	IC50	nM	32500.0	CHEMBL2041	Homo sapiens	IC50	uM	32.5
	18658981	CHEMBL4231724	Inhibition of GST-tagged human RET at 5 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-Spot kinase assay	B	COc1ccc2c(OCc3nnc4sc(-c5cnn(C)c5)nn34)ccnc2c1		CHEMBL4249147	=	Inhibition	%	-0.73	CHEMBL2041	Homo sapiens	INH	%	-0.73
	18663956	CHEMBL4232940	Inhibition of human RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	18664053	CHEMBL4233037	Binding affinity to human RET (E713 to D1014 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL2041	Homo sapiens	Kd	uM	5.0
	18665522	CHEMBL4233398	Inhibition of RET (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	18674875	CHEMBL4235427	Inhibition of RET (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL2041	Homo sapiens	Ki	nM	2000.0
	18674876	CHEMBL4235427	Inhibition of RET (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL2041	Homo sapiens	Ki	nM	2000.0
Not Determined	18674877	CHEMBL4235427	Inhibition of RET (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL2041	Homo sapiens	Ki		
	18694025	CHEMBL4253478	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	18694026	CHEMBL4253479	Inhibition of recombinant human GST-tagged RET V804L mutant expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	2.0	CHEMBL2041	Homo sapiens	INH	%	2.0
	18694107	CHEMBL4253560	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	INH	%	10.0
	18694108	CHEMBL4253561	Inhibition of recombinant human GST-tagged RET V804L mutant expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	16.0	CHEMBL2041	Homo sapiens	INH	%	16.0
	18697681	CHEMBL4254354	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	64.0	CHEMBL2041	Homo sapiens	Activity	%	64.0
	18724526	CHEMBL4258940	Inhibition of RET (unknown origin) at 100 nM using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA relative to control	B	C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)c1		CHEMBL4288562	>	Inhibition	%	70.0	CHEMBL2041	Homo sapiens	INH	%	70.0
	18724527	CHEMBL4258940	Inhibition of RET (unknown origin) at 100 nM using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA relative to control	B	C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(OC)c4)nc32)c1		CHEMBL4277912	>	Inhibition	%	70.0	CHEMBL2041	Homo sapiens	INH	%	70.0
	18737811	CHEMBL4261428	Inhibition of recombinant human Ret (658 to ed residues) using KKKSPGEYVNIEF as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	66.0	CHEMBL2041	Homo sapiens	IC50	nM	66.0
	18751224	CHEMBL4263933	Inhibition of RET (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	8.0	CHEMBL2041	Homo sapiens	INH	%	8.0
	18752175	CHEMBL4264512	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	18752176	CHEMBL4264513	Binding affinity to human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	90.0	CHEMBL2041	Homo sapiens	Activity	%	90.0
	18752177	CHEMBL4264514	Binding affinity to human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	92.0	CHEMBL2041	Homo sapiens	Activity	%	92.0
	18752178	CHEMBL4264515	Binding affinity to human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	98.0	CHEMBL2041	Homo sapiens	Activity	%	98.0
	18761572	CHEMBL4266623	Inhibition of recombinant human N-terminal GST-tagged RET (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1	Outside typical range	CHEMBL4279192	=	Inhibition	%	-16.0	CHEMBL2041	Homo sapiens	INH	%	-16.0
	18761573	CHEMBL4266624	Inhibition of recombinant human N-terminal GST-tagged RET V804L mutant (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	14.0	CHEMBL2041	Homo sapiens	INH	%	14.0
	18761574	CHEMBL4266625	Inhibition of recombinant human N-terminal GST-tagged RET V804M mutant (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	11.0	CHEMBL2041	Homo sapiens	INH	%	11.0
	18761843	CHEMBL4266623	Inhibition of recombinant human N-terminal GST-tagged RET (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	19.0	CHEMBL2041	Homo sapiens	INH	%	19.0
	18761844	CHEMBL4266624	Inhibition of recombinant human N-terminal GST-tagged RET V804L mutant (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	-5.0	CHEMBL2041	Homo sapiens	INH	%	-5.0
	18761845	CHEMBL4266625	Inhibition of recombinant human N-terminal GST-tagged RET V804M mutant (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	5.0	CHEMBL2041	Homo sapiens	INH	%	5.0
	18762006	CHEMBL4266623	Inhibition of recombinant human N-terminal GST-tagged RET (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	INH	%	4.0
	18762007	CHEMBL4266624	Inhibition of recombinant human N-terminal GST-tagged RET V804L mutant (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-6.0	CHEMBL2041	Homo sapiens	INH	%	-6.0
	18762008	CHEMBL4266625	Inhibition of recombinant human N-terminal GST-tagged RET V804M mutant (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-4.0	CHEMBL2041	Homo sapiens	INH	%	-4.0
	18763064	CHEMBL4266861	Inhibition of RET (unknown origin) at 1 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876	=	Inhibition	%	97.17	CHEMBL2041	Homo sapiens	INH	%	97.17
	18763095	CHEMBL4266892	Inhibition of RET (unknown origin) at 10 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081	=	Inhibition	%	98.37	CHEMBL2041	Homo sapiens	INH	%	98.37
	18763715	CHEMBL4267000	Inhibition of RET (unknown origin)	B	CN1CCN(c2ccc(-c3c(-c4cc(F)c(O)c(F)c4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4292020	<	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	uM	1.0
	18765537	CHEMBL4267268	Inhibition of N-terminal GST-tagged human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4288300	=	Inhibition	%	16.3	CHEMBL2041	Homo sapiens	INH	%	16.3
	18765538	CHEMBL4267268	Inhibition of N-terminal GST-tagged human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4283823	=	Inhibition	%	2.9	CHEMBL2041	Homo sapiens	INH	%	2.9
	18765539	CHEMBL4267268	Inhibition of N-terminal GST-tagged human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4282460	=	Inhibition	%	16.8	CHEMBL2041	Homo sapiens	INH	%	16.8
	18765540	CHEMBL4267268	Inhibition of N-terminal GST-tagged human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1		CHEMBL4290750	=	Inhibition	%	10.4	CHEMBL2041	Homo sapiens	INH	%	10.4
	18765541	CHEMBL4267268	Inhibition of N-terminal GST-tagged human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4294156	=	Inhibition	%	7.7	CHEMBL2041	Homo sapiens	INH	%	7.7
	18765542	CHEMBL4267268	Inhibition of N-terminal GST-tagged human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1		CHEMBL4283970	=	Inhibition	%	8.5	CHEMBL2041	Homo sapiens	INH	%	8.5
	18769889	CHEMBL4268028	Inhibition of recombinant human RET at 1000 nM after 60 mins by ELISA relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	76.7	CHEMBL2041	Homo sapiens	INH	%	76.7
	18769890	CHEMBL4268028	Inhibition of recombinant human RET at 1000 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCOCC4)ncc32)cc1		CHEMBL4282231	=	Inhibition	%	68.7	CHEMBL2041	Homo sapiens	INH	%	68.7
Not Determined	18769891	CHEMBL4268028	Inhibition of recombinant human RET at 1000 nM after 60 mins by ELISA relative to control	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	18769892	CHEMBL4268030	Inhibition of recombinant human RET at 100 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCOCC4)ncc32)cc1		CHEMBL4282231	=	Inhibition	%	28.7	CHEMBL2041	Homo sapiens	INH	%	28.7
	18812033	CHEMBL4276195	Inhibition of human RET at 100 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	97.0	CHEMBL2041	Homo sapiens	INH	%	97.0
	18812034	CHEMBL4276195	Inhibition of human RET at 100 uM	B	O=C(NCc1ccccc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4281295	=	Inhibition	%	68.0	CHEMBL2041	Homo sapiens	INH	%	68.0
	18812035	CHEMBL4276195	Inhibition of human RET at 100 uM	B	O=C1CC(c2ccc(C(=O)NCc3cccc(Cl)c3)cc2)Sc2ccccc2N1		CHEMBL4277682	=	Inhibition	%	18.5	CHEMBL2041	Homo sapiens	INH	%	18.5
Not Active	18847271	CHEMBL4304949	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	18858175	CHEMBL4308021	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	98.0	CHEMBL2041	Homo sapiens	Activity	%	98.0
	18858176	CHEMBL4308022	Binding affinity to human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	86.0	CHEMBL2041	Homo sapiens	Activity	%	86.0
	18858177	CHEMBL4308023	Binding affinity to human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	90.0	CHEMBL2041	Homo sapiens	Activity	%	90.0
	18858178	CHEMBL4308024	Binding affinity to human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	97.0	CHEMBL2041	Homo sapiens	Activity	%	97.0
	18885099	CHEMBL4313074	Inhibition of human Ret at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA relative to control	A	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835	=	Inhibition	%	78.4	CHEMBL2041	Homo sapiens	INH	%	78.4
	18885118	CHEMBL4313085	Inhibition of human Ret using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	A	C=CC(=O)NCc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4541330	>	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	18890209	CHEMBL4314016	Inhibition of recombinant GST-tagged human RET (658 to 1114 residues) expressed in baculovirus expression system at 0.5 uM using tyr 02 as substrate in presence of ATP at Km concentration after 1 hr by Z'-LYTE assay relative to control	B	COc1cc(C(=O)NC2CCNCC2)ccc1Nc1nc(Nc2ccccc2P(C)(C)=O)c2cc[nH]c2n1		CHEMBL4448754	=	Inhibition	%	10.0	CHEMBL2041	Homo sapiens	INH	%	10.0
	18892958	CHEMBL4314924	Inhibition of human Ret (658 to end residues) using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	18892959	CHEMBL4314925	Inhibition of human Ret V804L mutant (658 to end residues) using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	105.5	CHEMBL2041	Homo sapiens	Activity	%	105.5
	18892960	CHEMBL4314926	Inhibition of human Ret V804M mutant (658 to end residues) using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	105.5	CHEMBL2041	Homo sapiens	Activity	%	105.5
	18893328	CHEMBL4315087	Inhibition of recombinant human GST-tagged RET expressed in baculovirus expression system	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	nM	10.0
	18919436	CHEMBL4322723	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged RET (unknown origin) (658 to 1114 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	40.0	CHEMBL2041	Homo sapiens	Kd	nM	40.0
	18919624	CHEMBL4322723	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged RET (unknown origin) (658 to 1114 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	54.0	CHEMBL2041	Homo sapiens	Kd	nM	54.0
	18930935	CHEMBL4325593	Inhibition of recombinant human N-terminal GST-tagged RET (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	96.6	CHEMBL2041	Homo sapiens	INH	%	96.6
	18930959	CHEMBL4325617	Inhibition of recombinant human N-terminal GST-tagged RET (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 100 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	77.6	CHEMBL2041	Homo sapiens	INH	%	77.6
	18930983	CHEMBL4325641	Inhibition of recombinant human N-terminal GST-tagged RET (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	42.7	CHEMBL2041	Homo sapiens	INH	%	42.7
	18934106	CHEMBL4326638	Inhibition of human RET at 10 uM using MEK1 (K97R) as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	85.2	CHEMBL2041	Homo sapiens	INH	%	85.2
	18938265	CHEMBL4327859	Inhibition of human RET assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	96.44	CHEMBL2041	Homo sapiens	Activity	%	96.44
	18938266	CHEMBL4327859	Inhibition of human RET assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	93.22	CHEMBL2041	Homo sapiens	Activity	%	93.22
	18938704	CHEMBL4328223	Inhibition of human RET assessed as residual activity at 100 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2041	Homo sapiens	Activity	%	65.0
	18939089	CHEMBL4328587	Inhibition of human RET using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.43	CHEMBL2041	Homo sapiens	IC50	10'-9M	3.43
	18951029	CHEMBL4331427	Inhibition of human RET using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	Cc1ccc(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1NC(=O)C1(c2ncnc3[nH]cnc23)CC1		CHEMBL4466555	=	IC50	nM	5.2	CHEMBL2041	Homo sapiens	IC50	nM	5.2
	18958582	CHEMBL4333609	Binding affinity to human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	94.0	CHEMBL2041	Homo sapiens	Activity	%	94.0
	18958583	CHEMBL4333608	Binding affinity to human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	97.0	CHEMBL2041	Homo sapiens	Activity	%	97.0
	18958584	CHEMBL4333607	Binding affinity to human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	86.0	CHEMBL2041	Homo sapiens	Activity	%	86.0
	18958585	CHEMBL4333606	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	97.0	CHEMBL2041	Homo sapiens	Activity	%	97.0
	18964646	CHEMBL4335264	Inhibition of recombinant human Ret (658 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	92.0	CHEMBL2041	Homo sapiens	Activity	%	92.0
	18964647	CHEMBL4335264	Inhibition of recombinant human Ret (658 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	102.0	CHEMBL2041	Homo sapiens	Activity	%	102.0
	18964648	CHEMBL4335265	Inhibition of recombinant human Ret V804L mutant (658 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	97.0	CHEMBL2041	Homo sapiens	Activity	%	97.0
	18964649	CHEMBL4335265	Inhibition of recombinant human Ret V804L mutant (658 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	98.0	CHEMBL2041	Homo sapiens	Activity	%	98.0
	18964650	CHEMBL4335266	Inhibition of recombinant human Ret V804M mutant (658 to end residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	95.0	CHEMBL2041	Homo sapiens	Activity	%	95.0
	18964651	CHEMBL4335266	Inhibition of recombinant human Ret V804M mutant (658 to end residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	98.0	CHEMBL2041	Homo sapiens	Activity	%	98.0
	18972077	CHEMBL4337087	Inhibition of recombinant human Ret (658 to end residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	57.0	CHEMBL2041	Homo sapiens	Activity	%	57.0
	18972078	CHEMBL4337088	Inhibition of recombinant human Ret V804L mutant (658 to end residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	90.0	CHEMBL2041	Homo sapiens	Activity	%	90.0
	18972079	CHEMBL4337089	Inhibition of recombinant human Ret V804M mutant (658 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	69.0	CHEMBL2041	Homo sapiens	Activity	%	69.0
	18972846	CHEMBL4337345	Inhibition of full-length N-terminal GST-tagged human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 10 uM using propeptide-22 as substrate after 90 mins by electrophoretic mobility shift assay relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2c(c1)OCCO2		CHEMBL4580637	=	Inhibition	%	1.0	CHEMBL2041	Homo sapiens	INH	%	1.0
	18985706	CHEMBL4340005	Inhibition of RET (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	nM	10000.0
	19012674	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	1500.0	CHEMBL2041	Homo sapiens	IC50	uM	1.5
	19012675	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	IC50	nM	5000.0	CHEMBL2041	Homo sapiens	IC50	uM	5.0
	19012676	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	NC(=O)c1ccc(-c2cnn3ccc(NCc4ccncc4)nc23)cc1		CHEMBL4534366	=	IC50	nM	20.0	CHEMBL2041	Homo sapiens	IC50	uM	0.02
	19012677	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	CN(C)C(=O)c1ccc(-c2cnn3ccc(NCc4ccncc4)nc23)cc1		CHEMBL4463076	=	IC50	nM	7600.0	CHEMBL2041	Homo sapiens	IC50	uM	7.6
	19012678	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	NC(=O)c1ccc(-c2cnn3ccc(NCc4ccccn4)nc23)cc1		CHEMBL4468733	=	IC50	nM	44.0	CHEMBL2041	Homo sapiens	IC50	uM	0.044
	19012679	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	NC(=O)c1ccc(-c2cnn3ccc(NCc4cccnc4)nc23)cc1		CHEMBL4570029	=	IC50	nM	51.0	CHEMBL2041	Homo sapiens	IC50	uM	0.051
	19012680	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	CN(C)CCNc1ccn2ncc(-c3ccc(C(N)=O)cc3)c2n1		CHEMBL4457706	=	IC50	nM	350.0	CHEMBL2041	Homo sapiens	IC50	uM	0.35
	19012681	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	c1ccc(-c2cnn3ccc(NCc4ccncc4)nc23)cc1		CHEMBL4541958	=	IC50	nM	1140.0	CHEMBL2041	Homo sapiens	IC50	uM	1.14
	19012682	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	NC(=O)c1cccc(-c2cnn3ccc(NCc4ccncc4)nc23)c1		CHEMBL4475722	=	IC50	nM	4300.0	CHEMBL2041	Homo sapiens	IC50	uM	4.3
	19012683	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	NS(=O)(=O)c1ccc(-c2cnn3ccc(NCc4ccncc4)nc23)cc1		CHEMBL4536438	=	IC50	nM	360.0	CHEMBL2041	Homo sapiens	IC50	uM	0.36
	19012684	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	O=C(O)c1ccc(-c2cnn3ccc(NCc4ccncc4)nc23)cc1		CHEMBL4593942	=	IC50	nM	560.0	CHEMBL2041	Homo sapiens	IC50	uM	0.56
	19012685	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	CC(=O)Nc1ccc(-c2cnn3ccc(NCc4ccncc4)nc23)cc1		CHEMBL4544713	=	IC50	nM	6700.0	CHEMBL2041	Homo sapiens	IC50	uM	6.7
	19012686	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	CC(=O)Nc1cccc(-c2cnn3ccc(NCc4ccncc4)nc23)c1		CHEMBL4454509	=	IC50	nM	1600.0	CHEMBL2041	Homo sapiens	IC50	uM	1.6
	19012687	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	CS(=O)(=O)Nc1ccc(-c2cnn3ccc(NCc4ccncc4)nc23)cc1		CHEMBL4531066	=	IC50	nM	1500.0	CHEMBL2041	Homo sapiens	IC50	uM	1.5
	19012688	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	c1cc(CNc2ccn3ncc(-c4ccc5cn[nH]c5c4)c3n2)ccn1		CHEMBL4513446	=	IC50	nM	300.0	CHEMBL2041	Homo sapiens	IC50	uM	0.3
	19012689	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	c1cc(CNc2ccn3ncc(-c4ccc5c(c4)OCO5)c3n2)ccn1		CHEMBL4547553	=	IC50	nM	290.0	CHEMBL2041	Homo sapiens	IC50	uM	0.29
	19012690	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	c1ccc(CNc2ccn3ncc(-c4ccc5c(c4)OCO5)c3n2)nc1		CHEMBL4458622	=	IC50	nM	39.0	CHEMBL2041	Homo sapiens	IC50	uM	0.039
	19012691	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	c1ccc(CNc2ccn3ncc(-c4ccc5c(c4)OCO5)c3n2)cc1		CHEMBL4450404	=	IC50	nM	29000.0	CHEMBL2041	Homo sapiens	IC50	uM	29.0
	19012692	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	c1cc(Nc2ccn3ncc(-c4ccc5c(c4)OCO5)c3n2)ccn1		CHEMBL4537023	=	IC50	nM	63000.0	CHEMBL2041	Homo sapiens	IC50	uM	63.0
	19012693	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	c1cc2c(cc1-c1cnn3ccc(NCC4CCNCC4)nc13)OCO2		CHEMBL4532182	=	IC50	nM	200.0	CHEMBL2041	Homo sapiens	IC50	uM	0.2
	19012694	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	c1cc2c(cc1-c1cnn3ccc(NC4CCNCC4)nc13)OCO2		CHEMBL4560012	=	IC50	nM	880.0	CHEMBL2041	Homo sapiens	IC50	uM	0.88
	19012695	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	CN(C)CCNc1ccn2ncc(-c3ccc4c(c3)OCO4)c2n1		CHEMBL4536873	=	IC50	nM	91.0	CHEMBL2041	Homo sapiens	IC50	uM	0.091
	19012696	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	c1cc2c(cc1-c1cnn3ccc(NCCN4CCCCC4)nc13)OCO2		CHEMBL4476151	=	IC50	nM	660.0	CHEMBL2041	Homo sapiens	IC50	uM	0.66
	19012697	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	CN(C)CCCNc1ccn2ncc(-c3ccc4c(c3)OCO4)c2n1		CHEMBL4561280	=	IC50	nM	19.0	CHEMBL2041	Homo sapiens	IC50	uM	0.019
	19012698	CHEMBL4345863	Inhibition of recombinant N-Terminal GST-tagged human RET V804M mutant (658 to end residues) incubated for 15 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	OCCNc1ccn2ncc(-c3ccc4c(c3)OCO4)c2n1		CHEMBL4466600	=	IC50	nM	130.0	CHEMBL2041	Homo sapiens	IC50	uM	0.13
	19012748	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	1500.0	CHEMBL2041	Homo sapiens	IC50	uM	1.5
	19012749	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	180.0	CHEMBL2041	Homo sapiens	IC50	uM	0.18
	19012750	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	NC(=O)c1ccc(-c2cnn3ccc(NCc4ccncc4)nc23)cc1		CHEMBL4534366	=	IC50	nM	4400.0	CHEMBL2041	Homo sapiens	IC50	uM	4.4
	19012751	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	NC(=O)c1ccc(-c2cnn3ccc(NCc4ccccn4)nc23)cc1		CHEMBL4468733	=	IC50	nM	3700.0	CHEMBL2041	Homo sapiens	IC50	uM	3.7
	19012752	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	NC(=O)c1ccc(-c2cnn3ccc(NCc4cccnc4)nc23)cc1		CHEMBL4570029	=	IC50	nM	3900.0	CHEMBL2041	Homo sapiens	IC50	uM	3.9
	19012753	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	CN(C)CCNc1ccn2ncc(-c3ccc(C(N)=O)cc3)c2n1		CHEMBL4457706	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	19012754	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	NS(=O)(=O)c1ccc(-c2cnn3ccc(NCc4ccncc4)nc23)cc1		CHEMBL4536438	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	19012755	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	c1cc(CNc2ccn3ncc(-c4ccc5cn[nH]c5c4)c3n2)ccn1		CHEMBL4513446	=	IC50	nM	2800.0	CHEMBL2041	Homo sapiens	IC50	uM	2.8
	19012756	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	c1cc(CNc2ccn3ncc(-c4ccc5c(c4)OCO5)c3n2)ccn1		CHEMBL4547553	=	IC50	nM	1500.0	CHEMBL2041	Homo sapiens	IC50	uM	1.5
	19012757	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	c1ccc(CNc2ccn3ncc(-c4ccc5c(c4)OCO5)c3n2)nc1		CHEMBL4458622	=	IC50	nM	1100.0	CHEMBL2041	Homo sapiens	IC50	uM	1.1
	19012758	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	c1cc2c(cc1-c1cnn3ccc(NCC4CCNCC4)nc13)OCO2		CHEMBL4532182	=	IC50	nM	1300.0	CHEMBL2041	Homo sapiens	IC50	uM	1.3
	19012759	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	CN(C)CCNc1ccn2ncc(-c3ccc4c(c3)OCO4)c2n1		CHEMBL4536873	=	IC50	nM	740.0	CHEMBL2041	Homo sapiens	IC50	uM	0.74
	19012760	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	CN(C)CCCNc1ccn2ncc(-c3ccc4c(c3)OCO4)c2n1		CHEMBL4561280	=	IC50	nM	110.0	CHEMBL2041	Homo sapiens	IC50	uM	0.11
	19012761	CHEMBL4345866	Inhibition of RET V804M mutant (unknown origin)expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	OCCNc1ccn2ncc(-c3ccc4c(c3)OCO4)c2n1		CHEMBL4466600	=	IC50	nM	6800.0	CHEMBL2041	Homo sapiens	IC50	uM	6.8
	19012792	CHEMBL4345870	Inhibition of RET (unknown origin) expressed in human BaF3 cells assessed as reduction in cell viability incubated for 48 hrs by celltiter glo luminescence cell viability assay	B	CN(C)CCCNc1ccn2ncc(-c3ccc4c(c3)OCO4)c2n1		CHEMBL4561280	=	IC50	nM	4000.0	CHEMBL2041	Homo sapiens	IC50	uM	4.0
	19021560	CHEMBL4347783	Inhibition of recombinant human RET at 20 nM using biotinyl-beta amyloid-beta amyloid-beta AAEEEEYFELVAKKK as substrate after 30 mins by HTRF method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	92.0	CHEMBL2041	Homo sapiens	INH	%	92.0
	19021561	CHEMBL4347784	Inhibition of recombinant human RET at 200 nM using biotinyl-beta amyloid-beta amyloid-beta AAEEEEYFELVAKKK as substrate after 30 mins by HTRF method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	99.0	CHEMBL2041	Homo sapiens	INH	%	99.0
	19026303	CHEMBL4348498	Inhibition of N-terminal GST-tagged human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CCN(C)C)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4470529	>	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
Not Active	19040135	CHEMBL4352036	Inhibition of human Ret (658 to end residues) using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	19040136	CHEMBL4352037	Inhibition of human Ret V804L mutant (658 to end residues) using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	19040137	CHEMBL4352038	Inhibition of human Ret V804M mutant (658 to end residues) using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19041265	CHEMBL4352526	Inhibition of human RET at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	19048780	CHEMBL4354265	Inhibition of RET (unknown origin) at 1 uM	B	COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4523063	=	Inhibition	%	-3.0	CHEMBL2041	Homo sapiens	INH	%	-3.0
	19059800	CHEMBL4358101	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	19059801	CHEMBL4358102	Binding affinity to human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	87.0	CHEMBL2041	Homo sapiens	Activity	%	87.0
	19059802	CHEMBL4358103	Binding affinity to human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	19059803	CHEMBL4358104	Binding affinity to human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	19063664	CHEMBL4359450	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5'FAM-EPLYWSFPA as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	IC50	nM	1.0	CHEMBL2041	Homo sapiens	IC50	uM	0.001
	19063665	CHEMBL4359451	Inhibition of recombinant human N-terminal GST/His-tagged RET V804M mutant (658 to 1114 residues) expressed in Sf9 insect cells using 5'FAM-EPLYWSFPA as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	IC50	nM	8.0	CHEMBL2041	Homo sapiens	IC50	uM	0.008
	19063667	CHEMBL4359453	Binding affinity to recombinant phosphorylated RET kinase domain (705 to 1013 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells assessed as change in melting temperature at 40 uM measured over 240 mins by sypro orange dye based thermal shift assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	Delta Tm	degrees C	16.0	CHEMBL2041	Homo sapiens	deltaTm	degrees C	16.0
Active	19063668	CHEMBL4359454	Binding affinity to recombinant RET V804M mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells assessed as change in melting temperature at 40 uM by sypro orange dye based thermal shift assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Activity			CHEMBL2041	Homo sapiens	Activity		
Active	19063680	CHEMBL4359468	Inhibition of RET isoform 9 C634R mutant (unknown origin) expressed in rat Rat1 assessed as reduction in RET phosphorylation at Y905 residue at 0.3 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063681	CHEMBL4359469	Inhibition of RET isoform 9 C634R mutant (unknown origin) expressed in rat Rat1 assessed as reduction in RET phosphorylation at Y1062 residue at 0.3 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	19063682	CHEMBL4359470	Inhibition of RET isoform 9 C634R mutant (unknown origin) expressed in rat Rat1 assessed as reduction in RET phosphorylation at Y905 residue at 3 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	19063683	CHEMBL4359471	Inhibition of RET isoform 9 C634R mutant (unknown origin) expressed in rat Rat1 assessed as reduction in RET phosphorylation at Y1062 residue at 3 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
Active	19063684	CHEMBL4359472	Inhibition of RET isoform 9 M918T mutant (unknown origin) expressed in rat Rat1 assessed as reduction in RET phosphorylation at Y905 residue at 1 to 100 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063685	CHEMBL4359473	Inhibition of RET isoform 9 A883F mutant (unknown origin) expressed in rat Rat1 assessed as reduction in RET phosphorylation at Y905 residue at 1 to 100 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063686	CHEMBL4359474	Inhibition of RET isoform 9 V804L mutant (unknown origin) expressed in rat Rat1 assessed as reduction in RET phosphorylation at Y905 residue at 1 to 100 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063687	CHEMBL4359475	Inhibition of RET isoform 9 V804M mutant (unknown origin) expressed in rat Rat1 assessed as reduction in RET phosphorylation at Y905 residue at 1 to 100 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063688	CHEMBL4359476	Inhibition of RET isoform 9 M918T mutant (unknown origin) expressed in rat Rat1 assessed as reduction in RET phosphorylation at Y1062 residue at 1 to 100 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063689	CHEMBL4359477	Inhibition of RET isoform 9 A883F mutant (unknown origin) expressed in rat Rat1 assessed as reduction in RET phosphorylation at Y1062 residue at 1 to 100 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063690	CHEMBL4359478	Inhibition of RET isoform 9 V804L mutant (unknown origin) expressed in rat Rat1 assessed as reduction in RET phosphorylation at Y1062 residue at 1 to 100 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063691	CHEMBL4359479	Inhibition of RET isoform 9 V804M mutant (unknown origin) expressed in rat Rat1 assessed as reduction in RET phosphorylation at Y1062 residue at 1 to 100 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063699	CHEMBL4359487	Inhibition of Ret isoform 9 C634W mutant in human TT cells assessed as reduction in phosphorylation at Y1062 residue at 0.3 to 30 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063700	CHEMBL4359488	Inhibition of Ret isoform 9 M918T mutant in human MZ-CRC-1 cells assessed as reduction in phosphorylation at Y1062 residue at 0.3 to 30 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063703	CHEMBL4359491	Inhibition of Ret isoform 9 C634W mutant in human TT cells assessed as reduction in SHC phosphorylation at 0.3 to 30 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063704	CHEMBL4359492	Inhibition of Ret isoform 9 M918T mutant in human MZ-CRC-1 cells assessed as reduction in SHC phosphorylation at 0.3 to 30 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	19063707	CHEMBL4359495	Inhibition of Ret isoform 9 C634W mutant in human TT cells assessed as reduction in MAPK phosphorylation at 0.3 to 30 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Not Active	19063708	CHEMBL4359496	Inhibition of Ret isoform 9 M918T mutant in human MZ-CRC-1 cells assessed as reduction in MAPK phosphorylation at 0.3 to 30 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	19063721	CHEMBL4359508	Inhibition of RET isoform 15 C634R mutant (unknown origin) expressed in mouse BAF3 cells assessed as reduction in cell proliferation supplemented with fresh medium containing compound for every 2 to 3 days and measured daily	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	IC50	nM	1.7	CHEMBL2041	Homo sapiens	IC50	nM	1.7
	19063722	CHEMBL4359509	Inhibition of RET isoform 15 M918T mutant (unknown origin) expressed in mouse BAF3 cells assessed as reduction in cell proliferation supplemented with fresh medium containing compound for every 2 to 3 days and measured daily	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	IC50	nM	1.6	CHEMBL2041	Homo sapiens	IC50	nM	1.6
Active	19063725	CHEMBL4359512	Inhibition of RET isoform 15 C634R mutant (unknown origin) expressed in mouse BAF3 cells assessed as reduction in RET phosphorylation at Y905 residue at 0.3 to 30 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063726	CHEMBL4359513	Inhibition of RET isoform 15 M918T mutant (unknown origin) expressed in mouse BAF3 cells assessed as reduction in RET phosphorylation at Y905 residue at 0.3 to 30 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063728	CHEMBL4359515	Inhibition of RET isoform 15 C634R mutant (unknown origin) expressed in mouse BAF3 cells assessed as reduction in RET phosphorylation at Y1062 residue at 0.3 to 30 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19063729	CHEMBL4359516	Inhibition of RET isoform 15 M918T mutant (unknown origin) expressed in mouse BAF3 cells assessed as reduction in RET phosphorylation at Y1062 residue at 0.3 to 30 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	19063733	CHEMBL4359520	Inhibition of RET isoform 9 C634W mutant in human TT cells assessed as reduction in cell proliferation supplemented with fresh medium containing compound for every 2 to 3 days and measured during compound dosing	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	IC50	nM	0.67	CHEMBL2041	Homo sapiens	IC50	nM	0.67
	19063734	CHEMBL4359521	Inhibition of RET isoform 9 M918T mutant in human MZ-CRC-1 cells assessed as reduction in cell proliferation supplemented with fresh medium containing compound for every 2 to 3 days and measured during compound dosing	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	IC50	nM	0.67	CHEMBL2041	Homo sapiens	IC50	nM	0.67
	19063743	CHEMBL4359530	Inhibition of RET isoform 9 C634R mutant (unknown origin) expressed in mouse NIH/3T3 cells assessed as reduction in cell proliferation supplemented with fresh medium containing compound for every 2 to 3 days measured at 2 days interval during compound dosing	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	IC50	nM	4.17	CHEMBL2041	Homo sapiens	IC50	nM	4.17
	19063745	CHEMBL4359532	Inhibition of RET isoform 9 C634R mutant (unknown origin) expressed in mouse NIH/3T3 cells assessed as reduction in RET phosphorylation at Y1062 residue at 10 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	19063746	CHEMBL4359533	Inhibition of RET isoform 9 C634R mutant (unknown origin) expressed in mouse NIH/3T3 cells assessed as reduction in RET phosphorylation at Y905 residue at 10 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	19063747	CHEMBL4359534	Inhibition of RET isoform 9 C634R mutant (unknown origin) expressed in mouse NIH/3T3 cells assessed as reduction in SHC phosphorylation at 10 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	19063748	CHEMBL4359535	Inhibition of RET isoform 9 C634R mutant (unknown origin) expressed in mouse NIH/3T3 cells assessed as reduction in MAPK phosphorylation at 10 nM measured after 2 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	=	Inhibition	%	100.0	CHEMBL2041	Homo sapiens	INH	%	100.0
	19063774	CHEMBL4359455	Binding affinity to recombinant phosphorylated RET kinase domain (705 to 1013 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells assessed as change in melting temperature at 40 uM by sypro orange dye based thermal shift assay	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Delta Tm	degrees C	6.1	CHEMBL2041	Homo sapiens	deltaTm	degrees C	6.1
Not Active	19063775	CHEMBL4359454	Binding affinity to recombinant RET V804M mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells assessed as change in melting temperature at 40 uM by sypro orange dye based thermal shift assay	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380		Activity			CHEMBL2041	Homo sapiens	Activity		
	19069469	CHEMBL4361178	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)Cc4ccc(Cl)c(C(F)(F)F)c4)cc3)c2cc1OC		CHEMBL4577779	<	Activity	%	1.0	CHEMBL2041	Homo sapiens	Activity	%	1.0
	19069477	CHEMBL4361186	Inhibition of recombinant human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system by Z-lyte assay	B	COc1cc2nccc(Oc3ccc(NC(=O)Cc4ccc(Cl)c(C(F)(F)F)c4)cc3)c2cc1OC		CHEMBL4577779	=	IC50	nM	34.0	CHEMBL2041	Homo sapiens	IC50	nM	34.0
	19090364	CHEMBL4365938	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	19090365	CHEMBL4365939	Inhibition of human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	19090366	CHEMBL4365940	Inhibition of human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	19090367	CHEMBL4365941	Inhibition of human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	96.0	CHEMBL2041	Homo sapiens	Activity	%	96.0
	19092098	CHEMBL4366572	Inhibition of human RET at 100 nM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-65.36	CHEMBL2041	Homo sapiens	INH	%	-65.36
	19092279	CHEMBL4366699	Inhibition of RET (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	96.0	CHEMBL2041	Homo sapiens	INH	%	96.0
Active	19114575	CHEMBL4371373	Inhibition of RET (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	19114576	CHEMBL4371372	Inhibition of RET (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	19118532	CHEMBL4372376	Inhibition of recombinant human N-terminal GST-tagged Ret (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using IFG-1Rtide as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	Inhibition	%	-2.0	CHEMBL2041	Homo sapiens	INH	%	-2.0
	19140835	CHEMBL4376599	Inhibition of recombinant human GST/His6-tagged RET (658 to 1114 residues) expressed in baculovirus infected Sf9 insect cells at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19144824	CHEMBL4377840	Inhibition of human Ret (658 to end residues) at 1 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	55.0	CHEMBL2041	Homo sapiens	INH	%	55.0
	19144825	CHEMBL4377841	Inhibition of human Ret V804L mutant (658 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	46.0	CHEMBL2041	Homo sapiens	INH	%	46.0
	19144826	CHEMBL4377842	Inhibition of human Ret V804M mutant (658 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	58.0	CHEMBL2041	Homo sapiens	INH	%	58.0
	19148019	CHEMBL4379415	Inhibition of recombinant human Ret (658 to end residues) using KKKSPGEYVNIEF as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	19148020	CHEMBL4379416	Inhibition of recombinant human Ret V804L mutant (658 to end residues) using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	19148021	CHEMBL4379417	Inhibition of recombinant human Ret V804M mutant (658 to end residues) using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	19159628	CHEMBL4382732	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	13.0	CHEMBL2041	Homo sapiens	Activity	%	13.0
	19159629	CHEMBL4382733	Binding affinity to human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	9.7	CHEMBL2041	Homo sapiens	Activity	%	9.7
	19159630	CHEMBL4382734	Binding affinity to human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	14.0	CHEMBL2041	Homo sapiens	Activity	%	14.0
	19159631	CHEMBL4382735	Binding affinity to human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	15.0	CHEMBL2041	Homo sapiens	Activity	%	15.0
	19161581	CHEMBL4383427	Inhibition of wild type C-terminal FLAG-tagged human TEL fused RET (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay	B	CN1CCN(Cc2ccc(NC(=O)CCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1		CHEMBL4439424	=	GI50	nM	200.0	CHEMBL2041	Homo sapiens	GI50	uM	0.2
	19181137	CHEMBL4387348	Inhibition of recombinant human GST-tagged RET (658 to 1114 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	5.5	CHEMBL2041	Homo sapiens	INH	%	5.5
	19181362	CHEMBL4387348	Inhibition of recombinant human GST-tagged RET (658 to 1114 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	13.5	CHEMBL2041	Homo sapiens	INH	%	13.5
	19191376	CHEMBL4389454	Inhibition of human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	0.65	CHEMBL2041	Homo sapiens	INH	%	0.65
	19191377	CHEMBL4389453	Inhibition of human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	0.1	CHEMBL2041	Homo sapiens	INH	%	0.1
	19191378	CHEMBL4389452	Inhibition of human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	19191379	CHEMBL4389451	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	0.0	CHEMBL2041	Homo sapiens	INH	%	0.0
	19192114	CHEMBL4389928	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	0.3	CHEMBL2041	Homo sapiens	INH	%	0.3
	19192115	CHEMBL4389929	Inhibition of human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	0.05	CHEMBL2041	Homo sapiens	INH	%	0.05
	19192116	CHEMBL4389930	Inhibition of human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	0.2	CHEMBL2041	Homo sapiens	INH	%	0.2
	19192117	CHEMBL4389931	Inhibition of human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	0.95	CHEMBL2041	Homo sapiens	INH	%	0.95
	19200370	CHEMBL4391554	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	39.0	CHEMBL2041	Homo sapiens	Activity	%	39.0
	19200371	CHEMBL4391555	Binding affinity to human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	42.0	CHEMBL2041	Homo sapiens	Activity	%	42.0
	19200372	CHEMBL4391556	Binding affinity to human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	16.0	CHEMBL2041	Homo sapiens	Activity	%	16.0
	19200373	CHEMBL4391557	Binding affinity to human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	13.0	CHEMBL2041	Homo sapiens	Activity	%	13.0
	19218926	CHEMBL4394541	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	<	Kd	nM	225.0	CHEMBL2041	Homo sapiens	Kd	nM	225.0
	19236752	CHEMBL4398825	Inhibition of RET (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	<	Inhibition	%	25.0	CHEMBL2041	Homo sapiens	INH	%	25.0
	19250393	CHEMBL4401416	Inhibition of full length human N-terminal GST-tagged RET expressed in baculovirus expression system at 100 nM relative to control	B	C=CS(=O)(=O)Nc1ccc2c(c1)/C(=C/c1[nH]c(C)c(C(=O)NCCN(CC)CC)c1C)C(=O)N2		CHEMBL4553725	=	Inhibition	%	96.0	CHEMBL2041	Homo sapiens	INH	%	96.0
	19266592	CHEMBL4405542	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19276108	CHEMBL4408111	Inhibition of recombinant human RET (658 to end residues) at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	27.0	CHEMBL2041	Homo sapiens	INH	%	27.0
	19276109	CHEMBL4408112	Inhibition of recombinant human RET V804L mutant (658 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	42.0	CHEMBL2041	Homo sapiens	INH	%	42.0
	19276110	CHEMBL4408113	Inhibition of recombinant human RET V804M mutant (658 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	27.0	CHEMBL2041	Homo sapiens	INH	%	27.0
	19312970	CHEMBL4416525	Inhibition of recombinant human N-terminal GST-tagged RET (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 uM using IFG1Rtide as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	>	Inhibition	%	75.0	CHEMBL2041	Homo sapiens	INH	%	75.0
	19328915	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4441604	=	IC50	nM	1.1	CHEMBL2041	Homo sapiens	IC50	nM	1.1
	19328916	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4465661	=	IC50	nM	0.95	CHEMBL2041	Homo sapiens	IC50	nM	0.95
	19328917	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4454732	=	IC50	nM	1.7	CHEMBL2041	Homo sapiens	IC50	nM	1.7
	19328918	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4574005	=	IC50	nM	1.5	CHEMBL2041	Homo sapiens	IC50	nM	1.5
	19328919	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4466977	=	IC50	nM	1.0	CHEMBL2041	Homo sapiens	IC50	nM	1.0
	19328920	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4465573	=	IC50	nM	2.3	CHEMBL2041	Homo sapiens	IC50	nM	2.3
	19328921	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@@](C)(O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4524842	=	IC50	nM	1.1	CHEMBL2041	Homo sapiens	IC50	nM	1.1
	19328922	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C(C)C)CC3)c(C)c2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4528166	=	IC50	nM	1.3	CHEMBL2041	Homo sapiens	IC50	nM	1.3
	19328923	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@](C)(O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4438824	=	IC50	nM	1.0	CHEMBL2041	Homo sapiens	IC50	nM	1.0
	19328924	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4580325	=	IC50	nM	1.0	CHEMBL2041	Homo sapiens	IC50	nM	1.0
	19328925	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	Cc1cc(Nc2nc(N[C@H]3CC[C@H](O)CC3)c(Cl)nc2C(N)=O)ccc1N1CCC(N2CCN(C)CC2)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4580299	=	IC50	nM	1.3	CHEMBL2041	Homo sapiens	IC50	nM	1.3
	19328926	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4463071	=	IC50	nM	1.3	CHEMBL2041	Homo sapiens	IC50	nM	1.3
	19328927	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4524472	=	IC50	nM	3.4	CHEMBL2041	Homo sapiens	IC50	nM	3.4
	19328928	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4483656	=	IC50	nM	1.5	CHEMBL2041	Homo sapiens	IC50	nM	1.5
	19328929	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)c(F)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4461418	=	IC50	nM	1.1	CHEMBL2041	Homo sapiens	IC50	nM	1.1
	19328930	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	COc1cc(Nc2nc(NC3CCOCC3)c(C(C)C)nc2C(N)=O)ccc1N1CCN(C)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4438727	=	IC50	nM	3.6	CHEMBL2041	Homo sapiens	IC50	nM	3.6
	19328931	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4591953	=	IC50	nM	2.9	CHEMBL2041	Homo sapiens	IC50	nM	2.9
	19328932	CHEMBL4418512	Inhibition of GST-tagged human RET cytoplasmic domain (658 to 1114 amino acids) expressed in baculovirus expression system pre-incubated before peptide substrate and ATP addition and measured after 30 mins	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4591308	=	IC50	nM	1.1	CHEMBL2041	Homo sapiens	IC50	nM	1.1
	19328987	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4441604	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19328988	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4465661	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19328989	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4454732	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19328990	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4574005	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19328991	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4466977	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19328992	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4465573	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19328993	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@@](C)(O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4524842	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19328994	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C(C)C)CC3)c(C)c2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4528166	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19328995	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@](C)(O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4438824	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19328996	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4580325	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19328997	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	Cc1cc(Nc2nc(N[C@H]3CC[C@H](O)CC3)c(Cl)nc2C(N)=O)ccc1N1CCC(N2CCN(C)CC2)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4580299	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19328998	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4463071	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19328999	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4524472	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19329000	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4483656	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19329001	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)c(F)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4461418	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19329002	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	COc1cc(Nc2nc(NC3CCOCC3)c(C(C)C)nc2C(N)=O)ccc1N1CCN(C)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4438727	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19329003	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4591953	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19329004	CHEMBL4418516	Inhibition of GST-tagged human RET cytoplasmic domain (1883 to 2347 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4591308	>=	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	19432587	CHEMBL4429385	Inhibition of partial length human RET expressed in bacterial system	B	Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O		CHEMBL3918580	=	IC50	nM	110.0	CHEMBL2041	Homo sapiens	IC50	uM	0.11
	19433053	CHEMBL4429596	Inhibition of partial length human RET expressed in bacterial expression system assessed as activity remaining at 1 uM by kinome scan assay	B	CCC(=O)NCC1CCN(c2ccc(NC(=O)Nc3cccc(Oc4ccnc5cc(OC)c(OC)cc45)c3)cc2C(F)(F)F)CC1		CHEMBL4445808	=	Activity	%	0.0	CHEMBL2041	Homo sapiens	Activity	%	0.0
	19433058	CHEMBL4429599	Inhibition of TEL-fused partial length human RET expressed in mouse BA/F3 cells after 72 hrs by cell titer-glo assay	B	CCC(=O)NCC1CCN(c2ccc(NC(=O)Nc3cccc(Oc4ccnc5cc(OC)c(OC)cc45)c3)cc2C(F)(F)F)CC1		CHEMBL4445808	=	GI50	nM	120.0	CHEMBL2041	Homo sapiens	GI50	uM	0.12
	19435827	CHEMBL4430391	Inhibition of human RET at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4516793	=	Inhibition	%	5.0	CHEMBL2041	Homo sapiens	INH	%	5.0
	19435828	CHEMBL4430391	Inhibition of human RET at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4448596	=	Inhibition	%	16.0	CHEMBL2041	Homo sapiens	INH	%	16.0
	19435829	CHEMBL4430391	Inhibition of human RET at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL3353341	=	Inhibition	%	53.0	CHEMBL2041	Homo sapiens	INH	%	53.0
	19475355	CHEMBL4479450	Inhibition of human RET	B	C[C@@H](c1cc2cccnc2cc1F)n1cnc2ncc(-c3cnn(C)c3)nc21		CHEMBL4068255	>	IC50	nM	30000.0	CHEMBL2041	Homo sapiens	IC50	nM	30000.0
	20598204	CHEMBL4602931	Inhibition of human RET	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	uM	1.0
	20600656	CHEMBL4603608	Inhibition of recombinant human GST-tagged RET cytoplasmic domain expressed in baculovirus expression system using tyr02 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	20600657	CHEMBL4603609	Inhibition of recombinant human GST-tagged RET V804L mutant cytoplasmic domain expressed in baculovirus expression system using tyr02 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	20600658	CHEMBL4603610	Inhibition of recombinant human GST-tagged RET Y791F mutant cytoplasmic domain expressed in baculovirus expression system using tyr02 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2041	Homo sapiens	IC50	uM	100.0
	20609514	CHEMBL4605791	Inhibition of RET (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4640601	=	IC50	nM	170.0	CHEMBL2041	Homo sapiens	IC50	uM	0.17
	20609515	CHEMBL4605791	Inhibition of RET (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1		CHEMBL4634073	=	IC50	nM	6.0	CHEMBL2041	Homo sapiens	IC50	uM	0.006
	20609516	CHEMBL4605791	Inhibition of RET (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4636995	=	IC50	nM	210.0	CHEMBL2041	Homo sapiens	IC50	uM	0.21
	20679577	CHEMBL4622440	Binding affinity to recombinant human RET (713 to 1014 residues) expressed in bacterial expression system by Kinomescan method	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn(-c4ccc(OCCN5CCOCC5)cc4Cl)nn3)cc2)no1		CHEMBL4645320	=	Kd	nM	24.0	CHEMBL2041	Homo sapiens	Kd	nM	24.0
	20679578	CHEMBL4622440	Binding affinity to recombinant human RET (713 to 1014 residues) expressed in bacterial expression system by Kinomescan method	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	3.8	CHEMBL2041	Homo sapiens	Kd	nM	3.8
	20683645	CHEMBL4623624	Inhibition of RET (unknown origin) at 10 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl	Outside typical range	CHEMBL4644985	=	Inhibition	%	-11.0	CHEMBL2041	Homo sapiens	INH	%	-11.0
	20683646	CHEMBL4623625	Inhibition of RET (unknown origin) at 100 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	-3.0	CHEMBL2041	Homo sapiens	INH	%	-3.0
	22392158	CHEMBL4667253	Inhibition of recombinant human GST-tagged full length RET (658 to 1114 residues) expressed in baculovirus expression system using Tyr 02 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	4.0	CHEMBL2041	Homo sapiens	INH	%	4.0
	22423279	CHEMBL4674215	Inhibition of human RET using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	91.45	CHEMBL2041	Homo sapiens	Activity	%	91.45
	22423280	CHEMBL4674215	Inhibition of human RET using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	31.41	CHEMBL2041	Homo sapiens	Activity	%	31.41
	22471795	CHEMBL4685334	Inhibition of recombinant human GST-tagged RET (658 to 1114 residues) expressed in baculovirus expression system at 100 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP by Z'-LYTE assay relative to control	A	C=CC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL4746272	=	Inhibition	%	2.9	CHEMBL2041	Homo sapiens	INH	%	2.9
	22475890	CHEMBL4686315	Inhibition of human RET incubated for 30 mins by Kinobead based assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3oc(C(=O)c4cc5cc(O)ccc5[nH]4)cc3c2)no1		CHEMBL4745937	=	EC50	nM	2494.0	CHEMBL2041	Homo sapiens	EC50	nM	2494.0
	22792797	CHEMBL4709980	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by kinomescan method relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Oc1nc(-c2cccnc2)nc2[nH]ncc12		CHEMBL4790634	=	Activity	%	0.05	CHEMBL2041	Homo sapiens	Activity	%	0.05
	22792916	CHEMBL4709988	Inhibition of recombinant wild-type human N-terminal GST-HIS6 fused RET C-terminal domain (H658 to S1114 residues) expressed in Sf9 insect cells using TRK-C-derived peptide as substrate in presence of [33P]-ATP by filter binding assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Oc1nc(-c2cccnc2)nc2[nH]ncc12		CHEMBL4790634	=	IC50	nM	3.98	CHEMBL2041	Homo sapiens	IC50	nM	3.98
	22792917	CHEMBL4709988	Inhibition of recombinant wild-type human N-terminal GST-HIS6 fused RET C-terminal domain (H658 to S1114 residues) expressed in Sf9 insect cells using TRK-C-derived peptide as substrate in presence of [33P]-ATP by filter binding assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.39	CHEMBL2041	Homo sapiens	IC50	nM	1.39
	22792918	CHEMBL4709989	Inhibition of recombinant human N-terminal GST-HIS6 fused RET M918T mutant C-terminal domain (H658 to S1114 residues) expressed in Sf9 insect cells using TRK-C-derived peptide as substrate in presence of [33P]-ATP by filter binding assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Oc1nc(-c2cccnc2)nc2[nH]ncc12		CHEMBL4790634	=	IC50	nM	8.42	CHEMBL2041	Homo sapiens	IC50	nM	8.42
	22792919	CHEMBL4709989	Inhibition of recombinant human N-terminal GST-HIS6 fused RET M918T mutant C-terminal domain (H658 to S1114 residues) expressed in Sf9 insect cells using TRK-C-derived peptide as substrate in presence of [33P]-ATP by filter binding assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.29	CHEMBL2041	Homo sapiens	IC50	nM	1.29
	22792920	CHEMBL4709990	Inhibition of recombinant human N-terminal GST-HIS6 fused RET V804L mutant C-terminal domain (H658 to S1114 residues) expressed in Sf9 insect cells using TRK-C-derived peptide as substrate in presence of [33P]-ATP by filter binding assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Oc1nc(-c2cccnc2)nc2[nH]ncc12		CHEMBL4790634	=	IC50	nM	15.05	CHEMBL2041	Homo sapiens	IC50	nM	15.05
	22792921	CHEMBL4709990	Inhibition of recombinant human N-terminal GST-HIS6 fused RET V804L mutant C-terminal domain (H658 to S1114 residues) expressed in Sf9 insect cells using TRK-C-derived peptide as substrate in presence of [33P]-ATP by filter binding assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.82	CHEMBL2041	Homo sapiens	IC50	nM	0.82
	22792922	CHEMBL4709991	Inhibition of recombinant human N-terminal GST-HIS6 fused RET V804M mutant C-terminal domain (H658 to S1114 residues) expressed in Sf9 insect cells using TRK-C-derived peptide as substrate in presence of [33P]-ATP by filter binding assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Oc1nc(-c2cccnc2)nc2[nH]ncc12		CHEMBL4790634	=	IC50	nM	7.86	CHEMBL2041	Homo sapiens	IC50	nM	7.86
	22792923	CHEMBL4709991	Inhibition of recombinant human N-terminal GST-HIS6 fused RET V804M mutant C-terminal domain (H658 to S1114 residues) expressed in Sf9 insect cells using TRK-C-derived peptide as substrate in presence of [33P]-ATP by filter binding assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.27	CHEMBL2041	Homo sapiens	IC50	nM	1.27
	22792928	CHEMBL4709994	Binding affinity to wild-type human partial length RET M918T mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by kinomescan method relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Oc1nc(-c2cccnc2)nc2[nH]ncc12		CHEMBL4790634	=	Activity	%	0.0	CHEMBL2041	Homo sapiens	Activity	%	0.0
	22792929	CHEMBL4709995	Binding affinity to wild-type human partial length RET V804L mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by kinomescan method relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Oc1nc(-c2cccnc2)nc2[nH]ncc12		CHEMBL4790634	=	Activity	%	0.8	CHEMBL2041	Homo sapiens	Activity	%	0.8
	22792930	CHEMBL4709996	Binding affinity to wild-type human partial length RET V804M mutant (E713 to D1014 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by kinomescan method relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Oc1nc(-c2cccnc2)nc2[nH]ncc12		CHEMBL4790634	=	Activity	%	0.25	CHEMBL2041	Homo sapiens	Activity	%	0.25
Active	22792940	CHEMBL4710006	Inhibition of RET phosphorylation in human LC-2-ad cells	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Oc1nc(-c2cccnc2)nc2[nH]ncc12		CHEMBL4790634		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22792941	CHEMBL4710007	Inhibition of RET in human LC-2-ad cells assessed as reduction in SHC phosphorylation	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Oc1nc(-c2cccnc2)nc2[nH]ncc12		CHEMBL4790634		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	22809996	CHEMBL4713434	Inhibition of RET (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	IC50	nM	35.0	CHEMBL2041	Homo sapiens	IC50	nM	35.0
	22809997	CHEMBL4713434	Inhibition of RET (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	4.0	CHEMBL2041	Homo sapiens	IC50	nM	4.0
	22818128	CHEMBL4715351	Inhibition of recombinant human N-terminal GST-tagged RET (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 2 uM using IFG1Rtide as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	22820566	CHEMBL4716285	Inhibition of recombinant N-terminal GST-tagged human RET (658 to end residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	102.0	CHEMBL2041	Homo sapiens	Activity	%	102.0
	22820567	CHEMBL4716285	Inhibition of recombinant N-terminal GST-tagged human RET (658 to end residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	26.0	CHEMBL2041	Homo sapiens	Activity	%	26.0
	22822949	CHEMBL4716858	Inhibition of RET (unknown origin)	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3651854	=	IC50	nM	3600.0	CHEMBL2041	Homo sapiens	IC50	uM	3.6
	22826344	CHEMBL4717529	Inhibition of recombinant N-terminal GST-tagged human RET (658 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Inhibition	%	60.0	CHEMBL2041	Homo sapiens	INH	%	60.0
	22836396	CHEMBL4718888	Inhibition of recombinant human GST-tagged RET (658 to 1114 residues) expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	64.0	CHEMBL2041	Homo sapiens	INH	%	64.0
	22836397	CHEMBL4718888	Inhibition of recombinant human GST-tagged RET (658 to 1114 residues) expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	2.0	CHEMBL2041	Homo sapiens	INH	%	2.0
	22836398	CHEMBL4718888	Inhibition of recombinant human GST-tagged RET (658 to 1114 residues) expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	25.0	CHEMBL2041	Homo sapiens	INH	%	25.0
	22836399	CHEMBL4718888	Inhibition of recombinant human GST-tagged RET (658 to 1114 residues) expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	9.0	CHEMBL2041	Homo sapiens	INH	%	9.0
	22836400	CHEMBL4718888	Inhibition of recombinant human GST-tagged RET (658 to 1114 residues) expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	15.0	CHEMBL2041	Homo sapiens	INH	%	15.0
	22836401	CHEMBL4718888	Inhibition of recombinant human GST-tagged RET (658 to 1114 residues) expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	14.0	CHEMBL2041	Homo sapiens	INH	%	14.0
	22843215	CHEMBL4720240	Inhibition of RET (unknown origin)	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	=	IC50	nM	639.8	CHEMBL2041	Homo sapiens	IC50	nM	639.8
	22843216	CHEMBL4720240	Inhibition of RET (unknown origin)	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	36.5	CHEMBL2041	Homo sapiens	IC50	nM	36.5
	22843585	CHEMBL4720571	Inhibition of human RET using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.03	CHEMBL2041	Homo sapiens	IC50	10^-9M	2.03
	22843929	CHEMBL4720915	Inhibition of human RET assessed as residual activity using KKKVSRSGLYRSPSMPENLNRPR as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	81.98	CHEMBL2041	Homo sapiens	Activity	%	81.98
	22844850	CHEMBL4721525	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	101.45	CHEMBL2041	Homo sapiens	Activity	%	101.45
	22874810	CHEMBL4725501	Inhibition of human RET assessed as remaining enzyme activity at 1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	0.0	CHEMBL2041	Homo sapiens	Activity	%	0.0
	22874845	CHEMBL4725536	Inhibition of human RET assessed as remaining enzyme activity at 0.1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	6.0	CHEMBL2041	Homo sapiens	Activity	%	6.0
	22874871	CHEMBL4725562	Inhibition of human RET assessed as remaining enzyme activity at 0.01 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	50.0	CHEMBL2041	Homo sapiens	Activity	%	50.0
	22883456	CHEMBL4727548	Inhibition of RET (unknown origin)	B	CC(C)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3952214	=	IC50	nM	63.1	CHEMBL2041	Homo sapiens	pIC50		7.2
	22883457	CHEMBL4727548	Inhibition of RET (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)C2CCCCO2)n1		CHEMBL4759397	<	IC50	nM	19952.62	CHEMBL2041	Homo sapiens	pIC50		4.7
Not Active	22889557	CHEMBL4729076	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	22950592	CHEMBL4766159	Inhibition of human recombinant RET (658 to end residues) using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	4.0	CHEMBL2041	Homo sapiens	IC50	uM	0.004
Active	22952428	CHEMBL4766633	Inhibition of RET M918T mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in ERK activation at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952429	CHEMBL4766633	Inhibition of RET M918T mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in ERK activation at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952430	CHEMBL4766634	Inhibition of RET M918T mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in AKT activation at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952431	CHEMBL4766634	Inhibition of RET M918T mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in AKT activation at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952432	CHEMBL4766635	Inhibition of RET M918T mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in RET phosphorylation at Y905 residue at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952433	CHEMBL4766635	Inhibition of RET M918T mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in RET phosphorylation at Y905 residue at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952434	CHEMBL4766636	Inhibition of RET M918T mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in RET phosphorylation at Y1062 residue at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952435	CHEMBL4766636	Inhibition of RET M918T mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in RET phosphorylation at Y1062 residue at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952436	CHEMBL4766637	Inhibition of RET V804M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in ERK activation at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952437	CHEMBL4766637	Inhibition of RET V804M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in ERK activation at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952438	CHEMBL4766638	Inhibition of RET V804M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in AKT activation at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952439	CHEMBL4766638	Inhibition of RET V804M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in AKT activation at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952440	CHEMBL4766639	Inhibition of RET V804M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in RET phosphorylation at Y905 residue at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952441	CHEMBL4766639	Inhibition of RET V804M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in RET phosphorylation at Y905 residue at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952442	CHEMBL4766640	Inhibition of RET V804M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in RET phosphorylation at Y1062 residue at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952443	CHEMBL4766640	Inhibition of RET V804M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in RET phosphorylation at Y1062 residue at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952452	CHEMBL4766645	Inhibition of RET in human TT cells assessed as reduction in ERK activation at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952453	CHEMBL4766645	Inhibition of RET in human TT cells assessed as reduction in ERK activation at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952454	CHEMBL4766646	Inhibition of RET in human TT cells assessed as reduction in AKT activation at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952455	CHEMBL4766646	Inhibition of RET in human TT cells assessed as reduction in AKT activation at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952456	CHEMBL4766647	Inhibition of RET in human TT cells assessed as reduction in RET phosphorylation at Y905 residue at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952457	CHEMBL4766647	Inhibition of RET in human TT cells assessed as reduction in RET phosphorylation at Y905 residue at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952458	CHEMBL4766648	Inhibition of RET in human TT cells assessed as reduction in RET phosphorylation at Y1062 residue at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22952459	CHEMBL4766648	Inhibition of RET in human TT cells assessed as reduction in RET phosphorylation at Y1062 residue at > 0.3 uM incubated for 24 hrs by Western blot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	22952650	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	9.0	CHEMBL2041	Homo sapiens	IC50	uM	0.009000000000000001
	22952651	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	76.0	CHEMBL2041	Homo sapiens	IC50	uM	0.076
	22952652	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	2049.0	CHEMBL2041	Homo sapiens	IC50	uM	2.049
	22952653	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	9.0	CHEMBL2041	Homo sapiens	IC50	uM	0.009000000000000001
	22952654	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CN1CCCOc2c(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)ncnc21		CHEMBL4798842	=	IC50	nM	1133.0	CHEMBL2041	Homo sapiens	IC50	uM	1.133
	22952655	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CN1CCOc2c(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)ncnc21		CHEMBL4786825	=	IC50	nM	1501.0	CHEMBL2041	Homo sapiens	IC50	uM	1.501
	22952656	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)c(O)c2)no1		CHEMBL4797687	=	IC50	nM	163.0	CHEMBL2041	Homo sapiens	IC50	uM	0.163
	22952657	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1cc(NC(=O)Nc2cc(C(C)(C)C)on2)ccc1Nc1ncnc2c1OCCN2		CHEMBL4784000	=	IC50	nM	29.0	CHEMBL2041	Homo sapiens	IC50	uM	0.028999999999999998
	22952658	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Nc3ncnc4c3OCCN4)c2)no1		CHEMBL4798574	=	IC50	nM	6552.0	CHEMBL2041	Homo sapiens	IC50	uM	6.5520000000000005
	22952659	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	Cc1nc(Nc2ncnc3c2OCCN3)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL4789912	=	IC50	nM	877.0	CHEMBL2041	Homo sapiens	IC50	uM	0.877
	22952660	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)on2)ccc1Nc1ncnc2c1OCCN2		CHEMBL4798046	=	IC50	nM	85.0	CHEMBL2041	Homo sapiens	IC50	uM	0.085
	22952661	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2F)no1		CHEMBL4789515	=	IC50	nM	95.0	CHEMBL2041	Homo sapiens	IC50	uM	0.095
	22952662	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)c(F)c2)no1		CHEMBL4784865	=	IC50	nM	27.0	CHEMBL2041	Homo sapiens	IC50	uM	0.027000000000000003
	22952663	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1csc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)n1		CHEMBL4783259	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	22952664	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1cccc(-c2ccccc2)c1		CHEMBL4781659	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	22952665	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)c1		CHEMBL4797671	=	IC50	nM	7004.0	CHEMBL2041	Homo sapiens	IC50	uM	7.004
	22952666	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1ccc(C(F)(F)F)cc1		CHEMBL4793949	=	IC50	nM	2469.0	CHEMBL2041	Homo sapiens	IC50	uM	2.469
	22952667	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(Nc2ncnc3c2OCCN3)cc1		CHEMBL4794893	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	22952668	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(Nc2ncnc3c2OCCN3)cc1		CHEMBL4796114	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	22952669	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4797171	=	IC50	nM	285.0	CHEMBL2041	Homo sapiens	IC50	uM	0.285
	22952670	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1ccc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)cc1		CHEMBL4793991	=	IC50	nM	1221.0	CHEMBL2041	Homo sapiens	IC50	uM	1.2209999999999999
	22952671	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1cccc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)c1		CHEMBL4781910	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	22952672	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	Cc1cc(C)cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)c1		CHEMBL4792943	=	IC50	nM	3766.0	CHEMBL2041	Homo sapiens	IC50	uM	3.766
	22952673	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1cc(Cl)cc(Cl)c1		CHEMBL4786580	=	IC50	nM	4478.0	CHEMBL2041	Homo sapiens	IC50	uM	4.478
	22952674	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1cccc2ccccc12		CHEMBL4788477	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	22952675	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)no1		CHEMBL4779887	=	IC50	nM	58.0	CHEMBL2041	Homo sapiens	IC50	uM	0.057999999999999996
	22952676	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1cccs1		CHEMBL4794285	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	22952677	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)nc2)no1		CHEMBL4794949	=	IC50	nM	54.0	CHEMBL2041	Homo sapiens	IC50	uM	0.054000000000000006
	22952678	CHEMBL4766671	Inhibition of recombinant human RET V804L mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)N1CCOc2c(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)ncnc21		CHEMBL4779377	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	22952679	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	11.0	CHEMBL2041	Homo sapiens	IC50	uM	0.011000000000000001
	22952680	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	132.0	CHEMBL2041	Homo sapiens	IC50	uM	0.132
	22952681	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	2597.0	CHEMBL2041	Homo sapiens	IC50	uM	2.597
	22952682	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	15.0	CHEMBL2041	Homo sapiens	IC50	uM	0.015
	22952683	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)N1CCOc2c(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)ncnc21		CHEMBL4779377	=	IC50	nM	5369.0	CHEMBL2041	Homo sapiens	IC50	uM	5.369
	22952684	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CN1CCCOc2c(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)ncnc21		CHEMBL4798842	=	IC50	nM	716.0	CHEMBL2041	Homo sapiens	IC50	uM	0.716
	22952685	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CN1CCOc2c(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)ncnc21		CHEMBL4786825	=	IC50	nM	344.0	CHEMBL2041	Homo sapiens	IC50	uM	0.344
	22952686	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)c(O)c2)no1		CHEMBL4797687	=	IC50	nM	63.0	CHEMBL2041	Homo sapiens	IC50	uM	0.063
	22952687	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1cc(NC(=O)Nc2cc(C(C)(C)C)on2)ccc1Nc1ncnc2c1OCCN2		CHEMBL4784000	=	IC50	nM	33.0	CHEMBL2041	Homo sapiens	IC50	uM	0.033
	22952688	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Nc3ncnc4c3OCCN4)c2)no1		CHEMBL4798574	=	IC50	nM	3453.0	CHEMBL2041	Homo sapiens	IC50	uM	3.4530000000000003
	22952689	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	Cc1nc(Nc2ncnc3c2OCCN3)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL4789912	=	IC50	nM	1110.0	CHEMBL2041	Homo sapiens	IC50	uM	1.11
	22952690	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)nc2)no1		CHEMBL4794949	=	IC50	nM	180.0	CHEMBL2041	Homo sapiens	IC50	uM	0.18
	22952691	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)on2)ccc1Nc1ncnc2c1OCCN2		CHEMBL4798046	=	IC50	nM	44.0	CHEMBL2041	Homo sapiens	IC50	uM	0.044000000000000004
	22952692	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2F)no1		CHEMBL4789515	=	IC50	nM	57.0	CHEMBL2041	Homo sapiens	IC50	uM	0.057
	22952693	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)c(F)c2)no1		CHEMBL4784865	=	IC50	nM	22.0	CHEMBL2041	Homo sapiens	IC50	uM	0.022000000000000002
	22952694	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1csc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)n1		CHEMBL4783259	=	IC50	nM	5169.0	CHEMBL2041	Homo sapiens	IC50	uM	5.169
	22952695	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1cccc(-c2ccccc2)c1		CHEMBL4781659	=	IC50	nM	7591.0	CHEMBL2041	Homo sapiens	IC50	uM	7.591
	22952696	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	Cc1cc(C)cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)c1		CHEMBL4792943	=	IC50	nM	971.0	CHEMBL2041	Homo sapiens	IC50	uM	0.971
	22952697	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)c1		CHEMBL4797671	=	IC50	nM	5111.0	CHEMBL2041	Homo sapiens	IC50	uM	5.111000000000001
	22952698	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1ccc(C(F)(F)F)cc1		CHEMBL4793949	=	IC50	nM	276.0	CHEMBL2041	Homo sapiens	IC50	uM	0.276
	22952699	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(Nc2ncnc3c2OCCN3)cc1		CHEMBL4794893	=	IC50	nM	2347.0	CHEMBL2041	Homo sapiens	IC50	uM	2.347
	22952700	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(Nc2ncnc3c2OCCN3)cc1		CHEMBL4796114	=	IC50	nM	2275.0	CHEMBL2041	Homo sapiens	IC50	uM	2.275
	22952701	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4797171	=	IC50	nM	188.0	CHEMBL2041	Homo sapiens	IC50	uM	0.188
	22952702	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1ccc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)cc1		CHEMBL4793991	=	IC50	nM	824.0	CHEMBL2041	Homo sapiens	IC50	uM	0.8240000000000001
	22952703	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1cccc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)c1		CHEMBL4781910	=	IC50	nM	5290.0	CHEMBL2041	Homo sapiens	IC50	uM	5.29
	22952704	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1cc(Cl)cc(Cl)c1		CHEMBL4786580	=	IC50	nM	1303.0	CHEMBL2041	Homo sapiens	IC50	uM	1.3030000000000002
	22952705	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1cccc2ccccc12		CHEMBL4788477	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	22952706	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)no1		CHEMBL4779887	=	IC50	nM	34.0	CHEMBL2041	Homo sapiens	IC50	uM	0.034
	22952707	CHEMBL4766672	Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1cccs1		CHEMBL4794285	=	IC50	nM	8641.0	CHEMBL2041	Homo sapiens	IC50	uM	8.641
	22952708	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	9.0	CHEMBL2041	Homo sapiens	IC50	uM	0.009000000000000001
	22952709	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	13.0	CHEMBL2041	Homo sapiens	IC50	uM	0.013000000000000001
	22952710	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	9.0	CHEMBL2041	Homo sapiens	IC50	uM	0.009000000000000001
	22952711	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	uM	0.01
	22952712	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CN1CCCOc2c(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)ncnc21		CHEMBL4798842	=	IC50	nM	322.0	CHEMBL2041	Homo sapiens	IC50	uM	0.322
	22952713	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CN1CCOc2c(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)ncnc21		CHEMBL4786825	=	IC50	nM	324.0	CHEMBL2041	Homo sapiens	IC50	uM	0.324
	22952714	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)c(O)c2)no1		CHEMBL4797687	=	IC50	nM	25.0	CHEMBL2041	Homo sapiens	IC50	uM	0.025
	22952715	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1cc(NC(=O)Nc2cc(C(C)(C)C)on2)ccc1Nc1ncnc2c1OCCN2		CHEMBL4784000	=	IC50	nM	22.0	CHEMBL2041	Homo sapiens	IC50	uM	0.022000000000000002
	22952716	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Nc3ncnc4c3OCCN4)c2)no1		CHEMBL4798574	=	IC50	nM	944.0	CHEMBL2041	Homo sapiens	IC50	uM	0.9440000000000001
	22952717	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	Cc1nc(Nc2ncnc3c2OCCN3)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL4789912	=	IC50	nM	781.0	CHEMBL2041	Homo sapiens	IC50	uM	0.7809999999999999
	22952718	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)on2)ccc1Nc1ncnc2c1OCCN2		CHEMBL4798046	=	IC50	nM	50.0	CHEMBL2041	Homo sapiens	IC50	uM	0.05
	22952719	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2F)no1		CHEMBL4789515	=	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	uM	0.01
	22952720	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)c(F)c2)no1		CHEMBL4784865	=	IC50	nM	21.0	CHEMBL2041	Homo sapiens	IC50	uM	0.021
	22952721	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1csc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)n1		CHEMBL4783259	=	IC50	nM	3154.0	CHEMBL2041	Homo sapiens	IC50	uM	3.154
	22952722	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1cccc(-c2ccccc2)c1		CHEMBL4781659	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	22952723	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	Cc1cc(C)cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)c1		CHEMBL4792943	=	IC50	nM	1071.0	CHEMBL2041	Homo sapiens	IC50	uM	1.071
	22952724	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)c1		CHEMBL4797671	=	IC50	nM	1474.0	CHEMBL2041	Homo sapiens	IC50	uM	1.474
	22952725	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1ccc(C(F)(F)F)cc1		CHEMBL4793949	=	IC50	nM	306.0	CHEMBL2041	Homo sapiens	IC50	uM	0.306
	22952726	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(Nc2ncnc3c2OCCN3)cc1		CHEMBL4794893	=	IC50	nM	2223.0	CHEMBL2041	Homo sapiens	IC50	uM	2.2230000000000003
	22952727	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(Nc2ncnc3c2OCCN3)cc1		CHEMBL4796114	=	IC50	nM	3073.0	CHEMBL2041	Homo sapiens	IC50	uM	3.073
	22952728	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4797171	=	IC50	nM	177.0	CHEMBL2041	Homo sapiens	IC50	uM	0.177
	22952729	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1ccc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)cc1		CHEMBL4793991	=	IC50	nM	227.0	CHEMBL2041	Homo sapiens	IC50	uM	0.22699999999999998
	22952730	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	COc1cccc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)c1		CHEMBL4781910	=	IC50	nM	6811.0	CHEMBL2041	Homo sapiens	IC50	uM	6.811
	22952731	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1cc(Cl)cc(Cl)c1		CHEMBL4786580	=	IC50	nM	865.0	CHEMBL2041	Homo sapiens	IC50	uM	0.865
	22952732	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1cccc2ccccc12		CHEMBL4788477	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	22952733	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)cc2)no1		CHEMBL4779887	=	IC50	nM	10.0	CHEMBL2041	Homo sapiens	IC50	uM	0.01
	22952734	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	O=C(Nc1ccc(Nc2ncnc3c2OCCN3)cc1)Nc1cccs1		CHEMBL4794285	>	IC50	nM	10000.0	CHEMBL2041	Homo sapiens	IC50	uM	10.0
	22952735	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCN4)nc2)no1		CHEMBL4794949	=	IC50	nM	77.0	CHEMBL2041	Homo sapiens	IC50	uM	0.077
	22952736	CHEMBL4766673	Inhibition of recombinant human RET using KKKSPGEYVNIEFG as substrate incubated for 15 mins followed by Mg/ATP addition and measured after 40 mins by [gamma-33P]-ATP assay	B	CC(C)N1CCOc2c(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)ncnc21		CHEMBL4779377	=	IC50	nM	8766.0	CHEMBL2041	Homo sapiens	IC50	uM	8.766
	22952981	CHEMBL4766918	Inhibition of recombinant human Ret (658 to end residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	0.0	CHEMBL2041	Homo sapiens	Activity	%	0.0
	22955560	CHEMBL4767617	Inhibition of GST-tagged human RET cytoplasmic domain expressed in baculovirus expression system at 1 uM by Selectscreen kinase assay	B	COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)c(F)c3)nc12		CHEMBL4785582	=	Inhibition	%	97.0	CHEMBL2041	Homo sapiens	INH	%	97.0
	22956521	CHEMBL4767789	Inhibition of RET (unknown origin) at 0.1 uM incubated for 1 hr by ELISA relative to control	B	Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCNC4)nc23)c(C(F)F)n1		CHEMBL3634506	>	Inhibition	%	50.0	CHEMBL2041	Homo sapiens	INH	%	50.0
	22960878	CHEMBL4768793	Inhibition of human RET at 100 nM in presence of ATP relative to control	B	Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1		CHEMBL4791998	=	Inhibition	%	98.0	CHEMBL2041	Homo sapiens	INH	%	98.0
	22960879	CHEMBL4768794	Inhibition of human RET in presence of ATP	B	Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1		CHEMBL4791998	=	IC50	nM	1.21	CHEMBL2041	Homo sapiens	IC50	nM	1.21
	22969940	CHEMBL4770456	Binding affinity to human RET	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	62.0	CHEMBL2041	Homo sapiens	Kd	nM	62.0
	22979777	CHEMBL4772659	Binding affinity to wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	=	Kd	nM	55.0	CHEMBL2041	Homo sapiens	Kd	nM	55.0
Active	22979795	CHEMBL4772677	Binding affinity to RET M918T mutant (unknown origin)	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22979796	CHEMBL4772678	Binding affinity to RET V804L mutant (unknown origin)	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22979797	CHEMBL4772679	Binding affinity to RET V804M mutant (unknown origin)	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	22979811	CHEMBL4772693	Inhibition of wild-type human partial length RET (E713 to D1014 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	>	Activity	%	90.0	CHEMBL2041	Homo sapiens	Activity	%	90.0
	22981500	CHEMBL4773004	Inhibition of RET (unknown origin)	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5cccc(F)c5)c4)ncnc3c2)cn1		CHEMBL4799738	>=	IC50	nM	2000.0	CHEMBL2041	Homo sapiens	IC50	uM	2.0
	22986069	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)c1ccc(NC(=O)Cc2ccc(Nc3ncnc4[nH]ccc34)cc2)cc1		CHEMBL4785085	=	IC50	nM	7690.0	CHEMBL2041	Homo sapiens	IC50	uM	7.69
	22986070	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)(C)c1ccc(NC(=O)Cc2ccc(Nc3ncnc4[nH]ccc34)cc2)cc1		CHEMBL4794703	=	IC50	nM	15820.0	CHEMBL2041	Homo sapiens	IC50	uM	15.82
	22986071	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	COc1cc(NC(=O)Cc2ccc(Nc3ncnc4[nH]ccc34)cc2)cc(OC)c1OC		CHEMBL4790509	=	IC50	nM	47620.0	CHEMBL2041	Homo sapiens	IC50	uM	47.62
	22986072	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1ccc(Nc2ncnc3[nH]ccc23)cc1)Nc1ccc2c(c1)OCO2		CHEMBL4795440	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986073	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1ccc(Nc2ncnc3[nH]ccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4776658	=	IC50	nM	16220.0	CHEMBL2041	Homo sapiens	IC50	uM	16.22
	22986074	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1ccc(Nc2ncnc3[nH]ccc23)cc1)Nc1ccc(C(F)(F)F)c(Cl)c1		CHEMBL4779844	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986075	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1ccc(Nc2ncnc3[nH]ccc23)cc1)Nc1ccc(Cl)c(F)c1		CHEMBL4795925	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986076	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1ccc(Nc2ncnc3[nH]ccc23)cc1)Nc1cccc(F)c1		CHEMBL4781264	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986077	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1ccc(Nc2ncnc3[nH]ccc23)cc1)Nc1ccc(OC(F)(F)F)cc1		CHEMBL4788511	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986078	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1ccc(Nc2ncnc3[nH]ccc23)cc1)Nc1cccc2ncccc12		CHEMBL4779979	=	IC50	nM	18960.0	CHEMBL2041	Homo sapiens	IC50	uM	18.96
	22986079	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CS(=O)(=O)c1ccc(NC(=O)Cc2ccc(Nc3ncnc4[nH]ccc34)cc2)cc1		CHEMBL4782595	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986080	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1ccc(Nc2ncnc3[nH]ccc23)cc1)NC1CC1		CHEMBL4791894	=	IC50	nM	2370.0	CHEMBL2041	Homo sapiens	IC50	uM	2.37
	22986081	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1ccc(Nc2ncnc3[nH]ccc23)cc1)NC1CCC1		CHEMBL4778954	=	IC50	nM	3910.0	CHEMBL2041	Homo sapiens	IC50	uM	3.91
	22986082	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1ccc(Nc2ncnc3[nH]ccc23)cc1)NCc1ccccc1		CHEMBL4778887	=	IC50	nM	4650.0	CHEMBL2041	Homo sapiens	IC50	uM	4.65
	22986083	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Cc1ccc(Nc2ncnc3[nH]ccc23)cc1		CHEMBL4799653	=	IC50	nM	127.0	CHEMBL2041	Homo sapiens	IC50	uM	0.127
	22986084	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(Nc3ncnc4[nH]ccc34)cc2)no1		CHEMBL4787596	=	IC50	nM	76.0	CHEMBL2041	Homo sapiens	IC50	uM	0.076
	22986085	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1ccc2c(Nc3ccc(CC(=O)Nc4cc(C(C)(C)C)on4)cc3)ncnc21		CHEMBL4783262	=	IC50	nM	3510.0	CHEMBL2041	Homo sapiens	IC50	uM	3.51
	22986086	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Cc1ccc(Nc2ncnc3c2ccn3C)cc1		CHEMBL4782706	=	IC50	nM	3930.0	CHEMBL2041	Homo sapiens	IC50	uM	3.93
	22986087	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Cc1ccc(Nc2ncnc3sccc23)cc1		CHEMBL4796452	=	IC50	nM	1060.0	CHEMBL2041	Homo sapiens	IC50	uM	1.06
	22986088	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(Nc3ncnc4sccc34)cc2)no1		CHEMBL4798314	=	IC50	nM	960.0	CHEMBL2041	Homo sapiens	IC50	uM	0.96
	22986089	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1ccc(Nc2ncnc3sccc23)cc1)Nc1cccc(F)c1		CHEMBL4800112	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986090	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2cccc(Nc3ncnc4[nH]ccc34)c2)no1		CHEMBL4778459	=	IC50	nM	31560.0	CHEMBL2041	Homo sapiens	IC50	uM	31.56
	22986091	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Cc1cccc(Nc2ncnc3[nH]ccc23)c1		CHEMBL4779109	=	IC50	nM	39560.0	CHEMBL2041	Homo sapiens	IC50	uM	39.56
	22986092	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1cccc(Nc2ncnc3[nH]ccc23)c1)Nc1ccc(Cl)c(F)c1		CHEMBL4800102	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986093	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)(C)c1ccc(-c2cc3c(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)ncnc3[nH]2)cc1		CHEMBL4793536	=	IC50	nM	13520.0	CHEMBL2041	Homo sapiens	IC50	uM	13.52
	22986094	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)(C)c1ccc(-c2cc3c(Nc4ccc(CC(=O)Nc5cccc(F)c5)cc4)ncnc3[nH]2)cc1		CHEMBL4787848	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986095	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	COc1ccc(-c2cc3c(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)nn5C)cc4)ncnc3[nH]2)cc1		CHEMBL4781196	=	IC50	nM	120.0	CHEMBL2041	Homo sapiens	IC50	uM	0.12
	22986096	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	COc1ccc(-c2cc3c(Nc4ccc(CC(=O)Nc5ccc(C(C)C)cc5)cc4)ncnc3[nH]2)cc1		CHEMBL4798335	=	IC50	nM	2436.0	CHEMBL2041	Homo sapiens	IC50	uM	2.436
	22986097	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	COc1ccc(-c2cc3c(Nc4ccc(CC(=O)Nc5cccc(F)c5)cc4)ncnc3[nH]2)cc1		CHEMBL4794322	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986098	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	COc1ccc(-c2cc3c(Nc4ccc(CC(=O)Nc5ccc(F)cc5)cc4)ncnc3[nH]2)cc1		CHEMBL4799589	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986099	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(Nc3ncnc4[nH]c(-c5ccsc5)cc34)cc2)no1		CHEMBL4778228	=	IC50	nM	50.0	CHEMBL2041	Homo sapiens	IC50	uM	0.05
	22986100	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Cc1ccc(Nc2ncnc3[nH]c(-c4ccsc4)cc23)cc1		CHEMBL4778453	=	IC50	nM	52.0	CHEMBL2041	Homo sapiens	IC50	uM	0.052000000000000005
	22986101	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Cc1ccc(Nc2ncnc3[nH]c(-c4ccsc4)cc23)cc1)Nc1cccc(F)c1		CHEMBL4785273	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986102	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(=O)c1ccc(-c2cc3c(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)ncnc3[nH]2)cc1		CHEMBL4794686	=	IC50	nM	44.0	CHEMBL2041	Homo sapiens	IC50	uM	0.044000000000000004
	22986103	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2cc3c(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)nn5C)cc4)ncnc3[nH]2)cn1		CHEMBL4789906	=	IC50	nM	21.0	CHEMBL2041	Homo sapiens	IC50	uM	0.021
	22986104	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2cc3c(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)ncnc3[nH]2)cn1		CHEMBL4784249	=	IC50	nM	9.0	CHEMBL2041	Homo sapiens	IC50	uM	0.009000000000000001
	22986105	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2cc3c(Nc4ccc(CC(=O)Nc5cccc(F)c5)cc4)ncnc3[nH]2)cn1		CHEMBL4794666	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986106	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)c1ccc(NC(=O)Cc2ccc(Nc3ncnc4[nH]c(-c5cnn(C)c5)cc34)cc2)cc1		CHEMBL4791835	>	IC50	nM	20000.0	CHEMBL2041	Homo sapiens	IC50	uM	20.0
	22986107	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Cc1ccc(Nc2ncnc3[nH]c(-c4ccc(S(C)(=O)=O)cc4)cc23)cc1		CHEMBL4794965	=	IC50	nM	9.0	CHEMBL2041	Homo sapiens	IC50	uM	0.009000000000000001
	22986108	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(Nc3ncnc4[nH]c(-c5ccc(S(C)(=O)=O)cc5)cc34)cc2)no1		CHEMBL4791960	=	IC50	nM	6.8	CHEMBL2041	Homo sapiens	IC50	uM	0.0068
	22986109	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2cc3c(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)ncnc3s2)cn1		CHEMBL4789222	=	IC50	nM	820.0	CHEMBL2041	Homo sapiens	IC50	uM	0.82
	22986110	CHEMBL4774179	Inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2cc3c(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)nn5C)cc4)ncnc3s2)cn1		CHEMBL4799943	=	IC50	nM	1393.0	CHEMBL2041	Homo sapiens	IC50	uM	1.393
	22986111	CHEMBL4774180	Inhibition of recombinant human N-terminal GST-HIS6 fused RET V804M mutant (658 to 1114 residues) expressed in Sf9 insect cells using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2cc3c(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)nn5C)cc4)ncnc3[nH]2)cn1		CHEMBL4789906	=	IC50	nM	72.79	CHEMBL2041	Homo sapiens	IC50	nM	72.79
	22986112	CHEMBL4774180	Inhibition of recombinant human N-terminal GST-HIS6 fused RET V804M mutant (658 to 1114 residues) expressed in Sf9 insect cells using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2cc3c(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)ncnc3[nH]2)cn1		CHEMBL4784249	=	IC50	nM	63.47	CHEMBL2041	Homo sapiens	IC50	nM	63.47
	22986113	CHEMBL4774180	Inhibition of recombinant human N-terminal GST-HIS6 fused RET V804M mutant (658 to 1114 residues) expressed in Sf9 insect cells using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(Nc3ncnc4[nH]c(-c5ccc(S(C)(=O)=O)cc5)cc34)cc2)no1		CHEMBL4791960	=	IC50	nM	13.51	CHEMBL2041	Homo sapiens	IC50	nM	13.51
Active	22986114	CHEMBL4774181	Non ATP-competitive inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 3.125 to 50 nM using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(Nc3ncnc4[nH]c(-c5ccc(S(C)(=O)=O)cc5)cc34)cc2)no1		CHEMBL4791960		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
Active	22986115	CHEMBL4774182	Non competitive inhibition of recombinant human GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system at 3.125 to 50 nM using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate by Lineweaver-burk plot analysis	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(Nc3ncnc4[nH]c(-c5ccc(S(C)(=O)=O)cc5)cc34)cc2)no1		CHEMBL4791960		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	22987258	CHEMBL4774507	Inhibition of RET (unknown origin)	B	COc1cc2ncnc(Oc3ccc(Nc4nccc5[nH]cc(-c6ccc(F)cc6)c(=O)c45)cc3F)c2cc1OC		CHEMBL4794496	=	IC50	nM	65.3	CHEMBL2041	Homo sapiens	IC50	nM	65.3
	23122785	CHEMBL4805136	Inhibition of human RET assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	23122786	CHEMBL4805137	Inhibition of human RET M918T mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	85.0	CHEMBL2041	Homo sapiens	Activity	%	85.0
	23122787	CHEMBL4805138	Inhibition of human RET V804L mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	88.0	CHEMBL2041	Homo sapiens	Activity	%	88.0
	23122788	CHEMBL4805139	Inhibition of human RET V804M mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	91.0	CHEMBL2041	Homo sapiens	Activity	%	91.0
	23123480	CHEMBL4805724	Inhibition of human RET assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	23123481	CHEMBL4805725	Inhibition of human RET M918T mutant assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	85.0	CHEMBL2041	Homo sapiens	Activity	%	85.0
	23123482	CHEMBL4805726	Inhibition of human RET V804L mutant assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	75.0	CHEMBL2041	Homo sapiens	Activity	%	75.0
	23123483	CHEMBL4805727	Inhibition of human RET V804M mutant assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	23123935	CHEMBL4806179	Inhibition of DNA-tagged human RET assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	89.0	CHEMBL2041	Homo sapiens	Activity	%	89.0
	23123936	CHEMBL4806180	Inhibition of DNA-tagged human RET M918T mutant assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	23123937	CHEMBL4806181	Inhibition of DNA-tagged human RET V804L mutant assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	23123938	CHEMBL4806182	Inhibition of DNA-tagged human RET V804M mutant assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	23125050	CHEMBL4806741	Inhibition of human RET assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	93.0	CHEMBL2041	Homo sapiens	Activity	%	93.0
	23125051	CHEMBL4806741	Inhibition of human RET assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	86.0	CHEMBL2041	Homo sapiens	Activity	%	86.0
	23125052	CHEMBL4806742	Inhibition of human RET M918T mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL2041	Homo sapiens	Activity	%	98.0
	23125053	CHEMBL4806742	Inhibition of human RET M918T mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL2041	Homo sapiens	Activity	%	98.0
	23125054	CHEMBL4806743	Inhibition of human RET V804L mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	23125055	CHEMBL4806743	Inhibition of human RET V804L mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	23125056	CHEMBL4806744	Inhibition of human RET V804M mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	23125057	CHEMBL4806744	Inhibition of human RET V804M mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL2041	Homo sapiens	Activity	%	100.0
	23127450	CHEMBL4807614	Inhibition of RET (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	23.0	CHEMBL2041	Homo sapiens	Activity	%	23.0
	23127451	CHEMBL4807614	Inhibition of RET (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	98.0	CHEMBL2041	Homo sapiens	Activity	%	98.0
	23127452	CHEMBL4807614	Inhibition of RET (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	98.0	CHEMBL2041	Homo sapiens	Activity	%	98.0
	23128521	CHEMBL4807982	Inhibition of RET (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL2041	Homo sapiens	Activity	%	25.0
	23128522	CHEMBL4807982	Inhibition of RET (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2041	Homo sapiens	Activity	%	75.0
	23128523	CHEMBL4807982	Inhibition of RET (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	25.0	CHEMBL2041	Homo sapiens	Activity	%	25.0
	23158860	CHEMBL4812112	Inhibition of RET (658 to 1114 residues) (unknown origin) expressed in Sf21 at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control	B	CC(C)(C)OC(=O)c1ccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)cc1		CHEMBL4860361	=	Inhibition	%	-7.23	CHEMBL2041	Homo sapiens	INH	%	-7.23
	23216108	CHEMBL4823623	Inhibition of recombinant human Ret (658 to end residues) using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	>	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
	23250200	CHEMBL4831023	Inhibition of RET (unknown origin) using 5' FAM-EPLYWSFPA peptide as a substrate in the presence of ATP incubated for 60 mins by microfluidics assay	B	Cn1cc(-c2ccn3c(-c4ccc(-c5cccc(Cl)c5)s4)cnc3c2)cn1		CHEMBL4847680	=	IC50	nM	6830.0	CHEMBL2041	Homo sapiens	IC50	uM	6.83
	23250201	CHEMBL4831023	Inhibition of RET (unknown origin) using 5' FAM-EPLYWSFPA peptide as a substrate in the presence of ATP incubated for 60 mins by microfluidics assay	B	COc1cccc(OC)c1-c1ccc(-c2cnc3cc(-c4cnn(C)c4)ccn23)s1		CHEMBL4852822	=	IC50	nM	5430.0	CHEMBL2041	Homo sapiens	IC50	uM	5.43
	23265590	CHEMBL4834261	Inhibition of RET (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CO)C1		CHEMBL4858720	=	IC50	nM	51.0	CHEMBL2041	Homo sapiens	IC50	uM	0.051
	23265591	CHEMBL4834261	Inhibition of RET (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCCC1		CHEMBL169390	=	IC50	nM	4.0	CHEMBL2041	Homo sapiens	IC50	uM	0.004
	23265592	CHEMBL4834261	Inhibition of RET (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(O)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL4854822	=	IC50	nM	920.0	CHEMBL2041	Homo sapiens	IC50	uM	0.92
	23265699	CHEMBL4834295	Inhibition of RET (658 to 1072) (unknown origin) by HTRF assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(O)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL4854822	=	IC50	nM	0.54	CHEMBL2041	Homo sapiens	IC50	uM	0.00054
	23265700	CHEMBL4834295	Inhibition of RET (658 to 1072) (unknown origin) by HTRF assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(O)c4)c4c(N)ncnc43)C2)CC1		CHEMBL4848347	=	IC50	nM	5.0	CHEMBL2041	Homo sapiens	IC50	uM	0.005
	23265701	CHEMBL4834295	Inhibition of RET (658 to 1072) (unknown origin) by HTRF assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4ccccc4O)c4c(N)ncnc43)C2)CC1		CHEMBL4864386	=	IC50	nM	74.0	CHEMBL2041	Homo sapiens	IC50	uM	0.07400000000000001
	23265702	CHEMBL4834295	Inhibition of RET (658 to 1072) (unknown origin) by HTRF assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4ccc(O)cc4)c4c(N)ncnc43)C2)CC1		CHEMBL4855562	=	IC50	nM	9.0	CHEMBL2041	Homo sapiens	IC50	uM	0.009000000000000001
	23265703	CHEMBL4834295	Inhibition of RET (658 to 1072) (unknown origin) by HTRF assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4ccc(Cl)c(O)c4)c4c(N)ncnc43)C2)CC1		CHEMBL4853155	=	IC50	nM	0.73	CHEMBL2041	Homo sapiens	IC50	uM	0.00073
	23265704	CHEMBL4834295	Inhibition of RET (658 to 1072) (unknown origin) by HTRF assay	B	COc1cc(-c2cn([C@H]3C[C@@H](N4CCN(C(C)=O)CC4)C3)c3ncnc(N)c23)ccc1Cl		CHEMBL4860822	=	IC50	nM	76.0	CHEMBL2041	Homo sapiens	IC50	uM	0.076
	23265705	CHEMBL4834295	Inhibition of RET (658 to 1072) (unknown origin) by HTRF assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4ccc(Cl)c(N)c4)c4c(N)ncnc43)C2)CC1		CHEMBL4877264	=	IC50	nM	0.85	CHEMBL2041	Homo sapiens	IC50	uM	0.00085
	23277363	CHEMBL4836452	Inhibition of RET wild type (unknown origin)	B	CO[C@]1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CC[C@H](c2nc(C)cc(Nc3cc(C)[nH]n3)n2)CC1		CHEMBL4582651	=	IC50	nM	0.78	CHEMBL2041	Homo sapiens	IC50	nM	0.78
	23277364	CHEMBL4836452	Inhibition of RET wild type (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(C2CCC3(CC2)OCCN([C@@H](C)c2ccc(-n4cc(F)cn4)nc2)C3=O)n1		CHEMBL4861957	=	IC50	nM	1.12	CHEMBL2041	Homo sapiens	IC50	nM	1.12
	23277365	CHEMBL4836452	Inhibition of RET wild type (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(C2CCC3(CCCN([C@@H](C)c4ccc(-n5cc(F)cn5)nc4)C3=O)CC2)n1		CHEMBL4845703	=	IC50	nM	0.9	CHEMBL2041	Homo sapiens	IC50	nM	0.9
	23277366	CHEMBL4836452	Inhibition of RET wild type (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CC2)CCN([C@@H](C)c2ccc(-n4cc(F)cn4)nc2)C3=O)n1		CHEMBL4875034	=	IC50	nM	1.58	CHEMBL2041	Homo sapiens	IC50	nM	1.58
	23277367	CHEMBL4836452	Inhibition of RET wild type (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN([C@@H](C)c4ccc(-n5cc(F)cn5)nc4)C3=O)CC2)n1		CHEMBL4872605	=	IC50	nM	0.36	CHEMBL2041	Homo sapiens	IC50	nM	0.36
	23277368	CHEMBL4836452	Inhibition of RET wild type (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN([C@@H](C)c4cnc(-n5cc(F)cn5)cn4)C3=O)CC2)n1		CHEMBL4870957	=	IC50	nM	0.68	CHEMBL2041	Homo sapiens	IC50	nM	0.68
	23277369	CHEMBL4836452	Inhibition of RET wild type (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN([C@@H](C)c4ccc(-n5cc(F)cn5)cc4F)C3=O)CC2)n1		CHEMBL4859281	=	IC50	nM	1.39	CHEMBL2041	Homo sapiens	IC50	nM	1.39
	23277370	CHEMBL4836452	Inhibition of RET wild type (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CC2)CCN(C(C)c2ccc(-n4cc(F)cn4)nc2)C3=O)n1		CHEMBL4848545	=	IC50	nM	73.87	CHEMBL2041	Homo sapiens	IC50	nM	73.87
	23277371	CHEMBL4836452	Inhibition of RET wild type (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN(C(C)c4ccc(-n5cc(F)cn5)nc4)C3=O)CC2)n1		CHEMBL4859271	=	IC50	nM	92.99	CHEMBL2041	Homo sapiens	IC50	nM	92.99
	23277372	CHEMBL4836452	Inhibition of RET wild type (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CC2)OCCN([C@@H](C)c2ccc(-n4cc(F)cn4)nc2)C3=O)n1		CHEMBL4846521	=	IC50	nM	1.29	CHEMBL2041	Homo sapiens	IC50	nM	1.29
	23277373	CHEMBL4836452	Inhibition of RET wild type (unknown origin)	B	Cc1cc(Nc2nc(N3CCC4(CC3)OCCN([C@@H](C)c3ccc(-n5cc(F)cn5)nc3)C4=O)ncc2F)n[nH]1		CHEMBL4862303	=	IC50	nM	19.1	CHEMBL2041	Homo sapiens	IC50	nM	19.1
	23277374	CHEMBL4836453	Inhibition of RET V804M mutant (unknown origin)	B	CO[C@]1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CC[C@H](c2nc(C)cc(Nc3cc(C)[nH]n3)n2)CC1		CHEMBL4582651	=	IC50	nM	1.93	CHEMBL2041	Homo sapiens	IC50	nM	1.93
	23277375	CHEMBL4836453	Inhibition of RET V804M mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(C2CCC3(CC2)OCCN([C@@H](C)c2ccc(-n4cc(F)cn4)nc2)C3=O)n1		CHEMBL4861957	=	IC50	nM	5.28	CHEMBL2041	Homo sapiens	IC50	nM	5.28
	23277376	CHEMBL4836453	Inhibition of RET V804M mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(C2CCC3(CCCN([C@@H](C)c4ccc(-n5cc(F)cn5)nc4)C3=O)CC2)n1		CHEMBL4845703	=	IC50	nM	1.06	CHEMBL2041	Homo sapiens	IC50	nM	1.06
	23277377	CHEMBL4836453	Inhibition of RET V804M mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CC2)CCN([C@@H](C)c2ccc(-n4cc(F)cn4)nc2)C3=O)n1		CHEMBL4875034	=	IC50	nM	3.42	CHEMBL2041	Homo sapiens	IC50	nM	3.42
	23277378	CHEMBL4836453	Inhibition of RET V804M mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN([C@@H](C)c4ccc(-n5cc(F)cn5)nc4)C3=O)CC2)n1		CHEMBL4872605	=	IC50	nM	0.71	CHEMBL2041	Homo sapiens	IC50	nM	0.71
	23277379	CHEMBL4836453	Inhibition of RET V804M mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN([C@@H](C)c4cnc(-n5cc(F)cn5)cn4)C3=O)CC2)n1		CHEMBL4870957	=	IC50	nM	1.62	CHEMBL2041	Homo sapiens	IC50	nM	1.62
	23277380	CHEMBL4836453	Inhibition of RET V804M mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN([C@@H](C)c4ccc(-n5cc(F)cn5)cc4F)C3=O)CC2)n1		CHEMBL4859281	=	IC50	nM	1.95	CHEMBL2041	Homo sapiens	IC50	nM	1.95
	23277381	CHEMBL4836453	Inhibition of RET V804M mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CC2)CCN(C(C)c2ccc(-n4cc(F)cn4)nc2)C3=O)n1		CHEMBL4848545	=	IC50	nM	133.6	CHEMBL2041	Homo sapiens	IC50	nM	133.6
	23277382	CHEMBL4836453	Inhibition of RET V804M mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN(C(C)c4ccc(-n5cc(F)cn5)nc4)C3=O)CC2)n1		CHEMBL4859271	=	IC50	nM	128.7	CHEMBL2041	Homo sapiens	IC50	nM	128.7
	23277383	CHEMBL4836453	Inhibition of RET V804M mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CC2)OCCN([C@@H](C)c2ccc(-n4cc(F)cn4)nc2)C3=O)n1		CHEMBL4846521	=	IC50	nM	1.97	CHEMBL2041	Homo sapiens	IC50	nM	1.97
	23277384	CHEMBL4836453	Inhibition of RET V804M mutant (unknown origin)	B	Cc1cc(Nc2nc(N3CCC4(CC3)OCCN([C@@H](C)c3ccc(-n5cc(F)cn5)nc3)C4=O)ncc2F)n[nH]1		CHEMBL4862303	=	IC50	nM	13.5	CHEMBL2041	Homo sapiens	IC50	nM	13.5
	23277385	CHEMBL4836454	Inhibition of RET M918T mutant (unknown origin)	B	CO[C@]1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CC[C@H](c2nc(C)cc(Nc3cc(C)[nH]n3)n2)CC1		CHEMBL4582651	=	IC50	nM	0.7	CHEMBL2041	Homo sapiens	IC50	nM	0.7
	23277386	CHEMBL4836454	Inhibition of RET M918T mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(C2CCC3(CC2)OCCN([C@@H](C)c2ccc(-n4cc(F)cn4)nc2)C3=O)n1		CHEMBL4861957	=	IC50	nM	2.99	CHEMBL2041	Homo sapiens	IC50	nM	2.99
	23277387	CHEMBL4836454	Inhibition of RET M918T mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(C2CCC3(CCCN([C@@H](C)c4ccc(-n5cc(F)cn5)nc4)C3=O)CC2)n1		CHEMBL4845703	=	IC50	nM	3.09	CHEMBL2041	Homo sapiens	IC50	nM	3.09
Not Determined	23277388	CHEMBL4836454	Inhibition of RET M918T mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CC2)CCN([C@@H](C)c2ccc(-n4cc(F)cn4)nc2)C3=O)n1		CHEMBL4875034		IC50			CHEMBL2041	Homo sapiens	IC50		
	23277389	CHEMBL4836454	Inhibition of RET M918T mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN([C@@H](C)c4ccc(-n5cc(F)cn5)nc4)C3=O)CC2)n1		CHEMBL4872605	=	IC50	nM	1.14	CHEMBL2041	Homo sapiens	IC50	nM	1.14
	23277390	CHEMBL4836454	Inhibition of RET M918T mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN([C@@H](C)c4cnc(-n5cc(F)cn5)cn4)C3=O)CC2)n1		CHEMBL4870957	=	IC50	nM	0.61	CHEMBL2041	Homo sapiens	IC50	nM	0.61
	23277391	CHEMBL4836454	Inhibition of RET M918T mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN([C@@H](C)c4ccc(-n5cc(F)cn5)cc4F)C3=O)CC2)n1		CHEMBL4859281	=	IC50	nM	2.42	CHEMBL2041	Homo sapiens	IC50	nM	2.42
Not Determined	23277392	CHEMBL4836454	Inhibition of RET M918T mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CC2)CCN(C(C)c2ccc(-n4cc(F)cn4)nc2)C3=O)n1		CHEMBL4848545		IC50			CHEMBL2041	Homo sapiens	IC50		
Not Determined	23277393	CHEMBL4836454	Inhibition of RET M918T mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN(C(C)c4ccc(-n5cc(F)cn5)nc4)C3=O)CC2)n1		CHEMBL4859271		IC50			CHEMBL2041	Homo sapiens	IC50		
	23277394	CHEMBL4836454	Inhibition of RET M918T mutant (unknown origin)	B	Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CC2)OCCN([C@@H](C)c2ccc(-n4cc(F)cn4)nc2)C3=O)n1		CHEMBL4846521	=	IC50	nM	0.9	CHEMBL2041	Homo sapiens	IC50	nM	0.9
	23277395	CHEMBL4836454	Inhibition of RET M918T mutant (unknown origin)	B	Cc1cc(Nc2nc(N3CCC4(CC3)OCCN([C@@H](C)c3ccc(-n5cc(F)cn5)nc3)C4=O)ncc2F)n[nH]1		CHEMBL4862303	=	IC50	nM	95.5	CHEMBL2041	Homo sapiens	IC50	nM	95.5
	23284724	CHEMBL4838034	Inhibition of recombinant human Ret (658 to end residues) at 10 uM using KKKSPGEYVNIEF as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis relative to control	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576	>	Inhibition	%	90.0	CHEMBL2041	Homo sapiens	INH	%	90.0
	23289191	CHEMBL4839029	Inhibition of RET (unknown origin)	B	CCN1CCN(c2ccc(Nc3ncc4scc(-c5cccc(NS(C)(=O)=O)c5)c4n3)cc2)CC1		CHEMBL4846921	=	IC50	nM	2.9	CHEMBL2041	Homo sapiens	IC50	nM	2.9
	23289206	CHEMBL4839044	Inhibition of RET (unknown origin) at 0.1 uM	B	CCN1CCN(c2ccc(Nc3ncc4scc(-c5cccc(NS(C)(=O)=O)c5)c4n3)cc2)CC1		CHEMBL4846921	=	Inhibition	%	95.3	CHEMBL2041	Homo sapiens	INH	%	95.3
	23297786	CHEMBL4841266	Inhibition of RET (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL2041	Homo sapiens	IC50	nM	1000.0
Active	23298304	CHEMBL4841511	Inhibition of RET (unknown origin)	B	COc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCN(C6COC6)C5)cc34)cn2)cc1		CHEMBL4847487		Inhibition	%		CHEMBL2041	Homo sapiens	INH		
	23299244	CHEMBL4841722	Inhibition of RET (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	39.0	CHEMBL2041	Homo sapiens	INH	%	39.0
	23299245	CHEMBL4841722	Inhibition of RET (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	88.0	CHEMBL2041	Homo sapiens	INH	%	88.0
Not Active	23317621	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23317622	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23317623	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23317624	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23318089	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23318090	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	92.0	CHEMBL2041	Homo sapiens	% Control	%	92.0
Not Active	23318091	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23318092	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23318755	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23318756	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	95.0	CHEMBL2041	Homo sapiens	% Control	%	95.0
Not Active	23318757	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	82.0	CHEMBL2041	Homo sapiens	% Control	%	82.0
Not Active	23318758	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23319239	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23319240	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23319241	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	89.0	CHEMBL2041	Homo sapiens	% Control	%	89.0
Not Active	23319242	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23319876	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23319877	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23319878	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23319879	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23320351	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	86.1	CHEMBL2041	Homo sapiens	% Control	%	86.1
Not Active	23320352	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23320353	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23320354	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	82.4	CHEMBL2041	Homo sapiens	% Control	%	82.4
Not Active	23321029	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23321030	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23321031	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23321032	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23321497	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23321498	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23321499	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23321500	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23322127	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	86.0	CHEMBL2041	Homo sapiens	% Control	%	86.0
Not Active	23322128	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	84.0	CHEMBL2041	Homo sapiens	% Control	%	84.0
Not Active	23322129	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23322130	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23322595	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23322596	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23322597	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23322598	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23323284	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23323285	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	90.0	CHEMBL2041	Homo sapiens	% Control	%	90.0
Not Active	23323286	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	95.0	CHEMBL2041	Homo sapiens	% Control	%	95.0
Not Active	23323287	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	95.0	CHEMBL2041	Homo sapiens	% Control	%	95.0
Not Active	23323752	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23323753	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23323754	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	87.0	CHEMBL2041	Homo sapiens	% Control	%	87.0
Not Active	23323755	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23324118	CHEMBL4880737	Ret (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-12.0	CHEMBL2041	Homo sapiens	% inhibition	%	-12.0
Not Active	23324606	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23324607	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	97.2	CHEMBL2041	Homo sapiens	% Control	%	97.2
Not Active	23324608	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	96.4	CHEMBL2041	Homo sapiens	% Control	%	96.4
Not Active	23324609	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	73.8	CHEMBL2041	Homo sapiens	% Control	%	73.8
Not Active	23325241	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	82.0	CHEMBL2041	Homo sapiens	% Control	%	82.0
Not Active	23325242	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	76.0	CHEMBL2041	Homo sapiens	% Control	%	76.0
Not Active	23325243	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	77.0	CHEMBL2041	Homo sapiens	% Control	%	77.0
Not Active	23325244	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23325709	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23325710	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23325711	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23325712	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23326356	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23326357	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	83.0	CHEMBL2041	Homo sapiens	% Control	%	83.0
Not Active	23326358	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	80.0	CHEMBL2041	Homo sapiens	% Control	%	80.0
Not Active	23326359	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23326824	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	84.0	CHEMBL2041	Homo sapiens	% Control	%	84.0
Not Active	23326825	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	71.0	CHEMBL2041	Homo sapiens	% Control	%	71.0
Not Active	23326826	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	70.0	CHEMBL2041	Homo sapiens	% Control	%	70.0
Not Active	23326827	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23327524	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23327525	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23327526	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	92.0	CHEMBL2041	Homo sapiens	% Control	%	92.0
Not Active	23327527	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23327992	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23327993	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23327994	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23327995	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23328579	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23328580	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23328581	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23328582	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23329047	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23329048	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23329049	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	83.0	CHEMBL2041	Homo sapiens	% Control	%	83.0
Not Active	23329050	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23329507	CHEMBL4881214	Ret(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	122.0	CHEMBL2041	Homo sapiens	% residual kinase activity	%	122.0
Not Active	23329993	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23329994	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23329995	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23329996	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23330461	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23330462	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	86.0	CHEMBL2041	Homo sapiens	% Control	%	86.0
Not Active	23330463	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	73.0	CHEMBL2041	Homo sapiens	% Control	%	73.0
Not Active	23330464	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23331217	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23331218	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	92.0	CHEMBL2041	Homo sapiens	% Control	%	92.0
Not Active	23331219	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23331220	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23331685	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23331686	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23331687	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23331688	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23332272	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	82.0	CHEMBL2041	Homo sapiens	% Control	%	82.0
Not Active	23332273	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	77.1	CHEMBL2041	Homo sapiens	% Control	%	77.1
Not Active	23332274	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	93.6	CHEMBL2041	Homo sapiens	% Control	%	93.6
Not Active	23332275	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	94.5	CHEMBL2041	Homo sapiens	% Control	%	94.5
Not Active	23332738	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23332739	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23332740	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23332741	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	74.2	CHEMBL2041	Homo sapiens	% Control	%	74.2
Not Active	23333456	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	92.4	CHEMBL2041	Homo sapiens	% Control	%	92.4
Not Active	23333457	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23333458	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	97.4	CHEMBL2041	Homo sapiens	% Control	%	97.4
Not Active	23333459	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23333657	CHEMBL4881460	Ret(h) Eurofins Kinase panel	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% residual kinase activity	%	81.0	CHEMBL2041	Homo sapiens	% residual kinase activity	%	81.0
Not Active	23334095	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	86.0	CHEMBL2041	Homo sapiens	% Control	%	86.0
Not Active	23334096	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	70.0	CHEMBL2041	Homo sapiens	% Control	%	70.0
Not Active	23334097	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	73.0	CHEMBL2041	Homo sapiens	% Control	%	73.0
Not Active	23334098	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	90.0	CHEMBL2041	Homo sapiens	% Control	%	90.0
Not Active	23334563	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23334564	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23334565	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23334566	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23334951	CHEMBL4881573	Ret (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	52.0	CHEMBL2041	Homo sapiens	% inhibition	%	52.0
Not Active	23335542	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23335543	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23335544	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23335545	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23336010	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23336011	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	92.0	CHEMBL2041	Homo sapiens	% Control	%	92.0
Not Active	23336012	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23336013	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	95.0	CHEMBL2041	Homo sapiens	% Control	%	95.0
Not Active	23336637	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23336638	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23336639	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23336640	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	88.0	CHEMBL2041	Homo sapiens	% Control	%	88.0
Not Active	23337105	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23337106	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23337107	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23337108	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23337755	CHEMBL4882126	RET Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	56.0	CHEMBL2041	Homo sapiens	% Ctrl	%	56.0
Not Active	23337756	CHEMBL4882127	RET V804L Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	72.0	CHEMBL2041	Homo sapiens	% Ctrl	%	72.0
Not Active	23337757	CHEMBL4882128	RET Y791F Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	60.0	CHEMBL2041	Homo sapiens	% Ctrl	%	60.0
Not Active	23338186	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23338187	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	83.0	CHEMBL2041	Homo sapiens	% Control	%	83.0
Not Active	23338188	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23338189	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23338654	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23338655	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23338656	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23338657	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23339266	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23339267	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23339268	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23339269	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23339734	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23339735	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23339736	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23339737	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	74.0	CHEMBL2041	Homo sapiens	% Control	%	74.0
Not Active	23340371	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23340372	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23340373	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23340374	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23340839	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23340840	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23340841	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23340842	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23341496	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23341497	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	88.0	CHEMBL2041	Homo sapiens	% Control	%	88.0
Not Active	23341498	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23341499	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23341964	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23341965	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	90.0	CHEMBL2041	Homo sapiens	% Control	%	90.0
Not Active	23341966	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23341967	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23342580	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	92.0	CHEMBL2041	Homo sapiens	% Control	%	92.0
Not Active	23342581	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23342582	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23342583	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23343048	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23343049	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23343050	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23343051	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23343284	CHEMBL4882469	RET Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	64.0	CHEMBL2041	Homo sapiens	% Ctrl	%	64.0
Not Active	23343678	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	87.0	CHEMBL2041	Homo sapiens	% Control	%	87.0
Not Active	23343679	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23343680	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23343681	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	76.0	CHEMBL2041	Homo sapiens	% Control	%	76.0
Not Active	23344146	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	83.0	CHEMBL2041	Homo sapiens	% Control	%	83.0
Slightly Active	23344147	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	49.0	CHEMBL2041	Homo sapiens	% Control	%	49.0
Slightly Active	23344148	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	45.0	CHEMBL2041	Homo sapiens	% Control	%	45.0
Not Active	23344149	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23344784	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	83.0	CHEMBL2041	Homo sapiens	% Control	%	83.0
Not Active	23344785	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23344786	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23344787	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23345357	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23345358	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23345359	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	95.0	CHEMBL2041	Homo sapiens	% Control	%	95.0
Not Active	23345360	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23345825	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23345826	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23345827	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	86.0	CHEMBL2041	Homo sapiens	% Control	%	86.0
Not Active	23345828	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23346402	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	98.8	CHEMBL2041	Homo sapiens	% Control	%	98.8
Not Active	23346403	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	95.5	CHEMBL2041	Homo sapiens	% Control	%	95.5
Not Active	23346404	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	87.0	CHEMBL2041	Homo sapiens	% Control	%	87.0
Not Active	23346405	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	81.3	CHEMBL2041	Homo sapiens	% Control	%	81.3
Not Active	23346870	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23346871	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23346872	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23346873	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23347472	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	92.6	CHEMBL2041	Homo sapiens	% Control	%	92.6
Not Active	23347473	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23347474	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23347475	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23347962	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23347963	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23347964	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23347965	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	81.7	CHEMBL2041	Homo sapiens	% Control	%	81.7
Not Active	23348541	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23348542	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23348543	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23348544	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23349009	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23349010	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23349011	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23349012	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23349596	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	92.0	CHEMBL2041	Homo sapiens	% Control	%	92.0
Not Active	23349597	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	92.0	CHEMBL2041	Homo sapiens	% Control	%	92.0
Not Active	23349598	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	84.0	CHEMBL2041	Homo sapiens	% Control	%	84.0
Not Active	23349599	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23350214	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	84.0	CHEMBL2041	Homo sapiens	% Control	%	84.0
Not Active	23350215	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23350216	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23350217	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	88.0	CHEMBL2041	Homo sapiens	% Control	%	88.0
Not Active	23350682	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23350683	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23350684	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23350685	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23351287	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23351288	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23351289	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23351290	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23351755	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23351756	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23351757	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23351758	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23352207	CHEMBL4882896	RET Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	5.76	CHEMBL2041	Homo sapiens	% Inhibition	%	5.7602
Not Active	23352208	CHEMBL4882897	RET V804L Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	5.693	CHEMBL2041	Homo sapiens	% Inhibition	%	5.6928
Not Active	23352209	CHEMBL4882898	RET Y791F Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	5.349	CHEMBL2041	Homo sapiens	% Inhibition	%	5.3494
Not Active	23352779	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23352780	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23352781	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23352782	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23353247	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23353248	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	84.0	CHEMBL2041	Homo sapiens	% Control	%	84.0
Not Active	23353249	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	72.0	CHEMBL2041	Homo sapiens	% Control	%	72.0
Not Active	23353250	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23354129	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	90.0	CHEMBL2041	Homo sapiens	% Control	%	90.0
Not Active	23354130	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	92.0	CHEMBL2041	Homo sapiens	% Control	%	92.0
Not Active	23354131	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	88.0	CHEMBL2041	Homo sapiens	% Control	%	88.0
Not Active	23354132	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23354597	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23354598	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23354599	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23354600	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23355329	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	88.0	CHEMBL2041	Homo sapiens	% Control	%	88.0
Not Active	23355330	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	90.0	CHEMBL2041	Homo sapiens	% Control	%	90.0
Not Active	23355331	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23355332	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	89.0	CHEMBL2041	Homo sapiens	% Control	%	89.0
Not Active	23355797	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	68.0	CHEMBL2041	Homo sapiens	% Control	%	68.0
Not Active	23355798	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23355799	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23355800	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	82.0	CHEMBL2041	Homo sapiens	% Control	%	82.0
Not Active	23356433	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23356434	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23356435	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23356436	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23356901	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23356902	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23356903	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	81.0	CHEMBL2041	Homo sapiens	% Control	%	81.0
Not Active	23356904	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23357510	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23357511	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	86.0	CHEMBL2041	Homo sapiens	% Control	%	86.0
Not Active	23357512	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	85.0	CHEMBL2041	Homo sapiens	% Control	%	85.0
Not Active	23357513	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23358157	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23358158	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	80.0	CHEMBL2041	Homo sapiens	% Control	%	80.0
Not Active	23358159	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	86.0	CHEMBL2041	Homo sapiens	% Control	%	86.0
Not Active	23358160	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23358625	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23358626	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23358627	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23358628	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23359211	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	72.3	CHEMBL2041	Homo sapiens	% Control	%	72.3
Not Active	23359212	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	89.5	CHEMBL2041	Homo sapiens	% Control	%	89.5
Not Active	23359213	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	76.7	CHEMBL2041	Homo sapiens	% Control	%	76.7
Not Active	23359214	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	95.3	CHEMBL2041	Homo sapiens	% Control	%	95.3
Not Active	23359809	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23359810	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23359811	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	87.0	CHEMBL2041	Homo sapiens	% Control	%	87.0
Not Active	23359812	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23360277	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23360278	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23360279	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	86.0	CHEMBL2041	Homo sapiens	% Control	%	86.0
Not Active	23360280	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	89.0	CHEMBL2041	Homo sapiens	% Control	%	89.0
Not Active	23360862	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	87.0	CHEMBL2041	Homo sapiens	% Control	%	87.0
Not Active	23360863	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23360864	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23360865	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23361330	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	89.0	CHEMBL2041	Homo sapiens	% Control	%	89.0
Not Active	23361331	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23361332	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	99.0	CHEMBL2041	Homo sapiens	% Control	%	99.0
Not Active	23361333	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23361903	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	84.0	CHEMBL2041	Homo sapiens	% Control	%	84.0
Not Active	23361904	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23361905	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23361906	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23362439	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23362440	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23362441	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23362442	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23362907	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23362908	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	95.0	CHEMBL2041	Homo sapiens	% Control	%	95.0
Not Active	23362909	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	86.0	CHEMBL2041	Homo sapiens	% Control	%	86.0
Not Active	23362910	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	88.0	CHEMBL2041	Homo sapiens	% Control	%	88.0
Not Active	23363308	CHEMBL4883270	RET Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	-2.432	CHEMBL2041	Homo sapiens	% inhibition	%	-2.4316
Not Active	23363309	CHEMBL4883270	RET Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	-1.053	CHEMBL2041	Homo sapiens	% inhibition	%	-1.0528
Not Active	23364549	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23364550	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	85.0	CHEMBL2041	Homo sapiens	% Control	%	85.0
Not Active	23364551	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	88.0	CHEMBL2041	Homo sapiens	% Control	%	88.0
Not Active	23364552	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23365017	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	96.0	CHEMBL2041	Homo sapiens	% Control	%	96.0
Not Active	23365018	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23365019	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23365020	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23365756	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23365757	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23365758	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23365759	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23366299	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	81.0	CHEMBL2041	Homo sapiens	% Control	%	81.0
Not Active	23366300	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	80.0	CHEMBL2041	Homo sapiens	% Control	%	80.0
Not Active	23366301	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	83.0	CHEMBL2041	Homo sapiens	% Control	%	83.0
Not Active	23366302	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	84.0	CHEMBL2041	Homo sapiens	% Control	%	84.0
Not Active	23366889	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	89.0	CHEMBL2041	Homo sapiens	% Control	%	89.0
Not Active	23366890	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23366891	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23366892	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23367357	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	89.0	CHEMBL2041	Homo sapiens	% Control	%	89.0
Not Active	23367358	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23367359	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23367360	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23367724	CHEMBL4884077	RET V804L ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	115.0	CHEMBL2041	Homo sapiens	% Residual activity with Skepinone-L	%	115.0
Not Active	23367725	CHEMBL4884078	RET wt ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	102.0	CHEMBL2041	Homo sapiens	% Residual activity with Skepinone-L	%	102.0
Not Active	23367726	CHEMBL4884079	RET Y791F ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	141.0	CHEMBL2041	Homo sapiens	% Residual activity with Skepinone-L	%	141.0
Not Active	23368235	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23368236	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	95.0	CHEMBL2041	Homo sapiens	% Control	%	95.0
Not Active	23368237	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	86.0	CHEMBL2041	Homo sapiens	% Control	%	86.0
Not Active	23368238	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23368703	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23368704	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23368705	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	95.0	CHEMBL2041	Homo sapiens	% Control	%	95.0
Not Active	23368706	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23369302	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23369303	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	86.0	CHEMBL2041	Homo sapiens	% Control	%	86.0
Not Active	23369304	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	83.0	CHEMBL2041	Homo sapiens	% Control	%	83.0
Not Active	23369305	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	76.0	CHEMBL2041	Homo sapiens	% Control	%	76.0
Not Active	23369770	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	77.0	CHEMBL2041	Homo sapiens	% Control	%	77.0
Not Active	23369771	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23369772	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23369773	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23370222	CHEMBL4884464	Ret(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	23.0	CHEMBL2041	Homo sapiens	% residual kinase activity	%	23.0
Not Active	23370738	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	65.0	CHEMBL2041	Homo sapiens	% Control	%	65.0
Not Active	23370739	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	64.0	CHEMBL2041	Homo sapiens	% Control	%	64.0
Slightly Active	23370740	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	25.0	CHEMBL2041	Homo sapiens	% Control	%	25.0
Active	23370741	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	11.0	CHEMBL2041	Homo sapiens	% Control	%	11.0
Not Active	23371206	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23371207	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23371208	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23371209	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23372015	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	85.0	CHEMBL2041	Homo sapiens	% Control	%	85.0
Not Active	23372016	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23372017	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23372018	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23372483	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	87.0	CHEMBL2041	Homo sapiens	% Control	%	87.0
Not Active	23372484	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23372485	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	83.0	CHEMBL2041	Homo sapiens	% Control	%	83.0
Not Active	23372486	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	82.0	CHEMBL2041	Homo sapiens	% Control	%	82.0
	23373739	CHEMBL4885516	Ret(RET1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2041	Homo sapiens	pIC50		6.0
Not Active	23375094	CHEMBL4886082	Ret Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	31.5	CHEMBL2041	Homo sapiens	% Inhibition	%	31.5
Not Active	23375365	CHEMBL4886347	ret proto-oncogene  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	5.0	CHEMBL2041	Homo sapiens	% inhibition	%	5.0
Not Active	23375910	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	89.0	CHEMBL2041	Homo sapiens	% Control	%	89.0
Not Active	23375911	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23375912	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23375913	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23376378	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	97.0	CHEMBL2041	Homo sapiens	% Control	%	97.0
Not Active	23376379	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23376380	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23376381	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23376955	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	89.0	CHEMBL2041	Homo sapiens	% Control	%	89.0
Not Active	23376956	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	81.0	CHEMBL2041	Homo sapiens	% Control	%	81.0
Not Active	23376957	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	70.0	CHEMBL2041	Homo sapiens	% Control	%	70.0
Not Active	23376958	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23377423	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	88.0	CHEMBL2041	Homo sapiens	% Control	%	88.0
Not Active	23377424	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	64.0	CHEMBL2041	Homo sapiens	% Control	%	64.0
Not Active	23377425	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	69.0	CHEMBL2041	Homo sapiens	% Control	%	69.0
Not Active	23377426	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	86.0	CHEMBL2041	Homo sapiens	% Control	%	86.0
Not Active	23378283	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	90.0	CHEMBL2041	Homo sapiens	% Control	%	90.0
Not Active	23378284	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	95.0	CHEMBL2041	Homo sapiens	% Control	%	95.0
Not Active	23378285	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23378286	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	98.0	CHEMBL2041	Homo sapiens	% Control	%	98.0
Not Active	23378751	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	93.0	CHEMBL2041	Homo sapiens	% Control	%	93.0
Not Active	23378752	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23378753	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23378754	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23379918	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	95.0	CHEMBL2041	Homo sapiens	% Control	%	95.0
Not Active	23379919	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23379920	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23379921	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	92.0	CHEMBL2041	Homo sapiens	% Control	%	92.0
Not Active	23380386	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	74.0	CHEMBL2041	Homo sapiens	% Control	%	74.0
Not Active	23380387	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	88.0	CHEMBL2041	Homo sapiens	% Control	%	88.0
Not Active	23380388	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	92.0	CHEMBL2041	Homo sapiens	% Control	%	92.0
Not Active	23380389	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	95.0	CHEMBL2041	Homo sapiens	% Control	%	95.0
Not Active	23381080	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23381081	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	75.0	CHEMBL2041	Homo sapiens	% Control	%	75.0
Not Active	23381082	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	78.0	CHEMBL2041	Homo sapiens	% Control	%	78.0
Not Active	23381083	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23381728	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23381729	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23381730	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23381731	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23382196	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23382197	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23382198	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23382199	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2041	Homo sapiens	% Control	%	100.0
Not Active	23382820	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	60.0	CHEMBL2041	Homo sapiens	% Control	%	60.0
Not Active	23382821	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	72.0	CHEMBL2041	Homo sapiens	% Control	%	72.0
Slightly Active	23382822	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	30.0	CHEMBL2041	Homo sapiens	% Control	%	30.0
Slightly Active	23382823	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	30.0	CHEMBL2041	Homo sapiens	% Control	%	30.0
Slightly Active	23383288	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	49.0	CHEMBL2041	Homo sapiens	% Control	%	49.0
Not Active	23383289	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	50.0	CHEMBL2041	Homo sapiens	% Control	%	50.0
Slightly Active	23383290	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	21.0	CHEMBL2041	Homo sapiens	% Control	%	21.0
Slightly Active	23383291	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	31.0	CHEMBL2041	Homo sapiens	% Control	%	31.0
Not Active	23383968	CHEMBL4887574	RET Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	60.0	CHEMBL2041	Homo sapiens	% Ctrl	%	60.0
Slightly Active	23383969	CHEMBL4887574	RET Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	32.0	CHEMBL2041	Homo sapiens	% Ctrl	%	32.0
Not Active	23384444	CHEMBL4888039	Ret(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-3.56	CHEMBL2041	Homo sapiens	% inhibition	%	-3.56
Not Active	23384705	CHEMBL4888231	RET SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	7.0	CHEMBL2041	Homo sapiens	% Inhibition	%	7.0
Not Active	23385203	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23385204	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	95.0	CHEMBL2041	Homo sapiens	% Control	%	95.0
Not Active	23385205	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	86.0	CHEMBL2041	Homo sapiens	% Control	%	86.0
Not Active	23385206	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	94.0	CHEMBL2041	Homo sapiens	% Control	%	94.0
Not Active	23385670	CHEMBL4879927	KinomeScan assay: inhibition of RET	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	91.0	CHEMBL2041	Homo sapiens	% Control	%	91.0
Not Active	23385671	CHEMBL4879928	KinomeScan assay: inhibition of RET(M918T)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	85.0	CHEMBL2041	Homo sapiens	% Control	%	85.0
Not Active	23385672	CHEMBL4879929	KinomeScan assay: inhibition of RET(V804L)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	78.0	CHEMBL2041	Homo sapiens	% Control	%	78.0
Not Active	23385673	CHEMBL4879930	KinomeScan assay: inhibition of RET(V804M)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	87.0	CHEMBL2041	Homo sapiens	% Control	%	87.0
Not Active	23385905	CHEMBL4888378	Ret Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	3.0	CHEMBL2041	Homo sapiens	% inhibition	%	3.0
